data_1j8c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j8c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.5 mp -58.04 99.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.621 -0.674 . . . . 0.0 110.692 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 pt -78.74 146.29 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.123 -0.986 . . . . 0.0 109.353 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 25.5 mttp -91.44 132.76 36.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.1 p -123.13 114.25 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 m -86.25 108.09 18.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.27 128.38 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.283 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -97.26 122.73 40.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.393 -0.817 . . . . 0.0 109.838 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 65' ' ' PHE . 2.3 p -120.67 168.03 11.59 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.269 -0.895 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.6 Cg_endo -70.54 62.44 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.679 1.357 . . . . 0.0 110.238 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.67 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.6 -179.2 1.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.418 -0.801 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -105.61 115.31 30.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 134.04 54.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.58 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.5 151.53 19.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 0.0 109.714 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -126.45 150.1 48.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.458 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.16 133.43 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 28.4 m -143.93 147.62 38.99 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.092 -1.005 . . . . 0.0 109.452 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.8 Cg_endo -67.24 126.29 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.76 1.4 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 10.1 tt0 -42.45 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.93 -0.481 . . . . 0.0 111.769 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' PRO . 8.3 p-10 -115.01 63.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.601 -1.312 . . . . 0.0 110.378 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -130.58 154.99 47.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.129 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -98.8 156.46 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.364 -0.835 . . . . 0.0 109.853 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 88.3 t -60.94 -34.34 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 110.699 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.54 -44.11 36.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.051 -1.031 . . . . 0.0 110.627 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -51.65 32.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.904 . . . . 0.0 109.915 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.88 -37.07 78.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.413 -0.804 . . . . 0.0 110.129 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 2.1 mtpt -57.64 -46.05 84.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.516 -0.74 . . . . 0.0 109.8 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.25 -19.63 61.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.769 . . . . 0.0 110.167 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.27 52.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.26 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.8 mt -63.74 -41.91 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.297 -0.877 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -53.71 -52.01 61.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.63 -53.94 19.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.286 -0.884 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.17 -54.27 10.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.121 -0.987 . . . . 0.0 111.454 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.01 -36.47 80.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.176 -0.953 . . . . 0.0 110.181 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 16.4 ttpt 68.72 81.3 0.18 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 110.224 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -152.98 -65.4 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.5 -0.75 . . . . 0.0 110.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.93 -176.95 3.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -145.95 -63.91 0.32 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.86 -63.58 1.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.923 . . . . 0.0 110.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.82 -25.46 65.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.33 125.2 22.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.822 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.7 t -150.08 167.79 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 109.194 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 1.2 mm? -118.33 135.88 54.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.037 -1.04 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -97.19 96.91 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.42 -0.8 . . . . 0.0 109.948 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.445 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 9.3 t80 -95.31 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 110.232 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.49 35.86 18.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.403 -0.81 . . . . 0.0 110.697 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.01 -40.18 2.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -178.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.203 -1.175 . . . . 0.0 110.047 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.13 94.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.695 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 1.6 tp -65.07 81.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ILE . 3.5 ttmt -137.98 -155.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.339 0.59 . . . . 0.0 110.364 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.479 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.84 -19.63 61.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 0.0 110.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.7 -32.81 53.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.852 . . . . 0.0 109.807 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -133.59 -175.45 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 109.972 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.84 130.36 53.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.96 . . . . 0.0 109.932 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 14.1 tp -55.42 -46.91 76.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.759 . . . . 0.0 110.26 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.476 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 2.5 pp -72.76 -14.98 17.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 110.472 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -88.18 -10.83 48.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 112.062 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.35 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.45 -1.407 . . . . 0.0 111.574 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 76' ' ' PHE . . . -58.97 -41.73 96.5 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.189 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.509 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 4.0 mm -134.3 113.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -1.157 . . . . 0.0 111.023 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -87.11 -33.61 19.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 108.881 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.7 t70 -179.97 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.736 -0.603 . . . . 0.0 110.015 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 128.42 69.76 0.14 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 6.0 mt -108.83 162.64 14.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -1.211 . . . . 0.0 110.129 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.8 p -112.16 134.52 53.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.313 -0.867 . . . . 0.0 110.274 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.64 151.93 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.437 -0.789 . . . . 0.0 110.148 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 110.382 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.15 127.88 47.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.99 143.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.189 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.341 -0.849 . . . . 0.0 110.37 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mttt . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.51 124.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.734 -0.604 . . . . 0.0 110.724 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 18.0 pt -108.19 158.87 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.759 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 144.37 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.81 113.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.694 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.7 m -79.21 105.22 10.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.41 127.88 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.825 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -112.88 122.28 47.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 18.1 p -122.46 166.07 18.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 109.851 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.1 Cg_endo -70.72 61.23 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.648 1.341 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.61 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.469 -0.77 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -169.65 166.98 9.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 118.6 29.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.33 135.55 40.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.898 . . . . 0.0 110.556 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.47 150.23 36.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.649 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -120.38 108.89 14.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.532 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.63 105.22 13.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 0.0 109.503 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.53 157.05 79.23 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.363 -0.836 . . . . 0.0 110.711 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.61 108.42 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.793 1.417 . . . . 0.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 88' ' ' ILE . 11.7 pt-20 -51.12 -25.49 5.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.492 -0.755 . . . . 0.0 110.741 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -53.6 -23.95 12.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 110.556 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.07 140.63 30.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.885 . . . . 0.0 110.462 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.1 m -70.82 171.83 9.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 61.6 t -66.8 -35.75 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -42.78 31.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.054 -1.029 . . . . 0.0 110.108 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.4 -46.07 64.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.615 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -69.92 -38.36 76.23 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.218 -0.927 . . . . 0.0 110.626 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.74 -45.18 86.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -74.63 -16.7 60.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.65 79.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.297 -0.877 . . . . 0.0 109.932 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.2 mt -60.87 -37.94 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.654 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 29.1 t -53.94 -46.3 71.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.915 . . . . 0.0 110.78 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -67.89 -54.76 16.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 111.44 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.79 -54.08 9.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.122 -0.987 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.38 -36.25 78.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.381 -0.824 . . . . 0.0 110.551 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 69.33 81.69 0.17 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.574 -0.704 . . . . 0.0 110.03 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -155.04 -75.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.554 -0.716 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -161.0 179.46 8.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.2 m -139.99 -62.01 0.52 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.443 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.5 -66.69 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 0.0 110.32 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.63 -25.71 64.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.288 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.91 133.61 56.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.475 -0.766 . . . . 0.0 110.747 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.1 t -152.53 158.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.418 -0.801 . . . . 0.0 109.28 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.1 mp -121.15 122.02 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.232 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.8 103.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.045 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 81' ' ' LEU . 1.5 t80 -112.14 120.14 40.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.506 -0.746 . . . . 0.0 110.076 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.69 29.31 17.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.62 59.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -172.7 2.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -1.085 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -103.27 82.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 110.363 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 1.1 tt -66.43 83.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.242 -0.911 . . . . 0.0 108.645 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.96 -147.07 0.21 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.557 -0.715 . . . . 0.0 110.253 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.52 -14.36 61.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 111.315 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -52.15 -33.62 41.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.585 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -176.63 4.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 143.86 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 109.882 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD12 ' HA3' ' A' ' 91' ' ' GLY . 11.6 tp -56.23 -46.14 79.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.496 -0.752 . . . . 0.0 110.672 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.62 -8.27 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.411 -0.806 . . . . 0.0 111.095 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 14.3 mt-30 -110.08 -1.2 17.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.954 -1.092 . . . . 0.0 112.028 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 176.54 -30.78 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.589 -1.32 . . . . 0.0 111.807 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.624 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.26 -47.68 88.06 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.543 -1.313 . . . . 0.0 109.919 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -144.42 161.95 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.273 -1.134 . . . . 0.0 110.183 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 26.8 m170 -122.64 -41.74 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.539 -0.726 . . . . 0.0 109.359 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 3.2 p30 179.71 35.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.028 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.77 67.75 0.53 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.98 175.81 5.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -111.95 121.32 44.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.765 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.94 149.23 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 110.378 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.446 -0.784 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.98 120.12 32.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.373 -0.83 . . . . 0.0 110.019 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.8 m -148.72 156.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 110.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mm -58.47 124.15 11.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.705 -0.622 . . . . 0.0 110.85 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -106.77 149.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 0.0 109.522 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 144.23 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 110.647 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -132.92 130.38 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 109.583 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.17 110.25 22.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.47 127.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 122.83 47.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -125.73 169.74 10.83 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.301 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.94 60.51 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.702 1.369 . . . . 0.0 110.372 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.7 -46.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.316 -0.865 . . . . 0.0 109.812 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -173.19 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.101 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -123.12 129.82 51.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -135.12 127.63 30.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -84.86 147.73 26.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.397 -0.815 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -125.08 145.84 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.533 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.35 132.13 45.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.0 108.991 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.5 m -143.16 148.83 46.41 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.975 . . . . 0.0 110.266 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 40.5 Cg_endo -71.08 119.43 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.705 1.371 . . . . 0.0 110.418 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -32.73 -41.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.223 0.535 . . . . 0.0 111.642 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -83.88 50.97 1.93 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.051 -1.03 . . . . 0.0 110.571 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 51.4 p -126.21 112.77 16.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.29 156.86 21.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 61.0 t -63.02 -35.4 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.197 -0.94 . . . . 0.0 110.913 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -49.31 -50.15 40.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.123 -0.985 . . . . 0.0 111.055 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.0 -55.27 27.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.99 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.91 -36.57 77.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.457 -0.777 . . . . 0.0 110.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -57.15 -36.74 71.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 0.0 110.386 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -79.05 -24.47 43.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.61 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 0.0 109.573 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.8 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -66.45 -44.55 82.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 110.625 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -58.85 -53.12 61.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.253 -0.904 . . . . 0.0 110.952 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -52.68 63.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.688 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 39' ' ' THR . 10.5 m-85 -67.5 -36.91 82.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 0.0 110.445 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.91 79.52 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.469 -0.769 . . . . 0.0 110.091 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 t -153.92 -71.08 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.38 -0.825 . . . . 0.0 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.87 -171.57 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.0 m -153.51 -57.79 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.36 -0.837 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.49 -70.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.322 -0.861 . . . . 0.0 110.413 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -60.76 -25.53 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tt -52.93 106.46 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 110.763 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG2' ' HD2' ' A' ' 82' ' ' LYS . 51.0 t -127.14 151.18 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.651 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 5.0 mp -102.04 146.2 28.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.76 83.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.45 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.2 t80 -98.84 124.04 43.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.386 -0.821 . . . . 0.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.07 26.35 6.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.37 -0.831 . . . . 0.0 110.556 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.32 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 1.2 tttm -129.48 136.54 50.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -1.09 . . . . 0.0 110.061 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 84' ' ' GLN . 1.4 pp -59.68 88.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.816 . . . . 0.0 111.351 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 1.3 tt -66.79 86.87 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -140.34 -149.74 0.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.01 -177.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 37.7 p-10 -74.1 -20.71 60.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.698 . . . . 0.0 110.834 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.455 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -52.7 -32.75 44.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.103 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.91 140.21 46.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 147.94 33.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.541 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 13.8 tp -57.59 -48.52 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.705 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 1.8 pp -73.04 -13.7 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.051 -1.031 . . . . 0.0 110.367 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.73 -15.09 46.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 111.542 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.424 ' CE1' ' HD2' ' A' ' 79' ' ' LYS . 4.9 t-80 -171.69 -38.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.624 -1.297 . . . . 0.0 111.431 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . -59.44 -49.67 76.01 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.386 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.495 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.26 146.37 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -1.232 . . . . 0.0 110.808 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 13.1 m170 -109.76 -35.49 6.17 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.5 t0 -177.68 31.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.29 0.567 . . . . 0.0 109.861 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.4 69.33 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.17 174.22 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -1.223 . . . . 0.0 109.966 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.8 p -115.84 147.25 41.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 7.6 p -147.68 146.14 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.402 -0.811 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -90.63 116.15 28.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.489 -0.757 . . . . 0.0 110.118 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.17 121.28 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.306 -0.871 . . . . 0.0 110.13 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.95 131.85 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.386 -0.821 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.819 . . . . 0.0 110.218 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.2 mp -58.47 99.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.63 -0.669 . . . . 0.0 110.55 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 50' ' ' GLU . 4.3 pt -78.83 150.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -94.23 144.59 25.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 110.972 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.97 113.96 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.495 -0.753 . . . . 0.0 109.866 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -85.89 112.72 21.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 110.605 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.16 127.96 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.55 122.51 43.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -124.12 170.73 8.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.812 . . . . 0.0 109.921 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.4 Cg_endo -68.94 -16.06 40.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.697 1.367 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -49.13 6.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -173.54 174.47 3.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -103.04 122.05 43.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.949 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.14 135.48 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -90.29 150.97 21.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.443 -0.785 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.59 128.09 47.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.369 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.86 124.71 36.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.227 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.3 m -142.98 154.71 62.19 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 109.943 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.2 Cg_endo -66.48 121.65 8.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.814 1.429 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB2' HG21 ' A' ' 88' ' ' ILE . 17.6 pt-20 -36.31 -38.96 0.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.214 0.531 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.445 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 71.9 m-80 -86.96 53.07 2.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.516 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.5 p -119.23 154.02 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.345 -0.847 . . . . 0.0 110.194 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 t -103.02 148.04 26.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.011 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 71.3 t -59.38 -34.37 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -48.59 -46.12 38.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.047 -1.033 . . . . 0.0 110.547 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.72 -51.39 49.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -59.89 -36.91 77.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.54 -39.02 75.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.57 -22.13 47.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.22 78.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 20.0 mt -60.78 -38.76 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 109.669 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -53.75 -53.12 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.126 -0.984 . . . . 0.0 110.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -68.52 -54.76 14.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 111.694 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -72.55 -54.55 8.87 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.094 -1.004 . . . . 0.0 111.568 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.3 -36.48 79.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.189 -0.944 . . . . 0.0 110.443 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tttt 71.81 73.69 0.17 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -160.51 -153.91 0.35 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.529 -0.732 . . . . 0.0 109.959 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -173.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -148.18 -61.9 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.81 -63.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -27.09 65.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.158 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.71 105.93 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.489 -0.757 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.82 161.54 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 9.8 mt -113.7 139.66 48.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 110.084 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.42 93.54 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 91' ' ' GLY . 3.2 t80 -96.96 115.21 27.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.77 27.57 7.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -0.838 . . . . 0.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.79 -39.7 2.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -176.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -1.073 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.51 90.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.323 -0.861 . . . . 0.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 10.1 tt -61.84 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 20.5 tttt -154.03 -148.16 0.24 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.418 -0.801 . . . . 0.0 110.655 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t70 -72.13 -15.14 61.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.129 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -53.19 -32.52 48.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.68 161.38 39.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.631 -0.668 . . . . 0.0 109.9 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.425 ' OG1' ' CG ' ' A' ' 89' ' ' GLN . 64.4 p -79.21 165.0 23.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.697 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.24 -46.35 77.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.86 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 50' ' ' GLU . 1.8 pt -64.62 -18.95 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.032 -1.043 . . . . 0.0 110.453 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' CG ' ' OG1' ' A' ' 86' ' ' THR . 27.5 mm-40 -92.11 -15.79 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.922 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 178.42 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.027 -1.046 . . . . 0.0 111.638 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.04 -50.23 67.93 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.45 HG21 ' HG ' ' A' ' 87' ' ' LEU . 2.7 pp -148.86 171.65 2.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.529 -0.983 . . . . 0.0 108.706 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -118.65 -33.23 4.33 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.651 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.6 t70 179.83 34.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.569 -0.707 . . . . 0.0 109.97 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.05 69.98 0.34 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.04 -172.13 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m -131.42 146.35 52.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' CG2' ' CD2' ' A' ' 74' ' ' LEU . 27.4 m -143.7 149.51 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.356 -0.84 . . . . 0.0 110.504 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.57 118.71 30.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 110.352 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' CA ' HD22 ' A' ' 74' ' ' LEU . 6.8 tt -77.37 149.52 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.8 p -171.38 138.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.89 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.08 118.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.276 0.56 . . . . 0.0 110.905 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 HG13 HD11 ' A' ' 92' ' ' ILE . 1.9 pt -87.85 152.33 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -91.49 144.61 25.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 87' ' ' LEU . 18.3 m -138.86 140.32 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.455 -0.778 . . . . 0.0 110.043 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -109.56 104.25 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.857 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 127.84 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 122.47 43.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.957 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 7.3 p -113.72 166.63 10.91 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.947 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.8 Cg_endo -71.27 61.31 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.604 1.318 . . . . 0.0 110.424 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.15 -42.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.7 -169.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.407 -0.808 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -123.42 129.07 50.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -0.816 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -135.16 134.89 40.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.16 150.87 20.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.03 144.18 51.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.469 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.45 46.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.402 -0.811 . . . . 0.0 109.235 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.1 m -141.2 146.04 41.2 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.4 Cg_endo -67.97 122.07 9.15 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.669 1.352 . . . . 0.0 110.377 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.7 pp20? -31.07 -39.1 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' PRO . 43.9 p-10 -92.03 49.5 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.725 -1.235 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 1.7 t -114.38 112.96 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.068 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -65.5 147.96 52.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 90.3 t -56.41 -34.8 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -48.79 -43.83 38.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.05 -1.031 . . . . 0.0 110.53 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -68.44 -53.54 22.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.189 -0.945 . . . . 0.0 109.96 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.87 -36.82 77.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.498 -0.751 . . . . 0.0 110.365 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 4.8 mtpt -57.42 -43.04 83.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.747 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 -23.25 54.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.525 -0.734 . . . . 0.0 109.941 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.94 86.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.2 mt -60.77 -40.05 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.404 -0.81 . . . . 0.0 109.729 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -53.71 -51.95 61.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -68.42 -54.64 15.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 111.666 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mmt-85 -72.36 -54.3 9.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.091 -1.006 . . . . 0.0 111.511 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.08 -36.35 79.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.373 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tptm 72.31 76.02 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.594 -0.691 . . . . 0.0 110.082 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.9 t -161.9 -153.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.818 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.47 165.11 24.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -136.13 -59.69 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.94 -72.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -57.96 -25.17 60.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.421 -0.799 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.81 128.47 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.477 -0.764 . . . . 0.0 110.763 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -151.1 167.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.242 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -117.92 133.38 55.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 0.0 110.159 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.09 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 32.0 t80 -70.07 62.73 0.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.637 -0.665 . . . . 0.0 110.554 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.28 26.49 2.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.143 -0.973 . . . . 0.0 110.738 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.03 -48.19 0.64 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -83.01 -166.99 1.49 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -1.062 . . . . 0.0 110.098 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.47 96.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -65.23 79.94 0.05 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' ILE . 3.6 ttmt -140.55 -156.5 0.68 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.32 -14.97 61.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -33.09 69.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.804 . . . . 0.0 110.015 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -143.8 164.55 30.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 110.767 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.27 153.47 17.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.872 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.5 -46.65 75.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.342 -0.849 . . . . 0.0 110.897 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 1.1 pp -63.66 -19.62 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.023 . . . . 0.0 109.847 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -89.43 -18.79 26.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.805 . . . . 0.0 110.587 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.96 -26.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.948 -1.095 . . . . 0.0 112.063 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.32 -50.38 67.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -149.61 162.83 4.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -1.081 . . . . 0.0 108.682 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 5.9 m-70 -113.13 -30.8 6.85 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 109.75 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.3 t0 179.75 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 109.72 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.94 73.86 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.83 170.88 8.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -1.061 . . . . 0.0 110.295 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 t -115.25 144.64 43.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.68 154.85 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -90.83 144.36 25.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.44 121.96 42.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.901 . . . . 0.0 110.052 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.04 150.7 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.303 -0.873 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.341 -0.849 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.1 mm -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.593 -0.692 . . . . 0.0 110.758 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.0 pt -110.78 144.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.636 -0.665 . . . . 0.0 109.74 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 144.53 25.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.823 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 92' ' ' ILE . 7.4 p -135.94 113.57 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.0 109.759 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -85.17 102.35 13.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.92 127.63 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.97 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -111.44 122.71 48.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.164 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 29.1 p -120.37 168.24 10.96 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.454 -0.779 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.52 -10.28 28.36 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.577 1.303 . . . . 0.0 110.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -42.39 7.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.08 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.08 157.49 5.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -107.42 118.34 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 110.078 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -135.32 135.62 40.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.943 . . . . 0.0 110.811 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.51 154.38 22.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.47 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -128.08 128.71 45.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.36 129.93 37.28 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.31 153.71 59.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.041 -1.037 . . . . 0.0 110.492 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' GLU . 42.8 Cg_endo -71.59 119.82 6.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.875 1.461 . . . . 0.0 110.443 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -36.22 -37.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.812 -0.555 . . . . 0.0 111.091 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -82.9 50.12 1.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 t -126.66 141.25 51.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m -92.86 156.77 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 84.0 t -59.71 -34.59 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -48.96 -43.67 40.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.121 . . . . 0.0 110.532 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.74 -54.63 14.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -0.882 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.88 -36.97 78.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.385 -0.822 . . . . 0.0 110.191 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.32 -39.04 75.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.591 -0.693 . . . . 0.0 109.587 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.23 -18.78 44.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.501 -0.749 . . . . 0.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -49.68 71.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 12.8 mt -60.91 -36.34 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.358 -0.838 . . . . 0.0 109.693 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -53.85 -51.73 62.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 110.535 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -68.43 -54.28 18.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.318 -0.864 . . . . 0.0 111.711 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -54.07 10.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.115 -0.991 . . . . 0.0 111.497 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.31 -36.24 79.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.278 -0.889 . . . . 0.0 110.351 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 8.5 mttm 68.72 81.86 0.18 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.601 -0.687 . . . . 0.0 109.942 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -157.12 -73.56 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 110.206 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.45 -165.6 0.78 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.411 -0.806 . . . . 0.0 110.106 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -153.19 -51.19 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.594 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.36 -75.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.0 110.407 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -25.56 62.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.55 104.24 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.387 -0.821 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.59 156.1 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.503 -0.748 . . . . 0.0 109.38 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.519 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -118.73 141.2 48.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.973 -1.079 . . . . 0.0 110.519 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 75' ' ' ILE . 46.5 mm -101.16 93.68 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.5 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 91' ' ' GLY . 1.6 t80 -84.89 95.4 9.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.237 -0.914 . . . . 0.0 110.348 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.12 46.3 26.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 110.694 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.15 -45.72 2.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.0 179.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -115.84 93.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.267 -0.896 . . . . 0.0 110.855 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -65.28 82.44 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -144.09 -161.5 1.29 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.442 0.639 . . . . 0.0 110.491 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.5 p30 -73.33 -14.95 61.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.67 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 109.565 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -139.06 168.98 18.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 0.0 109.752 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.24 145.99 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.457 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.476 HD13 ' HA3' ' A' ' 91' ' ' GLY . 16.5 tp -55.81 -47.01 77.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.39 -28.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.659 . . . . 0.0 110.058 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -76.82 -6.21 51.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.704 . . . . 0.0 111.761 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.39 -37.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.536 -1.353 . . . . 0.0 111.759 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.476 ' HA3' HD13 ' A' ' 87' ' ' LEU . . . -58.98 -48.31 86.48 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.161 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.448 ' CD1' ' C ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -142.4 156.55 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.434 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -115.98 -41.63 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -177.87 34.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 109.87 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.95 71.08 0.22 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.57 174.87 5.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -1.104 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.7 m -116.51 147.31 41.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 74' ' ' LEU . 7.4 p -149.96 150.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.404 -0.81 . . . . 0.0 110.296 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.421 ' CD2' ' HD3' ' A' ' 38' ' ' LYS . 60.0 m170 -90.68 132.83 35.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.4 p -166.21 144.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.837 . . . . 0.0 110.177 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.519 HG22 HD13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.384 -0.823 . . . . 0.0 110.219 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.8 mttt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.28 116.48 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.668 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.496 HG13 HD12 ' A' ' 92' ' ' ILE . 2.1 pt -93.73 157.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.372 -0.83 . . . . 0.0 109.917 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -91.62 144.6 25.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.89 . . . . 0.0 110.865 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.7 113.79 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.495 -0.753 . . . . 0.0 109.992 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 34.4 m -88.91 108.47 19.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.01 127.87 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.799 . . . . 0.0 110.09 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.75 122.57 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p -121.64 165.12 20.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.949 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.41 60.78 2.66 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.637 1.335 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -175.1 -46.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.485 -0.759 . . . . 0.0 109.699 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -171.32 -176.74 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 110.018 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 126.88 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.03 120.03 22.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.17 147.17 28.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -123.78 121.1 34.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.32 34.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.5 m -143.34 150.35 51.36 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -67.63 123.33 10.64 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.768 1.404 . . . . 0.0 110.733 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -27.42 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.07 0.462 . . . . 0.0 112.058 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.3 p30 -85.54 47.38 1.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.115 -0.991 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -111.48 103.49 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.075 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -60.62 150.78 30.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 94.9 t -59.88 -34.28 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.731 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -48.38 -48.86 36.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.069 -1.02 . . . . 0.0 110.668 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -64.63 -50.56 66.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 109.726 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' CZ ' HD13 ' A' ' 61' ' ' ILE . 56.5 t80 -60.44 -36.87 79.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.441 -0.787 . . . . 0.0 110.16 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.59 -35.38 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.662 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.08 -17.99 31.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.89 74.65 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 11.2 mt -60.91 -37.48 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -53.9 -52.1 61.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.07 -1.019 . . . . 0.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -54.43 16.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.255 -0.903 . . . . 0.0 111.574 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -54.45 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 111.509 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.491 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.17 -36.21 79.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.868 . . . . 0.0 110.36 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 74.03 77.75 0.12 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.2 p -163.4 -153.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 109.913 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -68.95 -178.57 1.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -146.71 -56.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 110.382 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.61 -64.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.854 . . . . 0.0 110.042 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -64.08 -25.47 68.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.43 106.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.93 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.57 163.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -115.16 139.25 50.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.012 -1.055 . . . . 0.0 109.918 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 1.1 mm -94.13 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 110.394 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 30.5 t80 -70.08 167.85 16.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.756 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.52 69.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 110.459 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.56 25.07 4.75 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 -174.33 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.232 -1.157 . . . . 0.0 109.994 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -116.72 109.41 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.992 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.72 72.03 0.36 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -131.62 -159.71 0.99 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.368 0.604 . . . . 0.0 109.949 -178.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.7 t0 -72.75 -14.94 61.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 110.16 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -58.08 -33.2 68.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 110.15 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -142.38 166.28 25.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 110.602 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.47 155.03 17.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.531 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.37 -46.65 75.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.413 HG22 ' CA ' ' A' ' 50' ' ' GLU . 1.3 pp -63.93 -17.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 7.4 tm0? -94.98 -14.64 24.2 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.426 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 175.94 -25.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.988 -1.07 . . . . 0.0 111.86 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.18 -49.89 71.47 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.496 HD12 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -149.15 168.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.345 -1.091 . . . . 0.0 109.158 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 44.3 m170 -114.72 -33.5 5.48 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.7 t0 -179.01 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.566 -0.709 . . . . 0.0 109.911 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.66 70.43 0.36 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.2 174.48 5.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -1.066 . . . . 0.0 110.2 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.401 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 67.2 p -111.76 145.5 39.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.38 -0.825 . . . . 0.0 110.243 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 74' ' ' LEU . 59.0 t -143.28 151.13 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.272 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -90.26 115.78 27.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 110.213 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -74.22 148.38 41.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.59 152.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.805 . . . . 0.0 110.076 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 mttp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.2 mp -58.44 115.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.684 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.49 HG13 HD12 ' A' ' 92' ' ' ILE . 3.5 pt -87.99 166.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.49 144.28 25.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.415 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 27.5 t -134.62 113.45 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.186 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.92 106.41 17.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 110.026 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -95.01 129.42 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 0.0 110.337 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -96.86 123.08 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.45 -0.781 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 1.8 p -121.34 169.32 9.28 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.049 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.7 Cg_endo -68.1 -12.32 34.77 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.642 1.338 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -94.37 -48.19 6.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.92 -165.57 0.37 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.402 -0.811 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -115.45 130.66 56.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.93 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.7 135.19 43.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -0.919 . . . . 0.0 110.669 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -92.08 153.67 19.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.789 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -136.76 129.45 30.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.12 126.43 37.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.22 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.32 151.22 54.33 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.937 . . . . 0.0 109.768 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.6 Cg_endo -67.45 123.11 10.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.853 1.449 . . . . 0.0 110.469 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 51' ' ' ASN . 22.0 pt-20 -30.69 -39.78 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 120.965 0.412 . . . . 0.0 112.106 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.478 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 11.2 p30 -91.27 49.56 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -111.52 111.4 22.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.034 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -59.94 144.69 48.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 110.306 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 70.5 t -60.58 -34.19 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -50.38 35.04 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.067 -1.021 . . . . 0.0 110.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -65.9 -50.63 63.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -59.72 -36.26 76.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.544 -0.722 . . . . 0.0 109.999 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -57.55 -38.39 74.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 109.727 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -81.96 -20.34 38.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.55 84.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.006 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.66 -30.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.525 -0.734 . . . . 0.0 110.134 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -60.57 -43.98 96.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.778 . . . . 0.0 110.509 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.67 -50.84 69.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.312 -0.868 . . . . 0.0 111.0 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -71.18 -52.66 17.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.204 -0.935 . . . . 0.0 111.045 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 39' ' ' THR . 16.6 m-85 -65.66 -36.55 83.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.89 . . . . 0.0 110.306 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 12.3 tttt 68.8 57.74 0.4 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.572 -0.705 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -138.02 -154.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.403 -0.811 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.25 160.71 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -113.01 -67.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 109.114 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 40.33 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.833 -0.542 . . . . 0.0 111.011 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' THR . 1.1 mp0 -79.08 -49.31 12.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER 36.18 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.708 -0.62 . . . . 0.0 111.457 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.454 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . 4.6 p -136.28 147.25 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.708 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 8.2 mp -117.3 142.37 47.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.83 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.1 mm -92.79 100.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.821 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 82.0 t80 -74.59 78.28 1.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.501 -0.749 . . . . 0.0 109.522 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 55.79 23.53 6.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.41 -41.41 1.51 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -164.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.233 -1.157 . . . . 0.0 110.393 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -122.53 88.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 10.3 tt -65.27 86.49 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 73' ' ' VAL . 2.8 tttt -147.25 -150.25 0.33 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.571 -0.706 . . . . 0.0 110.53 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 19.5 p-10 -72.42 -21.6 61.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.522 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.42 -33.04 63.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.85 . . . . 0.0 110.006 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.34 157.11 44.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -84.91 161.7 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.496 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -65.93 -45.87 80.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.2 pt -62.13 -17.95 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 15.8 mm100 -98.08 -12.54 21.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -0.841 . . . . 0.0 111.191 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.99 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.883 -1.135 . . . . 0.0 111.934 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.51 -50.17 69.54 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.49 HD12 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -150.55 161.92 3.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.441 -1.035 . . . . 0.0 108.963 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -112.27 -24.51 9.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.992 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p30 179.84 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.373 -0.83 . . . . 0.0 110.077 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.97 68.08 0.78 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.03 -174.49 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -1.073 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -111.52 131.49 55.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.91 153.6 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 0.0 110.475 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -90.58 144.46 25.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.6 136.89 54.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.145 -0.972 . . . . 0.0 110.081 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.1 p -166.12 170.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.463 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.4 mm -58.45 140.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.721 -0.612 . . . . 0.0 110.816 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 50' ' ' GLU . 4.5 pt -119.64 152.33 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.412 -0.805 . . . . 0.0 109.353 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -91.03 144.16 25.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.616 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 38.6 t -132.81 113.41 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.612 -0.68 . . . . 0.0 109.784 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 6.5 m -91.44 102.53 15.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.85 127.55 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 110.184 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 122.51 46.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.0 109.846 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 51.5 p -124.18 166.9 17.14 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.447 -0.783 . . . . 0.0 109.864 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.1 Cg_endo -68.22 -12.65 35.69 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.622 1.327 . . . . 0.0 110.528 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -92.32 -44.05 8.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -172.5 -167.23 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 110.294 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 3.1 ptmt -130.96 121.55 25.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 109.951 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -135.47 135.48 40.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.124 -0.985 . . . . 0.0 110.809 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.02 150.4 24.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.587 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.35 130.17 48.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.668 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.31 36.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.4 154.58 63.91 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 52' ' ' SER . 41.1 Cg_endo -69.51 120.48 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.671 1.353 . . . . 0.0 110.358 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.521 ' HB2' HG21 ' A' ' 88' ' ' ILE . 1.7 pp20? -37.61 -37.61 0.22 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.875 -0.515 . . . . 0.0 111.689 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -86.74 52.04 2.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.029 -1.045 . . . . 0.0 110.776 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.2 t -126.42 126.5 43.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -70.09 151.29 45.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 91.6 t -61.77 -34.76 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.778 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -43.56 28.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.982 -1.074 . . . . 0.0 110.579 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -70.34 -46.53 63.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -65.71 -37.87 87.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.91 -39.28 77.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.406 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -20.94 60.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.607 -0.683 . . . . 0.0 109.942 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.86 -50.74 61.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 mt -63.13 -36.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -53.63 -44.92 69.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -54.72 15.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 111.336 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -72.89 -54.37 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.1 -1.0 . . . . 0.0 111.29 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.34 -36.5 79.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.2 tptt 71.7 79.19 0.16 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 t -131.78 -151.85 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 110.051 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -92.88 -17.28 24.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 110.565 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m 66.14 -66.09 0.17 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.783 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.7 t70 -55.12 -63.48 1.14 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.127 -0.983 . . . . 0.0 110.14 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -68.93 -25.3 64.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.798 . . . . 0.0 110.02 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.6 tp -56.21 95.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.397 -0.814 . . . . 0.0 110.826 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.47 154.56 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.783 . . . . 0.0 109.289 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -115.06 141.13 48.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.014 -1.054 . . . . 0.0 110.315 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 99' ' ' HIS . 50.2 mm -94.75 98.63 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 75.6 t80 -68.74 72.63 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.407 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.83 38.41 19.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.895 . . . . 0.0 110.579 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.12 -50.13 0.89 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -74.21 -161.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -126.83 93.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.388 -0.82 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 7.7 tt -64.05 89.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -152.81 -154.3 0.53 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.772 -0.58 . . . . 0.0 110.17 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.453 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.5 p30 -72.66 -19.52 61.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.431 -0.793 . . . . 0.0 110.219 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -33.05 62.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.71 149.01 33.64 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.476 -0.765 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -74.18 161.79 29.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 109.843 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.2 tp -65.56 -46.32 79.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 110.37 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' A' ' 50' ' ' GLU . 2.1 pp -65.46 -18.37 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 110.211 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -96.79 -10.71 26.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 111.1 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.99 -30.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.935 -1.103 . . . . 0.0 111.962 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -59.08 -51.01 61.76 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.492 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -149.83 177.14 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.371 -1.076 . . . . 0.0 108.963 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.455 ' N ' HD13 ' A' ' 92' ' ' ILE . 2.1 m-70 -126.94 -31.1 2.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.71 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.4 p30 -179.5 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -0.757 . . . . 0.0 109.703 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 113.38 58.07 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.3 mt -98.0 -169.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -1.109 . . . . 0.0 110.309 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 10.7 m -131.5 121.33 24.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.781 . . . . 0.0 110.299 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 76' ' ' PHE . 7.1 p -119.44 157.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 45.4 m80 -90.66 143.49 26.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.46 121.4 44.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.289 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.89 142.96 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.322 -0.861 . . . . 0.0 110.358 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.2 mp -58.47 108.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.693 -0.629 . . . . 0.0 110.654 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.47 HG13 HD13 ' A' ' 92' ' ' ILE . 4.6 pt -81.86 159.64 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -91.43 144.48 25.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 110.759 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 92' ' ' ILE . 47.5 t -135.66 114.09 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.271 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.4 m -98.99 105.68 17.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.92 . . . . 0.0 110.175 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.92 128.63 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -92.27 122.66 34.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.992 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -118.63 173.91 3.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.432 -0.793 . . . . 0.0 109.966 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.3 Cg_endo -69.64 -10.61 29.09 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.728 1.383 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -98.84 -53.27 3.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.13 -176.62 1.68 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -0.814 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.93 139.95 31.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.9 121.71 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.02 146.17 25.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -0.806 . . . . 0.0 110.077 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -132.3 128.9 38.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.72 124.47 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.541 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.1 m -142.28 149.66 52.43 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.3 Cg_endo -67.24 121.23 8.35 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.775 1.408 . . . . 0.0 110.495 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB2' HG22 ' A' ' 88' ' ' ILE . 14.1 pt-20 -35.32 -39.02 0.11 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.257 0.551 . . . . 0.0 111.231 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -89.9 55.89 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.462 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -114.67 -179.66 3.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.217 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.4 140.99 52.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 22.1 t -66.91 -35.04 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 110.578 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.6 -49.42 46.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.775 -1.203 . . . . 0.0 110.196 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -78.5 -45.91 20.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 110.354 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CE1' HG11 ' A' ' 48' ' ' VAL . 27.7 t80 -61.38 -51.21 69.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.5 -35.11 69.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.462 -0.774 . . . . 0.0 109.954 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -78.33 -26.28 46.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.73 -52.55 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 109.817 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -60.69 -29.2 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.695 -0.628 . . . . 0.0 109.652 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 66' ' ' LYS . 14.7 t -56.49 -44.16 80.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -0.827 . . . . 0.0 110.273 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.98 61.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -52.74 63.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.45 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -67.49 -35.88 80.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.0 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 3.2 ttpp 76.14 85.33 0.09 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.447 0.642 . . . . 0.0 110.213 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.47 -154.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.581 -0.699 . . . . 0.0 109.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.0 -177.85 6.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 m -140.88 -53.86 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 0.0 110.213 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -51.14 70.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.821 . . . . 0.0 110.233 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -77.98 -26.01 48.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 110.226 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.18 120.22 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.0 110.28 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' CG1' ' CD ' ' A' ' 82' ' ' LYS . 26.2 m -135.6 157.39 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.711 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -113.8 118.69 34.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.884 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.71 97.26 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.394 -0.816 . . . . 0.0 110.492 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 91' ' ' GLY . 6.7 t80 -98.89 109.61 22.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.455 -0.778 . . . . 0.0 109.913 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.58 26.48 12.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.409 -0.807 . . . . 0.0 110.358 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.13 -36.04 4.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -179.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -1.071 . . . . 0.0 110.145 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -110.17 82.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 110.316 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 7.3 tt -59.97 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' CD ' ' CG1' ' A' ' 73' ' ' VAL . 7.4 ttpp -160.75 -146.76 0.14 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.535 -0.728 . . . . 0.0 110.579 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.7 p30 -73.01 -18.86 61.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.323 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -32.76 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.051 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.45 167.67 28.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -0.855 . . . . 0.0 110.524 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 p -85.47 161.14 19.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.26 -46.44 77.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.882 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.47 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.7 pt -63.39 -19.09 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.008 . . . . 0.0 110.197 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 11.4 tp-100 -93.6 -12.85 28.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.96 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.03 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.916 -1.115 . . . . 0.0 111.752 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -59.05 -50.88 63.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.47 HD13 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -151.01 169.48 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.32 -1.106 . . . . 0.0 109.118 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 7.2 m170 -116.73 -31.34 5.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.4 t0 -178.65 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 117.48 70.21 0.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.18 171.36 7.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.31 -1.112 . . . . 0.0 110.221 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m -111.88 140.14 46.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 110.338 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.75 155.71 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.432 -0.793 . . . . 0.0 110.282 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -90.69 121.97 33.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 tt -99.97 119.14 37.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.07 142.22 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.423 -0.798 . . . . 0.0 110.29 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.38 137.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.347 0.594 . . . . 0.0 111.085 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 88' ' ' ILE . 8.1 pt -107.78 160.05 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.437 -0.789 . . . . 0.0 109.542 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -94.65 133.63 38.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.833 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 2.6 p -128.51 118.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -96.01 114.62 26.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.35 -0.844 . . . . 0.0 110.187 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -104.85 129.29 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.352 -0.843 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 122.46 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.445 -0.784 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 1.1 p -122.79 170.68 7.68 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.828 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.8 Cg_endo -67.93 -12.64 35.96 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.656 1.345 . . . . 0.0 110.726 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -51.24 5.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -173.74 178.4 2.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.351 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 125.86 44.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.902 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -135.1 134.89 40.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.689 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -90.26 151.08 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.495 -0.753 . . . . 0.0 109.682 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CZ ' ' NH1' ' A' ' 64' ' ' ARG . 2.2 m-85 -129.3 152.26 49.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -0.94 . . . . 0.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.55 133.37 50.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.074 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.3 m -143.35 143.7 25.27 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 51' ' ' ASN . 40.2 Cg_endo -66.82 128.82 19.58 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.706 1.371 . . . . 0.0 111.306 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HA ' HG23 ' A' ' 88' ' ' ILE . 2.2 tm-20 -39.43 -20.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' PRO . 17.2 p-10 -111.09 37.95 2.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.644 -1.285 . . . . 0.0 110.47 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.411 ' N ' HD13 ' A' ' 88' ' ' ILE . 27.8 p -96.55 -153.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -161.91 157.25 23.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.345 -0.847 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' O ' ' CG ' ' A' ' 58' ' ' LYS . 59.4 t -63.28 -34.91 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 110.793 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -49.17 -47.11 46.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.663 -1.273 . . . . 0.0 110.231 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -49.53 16.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.227 -0.921 . . . . 0.0 110.337 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 28.3 t80 -60.34 -50.28 74.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.97 -30.56 66.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -26.84 26.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 110.051 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.62 82.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -29.85 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.571 -0.706 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t -62.32 -43.92 97.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.476 -0.765 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -57.81 -48.56 79.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.862 . . . . 0.0 111.024 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' NH1' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -71.15 -52.81 17.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.203 -0.936 . . . . 0.0 110.931 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 8.8 m-85 -67.18 -36.16 81.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.85 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 12.3 mttp 69.6 81.44 0.17 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.418 0.628 . . . . 0.0 110.092 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 p -168.15 -154.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -74.94 157.56 34.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -128.51 -41.67 1.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.16 -62.72 1.56 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.358 -0.839 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -69.4 -25.57 64.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.427 -0.796 . . . . 0.0 110.165 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.36 118.01 8.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.339 -0.85 . . . . 0.0 110.524 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 168.46 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 98' ' ' VAL . 2.7 mm? -109.57 146.81 34.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.69 92.9 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 110.236 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 24.7 t80 -74.39 64.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.7 . . . . 0.0 110.357 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 49.2 79.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.86 -53.06 4.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -76.2 178.2 6.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -1.103 . . . . 0.0 109.873 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -115.97 106.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 0.0 109.916 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -69.5 72.04 0.32 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 80' ' ' ILE . 7.9 ttmt -125.95 -160.1 0.95 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.511 0.672 . . . . 0.0 110.547 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.7 p-10 -73.74 -16.71 61.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.629 -0.669 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.83 -32.36 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.942 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -132.08 169.66 16.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.799 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.66 137.01 32.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 ' CD1' HD23 ' A' ' 81' ' ' LEU . 22.3 tp -55.93 -47.49 77.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 110.428 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.539 HG23 HD11 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -73.62 -15.48 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.481 -0.762 . . . . 0.0 110.904 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 1.8 tt0 -90.35 -9.32 48.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 111.847 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -174.65 -36.61 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.586 -1.321 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.444 ' HA3' HD13 ' A' ' 87' ' ' LEU . . . -58.84 -42.8 96.77 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.441 HG12 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -138.64 138.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -1.19 . . . . 0.0 110.855 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 12.2 m170 -103.68 -36.03 8.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 24.0 p-10 179.81 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 0.0 109.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.08 71.19 0.24 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.16 167.49 10.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.9 m -118.33 147.14 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.333 -0.854 . . . . 0.0 110.252 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 74' ' ' LEU . 7.7 p -144.43 150.54 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 110.418 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.454 ' N ' HG21 ' A' ' 98' ' ' VAL . 38.2 t60 -90.63 122.49 33.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.503 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.94 149.98 26.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.204 -0.935 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.0 p -168.05 131.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.09 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.33 102.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 110.654 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HD12 ' CG2' ' A' ' 88' ' ' ILE . 7.1 pt -96.07 147.88 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.707 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -91.81 141.39 28.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.103 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.52 113.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.818 . . . . 0.0 110.129 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.7 m -90.15 109.4 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.832 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.78 127.79 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 110.285 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 122.51 47.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.437 -0.789 . . . . 0.0 109.67 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.1 p -124.13 162.22 42.84 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.078 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 59.54 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.71 1.373 . . . . 0.0 110.428 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.71 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -167.21 -170.02 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.513 -0.742 . . . . 0.0 109.922 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -142.7 125.37 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.831 . . . . 0.0 110.21 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -135.12 132.44 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.382 -0.824 . . . . 0.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -90.1 150.25 22.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -123.75 140.93 52.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 110.479 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.68 116.64 33.18 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 33' ' ' ILE . 21.8 m -120.59 147.68 46.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.677 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 51' ' ' ASN . 51.1 Cg_endo -76.65 52.83 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.856 1.451 . . . . 0.0 111.709 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 30.7 tp10 55.53 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.381 -0.824 . . . . 0.0 111.695 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.0 t30 -46.86 -20.06 0.12 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 0.0 112.063 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.411 ' CB ' ' HB ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -59.1 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 110.106 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.9 m -67.33 175.6 2.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.526 -0.734 . . . . 0.0 110.35 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' CG ' ' A' ' 58' ' ' LYS . 37.6 t -68.12 -35.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 110.272 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -50.21 -49.01 54.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.772 -1.205 . . . . 0.0 109.733 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -76.37 -47.4 23.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -61.52 -50.98 70.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.367 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.55 -29.85 64.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.783 . . . . 0.0 109.897 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' N ' ' HG3' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -80.37 -24.14 39.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.336 -0.852 . . . . 0.0 109.813 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.29 85.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 110.149 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 7.0 mt -60.9 -36.91 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.256 -0.903 . . . . 0.0 109.912 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 p -53.6 -49.64 67.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.0 110.506 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -68.21 -53.77 22.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.341 -0.849 . . . . 0.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -53.84 12.32 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.097 -1.002 . . . . 0.0 111.262 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.66 -36.45 80.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 109.991 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.06 81.68 0.19 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.612 -0.68 . . . . 0.0 110.224 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -156.04 -65.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.0 -176.15 2.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.437 -0.789 . . . . 0.0 110.061 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 m -140.85 -55.08 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 110.341 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.04 -67.4 0.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -60.47 -25.61 66.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.309 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.401 HD13 ' CG2' ' A' ' 61' ' ' ILE . 7.8 tt -53.29 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 110.826 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.63 148.7 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -117.94 135.86 53.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.17 101.65 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.438 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 71.8 t80 -77.35 82.71 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.238 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.79 36.19 13.88 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.33 -55.87 0.57 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -1.062 . . . . 0.0 110.056 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -118.05 94.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.281 -0.887 . . . . 0.0 110.694 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -67.09 79.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' ILE . 5.5 ttmt -137.15 -158.86 0.9 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.414 0.625 . . . . 0.0 110.358 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 84' ' ' GLN . 35.5 p30 -73.32 -14.81 61.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.452 -0.78 . . . . 0.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -55.78 -33.04 64.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.353 -0.842 . . . . 0.0 109.72 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.39 154.4 49.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.474 -0.766 . . . . 0.0 110.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 147.03 50.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.853 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 17.0 tp -55.59 -46.98 77.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.435 ' CG2' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -72.48 -14.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -85.63 -13.58 48.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 111.814 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -170.27 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.605 -1.309 . . . . 0.0 111.036 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 76' ' ' PHE . . . -59.46 -46.92 93.14 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.483 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -137.47 143.66 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.012 -1.287 . . . . 0.0 111.333 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -109.4 -33.72 6.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -179.73 35.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.246 0.546 . . . . 0.0 109.536 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.67 71.97 0.39 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -178.43 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.235 -1.156 . . . . 0.0 110.251 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -125.15 146.52 49.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 8.1 p -142.68 151.09 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.874 . . . . 0.0 110.401 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.71 144.31 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.81 . . . . 0.0 110.258 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.4 tt -97.44 119.97 36.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.67 128.57 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 0.0 110.045 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.6 mp -58.12 111.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.603 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.416 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.0 pt -89.68 154.46 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.38 -0.825 . . . . 0.0 110.039 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -94.11 144.89 25.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.56 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 92' ' ' ILE . 7.2 p -138.52 119.14 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.4 -0.813 . . . . 0.0 110.108 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -87.05 102.22 14.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 0.0 110.095 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.3 128.38 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -109.72 126.27 53.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 110.293 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 ' OG1' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -123.46 175.73 2.6 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.613 -0.679 . . . . 0.0 109.69 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.34 61.86 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.626 1.33 . . . . 0.0 110.395 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.447 -0.783 . . . . 0.0 109.928 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.71 179.48 3.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.39 -0.819 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -117.08 122.99 45.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.152 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.3 135.12 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.326 -0.859 . . . . 0.0 110.438 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -85.23 149.52 25.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -124.35 144.86 49.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.571 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -99.62 129.78 45.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.331 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 30.4 m -143.46 144.01 26.2 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.857 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 39.4 Cg_endo -67.08 121.44 8.61 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.756 1.398 . . . . 0.0 111.034 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -37.17 -34.73 0.09 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.117 0.484 . . . . 0.0 111.583 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.15 49.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 110.575 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 55.7 p -127.85 108.38 10.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.5 t -59.84 153.36 20.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.857 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 61.1 t -55.88 -35.0 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 110.86 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -48.48 -43.78 35.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.665 -1.272 . . . . 0.0 109.843 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.15 -41.48 41.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CD1' HG12 ' A' ' 48' ' ' VAL . 17.7 t80 -68.24 -51.46 45.11 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -30.8 65.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.921 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -86.29 -26.85 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -49.32 60.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -0.785 . . . . 0.0 109.675 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' C ' ' CD1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.35 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.008 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 p -63.85 -44.43 93.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.174 -0.953 . . . . 0.0 110.351 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -56.39 -42.66 78.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.78 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -52.07 23.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.283 -0.885 . . . . 0.0 110.463 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 5.2 m-85 -67.0 -36.5 82.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.817 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 44.5 mtmt 64.23 79.49 0.26 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.582 -0.699 . . . . 0.0 110.179 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 t -154.87 -59.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.486 -0.759 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -169.45 174.83 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 0.0 110.005 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -143.31 -44.19 0.29 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.37 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -64.97 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.18 -26.19 60.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.226 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.16 139.75 28.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.326 -0.859 . . . . 0.0 110.523 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 82' ' ' LYS . 8.0 p -172.84 169.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 109.928 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 2.6 mt -118.44 118.86 32.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -0.982 . . . . 0.0 109.31 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.61 103.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 110.146 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.462 ' CD2' HG21 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -91.86 124.11 35.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.452 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.94 103.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.313 -0.867 . . . . 0.0 110.607 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.46 -31.13 3.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 -166.8 0.89 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -1.003 . . . . 0.0 109.712 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.3 mm -108.77 118.26 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -69.97 71.05 0.37 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.786 178.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 80' ' ' ILE . 3.6 ptmt -136.1 -152.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.368 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.452 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.9 p30 -72.94 -12.84 61.1 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.301 -0.874 . . . . 0.0 112.482 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.6 -33.5 33.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.056 . . . . 0.0 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.61 156.37 45.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.198 -0.939 . . . . 0.0 109.972 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 149.78 41.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD12 ' HA3' ' A' ' 91' ' ' GLY . 16.0 tp -56.81 -48.16 78.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 110.868 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 2.1 pp -73.1 -18.45 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.172 -0.955 . . . . 0.0 110.829 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.29 -9.9 57.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 111.744 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.728 -1.233 . . . . 0.0 110.949 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.526 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -59.34 -47.0 92.98 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.464 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -145.56 156.23 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -1.176 . . . . 0.0 110.293 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 19.2 m170 -114.98 -42.42 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.4 t70 -178.49 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.28 65.91 0.18 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.8 mt -112.58 160.08 18.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -1.12 . . . . 0.0 110.256 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -115.06 145.72 42.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 76' ' ' PHE . 49.0 t -145.47 158.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.46 ' HB2' HG21 ' A' ' 75' ' ' ILE . 44.1 m170 -88.39 125.49 34.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 0.0 110.466 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.29 145.77 28.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.135 -0.978 . . . . 0.0 110.451 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.36 159.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.327 -0.858 . . . . 0.0 110.204 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mptt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.9 mp -58.04 110.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.835 -0.541 . . . . 0.0 110.476 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG1' HD12 ' A' ' 92' ' ' ILE . 3.3 pt -83.55 152.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -91.97 144.4 25.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 110.282 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 87' ' ' LEU . 7.3 p -139.69 113.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.093 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -82.33 109.08 16.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.396 -0.815 . . . . 0.0 110.018 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.55 127.59 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -0.859 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.38 122.64 46.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 80.7 p -121.58 165.93 18.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.726 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.1 Cg_endo -69.71 -10.28 28.2 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.636 1.335 . . . . 0.0 110.817 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -100.54 -35.91 9.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.184 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.36 -166.52 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.325 -0.859 . . . . 0.0 110.263 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 114.93 8.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 0.0 110.074 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -135.19 134.96 40.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 110.499 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.29 149.21 26.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -121.4 147.68 45.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.36 125.86 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.6 m -142.49 150.48 54.65 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.206 -0.934 . . . . 0.0 109.758 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -68.36 122.61 9.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.699 1.368 . . . . 0.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 49' ' ' PRO . 17.0 pt-20 -31.28 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.084 0.469 . . . . 0.0 111.716 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -88.58 50.83 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.213 -0.929 . . . . 0.0 110.121 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.1 t -115.12 130.77 57.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -82.14 146.47 29.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 61.0 t -61.16 -34.53 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.791 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -49.32 -48.07 46.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.988 -1.07 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.33 -49.76 52.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.82 -37.23 78.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 12.2 mtpt -57.77 -47.95 81.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.579 -0.701 . . . . 0.0 109.495 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.484 -0.76 . . . . 0.0 109.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.89 65.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.842 . . . . 0.0 110.045 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 65' ' ' PHE . 19.6 mt -60.92 -39.65 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.603 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -53.7 -52.24 60.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.039 . . . . 0.0 110.326 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -54.17 19.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.324 -0.86 . . . . 0.0 111.508 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -72.02 -54.11 10.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 111.442 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.91 -36.6 80.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 110.275 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 4.9 tttp 69.17 80.66 0.19 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.437 -0.789 . . . . 0.0 110.203 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 t -153.38 -69.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -164.36 -175.18 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.5 m -144.11 -60.04 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.312 -0.868 . . . . 0.0 110.483 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 -61.03 2.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -66.32 -25.65 66.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.2 tp -51.86 124.75 13.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.337 -0.852 . . . . 0.0 110.684 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.31 157.22 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 109.767 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.4 mp -123.6 123.76 41.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.134 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.19 104.33 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 110.626 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.3 t80 -70.52 67.06 0.34 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.755 . . . . 0.0 110.031 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.92 24.76 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.261 -0.899 . . . . 0.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.21 -39.24 1.51 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -162.14 0.53 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -1.121 . . . . 0.0 110.258 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.1 pp -123.49 84.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 110.61 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 8.1 tt -67.74 84.29 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 108.765 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.453 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -153.99 -146.82 0.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 110.148 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.58 -15.56 61.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.035 -1.041 . . . . 0.0 111.363 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.427 ' CB ' HD11 ' A' ' 80' ' ' ILE . 1.4 mm-40 -53.73 -33.42 55.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.129 -0.982 . . . . 0.0 110.237 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -150.24 -169.88 3.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -102.91 158.14 16.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 92' ' ' ILE . 1.5 tp -66.09 -46.23 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.6 pt -63.84 -17.25 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.562 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -97.27 -12.82 22.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 111.091 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.911 -1.118 . . . . 0.0 111.859 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.39 -50.34 67.68 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.474 HD12 ' CG1' ' A' ' 33' ' ' ILE . 2.7 pp -148.56 171.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.375 -1.074 . . . . 0.0 108.665 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -122.19 -29.62 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.967 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.8 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 109.982 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.91 59.5 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.38 -168.99 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.336 -1.097 . . . . 0.0 110.221 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -134.96 147.03 49.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.47 157.56 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 0.0 110.199 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -90.7 115.81 28.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 tt -89.31 131.33 35.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 110.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.08 130.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.783 . . . . 0.0 110.255 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 0.0 110.199 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tptp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.0 mp -58.16 110.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.252 0.549 . . . . 0.0 110.723 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 92' ' ' ILE . 1.6 pt -89.16 174.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.415 -0.803 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.45 144.39 37.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.768 . . . . 0.0 110.373 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.14 113.84 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 110.033 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -84.24 103.8 13.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.9 t -94.75 128.75 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.002 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -101.24 122.5 43.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.415 -0.803 . . . . 0.0 110.071 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 4.3 p -119.93 167.71 11.85 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.9 Cg_endo -71.1 61.06 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.661 1.348 . . . . 0.0 110.401 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -46.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 109.64 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -172.05 176.75 3.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.53 -0.731 . . . . 0.0 110.081 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.67 127.97 54.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -134.5 131.2 37.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.3 149.79 25.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.9 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.12 123.08 35.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.898 . . . . 0.0 110.197 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.133 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 25.6 m -143.21 153.57 59.93 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.233 -0.917 . . . . 0.0 109.825 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.2 Cg_endo -67.9 122.37 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.803 1.423 . . . . 0.0 110.726 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -30.74 -42.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.66 48.7 1.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.925 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.9 t -113.41 108.07 16.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.087 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.7 m -59.84 148.84 33.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.847 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 64.5 t -63.42 -34.67 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.811 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.05 -43.93 41.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.953 -1.092 . . . . 0.0 110.705 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.45 -53.48 16.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.925 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -59.86 -37.21 78.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.339 -0.851 . . . . 0.0 110.118 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -42.88 83.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.611 -0.68 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -75.87 -20.72 57.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.58 97.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.429 HG22 ' CD2' ' A' ' 65' ' ' PHE . 52.8 mt -60.39 -34.7 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.4 p -54.02 -52.98 59.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.985 -1.072 . . . . 0.0 110.464 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -54.73 14.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 111.78 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -72.7 -54.49 8.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.051 -1.031 . . . . 0.0 111.646 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.57 -36.11 78.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.887 . . . . 0.0 110.531 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 23.2 mtmt 70.67 79.97 0.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.662 -0.649 . . . . 0.0 110.015 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.9 t -168.24 -154.4 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.898 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.14 -170.03 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.7 m -157.33 -60.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -60.13 -70.31 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -61.86 -26.11 67.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -66.71 98.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 110.338 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.11 167.11 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.812 . . . . 0.0 109.951 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.75 144.68 36.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 110.018 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -105.16 89.31 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.828 . . . . 0.0 110.023 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 69.6 t80 -66.96 83.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.92 29.72 6.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.359 -0.838 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.04 -51.38 0.84 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 6.4 mttp -61.86 -175.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -1.046 . . . . 0.0 109.957 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -116.31 93.06 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.5 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -62.89 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 80' ' ' ILE . 2.4 tttt -145.91 -153.13 0.46 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.734 -0.604 . . . . 0.0 110.169 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -72.58 -15.54 61.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.385 -0.822 . . . . 0.0 110.523 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -62.81 -33.14 74.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.973 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.63 168.15 19.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 p -99.06 148.92 23.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.252 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' HG ' HG13 ' A' ' 92' ' ' ILE . 22.0 tp -55.81 -43.58 77.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.403 HG23 ' CA ' ' A' ' 50' ' ' GLU . 1.2 pt -71.61 -14.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.254 -0.904 . . . . 0.0 111.604 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.37 -2.98 24.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 112.197 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -176.06 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 118.331 -1.347 . . . . 0.0 112.303 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 92' ' ' ILE . . . -58.58 -50.32 68.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.558 HD11 HG13 ' A' ' 33' ' ' ILE . 2.8 pp -157.05 152.61 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -1.015 . . . . 0.0 109.322 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 14.5 m170 -100.8 -24.97 14.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 35.4 t70 179.96 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.622 -0.674 . . . . 0.0 109.596 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.07 73.93 0.86 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 176.85 4.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.248 -1.148 . . . . 0.0 110.186 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 13.4 m -115.9 147.32 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.93 146.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.75 . . . . 0.0 110.16 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.39 115.27 27.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.7 tt -82.74 148.64 27.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.899 . . . . 0.0 110.632 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -168.34 135.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -57.95 128.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.321 0.582 . . . . 0.0 111.006 -177.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 12.9 pt -98.4 159.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.696 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -91.45 144.08 25.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 110.533 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.0 113.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -90.31 102.99 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.05 127.84 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.463 -0.773 . . . . 0.0 110.12 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.44 122.45 46.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.6 p -117.1 163.81 21.54 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.55 59.76 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.664 1.349 . . . . 0.0 110.581 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -175.67 -39.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 109.762 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -171.31 173.58 4.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 119.8 40.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.076 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.78 124.9 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -84.7 149.55 25.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.663 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.51 140.14 53.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.353 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.65 135.44 39.46 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 28.1 m -143.43 143.1 22.77 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 109.018 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.4 Cg_endo -65.89 128.23 19.39 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.771 1.406 . . . . 0.0 110.825 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -38.05 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.008 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' PRO . 2.4 t30 -120.79 67.63 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.645 -1.284 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -149.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.0 110.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -159.38 153.75 23.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.95 . . . . 0.0 110.079 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 48.5 t -55.92 -35.3 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 111.088 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -45.17 40.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -71.36 -49.73 39.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.69 -38.02 88.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.448 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -58.15 -45.22 87.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.829 . . . . 0.0 109.653 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -81.67 -18.16 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 110.194 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.1 -52.34 63.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.442 HG23 ' CD2' ' A' ' 65' ' ' PHE . 26.5 mt -62.8 -33.65 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.345 -0.847 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -53.19 55.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.081 -1.012 . . . . 0.0 110.606 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.56 -54.56 15.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 111.797 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -54.48 8.97 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.083 -1.01 . . . . 0.0 111.633 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.22 -36.15 79.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 73.95 72.54 0.12 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.65 -0.657 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.6 p -159.06 -165.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.47 -0.768 . . . . 0.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -168.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.246 -0.909 . . . . 0.0 110.346 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.77 -51.63 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.371 -0.831 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.05 -51.94 66.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -78.13 -25.57 47.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 110.181 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.74 110.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 110.656 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.72 151.47 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.82 . . . . 0.0 109.727 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -111.39 122.07 46.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.109 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.84 100.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 81' ' ' LEU . 4.6 t80 -109.05 124.27 50.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 110.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.82 27.54 7.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.329 -0.857 . . . . 0.0 110.419 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.87 23.71 61.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -122.58 -167.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -1.084 . . . . 0.0 109.881 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.1 pp -112.13 79.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.221 -0.924 . . . . 0.0 110.499 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -61.37 89.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 108.54 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.468 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 7.1 ttpt -155.82 -146.67 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.547 -0.72 . . . . 0.0 110.874 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HA ' ' CB ' ' A' ' 54' ' ' VAL . 20.0 t0 -62.48 -15.41 49.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.667 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.409 ' CB ' HD12 ' A' ' 80' ' ' ILE . 2.1 mm-40 -52.47 -30.81 31.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -159.88 162.5 34.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.387 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.83 134.2 39.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.583 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' HG ' HG12 ' A' ' 92' ' ' ILE . 1.9 mp -55.75 -39.2 70.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 50' ' ' GLU . 2.4 pp -70.28 -17.88 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.141 -0.974 . . . . 0.0 109.566 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -88.78 -13.27 39.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.501 -0.749 . . . . 0.0 110.927 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.69 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.831 -1.168 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.9 97.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.501 HG12 ' HG ' ' A' ' 87' ' ' LEU . 3.7 mm -128.94 150.2 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -1.224 . . . . 0.0 111.004 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.69 -38.64 3.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 p30 179.88 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 116.88 69.95 0.42 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 4.9 mt -101.14 -177.18 3.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -1.151 . . . . 0.0 110.423 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.0 t -128.46 142.76 50.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -147.52 146.22 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 110.408 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -90.43 119.37 30.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.26 137.96 40.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.8 p -166.71 132.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.138 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.396 -0.815 . . . . 0.0 110.251 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.1 mp -58.23 120.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.681 -0.637 . . . . 0.0 110.557 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.554 HG13 HD12 ' A' ' 92' ' ' ILE . 1.6 pt -107.39 159.57 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -91.75 144.21 25.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.818 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 39.1 t -132.07 113.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.438 -0.789 . . . . 0.0 109.856 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m -98.26 114.67 27.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.309 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.45 127.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.85 . . . . 0.0 110.138 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -92.86 122.55 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.581 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -121.86 172.43 5.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 110.176 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.8 Cg_endo -68.68 -8.27 22.84 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.69 1.363 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.7 tptm -101.46 -50.55 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 1.8 mt-10 -170.57 -161.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.556 -0.715 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.4 135.98 53.49 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -135.3 135.45 40.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.168 -0.958 . . . . 0.0 110.785 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.14 145.75 24.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.45 -0.781 . . . . 0.0 109.75 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -128.29 124.88 37.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.948 . . . . 0.0 110.396 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.85 129.22 36.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 108.963 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.5 m -143.27 155.68 61.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.056 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -69.98 122.14 8.76 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.833 1.438 . . . . 0.0 110.409 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -25.83 -48.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.1 0.476 . . . . 0.0 111.597 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' PRO . 14.6 p-10 -86.25 52.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 t -109.13 111.48 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -64.07 144.19 57.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 85.4 t -59.12 -35.02 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.41 -44.51 35.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.015 -1.053 . . . . 0.0 110.479 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.32 -49.75 52.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.13 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -63.21 -37.52 87.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.442 -0.786 . . . . 0.0 110.41 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.09 -39.54 78.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.4 -23.1 60.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.49 -0.757 . . . . 0.0 110.278 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.89 81.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.184 -0.948 . . . . 0.0 109.992 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -34.95 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 110.174 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 66' ' ' LYS . 27.1 p -59.41 -43.91 92.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -58.77 -49.55 77.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.267 -0.896 . . . . 0.0 111.014 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -53.11 15.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.156 -0.965 . . . . 0.0 110.828 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 39' ' ' THR . 23.8 m-85 -67.54 -37.08 82.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 0.0 110.23 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' SER . 5.4 tttt 63.76 79.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.446 -0.784 . . . . 0.0 110.138 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 t -155.43 -62.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.52 -165.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 110.137 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -155.11 -44.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.863 . . . . 0.0 110.382 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -58.34 -62.49 1.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -70.84 -25.75 62.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.805 . . . . 0.0 110.041 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.76 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 0.0 110.396 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.68 167.77 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.797 . . . . 0.0 109.982 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -124.44 118.86 27.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.451 ' CG2' ' CB ' ' A' ' 99' ' ' HIS . 5.5 tp -82.93 104.85 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.445 ' CD1' HG13 ' A' ' 98' ' ' VAL . 15.1 t80 -116.02 136.19 53.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 110.32 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.3 26.73 4.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.374 -0.829 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.67 24.4 70.17 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -169.77 2.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.41 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -104.96 82.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 7.6 tt -62.92 92.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.994 -1.067 . . . . 0.0 108.584 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 3.0 ttpt -153.95 -143.29 0.13 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.362 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 34.8 p-10 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -53.7 -32.84 53.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.864 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -147.88 163.67 36.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.582 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -87.19 158.7 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.42 -46.55 76.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -63.31 -17.49 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.045 . . . . 0.0 109.985 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.04 -15.41 24.82 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 110.884 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.83 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.897 -1.127 . . . . 0.0 111.947 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.75 -50.15 70.35 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.554 HD12 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -152.19 160.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -1.008 . . . . 0.0 108.873 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.7 OUTLIER -110.27 -28.31 8.67 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.4 t70 -179.09 36.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.562 -0.711 . . . . 0.0 110.026 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.16 69.89 0.51 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.24 173.37 6.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.402 -1.057 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.4 p -111.86 130.77 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 110.105 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.445 HG13 ' CD1' ' A' ' 76' ' ' PHE . 34.2 m -127.41 150.35 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.451 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -90.78 133.75 34.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.106 -0.996 . . . . 0.0 110.03 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 134.67 33.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.242 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 p -149.41 125.78 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.336 -0.852 . . . . 0.0 110.185 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mttm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.71 118.2 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.701 -0.624 . . . . 0.0 110.56 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.542 HG13 HD13 ' A' ' 92' ' ' ILE . 2.3 pt -93.55 147.17 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -91.47 144.8 25.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 110.114 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 87' ' ' LEU . 14.0 m -140.81 136.49 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -107.7 117.37 33.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 0.0 110.214 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' VAL . 33.6 m -98.3 130.7 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.828 . . . . 0.0 110.249 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 122.67 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 110.0 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 3.1 p -127.09 166.16 24.4 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.11 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.49 61.12 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.728 1.383 . . . . 0.0 110.374 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.29 -47.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.13 -177.94 2.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.262 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -117.33 136.63 52.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.847 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.09 128.01 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.64 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.05 149.5 26.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 109.796 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -129.75 124.16 32.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.332 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.67 125.83 35.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.195 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.21 151.57 55.6 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.22 -0.925 . . . . 0.0 109.888 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -69.23 121.71 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.915 1.482 . . . . 0.0 110.743 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -27.89 -46.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.244 0.545 . . . . 0.0 111.566 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.76 52.38 2.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.449 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 17.8 t -112.81 124.5 52.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -0.817 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 m -71.19 144.55 50.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 64.9 t -62.43 -34.55 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.939 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -48.24 -44.07 32.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 110.873 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -53.77 21.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.009 . . . . 0.0 110.0 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.84 -37.27 78.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.487 -0.758 . . . . 0.0 110.255 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.76 -39.77 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.601 -0.687 . . . . 0.0 110.01 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -75.04 -21.89 58.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 110.318 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.94 82.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.965 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.467 ' CG1' ' CE2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -63.87 -33.2 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.718 . . . . 0.0 110.225 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' LYS . 12.5 t -64.03 -43.95 94.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.452 -0.78 . . . . 0.0 110.509 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.91 -50.66 72.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.863 . . . . 0.0 110.936 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -69.61 -53.01 20.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CE2' ' CG1' ' A' ' 61' ' ' ILE . 15.1 m-30 -67.46 -37.06 82.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 63.17 78.16 0.3 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.332 -0.855 . . . . 0.0 109.971 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 p -156.1 -66.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.744 . . . . 0.0 110.105 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.42 -175.03 3.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.793 . . . . 0.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -154.78 -40.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.09 -64.57 0.8 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.596 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' CB ' HG13 ' A' ' 102' ' ' ILE . 88.7 mm-40 -78.48 -25.78 45.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -56.86 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.395 -0.816 . . . . 0.0 110.353 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.445 ' CG1' ' CD ' ' A' ' 82' ' ' LYS . 26.0 m -109.76 163.12 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.5 mp -112.21 118.98 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.037 -1.039 . . . . 0.0 109.198 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.27 103.19 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 110.628 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.6 t80 -69.83 65.78 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.557 -0.714 . . . . 0.0 110.003 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.74 24.26 4.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.244 -0.91 . . . . 0.0 110.409 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.87 -47.16 0.82 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -161.43 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.326 -1.102 . . . . 0.0 110.274 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.89 85.23 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.397 -0.814 . . . . 0.0 110.423 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 3.3 tt -61.84 93.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' CD ' ' CG1' ' A' ' 73' ' ' VAL . 1.3 ttpm? -159.16 -150.08 0.23 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.639 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 9.0 p-10 -73.0 -19.22 61.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.527 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -52.81 -32.44 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 109.896 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -151.39 150.4 30.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.33 151.41 44.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.768 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -59.17 -46.08 89.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.428 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 1.2 pp -63.48 -18.42 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.788 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 50.8 tt0 -91.2 -16.52 27.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.2 OUTLIER 177.97 -27.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.95 -1.094 . . . . 0.0 111.799 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.66 -50.22 69.4 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.542 HD13 HG13 ' A' ' 33' ' ' ILE . 2.8 pp -148.12 175.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.231 -1.158 . . . . 0.0 109.143 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 3.1 m170 -123.45 -36.09 2.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 110.13 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 37.4 t70 -179.76 36.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 122.08 65.6 0.23 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 168.9 9.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -1.099 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -112.19 134.71 53.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 14.6 p -123.97 157.61 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 139.48 30.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.49 122.3 45.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.9 t -148.68 129.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.425 HG13 ' CB ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 109.911 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.7 mp -58.28 100.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.222 0.534 . . . . 0.0 110.791 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 5.2 pt -81.62 161.03 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.331 -0.855 . . . . 0.0 109.872 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.54 144.36 31.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.336 -0.853 . . . . 0.0 110.52 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 92' ' ' ILE . 8.4 p -137.59 114.11 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.0 109.992 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -80.92 110.28 16.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.98 127.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.455 -0.778 . . . . 0.0 110.051 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -108.85 122.54 47.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 23.1 p -126.84 166.81 20.01 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 109.836 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.04 -12.27 33.83 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.698 1.368 . . . . 0.0 110.57 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -40.76 10.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -172.35 -173.14 1.02 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.72 114.92 14.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.771 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -135.34 135.5 40.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.826 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.82 151.41 31.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.476 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.09 116.16 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 110.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.48 123.38 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 0.0 108.935 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.7 m -143.21 155.06 61.75 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.144 -0.972 . . . . 0.0 110.006 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -68.72 122.52 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.967 1.509 . . . . 0.0 110.836 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -30.0 -44.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.871 0.367 . . . . 0.0 111.858 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 49' ' ' PRO . 51.5 p-10 -78.33 43.4 0.46 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.023 -1.048 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -111.56 100.69 9.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.136 -0.977 . . . . 0.0 110.016 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -62.22 164.45 6.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.146 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 42.5 t -67.78 -35.32 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.824 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.48 -43.42 34.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.637 -1.29 . . . . 0.0 109.926 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -80.75 -37.47 30.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.326 -0.858 . . . . 0.0 110.361 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -70.08 -51.18 33.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.53 -42.32 82.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 109.738 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.9 -25.85 67.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 109.917 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.22 -44.65 79.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 110.312 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 13.7 mt -60.85 -39.67 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.0 109.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -53.57 -53.05 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.016 -1.053 . . . . 0.0 110.597 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -68.5 -53.92 20.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.331 -0.855 . . . . 0.0 111.655 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.86 -54.11 11.12 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.029 -1.044 . . . . 0.0 111.475 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.424 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -68.03 -36.61 80.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.223 -0.923 . . . . 0.0 110.21 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tptt 68.53 81.33 0.18 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -159.92 -71.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.778 . . . . 0.0 110.07 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.8 -170.14 3.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -153.63 -48.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.377 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.21 -67.23 0.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -61.19 -25.71 67.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.396 -0.815 . . . . 0.0 110.376 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.86 108.4 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.534 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -127.86 156.85 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.617 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 10.3 mt -113.51 142.79 45.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.224 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.94 89.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.426 -0.796 . . . . 0.0 110.385 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 90' ' ' HIS . 0.8 OUTLIER -78.09 83.54 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.06 63.13 2.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.631 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.22 -52.11 3.78 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -59.81 174.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -1.071 . . . . 0.0 110.23 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.14 99.23 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.836 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -65.9 79.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.6 tttt -146.21 -162.31 1.5 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.592 -0.693 . . . . 0.0 110.761 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.443 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 29.8 t70 -70.77 -14.26 62.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.649 -0.657 . . . . 0.0 110.298 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -52.06 -31.22 29.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.801 . . . . 0.0 109.756 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -147.87 -176.04 5.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.416 -0.802 . . . . 0.0 109.969 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -102.69 157.04 17.22 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.069 -1.02 . . . . 0.0 109.448 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.54 ' HG ' HG12 ' A' ' 92' ' ' ILE . 6.2 mp -66.18 -29.73 70.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 50' ' ' GLU . 2.3 mt -66.0 -19.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.153 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.9 tp60 -105.7 -10.09 16.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 112.012 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 178.03 -26.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.554 -1.341 . . . . 0.0 111.525 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.74 -37.73 90.53 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.74 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.54 HG12 ' HG ' ' A' ' 87' ' ' LEU . 1.4 mm -139.49 175.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -1.147 . . . . 0.0 110.085 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -147.03 -48.6 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.64 35.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.846 -0.533 . . . . 0.0 109.868 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.25 68.29 0.67 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -115.25 175.78 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -1.158 . . . . 0.0 110.352 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.445 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 5.0 m -114.66 147.04 40.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.23 148.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 110.446 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -90.96 115.92 28.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.24 150.07 31.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.17 -0.956 . . . . 0.0 110.537 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -169.01 125.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.05 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 110.192 -179.783 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 5.1 mttp . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.6 mp -57.47 117.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.814 -0.554 . . . . 0.0 110.813 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 48' ' ' VAL . 13.1 pt -84.9 157.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.827 . . . . 0.0 109.727 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -91.23 143.5 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.36 113.79 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.479 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.3 m -85.92 98.55 10.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 0.0 109.643 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.56 127.66 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 110.223 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.86 122.34 46.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 39.5 p -119.9 164.39 22.51 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 44.1 Cg_endo -71.31 60.85 2.59 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.61 1.321 . . . . 0.0 110.446 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -175.21 -42.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.58 176.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.387 -0.82 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -110.86 126.49 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 109.984 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -135.21 131.2 36.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.71 147.72 25.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.81 . . . . 0.0 109.833 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.15 144.93 48.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 110.281 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.25 133.2 45.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.048 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.2 m -143.6 143.12 22.51 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.234 -0.916 . . . . 0.0 108.853 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' ASN . 41.3 Cg_endo -68.22 127.98 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.622 1.328 . . . . 0.0 111.262 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -38.46 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.026 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 49' ' ' PRO . 31.7 t30 -113.36 61.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.772 -1.205 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -154.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.802 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 m -160.43 160.95 32.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.238 -0.914 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 59.7 t -61.08 -34.95 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.506 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -49.18 -46.79 45.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.682 -1.261 . . . . 0.0 109.849 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -78.01 -44.56 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 110.353 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.65 -51.42 65.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.867 . . . . 0.0 110.308 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.98 -31.74 67.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 110.037 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -23.43 35.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.2 82.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.342 -0.849 . . . . 0.0 110.186 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 4.7 mt -61.01 -36.96 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.6 p -53.85 -49.31 68.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.064 -1.022 . . . . 0.0 110.709 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -68.14 -54.21 19.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 111.521 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -54.09 10.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.092 -1.005 . . . . 0.0 111.406 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.16 -36.4 79.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.29 -0.881 . . . . 0.0 110.427 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER 71.79 80.62 0.15 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.535 -0.728 . . . . 0.0 110.094 -179.503 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.59 -164.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.493 -0.755 . . . . 0.0 109.951 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.39 173.87 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -139.46 -52.67 0.54 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.52 -61.36 2.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.171 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -61.15 -25.37 66.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 110.133 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.29 108.01 0.22 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.419 -0.801 . . . . 0.0 110.779 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.425 ' CG2' ' HD2' ' A' ' 82' ' ' LYS . 65.7 t -127.49 137.07 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.4 155.94 19.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.927 -1.108 . . . . 0.0 109.701 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.23 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.961 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 77' ' ' ALA . 48.3 t80 -69.78 70.64 0.33 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.261 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PHE . . . 28.68 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.895 -0.503 . . . . 0.0 112.283 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.58 -60.41 0.34 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.09 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.66 -160.81 0.77 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -1.174 . . . . 0.0 110.421 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -107.36 111.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.275 -0.89 . . . . 0.0 109.994 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.73 74.65 0.42 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.29 -159.23 0.95 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.37 0.605 . . . . 0.0 109.782 -178.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.1 p-10 -73.32 -13.8 61.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -51.95 -32.53 33.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -174.77 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 110.008 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.411 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.38 136.88 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.719 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 19.1 tp -55.66 -47.84 76.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.185 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 2.6 pp -73.74 -15.17 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 111.151 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 86' ' ' THR . 23.3 tt0 -104.71 7.64 34.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.133 -0.98 . . . . 0.0 112.116 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.55 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.634 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 92' ' ' ILE . . . -59.37 -41.7 97.09 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.457 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 6.2 mm -135.85 131.76 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -1.059 . . . . 0.0 110.7 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 64.7 m170 -96.52 -38.92 9.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.893 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 25.3 t0 -178.44 34.37 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.749 -0.594 . . . . 0.0 109.673 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 112.53 68.12 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -1.134 . . . . 0.0 110.114 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.6 m -111.45 144.47 40.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.505 -0.747 . . . . 0.0 109.844 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.411 ' CG1' ' CD1' ' A' ' 81' ' ' LEU . 13.9 m -137.61 136.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.29 115.38 27.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.296 -0.877 . . . . 0.0 110.077 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 tt -83.2 133.58 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.303 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -162.39 117.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 110.071 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.309 -0.869 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.96 -44.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.373 -0.829 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 52.11 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.33 81.16 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.77 152.99 29.89 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -153.24 98.52 2.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -1.096 . . . . 0.0 110.258 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -100.17 34.87 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -102.49 131.31 49.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 110.219 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.25 -161.78 33.34 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 140.62 31.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.806 1.424 . . . . 0.0 110.404 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.79 168.9 23.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.646 1.34 . . . . 0.0 110.47 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -61.93 -56.08 35.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.824 . . . . 0.0 110.274 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.1 Cg_endo -73.6 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.483 1.254 . . . . 0.0 110.391 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -166.77 94.12 0.49 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.88 120.58 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.27 -152.36 8.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.61 135.16 23.51 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.8 1.421 . . . . 0.0 110.363 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.46 -161.4 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.422 -0.799 . . . . 0.0 110.212 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.22 61.49 4.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.838 . . . . 0.0 110.23 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.21 -25.54 67.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 52.29 -174.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.344 -0.847 . . . . 0.0 110.469 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.14 -30.67 2.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -119.8 66.91 0.81 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -1.071 . . . . 0.0 110.166 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.4 82.56 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.59 83.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 110.407 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.54 98.27 4.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.136 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.47 -173.62 1.2 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.698 1.367 . . . . 0.0 110.468 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.63 26.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.309 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 51.77 81.04 0.27 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.97 38.75 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.741 1.39 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -74.37 64.81 1.16 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.5 mp -58.04 99.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.621 -0.674 . . . . 0.0 110.692 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 pt -78.74 146.29 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.123 -0.986 . . . . 0.0 109.353 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 25.5 mttp -91.44 132.76 36.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.1 p -123.13 114.25 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 m -86.25 108.09 18.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.27 128.38 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.283 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -97.26 122.73 40.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.393 -0.817 . . . . 0.0 109.838 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 65' ' ' PHE . 2.3 p -120.67 168.03 11.59 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.269 -0.895 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.6 Cg_endo -70.54 62.44 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.679 1.357 . . . . 0.0 110.238 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.67 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.6 -179.2 1.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.418 -0.801 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -105.61 115.31 30.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 134.04 54.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.58 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.5 151.53 19.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 0.0 109.714 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -126.45 150.1 48.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.458 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.16 133.43 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 28.4 m -143.93 147.62 38.99 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.092 -1.005 . . . . 0.0 109.452 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.8 Cg_endo -67.24 126.29 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.76 1.4 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 10.1 tt0 -42.45 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.93 -0.481 . . . . 0.0 111.769 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' PRO . 8.3 p-10 -115.01 63.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.601 -1.312 . . . . 0.0 110.378 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -130.58 154.99 47.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.129 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -98.8 156.46 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.364 -0.835 . . . . 0.0 109.853 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 88.3 t -60.94 -34.34 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 110.699 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.54 -44.11 36.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.051 -1.031 . . . . 0.0 110.627 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -51.65 32.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.904 . . . . 0.0 109.915 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.88 -37.07 78.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.413 -0.804 . . . . 0.0 110.129 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 2.1 mtpt -57.64 -46.05 84.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.516 -0.74 . . . . 0.0 109.8 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.25 -19.63 61.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.769 . . . . 0.0 110.167 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.27 52.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.26 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.8 mt -63.74 -41.91 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.297 -0.877 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -53.71 -52.01 61.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.63 -53.94 19.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.286 -0.884 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.17 -54.27 10.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.121 -0.987 . . . . 0.0 111.454 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.01 -36.47 80.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.176 -0.953 . . . . 0.0 110.181 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 16.4 ttpt 68.72 81.3 0.18 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 110.224 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -152.98 -65.4 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.5 -0.75 . . . . 0.0 110.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.93 -176.95 3.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -145.95 -63.91 0.32 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.86 -63.58 1.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.923 . . . . 0.0 110.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.82 -25.46 65.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.33 125.2 22.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.822 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.7 t -150.08 167.79 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 109.194 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 1.2 mm? -118.33 135.88 54.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.037 -1.04 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -97.19 96.91 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.42 -0.8 . . . . 0.0 109.948 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.445 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 9.3 t80 -95.31 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 110.232 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.49 35.86 18.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.403 -0.81 . . . . 0.0 110.697 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.01 -40.18 2.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -178.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.203 -1.175 . . . . 0.0 110.047 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.13 94.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.695 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 1.6 tp -65.07 81.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' ILE . 3.5 ttmt -137.98 -155.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.339 0.59 . . . . 0.0 110.364 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.479 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.84 -19.63 61.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 0.0 110.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.7 -32.81 53.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.852 . . . . 0.0 109.807 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -133.59 -175.45 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 109.972 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.84 130.36 53.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.96 . . . . 0.0 109.932 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 14.1 tp -55.42 -46.91 76.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.759 . . . . 0.0 110.26 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.476 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 2.5 pp -72.76 -14.98 17.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 110.472 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -88.18 -10.83 48.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 112.062 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.35 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.45 -1.407 . . . . 0.0 111.574 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 76' ' ' PHE . . . -58.97 -41.73 96.5 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.189 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.509 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 4.0 mm -134.3 113.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -1.157 . . . . 0.0 111.023 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -87.11 -33.61 19.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 108.881 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.7 t70 -179.97 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.736 -0.603 . . . . 0.0 110.015 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 128.42 69.76 0.14 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 6.0 mt -108.83 162.64 14.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -1.211 . . . . 0.0 110.129 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.8 p -112.16 134.52 53.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.313 -0.867 . . . . 0.0 110.274 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.64 151.93 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.437 -0.789 . . . . 0.0 110.148 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 110.382 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.15 127.88 47.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.99 143.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.189 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.77 104.98 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.341 -0.849 . . . . 0.0 110.37 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mtm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.71 134.75 14.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.04 141.5 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.377 -0.827 . . . . 0.0 110.108 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -161.8 89.77 0.75 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.246 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.62 -101.97 0.33 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -165.54 88.36 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -1.044 . . . . 0.0 110.231 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.43 58.74 1.61 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 0.0 110.237 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.3 m -118.0 -164.56 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.13 -163.2 30.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.16 153.64 51.65 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.798 1.42 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.72 -31.59 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.792 1.417 . . . . 0.0 110.558 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 51.87 63.16 9.67 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.22 -24.6 16.67 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.767 1.404 . . . . 0.0 110.476 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.71 133.63 56.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.37 -0.831 . . . . 0.0 110.287 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -108.31 112.69 25.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.442 -0.786 . . . . 0.0 110.257 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.73 58.16 12.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.83 66.89 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.763 1.402 . . . . 0.0 110.46 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.17 32.14 15.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.332 -0.855 . . . . 0.0 110.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.69 -42.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.16 50.51 1.87 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.87 47.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.1 -106.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.34 56.42 7.74 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.328 -1.101 . . . . 0.0 110.452 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.87 79.99 5.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -0.864 . . . . 0.0 110.28 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.61 25.74 10.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.282 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.16 62.56 0.48 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.348 -0.845 . . . . 0.0 110.226 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.05 66.25 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.685 1.361 . . . . 0.0 110.421 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.34 -172.82 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 9.1 pt-20 -151.95 79.37 6.37 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.369 -0.832 . . . . 0.0 110.267 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.8 Cg_endo -78.77 43.0 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.708 1.373 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -73.2 65.63 0.83 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 30' ' ' PRO . 2.3 mp -58.51 124.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.734 -0.604 . . . . 0.0 110.724 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 18.0 pt -108.19 158.87 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.759 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 144.37 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.81 113.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.694 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.7 m -79.21 105.22 10.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.41 127.88 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.825 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -112.88 122.28 47.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 18.1 p -122.46 166.07 18.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 109.851 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.1 Cg_endo -70.72 61.23 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.648 1.341 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.61 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.469 -0.77 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -169.65 166.98 9.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 118.6 29.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.33 135.55 40.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.898 . . . . 0.0 110.556 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.47 150.23 36.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.649 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -120.38 108.89 14.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.532 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.63 105.22 13.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 0.0 109.503 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.53 157.05 79.23 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.363 -0.836 . . . . 0.0 110.711 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.61 108.42 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.793 1.417 . . . . 0.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 88' ' ' ILE . 11.7 pt-20 -51.12 -25.49 5.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.492 -0.755 . . . . 0.0 110.741 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -53.6 -23.95 12.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 110.556 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.07 140.63 30.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.885 . . . . 0.0 110.462 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.1 m -70.82 171.83 9.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 61.6 t -66.8 -35.75 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -42.78 31.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.054 -1.029 . . . . 0.0 110.108 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.4 -46.07 64.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.615 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -69.92 -38.36 76.23 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.218 -0.927 . . . . 0.0 110.626 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.74 -45.18 86.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -74.63 -16.7 60.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.65 79.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.297 -0.877 . . . . 0.0 109.932 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.2 mt -60.87 -37.94 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.654 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 29.1 t -53.94 -46.3 71.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.915 . . . . 0.0 110.78 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -67.89 -54.76 16.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 111.44 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.79 -54.08 9.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.122 -0.987 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.38 -36.25 78.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.381 -0.824 . . . . 0.0 110.551 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 69.33 81.69 0.17 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.574 -0.704 . . . . 0.0 110.03 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -155.04 -75.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.554 -0.716 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -161.0 179.46 8.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.2 m -139.99 -62.01 0.52 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.443 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.5 -66.69 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 0.0 110.32 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.63 -25.71 64.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.288 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.91 133.61 56.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.475 -0.766 . . . . 0.0 110.747 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.1 t -152.53 158.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.418 -0.801 . . . . 0.0 109.28 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.1 mp -121.15 122.02 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.232 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.8 103.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.045 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 81' ' ' LEU . 1.5 t80 -112.14 120.14 40.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.506 -0.746 . . . . 0.0 110.076 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.69 29.31 17.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.62 59.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -172.7 2.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -1.085 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -103.27 82.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 110.363 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 1.1 tt -66.43 83.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.242 -0.911 . . . . 0.0 108.645 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.96 -147.07 0.21 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.557 -0.715 . . . . 0.0 110.253 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.52 -14.36 61.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 111.315 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -52.15 -33.62 41.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.585 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -176.63 4.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 143.86 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 109.882 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD12 ' HA3' ' A' ' 91' ' ' GLY . 11.6 tp -56.23 -46.14 79.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.496 -0.752 . . . . 0.0 110.672 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.62 -8.27 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.411 -0.806 . . . . 0.0 111.095 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 14.3 mt-30 -110.08 -1.2 17.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.954 -1.092 . . . . 0.0 112.028 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 176.54 -30.78 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.589 -1.32 . . . . 0.0 111.807 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.624 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.26 -47.68 88.06 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.543 -1.313 . . . . 0.0 109.919 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -144.42 161.95 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.273 -1.134 . . . . 0.0 110.183 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 26.8 m170 -122.64 -41.74 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.539 -0.726 . . . . 0.0 109.359 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 3.2 p30 179.71 35.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.028 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.77 67.75 0.53 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.98 175.81 5.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -111.95 121.32 44.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.765 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.94 149.23 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 110.378 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.446 -0.784 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.98 120.12 32.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.373 -0.83 . . . . 0.0 110.019 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.8 m -148.72 156.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 110.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.82 137.16 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.215 0.531 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.3 44.78 0.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.258 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.03 130.93 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.348 -0.845 . . . . 0.0 110.177 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -140.43 81.75 1.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.96 138.14 24.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.31 81.42 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.338 -1.095 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 t -85.79 172.32 10.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m 52.51 -171.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.352 -0.842 . . . . 0.0 110.433 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.01 -88.23 2.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.4 162.2 40.76 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.741 1.39 . . . . 0.0 110.421 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.85 -179.66 4.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.75 1.395 . . . . 0.0 110.345 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 -62.34 138.62 96.32 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.26 -82.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.774 1.407 . . . . 0.0 110.7 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -141.01 -71.29 0.36 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.087 -1.008 . . . . 0.0 110.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.53 -60.02 2.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.32 57.39 15.37 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.97 116.4 4.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.709 1.373 . . . . 0.0 110.406 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.72 161.78 30.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.414 -0.804 . . . . 0.0 110.223 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.45 109.55 4.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.78 -35.12 10.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -58.82 -176.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.374 -0.829 . . . . 0.0 110.367 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.9 -29.14 12.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -70.81 -16.93 62.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.12 . . . . 0.0 110.452 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.52 136.8 38.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 110.392 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.71 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.24 78.81 12.06 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 110.163 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 150.26 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.766 1.403 . . . . 0.0 110.386 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.23 -54.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.29 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.67 71.11 1.54 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.862 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.5 Cg_endo -81.93 21.05 0.99 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.756 1.398 . . . . 0.0 111.454 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.46 67.25 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' PRO . 18.3 mm -58.47 124.15 11.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.705 -0.622 . . . . 0.0 110.85 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -106.77 149.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 0.0 109.522 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 144.23 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 110.647 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -132.92 130.38 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 109.583 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.17 110.25 22.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.47 127.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 122.83 47.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -125.73 169.74 10.83 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.301 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.94 60.51 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.702 1.369 . . . . 0.0 110.372 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.7 -46.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.316 -0.865 . . . . 0.0 109.812 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -173.19 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.101 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -123.12 129.82 51.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -135.12 127.63 30.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -84.86 147.73 26.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.397 -0.815 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -125.08 145.84 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.533 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.35 132.13 45.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.0 108.991 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.5 m -143.16 148.83 46.41 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.975 . . . . 0.0 110.266 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 40.5 Cg_endo -71.08 119.43 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.705 1.371 . . . . 0.0 110.418 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -32.73 -41.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.223 0.535 . . . . 0.0 111.642 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -83.88 50.97 1.93 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.051 -1.03 . . . . 0.0 110.571 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 51.4 p -126.21 112.77 16.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.29 156.86 21.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 61.0 t -63.02 -35.4 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.197 -0.94 . . . . 0.0 110.913 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -49.31 -50.15 40.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.123 -0.985 . . . . 0.0 111.055 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.0 -55.27 27.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.99 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.91 -36.57 77.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.457 -0.777 . . . . 0.0 110.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -57.15 -36.74 71.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 0.0 110.386 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -79.05 -24.47 43.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.61 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 0.0 109.573 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.8 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -66.45 -44.55 82.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 110.625 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -58.85 -53.12 61.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.253 -0.904 . . . . 0.0 110.952 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -52.68 63.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.688 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 39' ' ' THR . 10.5 m-85 -67.5 -36.91 82.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 0.0 110.445 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.91 79.52 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.469 -0.769 . . . . 0.0 110.091 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 t -153.92 -71.08 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.38 -0.825 . . . . 0.0 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.87 -171.57 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.0 m -153.51 -57.79 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.36 -0.837 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.49 -70.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.322 -0.861 . . . . 0.0 110.413 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -60.76 -25.53 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tt -52.93 106.46 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 110.763 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG2' ' HD2' ' A' ' 82' ' ' LYS . 51.0 t -127.14 151.18 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.651 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 5.0 mp -102.04 146.2 28.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.76 83.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.45 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.2 t80 -98.84 124.04 43.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.386 -0.821 . . . . 0.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.07 26.35 6.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.37 -0.831 . . . . 0.0 110.556 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.32 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 1.2 tttm -129.48 136.54 50.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -1.09 . . . . 0.0 110.061 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 84' ' ' GLN . 1.4 pp -59.68 88.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.816 . . . . 0.0 111.351 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 1.3 tt -66.79 86.87 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -140.34 -149.74 0.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.01 -177.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 37.7 p-10 -74.1 -20.71 60.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.698 . . . . 0.0 110.834 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.455 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -52.7 -32.75 44.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.103 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.91 140.21 46.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 147.94 33.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.541 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 13.8 tp -57.59 -48.52 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.705 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 1.8 pp -73.04 -13.7 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.051 -1.031 . . . . 0.0 110.367 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.73 -15.09 46.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 111.542 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.424 ' CE1' ' HD2' ' A' ' 79' ' ' LYS . 4.9 t-80 -171.69 -38.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.624 -1.297 . . . . 0.0 111.431 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . -59.44 -49.67 76.01 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.386 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.495 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.26 146.37 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -1.232 . . . . 0.0 110.808 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 13.1 m170 -109.76 -35.49 6.17 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.5 t0 -177.68 31.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.29 0.567 . . . . 0.0 109.861 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.4 69.33 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.17 174.22 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -1.223 . . . . 0.0 109.966 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.8 p -115.84 147.25 41.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 7.6 p -147.68 146.14 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.402 -0.811 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -90.63 116.15 28.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.489 -0.757 . . . . 0.0 110.118 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.17 121.28 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.306 -0.871 . . . . 0.0 110.13 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.95 131.85 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.386 -0.821 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -99.38 131.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.819 . . . . 0.0 110.218 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.218 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.35 116.98 19.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.7 -30.14 21.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.265 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -106.49 53.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.315 -0.866 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.04 83.8 0.21 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 167.25 16.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -1.098 . . . . 0.0 110.22 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -80.87 172.31 13.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -148.15 110.45 4.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.93 -79.08 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 113.11 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.731 1.385 . . . . 0.0 110.374 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.05 -27.99 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.661 1.348 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -105.54 127.6 28.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.88 -163.83 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.679 1.357 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.54 113.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.62 -49.59 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.9 -69.16 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.03 -28.2 13.21 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.826 1.435 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.31 -45.83 83.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.0 110.347 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 174.93 5.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.391 -0.818 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.37 -166.84 0.56 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.38 -0.825 . . . . 0.0 110.18 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.86 80.42 6.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.18 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 55.5 0.62 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 p -83.93 -73.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.347 -1.09 . . . . 0.0 110.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.82 62.88 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.77 93.2 5.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.239 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 27' ' ' PRO . . . -75.1 -55.12 2.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 110.64 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 26' ' ' ALA . 47.4 Cg_endo -74.41 122.96 7.83 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.403 1.212 . . . . 0.0 110.445 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.8 131.43 24.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 51.9 73.09 1.02 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.377 -0.827 . . . . 0.0 110.512 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ILE . 52.1 Cg_endo -81.7 37.87 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.774 1.407 . . . . 0.0 111.361 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 67.26 0.52 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.2 mp -58.47 99.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.63 -0.669 . . . . 0.0 110.55 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 50' ' ' GLU . 4.3 pt -78.83 150.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -94.23 144.59 25.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 110.972 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.97 113.96 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.495 -0.753 . . . . 0.0 109.866 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -85.89 112.72 21.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 110.605 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.16 127.96 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.55 122.51 43.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -124.12 170.73 8.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.812 . . . . 0.0 109.921 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.4 Cg_endo -68.94 -16.06 40.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.697 1.367 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -49.13 6.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -173.54 174.47 3.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -103.04 122.05 43.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.949 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.14 135.48 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -90.29 150.97 21.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.443 -0.785 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.59 128.09 47.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.369 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.86 124.71 36.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.227 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.3 m -142.98 154.71 62.19 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 109.943 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.2 Cg_endo -66.48 121.65 8.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.814 1.429 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB2' HG21 ' A' ' 88' ' ' ILE . 17.6 pt-20 -36.31 -38.96 0.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.214 0.531 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.445 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 71.9 m-80 -86.96 53.07 2.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.516 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.5 p -119.23 154.02 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.345 -0.847 . . . . 0.0 110.194 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 t -103.02 148.04 26.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.011 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 71.3 t -59.38 -34.37 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -48.59 -46.12 38.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.047 -1.033 . . . . 0.0 110.547 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.72 -51.39 49.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -59.89 -36.91 77.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.54 -39.02 75.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.57 -22.13 47.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.22 78.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 20.0 mt -60.78 -38.76 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 109.669 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -53.75 -53.12 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.126 -0.984 . . . . 0.0 110.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -68.52 -54.76 14.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 111.694 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -72.55 -54.55 8.87 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.094 -1.004 . . . . 0.0 111.568 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.3 -36.48 79.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.189 -0.944 . . . . 0.0 110.443 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tttt 71.81 73.69 0.17 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -160.51 -153.91 0.35 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.529 -0.732 . . . . 0.0 109.959 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -173.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -148.18 -61.9 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.81 -63.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -27.09 65.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.158 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.71 105.93 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.489 -0.757 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.82 161.54 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 9.8 mt -113.7 139.66 48.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 110.084 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.42 93.54 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 91' ' ' GLY . 3.2 t80 -96.96 115.21 27.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.77 27.57 7.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -0.838 . . . . 0.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.79 -39.7 2.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -176.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -1.073 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.51 90.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.323 -0.861 . . . . 0.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 10.1 tt -61.84 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 20.5 tttt -154.03 -148.16 0.24 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.418 -0.801 . . . . 0.0 110.655 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t70 -72.13 -15.14 61.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.129 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -53.19 -32.52 48.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.68 161.38 39.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.631 -0.668 . . . . 0.0 109.9 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.425 ' OG1' ' CG ' ' A' ' 89' ' ' GLN . 64.4 p -79.21 165.0 23.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.697 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.24 -46.35 77.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.86 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 50' ' ' GLU . 1.8 pt -64.62 -18.95 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.032 -1.043 . . . . 0.0 110.453 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' CG ' ' OG1' ' A' ' 86' ' ' THR . 27.5 mm-40 -92.11 -15.79 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.922 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 178.42 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.027 -1.046 . . . . 0.0 111.638 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.04 -50.23 67.93 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.45 HG21 ' HG ' ' A' ' 87' ' ' LEU . 2.7 pp -148.86 171.65 2.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.529 -0.983 . . . . 0.0 108.706 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -118.65 -33.23 4.33 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.651 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.6 t70 179.83 34.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.569 -0.707 . . . . 0.0 109.97 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.05 69.98 0.34 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.04 -172.13 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m -131.42 146.35 52.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' CG2' ' CD2' ' A' ' 74' ' ' LEU . 27.4 m -143.7 149.51 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.356 -0.84 . . . . 0.0 110.504 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.57 118.71 30.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 110.352 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' CA ' HD22 ' A' ' 74' ' ' LEU . 6.8 tt -77.37 149.52 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.8 p -171.38 138.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.89 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -99.32 126.34 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.9 mttt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.19 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.204 0.526 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.13 102.54 15.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.19 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -96.21 38.92 1.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -97.56 27.77 4.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.307 -0.871 . . . . 0.0 110.251 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.72 -166.91 1.33 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.56 -46.08 41.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.352 -1.087 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -114.96 -26.77 7.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -0.832 . . . . 0.0 110.341 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m 54.99 177.5 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.304 -0.872 . . . . 0.0 110.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.6 93.52 0.1 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 158.67 51.33 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.66 1.347 . . . . 0.0 110.435 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.15 -164.82 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 0.0 110.321 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -62.84 -57.78 19.95 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.491 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 12' ' ' ARG . 46.3 Cg_endo -72.36 179.15 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.506 1.266 . . . . 0.0 110.487 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.92 -41.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 0.0 110.265 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.94 177.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.328 -0.858 . . . . 0.0 110.32 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.69 -145.83 5.64 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 19' ' ' ALA . 46.0 Cg_endo -72.64 65.86 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.687 1.361 . . . . 0.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 55.77 -85.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 56.13 174.22 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -1.0 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.23 -44.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 110.248 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -141.2 -61.38 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.55 132.29 20.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -125.55 54.57 1.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 110.225 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.51 133.54 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 0.0 110.242 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.21 161.51 17.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.352 -0.842 . . . . 0.0 110.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.63 147.85 39.79 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.0 110.149 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.02 -53.53 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.777 1.409 . . . . 0.0 110.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.92 -48.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.326 -0.858 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 52.15 82.6 0.24 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.3 Cg_endo -71.68 -93.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.811 1.427 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 43.68 41.53 3.64 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.08 118.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.276 0.56 . . . . 0.0 110.905 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 HG13 HD11 ' A' ' 92' ' ' ILE . 1.9 pt -87.85 152.33 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -91.49 144.61 25.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 87' ' ' LEU . 18.3 m -138.86 140.32 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.455 -0.778 . . . . 0.0 110.043 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -109.56 104.25 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.857 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 127.84 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 122.47 43.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.957 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 7.3 p -113.72 166.63 10.91 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.947 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.8 Cg_endo -71.27 61.31 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.604 1.318 . . . . 0.0 110.424 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.15 -42.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.7 -169.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.407 -0.808 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -123.42 129.07 50.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -0.816 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -135.16 134.89 40.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.16 150.87 20.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.03 144.18 51.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.469 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.45 46.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.402 -0.811 . . . . 0.0 109.235 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.1 m -141.2 146.04 41.2 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.4 Cg_endo -67.97 122.07 9.15 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.669 1.352 . . . . 0.0 110.377 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.7 pp20? -31.07 -39.1 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' PRO . 43.9 p-10 -92.03 49.5 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.725 -1.235 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 1.7 t -114.38 112.96 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.068 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -65.5 147.96 52.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 90.3 t -56.41 -34.8 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -48.79 -43.83 38.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.05 -1.031 . . . . 0.0 110.53 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -68.44 -53.54 22.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.189 -0.945 . . . . 0.0 109.96 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.87 -36.82 77.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.498 -0.751 . . . . 0.0 110.365 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 4.8 mtpt -57.42 -43.04 83.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.747 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 -23.25 54.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.525 -0.734 . . . . 0.0 109.941 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.94 86.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.2 mt -60.77 -40.05 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.404 -0.81 . . . . 0.0 109.729 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -53.71 -51.95 61.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -68.42 -54.64 15.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 111.666 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mmt-85 -72.36 -54.3 9.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.091 -1.006 . . . . 0.0 111.511 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.08 -36.35 79.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.373 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tptm 72.31 76.02 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.594 -0.691 . . . . 0.0 110.082 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.9 t -161.9 -153.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.818 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.47 165.11 24.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -136.13 -59.69 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.94 -72.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -57.96 -25.17 60.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.421 -0.799 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.81 128.47 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.477 -0.764 . . . . 0.0 110.763 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -151.1 167.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.242 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -117.92 133.38 55.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 0.0 110.159 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.09 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 32.0 t80 -70.07 62.73 0.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.637 -0.665 . . . . 0.0 110.554 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.28 26.49 2.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.143 -0.973 . . . . 0.0 110.738 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.03 -48.19 0.64 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -83.01 -166.99 1.49 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -1.062 . . . . 0.0 110.098 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.47 96.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -65.23 79.94 0.05 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' ILE . 3.6 ttmt -140.55 -156.5 0.68 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.32 -14.97 61.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -33.09 69.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.804 . . . . 0.0 110.015 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -143.8 164.55 30.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 110.767 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.27 153.47 17.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.872 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.5 -46.65 75.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.342 -0.849 . . . . 0.0 110.897 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 1.1 pp -63.66 -19.62 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.023 . . . . 0.0 109.847 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -89.43 -18.79 26.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.805 . . . . 0.0 110.587 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.96 -26.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.948 -1.095 . . . . 0.0 112.063 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.32 -50.38 67.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -149.61 162.83 4.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -1.081 . . . . 0.0 108.682 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 5.9 m-70 -113.13 -30.8 6.85 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 109.75 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.3 t0 179.75 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 109.72 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.94 73.86 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.83 170.88 8.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -1.061 . . . . 0.0 110.295 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 t -115.25 144.64 43.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.68 154.85 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -90.83 144.36 25.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.44 121.96 42.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.901 . . . . 0.0 110.052 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.04 150.7 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.303 -0.873 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.61 123.77 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.341 -0.849 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.192 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.215 0.531 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.46 -56.24 0.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 52.27 78.8 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.86 106.85 3.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.872 . . . . 0.0 110.232 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.76 105.22 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.51 138.01 54.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -1.072 . . . . 0.0 110.171 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.6 p -129.25 123.24 31.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.846 . . . . 0.0 110.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -90.39 -169.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.216 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.05 -160.49 34.07 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.9 133.9 20.76 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.807 1.425 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.24 -29.55 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.636 1.335 . . . . 0.0 110.376 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.62 94.22 11.62 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.311 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 179.21 5.35 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.74 1.39 . . . . 0.0 110.337 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -142.43 35.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -165.33 49.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.25 71.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.83 148.08 45.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.786 1.414 . . . . 0.0 110.453 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.45 -34.8 6.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.5 -69.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.77 -70.24 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -116.53 -70.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -96.75 -175.67 35.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -115.89 136.09 53.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.233 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 52.41 87.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.392 -0.817 . . . . 0.0 110.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.74 -46.07 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 110.259 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' N ' ' HD2' ' A' ' 27' ' ' PRO . . . -68.74 -54.92 12.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 26' ' ' ALA . 48.2 Cg_endo -74.58 177.42 8.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.559 1.294 . . . . 0.0 110.382 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.72 80.77 0.5 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.815 . . . . 0.0 110.28 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.93 67.07 2.07 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.6 Cg_endo -82.34 29.07 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.708 1.372 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -69.68 69.21 0.28 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 30' ' ' PRO . 28.1 mm -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.593 -0.692 . . . . 0.0 110.758 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.0 pt -110.78 144.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.636 -0.665 . . . . 0.0 109.74 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 144.53 25.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.823 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 92' ' ' ILE . 7.4 p -135.94 113.57 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.0 109.759 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -85.17 102.35 13.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.92 127.63 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.97 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -111.44 122.71 48.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.164 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 29.1 p -120.37 168.24 10.96 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.454 -0.779 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.52 -10.28 28.36 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.577 1.303 . . . . 0.0 110.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -42.39 7.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.08 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.08 157.49 5.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -107.42 118.34 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 110.078 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -135.32 135.62 40.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.943 . . . . 0.0 110.811 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.51 154.38 22.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.47 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -128.08 128.71 45.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.36 129.93 37.28 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.31 153.71 59.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.041 -1.037 . . . . 0.0 110.492 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' GLU . 42.8 Cg_endo -71.59 119.82 6.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.875 1.461 . . . . 0.0 110.443 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -36.22 -37.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.812 -0.555 . . . . 0.0 111.091 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -82.9 50.12 1.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 t -126.66 141.25 51.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m -92.86 156.77 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 84.0 t -59.71 -34.59 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -48.96 -43.67 40.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.121 . . . . 0.0 110.532 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.74 -54.63 14.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -0.882 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.88 -36.97 78.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.385 -0.822 . . . . 0.0 110.191 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.32 -39.04 75.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.591 -0.693 . . . . 0.0 109.587 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.23 -18.78 44.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.501 -0.749 . . . . 0.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -49.68 71.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 12.8 mt -60.91 -36.34 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.358 -0.838 . . . . 0.0 109.693 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -53.85 -51.73 62.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 110.535 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -68.43 -54.28 18.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.318 -0.864 . . . . 0.0 111.711 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -54.07 10.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.115 -0.991 . . . . 0.0 111.497 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.31 -36.24 79.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.278 -0.889 . . . . 0.0 110.351 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 8.5 mttm 68.72 81.86 0.18 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.601 -0.687 . . . . 0.0 109.942 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -157.12 -73.56 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 110.206 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.45 -165.6 0.78 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.411 -0.806 . . . . 0.0 110.106 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -153.19 -51.19 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.594 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.36 -75.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.0 110.407 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -25.56 62.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.55 104.24 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.387 -0.821 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.59 156.1 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.503 -0.748 . . . . 0.0 109.38 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.519 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -118.73 141.2 48.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.973 -1.079 . . . . 0.0 110.519 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 75' ' ' ILE . 46.5 mm -101.16 93.68 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.5 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 91' ' ' GLY . 1.6 t80 -84.89 95.4 9.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.237 -0.914 . . . . 0.0 110.348 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.12 46.3 26.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 110.694 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.15 -45.72 2.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.0 179.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -115.84 93.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.267 -0.896 . . . . 0.0 110.855 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -65.28 82.44 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -144.09 -161.5 1.29 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.442 0.639 . . . . 0.0 110.491 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.5 p30 -73.33 -14.95 61.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.67 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 109.565 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -139.06 168.98 18.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 0.0 109.752 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.24 145.99 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.457 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.476 HD13 ' HA3' ' A' ' 91' ' ' GLY . 16.5 tp -55.81 -47.01 77.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.39 -28.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.659 . . . . 0.0 110.058 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -76.82 -6.21 51.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.704 . . . . 0.0 111.761 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.39 -37.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.536 -1.353 . . . . 0.0 111.759 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.476 ' HA3' HD13 ' A' ' 87' ' ' LEU . . . -58.98 -48.31 86.48 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.161 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.448 ' CD1' ' C ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -142.4 156.55 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.434 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -115.98 -41.63 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -177.87 34.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 109.87 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.95 71.08 0.22 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.57 174.87 5.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -1.104 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.7 m -116.51 147.31 41.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 74' ' ' LEU . 7.4 p -149.96 150.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.404 -0.81 . . . . 0.0 110.296 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.421 ' CD2' ' HD3' ' A' ' 38' ' ' LYS . 60.0 m170 -90.68 132.83 35.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.4 p -166.21 144.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.837 . . . . 0.0 110.177 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.519 HG22 HD13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.4 136.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.384 -0.823 . . . . 0.0 110.219 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.17 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.29 0.566 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.67 96.98 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.25 -174.41 2.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -105.97 -171.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.08 99.81 2.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -131.95 -176.52 4.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -1.029 . . . . 0.0 110.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -78.99 111.3 15.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.37 -0.831 . . . . 0.0 110.206 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 t -62.97 87.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.83 -166.92 42.73 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 127.48 12.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.815 1.429 . . . . 0.0 110.28 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 -44.41 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.558 1.294 . . . . 0.0 110.453 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.08 136.62 16.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.139 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.79 102.92 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.594 1.313 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.27 35.4 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.11 -43.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 0.0 110.18 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.29 77.16 0.95 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.17 94.53 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.854 1.45 . . . . 0.0 110.484 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.6 -79.95 0.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.98 -75.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.88 48.61 1.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.25 92.78 1.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.361 -0.837 . . . . 0.0 110.216 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.28 8.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 p -117.26 -33.75 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.313 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 101.48 10.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.69 128.26 49.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.446 -0.783 . . . . 0.0 110.163 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 147.07 98.3 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.27 88.63 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.749 1.394 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.87 32.46 5.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.268 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.47 114.39 58.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 31' ' ' LYS . 46.5 Cg_endo -71.34 -93.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.671 1.353 . . . . 0.0 110.771 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 30' ' ' PRO . 28.8 mttt 45.02 37.59 2.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.98 -1.075 . . . . 0.0 108.104 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.28 116.48 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.668 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.496 HG13 HD12 ' A' ' 92' ' ' ILE . 2.1 pt -93.73 157.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.372 -0.83 . . . . 0.0 109.917 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -91.62 144.6 25.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.89 . . . . 0.0 110.865 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.7 113.79 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.495 -0.753 . . . . 0.0 109.992 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 34.4 m -88.91 108.47 19.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.01 127.87 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.799 . . . . 0.0 110.09 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.75 122.57 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p -121.64 165.12 20.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.949 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.41 60.78 2.66 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.637 1.335 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -175.1 -46.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.485 -0.759 . . . . 0.0 109.699 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -171.32 -176.74 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 110.018 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 126.88 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.03 120.03 22.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.17 147.17 28.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -123.78 121.1 34.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.32 34.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.5 m -143.34 150.35 51.36 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -67.63 123.33 10.64 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.768 1.404 . . . . 0.0 110.733 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -27.42 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.07 0.462 . . . . 0.0 112.058 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.3 p30 -85.54 47.38 1.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.115 -0.991 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -111.48 103.49 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.075 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -60.62 150.78 30.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 94.9 t -59.88 -34.28 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.731 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -48.38 -48.86 36.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.069 -1.02 . . . . 0.0 110.668 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -64.63 -50.56 66.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 109.726 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' CZ ' HD13 ' A' ' 61' ' ' ILE . 56.5 t80 -60.44 -36.87 79.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.441 -0.787 . . . . 0.0 110.16 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.59 -35.38 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.662 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.08 -17.99 31.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.89 74.65 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 11.2 mt -60.91 -37.48 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -53.9 -52.1 61.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.07 -1.019 . . . . 0.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -54.43 16.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.255 -0.903 . . . . 0.0 111.574 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -54.45 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 111.509 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.491 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.17 -36.21 79.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.868 . . . . 0.0 110.36 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 74.03 77.75 0.12 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.2 p -163.4 -153.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 109.913 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -68.95 -178.57 1.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -146.71 -56.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 110.382 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.61 -64.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.854 . . . . 0.0 110.042 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -64.08 -25.47 68.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.43 106.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.93 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.57 163.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.493 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -115.16 139.25 50.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.012 -1.055 . . . . 0.0 109.918 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 1.1 mm -94.13 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 110.394 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 30.5 t80 -70.08 167.85 16.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.756 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.52 69.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 110.459 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.56 25.07 4.75 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 -174.33 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.232 -1.157 . . . . 0.0 109.994 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -116.72 109.41 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.992 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.72 72.03 0.36 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -131.62 -159.71 0.99 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.368 0.604 . . . . 0.0 109.949 -178.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.7 t0 -72.75 -14.94 61.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 110.16 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -58.08 -33.2 68.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 110.15 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -142.38 166.28 25.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 110.602 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.47 155.03 17.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.531 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.37 -46.65 75.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.413 HG22 ' CA ' ' A' ' 50' ' ' GLU . 1.3 pp -63.93 -17.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 7.4 tm0? -94.98 -14.64 24.2 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.426 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 175.94 -25.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.988 -1.07 . . . . 0.0 111.86 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.18 -49.89 71.47 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.496 HD12 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -149.15 168.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.345 -1.091 . . . . 0.0 109.158 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 44.3 m170 -114.72 -33.5 5.48 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.7 t0 -179.01 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.566 -0.709 . . . . 0.0 109.911 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.66 70.43 0.36 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.2 174.48 5.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -1.066 . . . . 0.0 110.2 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.401 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 67.2 p -111.76 145.5 39.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.38 -0.825 . . . . 0.0 110.243 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 74' ' ' LEU . 59.0 t -143.28 151.13 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.272 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -90.26 115.78 27.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 110.213 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -74.22 148.38 41.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.59 152.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.805 . . . . 0.0 110.076 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.8 136.61 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.243 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.161 0.505 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.29 -158.77 0.7 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 110.189 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.69 -179.8 3.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 0.0 110.276 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -127.95 167.87 16.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.95 45.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -131.22 65.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.448 -1.031 . . . . 0.0 110.21 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 p -139.24 -64.97 0.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.794 . . . . 0.0 110.186 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.43 117.41 18.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.15 103.79 0.33 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.96 112.94 3.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.586 1.308 . . . . 0.0 110.287 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.33 165.57 32.27 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.607 1.319 . . . . 0.0 110.452 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.7 ptt-85 -136.87 158.25 73.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.376 -0.828 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.99 169.11 22.99 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.709 1.373 . . . . 0.0 110.442 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 t -165.11 147.16 7.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.07 78.02 1.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.224 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.15 -85.43 1.78 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.44 106.02 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.786 1.414 . . . . 0.0 110.384 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.02 -40.15 54.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 110.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.29 -161.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.405 -0.81 . . . . 0.0 110.124 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.82 83.22 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.867 . . . . 0.0 110.118 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -159.27 145.13 16.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.25 119.13 0.49 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -81.39 -39.51 24.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -1.099 . . . . 0.0 110.249 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.85 66.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.82 . . . . 0.0 110.202 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.47 -67.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.39 -0.819 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.1 93.65 46.61 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.33 -83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.798 1.42 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 176.23 6.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.036 -1.04 . . . . 0.0 110.216 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -111.75 142.11 26.01 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 110.119 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' LYS . 48.1 Cg_endo -73.27 -94.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.675 1.355 . . . . 0.0 110.741 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' PRO . 6.6 mttp 43.57 39.3 2.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 108.286 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.2 mp -58.44 115.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.684 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.49 HG13 HD12 ' A' ' 92' ' ' ILE . 3.5 pt -87.99 166.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.49 144.28 25.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 27.5 t -134.62 113.45 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.186 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.92 106.41 17.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 110.026 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -95.01 129.42 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 0.0 110.337 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -96.86 123.08 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.45 -0.781 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 1.8 p -121.34 169.32 9.28 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.049 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.7 Cg_endo -68.1 -12.32 34.77 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.642 1.338 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -94.37 -48.19 6.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.92 -165.57 0.37 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.402 -0.811 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -115.45 130.66 56.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.93 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.7 135.19 43.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -0.919 . . . . 0.0 110.669 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -92.08 153.67 19.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.789 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -136.76 129.45 30.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.12 126.43 37.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.22 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.32 151.22 54.33 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.937 . . . . 0.0 109.768 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.6 Cg_endo -67.45 123.11 10.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.853 1.449 . . . . 0.0 110.469 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 51' ' ' ASN . 22.0 pt-20 -30.69 -39.78 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 120.965 0.412 . . . . 0.0 112.106 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.478 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 11.2 p30 -91.27 49.56 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -111.52 111.4 22.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.034 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -59.94 144.69 48.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 110.306 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 70.5 t -60.58 -34.19 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -50.38 35.04 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.067 -1.021 . . . . 0.0 110.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -65.9 -50.63 63.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -59.72 -36.26 76.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.544 -0.722 . . . . 0.0 109.999 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -57.55 -38.39 74.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 109.727 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -81.96 -20.34 38.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.55 84.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.006 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.66 -30.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.525 -0.734 . . . . 0.0 110.134 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -60.57 -43.98 96.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.778 . . . . 0.0 110.509 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.67 -50.84 69.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.312 -0.868 . . . . 0.0 111.0 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -71.18 -52.66 17.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.204 -0.935 . . . . 0.0 111.045 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 39' ' ' THR . 16.6 m-85 -65.66 -36.55 83.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.89 . . . . 0.0 110.306 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 12.3 tttt 68.8 57.74 0.4 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.572 -0.705 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -138.02 -154.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.403 -0.811 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.25 160.71 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -113.01 -67.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 109.114 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 40.33 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.833 -0.542 . . . . 0.0 111.011 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' THR . 1.1 mp0 -79.08 -49.31 12.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER 36.18 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.708 -0.62 . . . . 0.0 111.457 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.454 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . 4.6 p -136.28 147.25 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.708 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 8.2 mp -117.3 142.37 47.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.83 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.1 mm -92.79 100.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.821 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 82.0 t80 -74.59 78.28 1.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.501 -0.749 . . . . 0.0 109.522 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 55.79 23.53 6.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.41 -41.41 1.51 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -164.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.233 -1.157 . . . . 0.0 110.393 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -122.53 88.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 10.3 tt -65.27 86.49 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 73' ' ' VAL . 2.8 tttt -147.25 -150.25 0.33 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.571 -0.706 . . . . 0.0 110.53 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 19.5 p-10 -72.42 -21.6 61.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.522 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.42 -33.04 63.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.85 . . . . 0.0 110.006 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.34 157.11 44.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -84.91 161.7 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.496 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -65.93 -45.87 80.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.2 pt -62.13 -17.95 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 15.8 mm100 -98.08 -12.54 21.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -0.841 . . . . 0.0 111.191 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.99 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.883 -1.135 . . . . 0.0 111.934 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.51 -50.17 69.54 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.49 HD12 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -150.55 161.92 3.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.441 -1.035 . . . . 0.0 108.963 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -112.27 -24.51 9.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.992 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p30 179.84 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.373 -0.83 . . . . 0.0 110.077 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.97 68.08 0.78 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.03 -174.49 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -1.073 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -111.52 131.49 55.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.91 153.6 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 0.0 110.475 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -90.58 144.46 25.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.6 136.89 54.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.145 -0.972 . . . . 0.0 110.081 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 73' ' ' VAL . 11.1 p -166.12 170.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 tt -105.9 136.26 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.298 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.184 0.516 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.25 -173.53 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.403 -0.81 . . . . 0.0 110.267 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.66 54.43 10.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -119.65 53.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.6 97.73 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.62 80.14 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.39 -1.065 . . . . 0.0 110.395 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.0 m -89.62 -167.73 1.94 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m -110.48 -29.38 8.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.6 75.78 1.17 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.97 148.57 45.52 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.745 1.392 . . . . 0.0 110.355 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 -32.56 8.18 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.753 1.397 . . . . 0.0 110.314 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.64 142.85 14.8 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.06 -51.79 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.634 1.334 . . . . 0.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -159.78 -45.72 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -167.24 170.83 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.814 . . . . 0.0 110.129 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.55 -85.49 0.18 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.06 152.98 51.85 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.788 1.415 . . . . 0.0 110.448 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.47 117.1 24.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -0.823 . . . . 0.0 110.107 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.23 -56.4 1.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.875 . . . . 0.0 110.307 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.95 -52.99 2.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.235 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 52.17 89.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.78 98.68 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.1 p -126.42 109.24 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.379 -1.071 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.83 112.17 13.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.137 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.48 38.38 3.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.42 151.41 40.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.46 104.1 1.74 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.788 1.415 . . . . 0.0 110.444 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.26 -36.13 9.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 96.86 5.07 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.749 . . . . 0.0 110.133 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' ILE . 50.2 Cg_endo -81.16 30.09 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.699 1.368 . . . . 0.0 111.379 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.27 68.04 0.49 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 30' ' ' PRO . 41.4 mm -58.45 140.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.721 -0.612 . . . . 0.0 110.816 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 50' ' ' GLU . 4.5 pt -119.64 152.33 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.412 -0.805 . . . . 0.0 109.353 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -91.03 144.16 25.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.616 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 38.6 t -132.81 113.41 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.612 -0.68 . . . . 0.0 109.784 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 6.5 m -91.44 102.53 15.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.85 127.55 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 110.184 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 122.51 46.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.0 109.846 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 51.5 p -124.18 166.9 17.14 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.447 -0.783 . . . . 0.0 109.864 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.1 Cg_endo -68.22 -12.65 35.69 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.622 1.327 . . . . 0.0 110.528 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -92.32 -44.05 8.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -172.5 -167.23 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 110.294 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 3.1 ptmt -130.96 121.55 25.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 109.951 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -135.47 135.48 40.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.124 -0.985 . . . . 0.0 110.809 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.02 150.4 24.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.587 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.35 130.17 48.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.668 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.31 36.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.4 154.58 63.91 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 52' ' ' SER . 41.1 Cg_endo -69.51 120.48 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.671 1.353 . . . . 0.0 110.358 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' HB2' HG21 ' A' ' 88' ' ' ILE . 1.7 pp20? -37.61 -37.61 0.22 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.875 -0.515 . . . . 0.0 111.689 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -86.74 52.04 2.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.029 -1.045 . . . . 0.0 110.776 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.2 t -126.42 126.5 43.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 t -70.09 151.29 45.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 91.6 t -61.77 -34.76 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.778 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -43.56 28.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.982 -1.074 . . . . 0.0 110.579 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -70.34 -46.53 63.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -65.71 -37.87 87.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.91 -39.28 77.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.406 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -20.94 60.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.607 -0.683 . . . . 0.0 109.942 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.86 -50.74 61.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 mt -63.13 -36.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -53.63 -44.92 69.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -54.72 15.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 111.336 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -72.89 -54.37 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.1 -1.0 . . . . 0.0 111.29 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.34 -36.5 79.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.2 tptt 71.7 79.19 0.16 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 t -131.78 -151.85 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 110.051 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -92.88 -17.28 24.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 110.565 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m 66.14 -66.09 0.17 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.783 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.7 t70 -55.12 -63.48 1.14 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.127 -0.983 . . . . 0.0 110.14 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -68.93 -25.3 64.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.798 . . . . 0.0 110.02 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.6 tp -56.21 95.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.397 -0.814 . . . . 0.0 110.826 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.47 154.56 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.783 . . . . 0.0 109.289 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -115.06 141.13 48.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.014 -1.054 . . . . 0.0 110.315 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 99' ' ' HIS . 50.2 mm -94.75 98.63 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 75.6 t80 -68.74 72.63 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.407 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.83 38.41 19.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.895 . . . . 0.0 110.579 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.12 -50.13 0.89 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -74.21 -161.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -126.83 93.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.388 -0.82 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 7.7 tt -64.05 89.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -152.81 -154.3 0.53 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.772 -0.58 . . . . 0.0 110.17 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.453 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.5 p30 -72.66 -19.52 61.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.431 -0.793 . . . . 0.0 110.219 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -33.05 62.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.71 149.01 33.64 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.476 -0.765 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -74.18 161.79 29.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 109.843 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.2 tp -65.56 -46.32 79.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 110.37 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' A' ' 50' ' ' GLU . 2.1 pp -65.46 -18.37 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 110.211 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -96.79 -10.71 26.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 111.1 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.99 -30.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.935 -1.103 . . . . 0.0 111.962 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -59.08 -51.01 61.76 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.492 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -149.83 177.14 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.371 -1.076 . . . . 0.0 108.963 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.455 ' N ' HD13 ' A' ' 92' ' ' ILE . 2.1 m-70 -126.94 -31.1 2.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.71 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.4 p30 -179.5 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -0.757 . . . . 0.0 109.703 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 113.38 58.07 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.3 mt -98.0 -169.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -1.109 . . . . 0.0 110.309 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 10.7 m -131.5 121.33 24.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.781 . . . . 0.0 110.299 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 76' ' ' PHE . 7.1 p -119.44 157.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 45.4 m80 -90.66 143.49 26.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.46 121.4 44.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.289 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.89 142.96 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.51 134.64 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.322 -0.861 . . . . 0.0 110.358 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.216 0.531 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.21 -166.2 1.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.226 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.39 87.59 0.7 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -161.05 -174.8 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.855 . . . . 0.0 110.188 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.44 -118.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -158.48 72.9 0.62 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -1.083 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -160.33 -72.65 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 0.0 110.292 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.2 m -65.36 110.43 2.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 110.184 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -80.29 128.15 8.33 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.597 ' HG2' ' HD3' ' A' ' 11' ' ' PRO . 39.5 Cg_endo -70.63 -31.58 16.4 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.666 1.351 . . . . 0.0 113.297 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 44.4 Cg_endo -73.43 -84.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 122.324 0.644 . . . . 0.0 110.638 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -156.14 76.87 4.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.983 -1.073 . . . . 0.0 110.174 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 97.58 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.867 1.456 . . . . 0.0 110.42 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 t -152.61 166.49 31.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 0.0 110.201 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.86 -158.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 110.242 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.74 152.34 16.84 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 119.7 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.732 1.385 . . . . 0.0 110.394 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.34 -165.46 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 110.231 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.63 154.02 26.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.227 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.62 90.44 0.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.413 -0.804 . . . . 0.0 110.149 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -71.3 126.99 31.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.191 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.74 32.1 6.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.5 t -101.75 49.98 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -1.079 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.81 80.61 1.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.444 -0.785 . . . . 0.0 110.219 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.98 -170.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.352 -0.842 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.61 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.54 144.39 35.89 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.831 1.437 . . . . 0.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.74 -53.12 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.38 -0.825 . . . . 0.0 110.116 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -136.37 90.14 18.14 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 110.057 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' N ' ' A' ' 32' ' ' ILE . 50.8 Cg_endo -81.24 20.18 1.06 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.814 1.429 . . . . 0.0 111.384 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.4 69.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 30' ' ' PRO . 2.2 mp -58.47 108.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.693 -0.629 . . . . 0.0 110.654 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.47 HG13 HD13 ' A' ' 92' ' ' ILE . 4.6 pt -81.86 159.64 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -91.43 144.48 25.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 110.759 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 92' ' ' ILE . 47.5 t -135.66 114.09 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.271 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.4 m -98.99 105.68 17.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.92 . . . . 0.0 110.175 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.92 128.63 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -92.27 122.66 34.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.992 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -118.63 173.91 3.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.432 -0.793 . . . . 0.0 109.966 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.3 Cg_endo -69.64 -10.61 29.09 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.728 1.383 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -98.84 -53.27 3.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.13 -176.62 1.68 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -0.814 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.93 139.95 31.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.9 121.71 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.02 146.17 25.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -0.806 . . . . 0.0 110.077 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -132.3 128.9 38.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.72 124.47 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.541 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.1 m -142.28 149.66 52.43 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.3 Cg_endo -67.24 121.23 8.35 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.775 1.408 . . . . 0.0 110.495 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB2' HG22 ' A' ' 88' ' ' ILE . 14.1 pt-20 -35.32 -39.02 0.11 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.257 0.551 . . . . 0.0 111.231 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -89.9 55.89 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.462 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -114.67 -179.66 3.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.217 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.4 140.99 52.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 22.1 t -66.91 -35.04 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 110.578 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.6 -49.42 46.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.775 -1.203 . . . . 0.0 110.196 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -78.5 -45.91 20.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 110.354 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CE1' HG11 ' A' ' 48' ' ' VAL . 27.7 t80 -61.38 -51.21 69.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.5 -35.11 69.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.462 -0.774 . . . . 0.0 109.954 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -78.33 -26.28 46.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.73 -52.55 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 109.817 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -60.69 -29.2 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.695 -0.628 . . . . 0.0 109.652 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 66' ' ' LYS . 14.7 t -56.49 -44.16 80.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -0.827 . . . . 0.0 110.273 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.98 61.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -52.74 63.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.45 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -67.49 -35.88 80.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.0 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 3.2 ttpp 76.14 85.33 0.09 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.447 0.642 . . . . 0.0 110.213 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.47 -154.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.581 -0.699 . . . . 0.0 109.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.0 -177.85 6.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 m -140.88 -53.86 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 0.0 110.213 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -51.14 70.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.821 . . . . 0.0 110.233 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -77.98 -26.01 48.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 110.226 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.18 120.22 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.0 110.28 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' CG1' ' CD ' ' A' ' 82' ' ' LYS . 26.2 m -135.6 157.39 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.711 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -113.8 118.69 34.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.884 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.71 97.26 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.394 -0.816 . . . . 0.0 110.492 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 91' ' ' GLY . 6.7 t80 -98.89 109.61 22.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.455 -0.778 . . . . 0.0 109.913 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.58 26.48 12.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.409 -0.807 . . . . 0.0 110.358 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.13 -36.04 4.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -179.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -1.071 . . . . 0.0 110.145 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -110.17 82.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 110.316 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 7.3 tt -59.97 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' CD ' ' CG1' ' A' ' 73' ' ' VAL . 7.4 ttpp -160.75 -146.76 0.14 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.535 -0.728 . . . . 0.0 110.579 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.7 p30 -73.01 -18.86 61.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.323 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -32.76 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.051 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.45 167.67 28.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -0.855 . . . . 0.0 110.524 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 p -85.47 161.14 19.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.26 -46.44 77.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.882 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.47 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.7 pt -63.39 -19.09 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.008 . . . . 0.0 110.197 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 11.4 tp-100 -93.6 -12.85 28.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.96 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.03 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.916 -1.115 . . . . 0.0 111.752 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -59.05 -50.88 63.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.47 HD13 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -151.01 169.48 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.32 -1.106 . . . . 0.0 109.118 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 7.2 m170 -116.73 -31.34 5.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.4 t0 -178.65 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 117.48 70.21 0.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.18 171.36 7.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.31 -1.112 . . . . 0.0 110.221 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m -111.88 140.14 46.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 110.338 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.75 155.71 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.432 -0.793 . . . . 0.0 110.282 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -90.69 121.97 33.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 tt -99.97 119.14 37.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.07 142.22 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -107.13 137.13 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.423 -0.798 . . . . 0.0 110.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.1 mttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.165 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.2 0.524 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.13 -26.5 47.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.333 -0.854 . . . . 0.0 110.249 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.1 168.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 110.373 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -106.65 -30.39 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.77 92.16 0.08 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.01 85.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -1.085 . . . . 0.0 110.482 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 m -79.33 -4.74 52.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.323 -0.861 . . . . 0.0 110.581 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -32.07 8.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.7 176.36 46.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.06 126.23 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.777 1.409 . . . . 0.0 110.405 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.04 171.17 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.624 1.328 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.82 61.54 12.26 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.372 -0.83 . . . . 0.0 110.505 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.11 -8.23 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.758 1.399 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -57.37 108.4 0.54 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.187 -0.946 . . . . 0.0 110.342 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -148.63 -63.72 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.167 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.37 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.57 162.81 39.03 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.688 1.362 . . . . 0.0 110.398 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.53 -72.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.333 -0.854 . . . . 0.0 110.207 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 -29.79 15.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 52.85 -161.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 110.483 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 52.96 49.01 21.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 110.388 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.21 129.59 15.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 m -83.67 -67.24 0.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -1.092 . . . . 0.0 110.264 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -159.45 60.31 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.92 65.71 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.14 34.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.03 78.8 2.13 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.78 1.41 . . . . 0.0 110.404 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.48 -60.13 1.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.222 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -127.18 95.09 37.31 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.836 . . . . 0.0 110.179 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.3 Cg_endo -71.57 -93.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.71 1.373 . . . . 0.0 110.625 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER 44.01 41.95 4.41 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.38 137.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.347 0.594 . . . . 0.0 111.085 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 88' ' ' ILE . 8.1 pt -107.78 160.05 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.437 -0.789 . . . . 0.0 109.542 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -94.65 133.63 38.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.833 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 2.6 p -128.51 118.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -96.01 114.62 26.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.35 -0.844 . . . . 0.0 110.187 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -104.85 129.29 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.352 -0.843 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 122.46 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.445 -0.784 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 1.1 p -122.79 170.68 7.68 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.828 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.8 Cg_endo -67.93 -12.64 35.96 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.656 1.345 . . . . 0.0 110.726 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -51.24 5.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -173.74 178.4 2.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.351 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 125.86 44.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.902 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -135.1 134.89 40.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.689 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -90.26 151.08 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.495 -0.753 . . . . 0.0 109.682 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CZ ' ' NH1' ' A' ' 64' ' ' ARG . 2.2 m-85 -129.3 152.26 49.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -0.94 . . . . 0.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.55 133.37 50.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.074 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.3 m -143.35 143.7 25.27 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 51' ' ' ASN . 40.2 Cg_endo -66.82 128.82 19.58 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.706 1.371 . . . . 0.0 111.306 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HA ' HG23 ' A' ' 88' ' ' ILE . 2.2 tm-20 -39.43 -20.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' PRO . 17.2 p-10 -111.09 37.95 2.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.644 -1.285 . . . . 0.0 110.47 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.411 ' N ' HD13 ' A' ' 88' ' ' ILE . 27.8 p -96.55 -153.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -161.91 157.25 23.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.345 -0.847 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' O ' ' CG ' ' A' ' 58' ' ' LYS . 59.4 t -63.28 -34.91 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 110.793 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -49.17 -47.11 46.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.663 -1.273 . . . . 0.0 110.231 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -49.53 16.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.227 -0.921 . . . . 0.0 110.337 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 28.3 t80 -60.34 -50.28 74.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.97 -30.56 66.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -26.84 26.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 110.051 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.62 82.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -29.85 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.571 -0.706 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t -62.32 -43.92 97.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.476 -0.765 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -57.81 -48.56 79.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.862 . . . . 0.0 111.024 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' NH1' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -71.15 -52.81 17.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.203 -0.936 . . . . 0.0 110.931 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 8.8 m-85 -67.18 -36.16 81.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.85 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 12.3 mttp 69.6 81.44 0.17 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.418 0.628 . . . . 0.0 110.092 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 p -168.15 -154.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -74.94 157.56 34.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -128.51 -41.67 1.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.16 -62.72 1.56 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.358 -0.839 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -69.4 -25.57 64.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.427 -0.796 . . . . 0.0 110.165 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.36 118.01 8.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.339 -0.85 . . . . 0.0 110.524 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.0 168.46 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 98' ' ' VAL . 2.7 mm? -109.57 146.81 34.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.69 92.9 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 110.236 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 24.7 t80 -74.39 64.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.7 . . . . 0.0 110.357 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 49.2 79.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.86 -53.06 4.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -76.2 178.2 6.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -1.103 . . . . 0.0 109.873 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -115.97 106.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 0.0 109.916 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -69.5 72.04 0.32 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 80' ' ' ILE . 7.9 ttmt -125.95 -160.1 0.95 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.511 0.672 . . . . 0.0 110.547 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.7 p-10 -73.74 -16.71 61.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.629 -0.669 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.83 -32.36 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.942 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -132.08 169.66 16.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.799 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.66 137.01 32.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' CD1' HD23 ' A' ' 81' ' ' LEU . 22.3 tp -55.93 -47.49 77.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 110.428 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.539 HG23 HD11 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -73.62 -15.48 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.481 -0.762 . . . . 0.0 110.904 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 1.8 tt0 -90.35 -9.32 48.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 111.847 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -174.65 -36.61 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.586 -1.321 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.444 ' HA3' HD13 ' A' ' 87' ' ' LEU . . . -58.84 -42.8 96.77 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.441 HG12 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -138.64 138.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -1.19 . . . . 0.0 110.855 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 12.2 m170 -103.68 -36.03 8.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 24.0 p-10 179.81 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 0.0 109.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.08 71.19 0.24 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.16 167.49 10.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.9 m -118.33 147.14 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.333 -0.854 . . . . 0.0 110.252 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 74' ' ' LEU . 7.7 p -144.43 150.54 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 110.418 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.454 ' N ' HG21 ' A' ' 98' ' ' VAL . 38.2 t60 -90.63 122.49 33.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.503 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.94 149.98 26.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.204 -0.935 . . . . 0.0 110.673 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.0 p -168.05 131.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.09 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -94.89 131.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 tttt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.277 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.218 0.533 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.9 133.43 43.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.51 116.65 17.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.22 110.92 4.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.64 -118.98 0.67 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -65.18 169.07 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -1.101 . . . . 0.0 110.231 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -107.3 52.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 46.4 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.56 -164.24 34.61 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.21 166.99 28.48 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 132.78 18.47 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 110.437 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 9.7 mtp180 -67.42 -54.87 16.7 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 0.0 110.381 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.8 Cg_endo -73.78 66.01 4.87 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.588 1.309 . . . . 0.0 110.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -64.95 160.43 20.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.395 -0.815 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 118.42 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.0 -27.43 14.1 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.497 1.262 . . . . 0.0 110.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.36 50.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.872 . . . . 0.0 110.204 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.0 158.66 15.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.95 138.33 54.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.85 -41.09 6.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.91 -166.56 42.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -70.87 142.16 51.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -1.106 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.59 167.36 16.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 110.244 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.74 -61.55 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.877 . . . . 0.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.36 91.45 7.72 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.85 . . . . 0.0 110.208 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 142.67 37.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.761 1.4 . . . . 0.0 110.386 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.68 108.3 17.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mm-40 -177.81 -55.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 110.247 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 29' ' ' GLU . 53.1 Cg_endo -80.51 33.11 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.422 1.222 . . . . 0.0 111.463 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.89 66.93 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 30' ' ' PRO . 16.3 mm -58.33 102.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 110.654 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HD12 ' CG2' ' A' ' 88' ' ' ILE . 7.1 pt -96.07 147.88 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.707 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -91.81 141.39 28.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.103 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.52 113.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.818 . . . . 0.0 110.129 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.7 m -90.15 109.4 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.832 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.78 127.79 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 110.285 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 122.51 47.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.437 -0.789 . . . . 0.0 109.67 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.1 p -124.13 162.22 42.84 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.078 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 59.54 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.71 1.373 . . . . 0.0 110.428 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.71 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -167.21 -170.02 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.513 -0.742 . . . . 0.0 109.922 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -142.7 125.37 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.831 . . . . 0.0 110.21 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -135.12 132.44 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.382 -0.824 . . . . 0.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -90.1 150.25 22.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -123.75 140.93 52.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 110.479 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.68 116.64 33.18 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 33' ' ' ILE . 21.8 m -120.59 147.68 46.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.677 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 51' ' ' ASN . 51.1 Cg_endo -76.65 52.83 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.856 1.451 . . . . 0.0 111.709 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 30.7 tp10 55.53 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.381 -0.824 . . . . 0.0 111.695 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.0 t30 -46.86 -20.06 0.12 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 0.0 112.063 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.411 ' CB ' ' HB ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -59.1 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 110.106 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.9 m -67.33 175.6 2.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.526 -0.734 . . . . 0.0 110.35 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' CG ' ' A' ' 58' ' ' LYS . 37.6 t -68.12 -35.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 110.272 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -50.21 -49.01 54.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.772 -1.205 . . . . 0.0 109.733 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -76.37 -47.4 23.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -61.52 -50.98 70.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.367 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.55 -29.85 64.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.783 . . . . 0.0 109.897 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' N ' ' HG3' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -80.37 -24.14 39.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.336 -0.852 . . . . 0.0 109.813 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.29 85.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 110.149 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 7.0 mt -60.9 -36.91 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.256 -0.903 . . . . 0.0 109.912 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 p -53.6 -49.64 67.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.0 110.506 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -68.21 -53.77 22.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.341 -0.849 . . . . 0.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -53.84 12.32 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.097 -1.002 . . . . 0.0 111.262 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.66 -36.45 80.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 109.991 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.06 81.68 0.19 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.612 -0.68 . . . . 0.0 110.224 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -156.04 -65.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.0 -176.15 2.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.437 -0.789 . . . . 0.0 110.061 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 m -140.85 -55.08 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 110.341 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.04 -67.4 0.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -60.47 -25.61 66.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.309 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.401 HD13 ' CG2' ' A' ' 61' ' ' ILE . 7.8 tt -53.29 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 110.826 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.63 148.7 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 109.472 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -117.94 135.86 53.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.17 101.65 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.438 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 71.8 t80 -77.35 82.71 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.238 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.79 36.19 13.88 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.33 -55.87 0.57 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -1.062 . . . . 0.0 110.056 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -118.05 94.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.281 -0.887 . . . . 0.0 110.694 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -67.09 79.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' ILE . 5.5 ttmt -137.15 -158.86 0.9 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.414 0.625 . . . . 0.0 110.358 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 84' ' ' GLN . 35.5 p30 -73.32 -14.81 61.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.452 -0.78 . . . . 0.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -55.78 -33.04 64.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.353 -0.842 . . . . 0.0 109.72 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.39 154.4 49.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.474 -0.766 . . . . 0.0 110.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 147.03 50.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.853 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 17.0 tp -55.59 -46.98 77.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.435 ' CG2' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -72.48 -14.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -85.63 -13.58 48.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 111.814 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -170.27 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.605 -1.309 . . . . 0.0 111.036 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 76' ' ' PHE . . . -59.46 -46.92 93.14 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.483 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -137.47 143.66 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.012 -1.287 . . . . 0.0 111.333 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -109.4 -33.72 6.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -179.73 35.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.246 0.546 . . . . 0.0 109.536 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.67 71.97 0.39 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -178.43 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.235 -1.156 . . . . 0.0 110.251 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -125.15 146.52 49.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 8.1 p -142.68 151.09 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.874 . . . . 0.0 110.401 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.71 144.31 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.81 . . . . 0.0 110.258 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.4 tt -97.44 119.97 36.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.67 128.57 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 0.0 110.045 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -104.6 130.49 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.196 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.17 0.51 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.28 28.87 4.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.837 . . . . 0.0 110.111 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -116.79 -34.06 4.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -0.828 . . . . 0.0 110.141 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -113.7 100.65 8.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.183 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 164.3 44.59 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -138.13 -66.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -1.082 . . . . 0.0 110.123 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 p -112.27 -31.03 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 110.25 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 t -158.96 126.49 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.247 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.12 -84.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.56 163.92 36.26 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.84 1.442 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -23.11 20.33 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.797 1.42 . . . . 0.0 110.435 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -109.53 99.94 39.61 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.97 151.17 55.98 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.676 1.356 . . . . 0.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.21 172.96 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.224 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -126.81 -170.62 2.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.181 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.74 74.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 -167.92 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.815 1.429 . . . . 0.0 110.422 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 -40.03 15.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.83 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.01 79.69 1.49 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.758 . . . . 0.0 110.174 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.71 -170.95 3.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -117.27 126.7 53.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 110.121 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.17 98.78 0.29 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t -162.2 85.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.048 . . . . 0.0 110.169 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.6 145.09 56.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.217 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.77 59.4 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.139 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.47 72.24 3.84 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.871 . . . . 0.0 110.323 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -26.14 14.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.831 1.437 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 115.42 4.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -104.11 158.25 32.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.354 -0.841 . . . . 0.0 110.121 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.5 Cg_endo -71.87 -93.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.745 1.392 . . . . 0.0 110.641 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER 44.04 43.53 5.56 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.6 mp -58.12 111.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.603 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.416 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.0 pt -89.68 154.46 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.38 -0.825 . . . . 0.0 110.039 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -94.11 144.89 25.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.56 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 92' ' ' ILE . 7.2 p -138.52 119.14 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.4 -0.813 . . . . 0.0 110.108 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -87.05 102.22 14.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 0.0 110.095 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.3 128.38 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -109.72 126.27 53.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 110.293 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 ' OG1' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -123.46 175.73 2.6 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.613 -0.679 . . . . 0.0 109.69 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.34 61.86 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.626 1.33 . . . . 0.0 110.395 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.447 -0.783 . . . . 0.0 109.928 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.71 179.48 3.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.39 -0.819 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -117.08 122.99 45.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.152 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.3 135.12 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.326 -0.859 . . . . 0.0 110.438 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -85.23 149.52 25.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -124.35 144.86 49.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.571 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -99.62 129.78 45.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.331 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 30.4 m -143.46 144.01 26.2 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.857 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 39.4 Cg_endo -67.08 121.44 8.61 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.756 1.398 . . . . 0.0 111.034 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -37.17 -34.73 0.09 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.117 0.484 . . . . 0.0 111.583 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.15 49.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 110.575 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 55.7 p -127.85 108.38 10.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.5 t -59.84 153.36 20.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.857 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 61.1 t -55.88 -35.0 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 110.86 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -48.48 -43.78 35.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.665 -1.272 . . . . 0.0 109.843 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.15 -41.48 41.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CD1' HG12 ' A' ' 48' ' ' VAL . 17.7 t80 -68.24 -51.46 45.11 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -30.8 65.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.921 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -86.29 -26.85 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -49.32 60.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -0.785 . . . . 0.0 109.675 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' C ' ' CD1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.35 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.008 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 p -63.85 -44.43 93.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.174 -0.953 . . . . 0.0 110.351 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -56.39 -42.66 78.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.78 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -52.07 23.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.283 -0.885 . . . . 0.0 110.463 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 5.2 m-85 -67.0 -36.5 82.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.817 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 44.5 mtmt 64.23 79.49 0.26 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.582 -0.699 . . . . 0.0 110.179 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 t -154.87 -59.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.486 -0.759 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -169.45 174.83 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 0.0 110.005 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -143.31 -44.19 0.29 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.37 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -64.97 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.18 -26.19 60.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.226 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.16 139.75 28.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.326 -0.859 . . . . 0.0 110.523 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 82' ' ' LYS . 8.0 p -172.84 169.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 109.928 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 2.6 mt -118.44 118.86 32.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -0.982 . . . . 0.0 109.31 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.61 103.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 110.146 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.462 ' CD2' HG21 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -91.86 124.11 35.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.452 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.94 103.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.313 -0.867 . . . . 0.0 110.607 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.46 -31.13 3.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 -166.8 0.89 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -1.003 . . . . 0.0 109.712 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.3 mm -108.77 118.26 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -69.97 71.05 0.37 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.786 178.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 80' ' ' ILE . 3.6 ptmt -136.1 -152.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.368 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.452 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.9 p30 -72.94 -12.84 61.1 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.301 -0.874 . . . . 0.0 112.482 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.6 -33.5 33.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.056 . . . . 0.0 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.61 156.37 45.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.198 -0.939 . . . . 0.0 109.972 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 149.78 41.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD12 ' HA3' ' A' ' 91' ' ' GLY . 16.0 tp -56.81 -48.16 78.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 110.868 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 50' ' ' GLU . 2.1 pp -73.1 -18.45 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.172 -0.955 . . . . 0.0 110.829 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.29 -9.9 57.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 111.744 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.728 -1.233 . . . . 0.0 110.949 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.526 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -59.34 -47.0 92.98 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.464 ' CG1' ' HG ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -145.56 156.23 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -1.176 . . . . 0.0 110.293 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 19.2 m170 -114.98 -42.42 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.4 t70 -178.49 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.28 65.91 0.18 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.8 mt -112.58 160.08 18.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -1.12 . . . . 0.0 110.256 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -115.06 145.72 42.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 76' ' ' PHE . 49.0 t -145.47 158.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.46 ' HB2' HG21 ' A' ' 75' ' ' ILE . 44.1 m170 -88.39 125.49 34.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 0.0 110.466 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.29 145.77 28.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.135 -0.978 . . . . 0.0 110.451 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.36 159.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.08 137.22 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.327 -0.858 . . . . 0.0 110.204 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.6 mttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.314 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.259 0.552 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.42 171.04 14.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.319 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.36 46.06 1.03 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.184 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -137.82 33.49 2.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.247 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.33 57.68 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -38.0 89.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -1.098 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.9 p -80.31 -165.04 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.02 150.38 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.831 . . . . 0.0 110.215 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.26 -132.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 156.97 55.34 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.525 1.276 . . . . 0.0 110.292 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.37 173.62 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.785 1.413 . . . . 0.0 110.409 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -128.9 98.91 23.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 110.276 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.21 112.33 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.692 1.364 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.75 -2.82 58.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.352 -0.842 . . . . 0.0 110.691 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.52 -42.18 87.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.179 -0.95 . . . . 0.0 110.22 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.68 134.0 2.44 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.83 87.3 1.15 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.576 1.303 . . . . 0.0 110.33 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.65 -164.53 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 110.426 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -170.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.857 . . . . 0.0 110.248 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.24 170.53 15.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.864 . . . . 0.0 110.284 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.69 117.6 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.39 -0.819 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.71 162.48 30.08 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.8 m -98.32 29.23 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.21 105.92 16.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.55 42.87 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.45 150.95 22.91 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.293 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 144.68 36.66 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.73 1.384 . . . . 0.0 110.367 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.81 101.19 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 12.6 tp10 -177.45 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.328 -0.858 . . . . 0.0 110.118 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 29' ' ' GLU . 43.4 Cg_endo -69.32 -92.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.291 1.153 . . . . 0.0 110.434 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 mptt 45.47 44.38 9.63 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.9 mp -58.04 110.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.835 -0.541 . . . . 0.0 110.476 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG1' HD12 ' A' ' 92' ' ' ILE . 3.3 pt -83.55 152.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -91.97 144.4 25.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 110.282 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 HD23 ' A' ' 87' ' ' LEU . 7.3 p -139.69 113.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.093 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -82.33 109.08 16.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.396 -0.815 . . . . 0.0 110.018 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.55 127.59 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -0.859 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.38 122.64 46.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 80.7 p -121.58 165.93 18.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.726 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.1 Cg_endo -69.71 -10.28 28.2 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.636 1.335 . . . . 0.0 110.817 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -100.54 -35.91 9.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.184 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.36 -166.52 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.325 -0.859 . . . . 0.0 110.263 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 114.93 8.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 0.0 110.074 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -135.19 134.96 40.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 110.499 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.29 149.21 26.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -121.4 147.68 45.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.36 125.86 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.6 m -142.49 150.48 54.65 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.206 -0.934 . . . . 0.0 109.758 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -68.36 122.61 9.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.699 1.368 . . . . 0.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 49' ' ' PRO . 17.0 pt-20 -31.28 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.084 0.469 . . . . 0.0 111.716 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -88.58 50.83 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.213 -0.929 . . . . 0.0 110.121 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.1 t -115.12 130.77 57.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -82.14 146.47 29.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 61.0 t -61.16 -34.53 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.791 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -49.32 -48.07 46.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.988 -1.07 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.33 -49.76 52.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.82 -37.23 78.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 12.2 mtpt -57.77 -47.95 81.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.579 -0.701 . . . . 0.0 109.495 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.484 -0.76 . . . . 0.0 109.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.89 65.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.842 . . . . 0.0 110.045 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 65' ' ' PHE . 19.6 mt -60.92 -39.65 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.603 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -53.7 -52.24 60.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.039 . . . . 0.0 110.326 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -54.17 19.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.324 -0.86 . . . . 0.0 111.508 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -72.02 -54.11 10.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 111.442 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.91 -36.6 80.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 110.275 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 4.9 tttp 69.17 80.66 0.19 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.437 -0.789 . . . . 0.0 110.203 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 t -153.38 -69.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -164.36 -175.18 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.5 m -144.11 -60.04 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.312 -0.868 . . . . 0.0 110.483 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 -61.03 2.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -66.32 -25.65 66.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.2 tp -51.86 124.75 13.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.337 -0.852 . . . . 0.0 110.684 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.31 157.22 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 109.767 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.4 mp -123.6 123.76 41.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.134 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.19 104.33 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 110.626 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.3 t80 -70.52 67.06 0.34 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.755 . . . . 0.0 110.031 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.92 24.76 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.261 -0.899 . . . . 0.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.21 -39.24 1.51 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -162.14 0.53 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -1.121 . . . . 0.0 110.258 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.1 pp -123.49 84.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 110.61 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 8.1 tt -67.74 84.29 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 108.765 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.453 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -153.99 -146.82 0.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 110.148 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.58 -15.56 61.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.035 -1.041 . . . . 0.0 111.363 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.427 ' CB ' HD11 ' A' ' 80' ' ' ILE . 1.4 mm-40 -53.73 -33.42 55.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.129 -0.982 . . . . 0.0 110.237 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -150.24 -169.88 3.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -102.91 158.14 16.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 92' ' ' ILE . 1.5 tp -66.09 -46.23 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.6 pt -63.84 -17.25 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.562 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -97.27 -12.82 22.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 111.091 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.911 -1.118 . . . . 0.0 111.859 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.39 -50.34 67.68 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.474 HD12 ' CG1' ' A' ' 33' ' ' ILE . 2.7 pp -148.56 171.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.375 -1.074 . . . . 0.0 108.665 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -122.19 -29.62 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.967 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.8 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 109.982 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.91 59.5 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.38 -168.99 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.336 -1.097 . . . . 0.0 110.221 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -134.96 147.03 49.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.47 157.56 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 0.0 110.199 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -90.7 115.81 28.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 tt -89.31 131.33 35.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 110.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.08 130.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.783 . . . . 0.0 110.255 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -106.79 130.09 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 0.0 110.199 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.106 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mtp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.22 0.533 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.3 147.33 34.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.12 138.3 33.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 52.82 49.81 19.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.338 -0.851 . . . . 0.0 110.463 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.96 -82.11 0.87 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.59 110.0 5.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -1.064 . . . . 0.0 110.19 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -68.08 0.15 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.451 -0.78 . . . . 0.0 110.186 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -93.14 -55.34 3.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.01 -153.32 9.4 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 160.49 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.801 1.422 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.49 119.73 6.11 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.89 1.469 . . . . 0.0 110.387 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 1.1 tpt180 -69.5 -54.8 10.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.5 Cg_endo -74.54 136.34 21.3 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.476 1.251 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.6 p -64.43 161.29 17.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.242 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.29 48.49 2.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.32 87.32 1.92 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.05 74.64 2.92 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.832 1.438 . . . . 0.0 110.355 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.54 164.33 18.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.98 80.53 5.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.23 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.25 40.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 155.34 18.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -0.911 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.76 63.32 0.23 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 m -88.13 123.99 33.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.239 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.23 -43.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.377 -0.827 . . . . 0.0 110.192 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.12 178.05 4.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.38 113.88 30.27 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.822 . . . . 0.0 110.16 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.87 -17.33 29.02 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.545 1.287 . . . . 0.0 110.567 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -118.93 44.02 2.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.235 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 mt-10 -73.89 -55.81 3.06 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 31' ' ' LYS . 49.0 Cg_endo -73.46 -93.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.579 1.305 . . . . 0.0 110.502 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.5 tptp 42.71 41.74 2.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.0 mp -58.16 110.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.252 0.549 . . . . 0.0 110.723 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 92' ' ' ILE . 1.6 pt -89.16 174.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.415 -0.803 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.45 144.39 37.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.768 . . . . 0.0 110.373 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.14 113.84 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 110.033 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -84.24 103.8 13.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.9 t -94.75 128.75 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.002 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -101.24 122.5 43.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.415 -0.803 . . . . 0.0 110.071 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 4.3 p -119.93 167.71 11.85 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.9 Cg_endo -71.1 61.06 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.661 1.348 . . . . 0.0 110.401 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -46.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 109.64 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -172.05 176.75 3.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.53 -0.731 . . . . 0.0 110.081 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.67 127.97 54.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -134.5 131.2 37.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.3 149.79 25.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.9 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.12 123.08 35.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.898 . . . . 0.0 110.197 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.133 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 25.6 m -143.21 153.57 59.93 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.233 -0.917 . . . . 0.0 109.825 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.2 Cg_endo -67.9 122.37 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.803 1.423 . . . . 0.0 110.726 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -30.74 -42.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.66 48.7 1.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.925 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.9 t -113.41 108.07 16.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.087 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.7 m -59.84 148.84 33.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.847 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 64.5 t -63.42 -34.67 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.811 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.05 -43.93 41.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.953 -1.092 . . . . 0.0 110.705 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.45 -53.48 16.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.925 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -59.86 -37.21 78.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.339 -0.851 . . . . 0.0 110.118 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -42.88 83.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.611 -0.68 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -75.87 -20.72 57.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.58 97.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.429 HG22 ' CD2' ' A' ' 65' ' ' PHE . 52.8 mt -60.39 -34.7 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.4 p -54.02 -52.98 59.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.985 -1.072 . . . . 0.0 110.464 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -54.73 14.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 111.78 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -72.7 -54.49 8.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.051 -1.031 . . . . 0.0 111.646 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.57 -36.11 78.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.887 . . . . 0.0 110.531 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 23.2 mtmt 70.67 79.97 0.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.662 -0.649 . . . . 0.0 110.015 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.9 t -168.24 -154.4 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.898 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.14 -170.03 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.7 m -157.33 -60.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -60.13 -70.31 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -61.86 -26.11 67.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -66.71 98.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 110.338 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.11 167.11 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.812 . . . . 0.0 109.951 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.75 144.68 36.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 110.018 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -105.16 89.31 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.828 . . . . 0.0 110.023 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 69.6 t80 -66.96 83.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.92 29.72 6.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.359 -0.838 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.04 -51.38 0.84 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 6.4 mttp -61.86 -175.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -1.046 . . . . 0.0 109.957 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -116.31 93.06 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.5 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.444 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -62.89 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 80' ' ' ILE . 2.4 tttt -145.91 -153.13 0.46 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.734 -0.604 . . . . 0.0 110.169 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -72.58 -15.54 61.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.385 -0.822 . . . . 0.0 110.523 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -62.81 -33.14 74.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.973 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.63 168.15 19.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 p -99.06 148.92 23.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.252 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' HG ' HG13 ' A' ' 92' ' ' ILE . 22.0 tp -55.81 -43.58 77.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.403 HG23 ' CA ' ' A' ' 50' ' ' GLU . 1.2 pt -71.61 -14.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.254 -0.904 . . . . 0.0 111.604 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.37 -2.98 24.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 112.197 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -176.06 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 118.331 -1.347 . . . . 0.0 112.303 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 92' ' ' ILE . . . -58.58 -50.32 68.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.558 HD11 HG13 ' A' ' 33' ' ' ILE . 2.8 pp -157.05 152.61 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -1.015 . . . . 0.0 109.322 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 14.5 m170 -100.8 -24.97 14.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 35.4 t70 179.96 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.622 -0.674 . . . . 0.0 109.596 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.07 73.93 0.86 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 176.85 4.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.248 -1.148 . . . . 0.0 110.186 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 13.4 m -115.9 147.32 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.93 146.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.75 . . . . 0.0 110.16 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.39 115.27 27.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.7 tt -82.74 148.64 27.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.899 . . . . 0.0 110.632 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -168.34 135.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.82 136.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.81 162.71 37.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 110.181 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -82.97 -56.66 3.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 126.86 31.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.24 -32.32 83.74 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.53 42.44 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -1.101 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.5 t -144.69 60.29 1.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.83 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -108.44 59.04 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 110.265 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.75 -162.83 47.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 141.46 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.79 1.416 . . . . 0.0 110.319 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.56 -56.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.639 1.336 . . . . 0.0 110.516 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.443 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 179.6 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 12' ' ' ARG . 46.7 Cg_endo -73.05 73.54 3.12 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.464 1.244 . . . . 0.0 110.434 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -56.98 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.404 -0.81 . . . . 0.0 110.108 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 135.65 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.29 84.73 1.35 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 162.15 41.43 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.803 1.422 . . . . 0.0 110.362 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.62 -163.89 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.65 -69.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.265 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -95.45 -169.41 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 56.72 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.336 -0.853 . . . . 0.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.16 106.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -140.19 81.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 110.228 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.02 171.71 18.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.32 88.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.385 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.81 114.77 63.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 110.185 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 -168.68 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.661 1.348 . . . . 0.0 110.504 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -118.79 112.08 19.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.201 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 52.34 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 31' ' ' LYS . 46.3 Cg_endo -71.75 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.846 1.445 . . . . 0.0 110.557 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 42.32 45.01 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -57.95 128.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.321 0.582 . . . . 0.0 111.006 -177.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 12.9 pt -98.4 159.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.696 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -91.45 144.08 25.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 110.533 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.6 t -137.0 113.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -90.31 102.99 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.05 127.84 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.463 -0.773 . . . . 0.0 110.12 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.44 122.45 46.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.6 p -117.1 163.81 21.54 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.55 59.76 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.664 1.349 . . . . 0.0 110.581 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -175.67 -39.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 109.762 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -171.31 173.58 4.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 119.8 40.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.076 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.78 124.9 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -84.7 149.55 25.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.663 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.51 140.14 53.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.353 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.65 135.44 39.46 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 28.1 m -143.43 143.1 22.77 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 109.018 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.4 Cg_endo -65.89 128.23 19.39 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.771 1.406 . . . . 0.0 110.825 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -38.05 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.008 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' PRO . 2.4 t30 -120.79 67.63 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.645 -1.284 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -149.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.0 110.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -159.38 153.75 23.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.95 . . . . 0.0 110.079 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 48.5 t -55.92 -35.3 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 111.088 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -45.17 40.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -71.36 -49.73 39.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.69 -38.02 88.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.448 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -58.15 -45.22 87.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.829 . . . . 0.0 109.653 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -81.67 -18.16 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 110.194 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.1 -52.34 63.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.442 HG23 ' CD2' ' A' ' 65' ' ' PHE . 26.5 mt -62.8 -33.65 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.345 -0.847 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -53.19 55.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.081 -1.012 . . . . 0.0 110.606 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.56 -54.56 15.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 111.797 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -54.48 8.97 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.083 -1.01 . . . . 0.0 111.633 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.22 -36.15 79.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 73.95 72.54 0.12 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.65 -0.657 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.6 p -159.06 -165.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.47 -0.768 . . . . 0.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -168.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.246 -0.909 . . . . 0.0 110.346 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.77 -51.63 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.371 -0.831 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.05 -51.94 66.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -78.13 -25.57 47.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 110.181 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.74 110.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 110.656 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.72 151.47 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.82 . . . . 0.0 109.727 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -111.39 122.07 46.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.109 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.84 100.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 81' ' ' LEU . 4.6 t80 -109.05 124.27 50.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 110.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.82 27.54 7.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.329 -0.857 . . . . 0.0 110.419 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.87 23.71 61.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -122.58 -167.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -1.084 . . . . 0.0 109.881 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.1 pp -112.13 79.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.221 -0.924 . . . . 0.0 110.499 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -61.37 89.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 108.54 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 7.1 ttpt -155.82 -146.67 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.547 -0.72 . . . . 0.0 110.874 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HA ' ' CB ' ' A' ' 54' ' ' VAL . 20.0 t0 -62.48 -15.41 49.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.667 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.409 ' CB ' HD12 ' A' ' 80' ' ' ILE . 2.1 mm-40 -52.47 -30.81 31.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -159.88 162.5 34.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.387 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.83 134.2 39.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.583 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' HG ' HG12 ' A' ' 92' ' ' ILE . 1.9 mp -55.75 -39.2 70.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 50' ' ' GLU . 2.4 pp -70.28 -17.88 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.141 -0.974 . . . . 0.0 109.566 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -88.78 -13.27 39.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.501 -0.749 . . . . 0.0 110.927 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.69 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.831 -1.168 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.9 97.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.501 HG12 ' HG ' ' A' ' 87' ' ' LEU . 3.7 mm -128.94 150.2 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -1.224 . . . . 0.0 111.004 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.69 -38.64 3.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 p30 179.88 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 116.88 69.95 0.42 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 4.9 mt -101.14 -177.18 3.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -1.151 . . . . 0.0 110.423 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.0 t -128.46 142.76 50.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -147.52 146.22 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 110.408 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -90.43 119.37 30.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.26 137.96 40.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.8 p -166.71 132.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.138 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.66 137.08 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.396 -0.815 . . . . 0.0 110.251 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 tttt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.272 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mtt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.75 63.27 1.64 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 110.186 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 53.1 -178.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.283 -0.886 . . . . 0.0 110.441 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.67 55.18 9.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.6 49.06 1.0 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -96.77 -178.16 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -1.032 . . . . 0.0 110.136 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.91 -54.26 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 110.335 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -102.99 92.03 4.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.399 -0.813 . . . . 0.0 110.42 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.68 -149.35 7.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.17 145.36 43.86 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.691 1.364 . . . . 0.0 110.187 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.05 -175.88 2.14 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.734 1.386 . . . . 0.0 110.589 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -162.05 76.15 2.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 109.965 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.58 95.55 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.821 1.432 . . . . 0.0 110.568 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 t -94.84 -37.57 11.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 90.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -0.846 . . . . 0.0 110.428 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.64 -87.72 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.59 -42.96 0.72 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.704 1.371 . . . . 0.0 110.357 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.77 76.04 8.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 0.0 110.255 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.64 164.83 11.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.74 133.78 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -81.74 -29.64 32.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.867 . . . . 0.0 110.146 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.95 -147.93 5.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -144.38 107.78 4.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -1.09 . . . . 0.0 110.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.42 165.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.462 -0.774 . . . . 0.0 110.283 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -168.93 87.69 0.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' CB ' ' HD2' ' A' ' 27' ' ' PRO . . . 55.31 175.97 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.325 -0.859 . . . . 0.0 110.381 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 26' ' ' ALA . 46.1 Cg_endo -72.76 63.92 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.741 1.39 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.7 140.16 4.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.91 153.56 45.17 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.859 . . . . 0.0 110.05 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' ILE . 50.3 Cg_endo -79.2 41.21 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.776 1.408 . . . . 0.0 111.253 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -72.43 67.01 0.71 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.1 mp -58.23 120.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.681 -0.637 . . . . 0.0 110.557 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.554 HG13 HD12 ' A' ' 92' ' ' ILE . 1.6 pt -107.39 159.57 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -91.75 144.21 25.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.818 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 39.1 t -132.07 113.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.438 -0.789 . . . . 0.0 109.856 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m -98.26 114.67 27.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.309 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.45 127.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.85 . . . . 0.0 110.138 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -92.86 122.55 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.581 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -121.86 172.43 5.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 110.176 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.8 Cg_endo -68.68 -8.27 22.84 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.69 1.363 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.7 tptm -101.46 -50.55 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 1.8 mt-10 -170.57 -161.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.556 -0.715 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.4 135.98 53.49 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -135.3 135.45 40.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.168 -0.958 . . . . 0.0 110.785 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.14 145.75 24.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.45 -0.781 . . . . 0.0 109.75 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -128.29 124.88 37.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.948 . . . . 0.0 110.396 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.85 129.22 36.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 108.963 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.5 m -143.27 155.68 61.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.056 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -69.98 122.14 8.76 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.833 1.438 . . . . 0.0 110.409 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -25.83 -48.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.1 0.476 . . . . 0.0 111.597 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' PRO . 14.6 p-10 -86.25 52.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 t -109.13 111.48 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -64.07 144.19 57.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 85.4 t -59.12 -35.02 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.41 -44.51 35.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.015 -1.053 . . . . 0.0 110.479 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.32 -49.75 52.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.13 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -63.21 -37.52 87.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.442 -0.786 . . . . 0.0 110.41 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.09 -39.54 78.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.4 -23.1 60.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.49 -0.757 . . . . 0.0 110.278 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.89 81.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.184 -0.948 . . . . 0.0 109.992 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -34.95 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 110.174 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 66' ' ' LYS . 27.1 p -59.41 -43.91 92.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -58.77 -49.55 77.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.267 -0.896 . . . . 0.0 111.014 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -53.11 15.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.156 -0.965 . . . . 0.0 110.828 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 39' ' ' THR . 23.8 m-85 -67.54 -37.08 82.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 0.0 110.23 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' SER . 5.4 tttt 63.76 79.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.446 -0.784 . . . . 0.0 110.138 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 t -155.43 -62.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.52 -165.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 110.137 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -155.11 -44.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.863 . . . . 0.0 110.382 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -58.34 -62.49 1.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -70.84 -25.75 62.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.805 . . . . 0.0 110.041 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.76 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 0.0 110.396 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.68 167.77 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.797 . . . . 0.0 109.982 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -124.44 118.86 27.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.451 ' CG2' ' CB ' ' A' ' 99' ' ' HIS . 5.5 tp -82.93 104.85 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.445 ' CD1' HG13 ' A' ' 98' ' ' VAL . 15.1 t80 -116.02 136.19 53.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 110.32 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.3 26.73 4.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.374 -0.829 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.67 24.4 70.17 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -169.77 2.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.41 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -104.96 82.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 7.6 tt -62.92 92.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.994 -1.067 . . . . 0.0 108.584 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 3.0 ttpt -153.95 -143.29 0.13 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.362 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 34.8 p-10 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -53.7 -32.84 53.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.864 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -147.88 163.67 36.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.582 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -87.19 158.7 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.42 -46.55 76.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -63.31 -17.49 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.045 . . . . 0.0 109.985 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.04 -15.41 24.82 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 110.884 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.83 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.897 -1.127 . . . . 0.0 111.947 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.75 -50.15 70.35 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.554 HD12 HG13 ' A' ' 33' ' ' ILE . 2.7 pp -152.19 160.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -1.008 . . . . 0.0 108.873 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.7 OUTLIER -110.27 -28.31 8.67 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.4 t70 -179.09 36.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.562 -0.711 . . . . 0.0 110.026 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.16 69.89 0.51 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.24 173.37 6.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.402 -1.057 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.4 p -111.86 130.77 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 110.105 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.445 HG13 ' CD1' ' A' ' 76' ' ' PHE . 34.2 m -127.41 150.35 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.451 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -90.78 133.75 34.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.106 -0.996 . . . . 0.0 110.03 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.92 134.67 33.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.242 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 p -149.41 125.78 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -96.47 131.78 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.336 -0.852 . . . . 0.0 110.185 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.223 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ttp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.198 0.523 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.83 -43.28 10.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -162.99 164.47 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -133.77 32.55 3.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 110.274 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.18 77.42 0.34 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 51.88 -175.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.386 -1.067 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.37 -165.75 1.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.37 -0.831 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -118.55 27.1 9.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.308 -0.87 . . . . 0.0 110.322 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.3 159.19 32.06 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 148.05 43.04 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.906 1.477 . . . . 0.0 110.403 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.01 157.75 46.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.677 1.356 . . . . 0.0 110.385 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.08 137.39 6.21 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.77 100.12 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.655 1.345 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 86.0 p -84.16 116.47 22.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -94.48 -73.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.844 . . . . 0.0 110.279 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.85 91.22 0.08 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.15 81.76 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.632 1.333 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.2 96.7 5.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.435 -0.791 . . . . 0.0 110.247 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.66 81.69 5.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.142 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.43 45.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 110.22 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.62 -172.67 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.72 134.86 7.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -154.71 33.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -1.107 . . . . 0.0 110.235 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.07 162.02 35.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.08 56.02 0.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.8 113.64 41.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.65 126.22 11.26 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.561 1.295 . . . . 0.0 110.398 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.23 -166.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -136.13 64.44 54.37 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.2 Cg_endo -82.77 30.0 0.54 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 0.0 111.293 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -70.6 66.3 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.71 118.2 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.701 -0.624 . . . . 0.0 110.56 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.542 HG13 HD13 ' A' ' 92' ' ' ILE . 2.3 pt -93.55 147.17 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -91.47 144.8 25.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 110.114 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 87' ' ' LEU . 14.0 m -140.81 136.49 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -107.7 117.37 33.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 0.0 110.214 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' VAL . 33.6 m -98.3 130.7 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.828 . . . . 0.0 110.249 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 122.67 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 110.0 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 3.1 p -127.09 166.16 24.4 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.11 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.49 61.12 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.728 1.383 . . . . 0.0 110.374 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.29 -47.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.13 -177.94 2.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.262 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -117.33 136.63 52.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.847 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.09 128.01 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.64 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.05 149.5 26.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 109.796 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -129.75 124.16 32.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.332 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.67 125.83 35.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.195 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.21 151.57 55.6 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.22 -0.925 . . . . 0.0 109.888 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -69.23 121.71 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.915 1.482 . . . . 0.0 110.743 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -27.89 -46.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.244 0.545 . . . . 0.0 111.566 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.76 52.38 2.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.449 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 17.8 t -112.81 124.5 52.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -0.817 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 m -71.19 144.55 50.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 64.9 t -62.43 -34.55 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.939 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -48.24 -44.07 32.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 110.873 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -53.77 21.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.009 . . . . 0.0 110.0 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.84 -37.27 78.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.487 -0.758 . . . . 0.0 110.255 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.76 -39.77 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.601 -0.687 . . . . 0.0 110.01 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -75.04 -21.89 58.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 110.318 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.94 82.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.965 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.467 ' CG1' ' CE2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -63.87 -33.2 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.718 . . . . 0.0 110.225 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' LYS . 12.5 t -64.03 -43.95 94.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.452 -0.78 . . . . 0.0 110.509 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.91 -50.66 72.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.863 . . . . 0.0 110.936 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -69.61 -53.01 20.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CE2' ' CG1' ' A' ' 61' ' ' ILE . 15.1 m-30 -67.46 -37.06 82.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 63.17 78.16 0.3 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.332 -0.855 . . . . 0.0 109.971 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 p -156.1 -66.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.744 . . . . 0.0 110.105 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.42 -175.03 3.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.793 . . . . 0.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -154.78 -40.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.09 -64.57 0.8 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.596 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' CB ' HG13 ' A' ' 102' ' ' ILE . 88.7 mm-40 -78.48 -25.78 45.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -56.86 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.395 -0.816 . . . . 0.0 110.353 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.445 ' CG1' ' CD ' ' A' ' 82' ' ' LYS . 26.0 m -109.76 163.12 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.5 mp -112.21 118.98 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.037 -1.039 . . . . 0.0 109.198 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.27 103.19 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 110.628 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.6 t80 -69.83 65.78 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.557 -0.714 . . . . 0.0 110.003 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.74 24.26 4.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.244 -0.91 . . . . 0.0 110.409 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.87 -47.16 0.82 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -161.43 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.326 -1.102 . . . . 0.0 110.274 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.89 85.23 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.397 -0.814 . . . . 0.0 110.423 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 3.3 tt -61.84 93.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' CD ' ' CG1' ' A' ' 73' ' ' VAL . 1.3 ttpm? -159.16 -150.08 0.23 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.639 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 9.0 p-10 -73.0 -19.22 61.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.527 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -52.81 -32.44 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 109.896 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -151.39 150.4 30.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.33 151.41 44.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.768 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HA ' ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -59.17 -46.08 89.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.428 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 1.2 pp -63.48 -18.42 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.788 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 50.8 tt0 -91.2 -16.52 27.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.2 OUTLIER 177.97 -27.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.95 -1.094 . . . . 0.0 111.799 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.66 -50.22 69.4 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.542 HD13 HG13 ' A' ' 33' ' ' ILE . 2.8 pp -148.12 175.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.231 -1.158 . . . . 0.0 109.143 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 3.1 m170 -123.45 -36.09 2.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 110.13 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 37.4 t70 -179.76 36.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 122.08 65.6 0.23 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 168.9 9.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -1.099 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -112.19 134.71 53.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 14.6 p -123.97 157.61 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 139.48 30.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.49 122.3 45.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.9 t -148.68 129.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.425 HG13 ' CB ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -107.17 132.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 109.911 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.248 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tpp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.11 0.481 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.19 162.96 28.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.386 -0.821 . . . . 0.0 110.153 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.67 -42.78 1.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.243 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -67.87 95.38 0.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.233 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.03 156.57 28.57 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -92.09 -172.79 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -1.04 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 t -128.68 -41.09 1.52 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.0 p -59.42 142.76 51.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.314 -0.866 . . . . 0.0 110.282 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.05 88.47 1.9 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.55 135.12 23.57 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.691 1.364 . . . . 0.0 110.469 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 -161.78 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.683 1.359 . . . . 0.0 110.272 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.449 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -52.12 -55.43 31.18 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 46.4 Cg_endo -73.64 175.55 10.56 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.587 1.309 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -145.48 156.92 44.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 51.96 -170.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.426 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.9 132.49 11.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.98 62.76 4.97 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.531 1.279 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.97 117.86 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.24 21.53 11.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.29 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.49 83.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -118.0 -72.4 0.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.249 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.46 -134.02 11.98 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -145.63 105.37 3.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.396 -1.061 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.15 -160.23 0.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.49 -27.63 14.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 110.253 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.67 174.35 3.66 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.72 179.58 5.1 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.821 1.432 . . . . 0.0 110.485 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.97 76.13 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -130.5 148.43 69.93 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.315 -0.866 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.0 Cg_endo -72.68 -92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.736 1.388 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 30' ' ' PRO . 9.3 mmtt 44.97 42.28 6.14 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.7 mp -58.28 100.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.222 0.534 . . . . 0.0 110.791 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 5.2 pt -81.62 161.03 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.331 -0.855 . . . . 0.0 109.872 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.54 144.36 31.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.336 -0.853 . . . . 0.0 110.52 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 92' ' ' ILE . 8.4 p -137.59 114.11 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.0 109.992 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -80.92 110.28 16.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.98 127.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.455 -0.778 . . . . 0.0 110.051 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -108.85 122.54 47.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 23.1 p -126.84 166.81 20.01 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 109.836 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.04 -12.27 33.83 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.698 1.368 . . . . 0.0 110.57 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -40.76 10.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -172.35 -173.14 1.02 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.72 114.92 14.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.771 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -135.34 135.5 40.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.826 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.82 151.41 31.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.476 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -126.09 116.16 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 110.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.48 123.38 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 0.0 108.935 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.7 m -143.21 155.06 61.75 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.144 -0.972 . . . . 0.0 110.006 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -68.72 122.52 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.967 1.509 . . . . 0.0 110.836 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -30.0 -44.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.871 0.367 . . . . 0.0 111.858 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 49' ' ' PRO . 51.5 p-10 -78.33 43.4 0.46 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.023 -1.048 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -111.56 100.69 9.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.136 -0.977 . . . . 0.0 110.016 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -62.22 164.45 6.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.146 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 82' ' ' LYS . 42.5 t -67.78 -35.32 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.824 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.48 -43.42 34.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.637 -1.29 . . . . 0.0 109.926 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -80.75 -37.47 30.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.326 -0.858 . . . . 0.0 110.361 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -70.08 -51.18 33.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.53 -42.32 82.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 109.738 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.9 -25.85 67.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 109.917 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.22 -44.65 79.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 110.312 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 13.7 mt -60.85 -39.67 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.0 109.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -53.57 -53.05 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.016 -1.053 . . . . 0.0 110.597 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -68.5 -53.92 20.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.331 -0.855 . . . . 0.0 111.655 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.86 -54.11 11.12 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.029 -1.044 . . . . 0.0 111.475 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.424 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -68.03 -36.61 80.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.223 -0.923 . . . . 0.0 110.21 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tptt 68.53 81.33 0.18 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -159.92 -71.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.778 . . . . 0.0 110.07 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.8 -170.14 3.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -153.63 -48.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.377 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.21 -67.23 0.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -61.19 -25.71 67.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.396 -0.815 . . . . 0.0 110.376 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.3 tp -61.86 108.4 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.534 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -127.86 156.85 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.617 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 10.3 mt -113.51 142.79 45.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.224 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.94 89.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.426 -0.796 . . . . 0.0 110.385 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 90' ' ' HIS . 0.8 OUTLIER -78.09 83.54 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.06 63.13 2.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.631 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.22 -52.11 3.78 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -59.81 174.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -1.071 . . . . 0.0 110.23 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.14 99.23 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.836 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -65.9 79.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.6 tttt -146.21 -162.31 1.5 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.592 -0.693 . . . . 0.0 110.761 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.443 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 29.8 t70 -70.77 -14.26 62.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.649 -0.657 . . . . 0.0 110.298 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -52.06 -31.22 29.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.801 . . . . 0.0 109.756 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -147.87 -176.04 5.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.416 -0.802 . . . . 0.0 109.969 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -102.69 157.04 17.22 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.069 -1.02 . . . . 0.0 109.448 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.54 ' HG ' HG12 ' A' ' 92' ' ' ILE . 6.2 mp -66.18 -29.73 70.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 50' ' ' GLU . 2.3 mt -66.0 -19.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.153 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.9 tp60 -105.7 -10.09 16.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 112.012 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 178.03 -26.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.554 -1.341 . . . . 0.0 111.525 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 87' ' ' LEU . . . -58.74 -37.73 90.53 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.74 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.54 HG12 ' HG ' ' A' ' 87' ' ' LEU . 1.4 mm -139.49 175.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -1.147 . . . . 0.0 110.085 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -147.03 -48.6 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.64 35.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.846 -0.533 . . . . 0.0 109.868 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.25 68.29 0.67 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -115.25 175.78 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -1.158 . . . . 0.0 110.352 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.445 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 5.0 m -114.66 147.04 40.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.23 148.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 110.446 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -90.96 115.92 28.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.24 150.07 31.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.17 -0.956 . . . . 0.0 110.537 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -169.01 125.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.05 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.07 132.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 110.192 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.107 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.156 0.503 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.7 -75.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.299 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 52.66 83.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.317 -0.864 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -85.59 124.96 32.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.7 -112.07 0.99 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -137.67 104.03 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.362 -1.081 . . . . 0.0 110.202 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 m -115.86 39.36 3.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.45 -0.781 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.85 91.16 1.84 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.61 -152.9 0.09 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.61 165.02 33.9 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.728 1.383 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.07 -52.63 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.87 113.34 44.73 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.15 157.72 50.11 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.503 1.265 . . . . 0.0 110.461 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.4 p -150.54 -58.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.129 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 -69.45 0.85 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.323 -0.86 . . . . 0.0 110.143 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.5 -153.95 16.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.91 -50.6 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.761 1.4 . . . . 0.0 110.405 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.2 -171.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.321 -0.862 . . . . 0.0 110.441 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.26 63.14 2.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.34 -0.85 . . . . 0.0 110.548 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.65 93.49 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.179 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -147.36 -70.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.828 . . . . 0.0 110.263 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.03 -88.05 1.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -82.01 75.98 8.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -1.083 . . . . 0.0 110.194 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.19 68.6 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 0.0 110.202 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.64 144.03 31.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.81 83.85 1.33 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 104.64 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.813 1.428 . . . . 0.0 110.375 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.65 53.41 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -0.831 . . . . 0.0 110.318 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -117.25 90.16 33.2 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' LYS . 48.1 Cg_endo -72.12 -93.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.763 1.402 . . . . 0.0 110.565 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 mttp 44.05 48.26 7.4 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.6 mp -57.47 117.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.814 -0.554 . . . . 0.0 110.813 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 48' ' ' VAL . 13.1 pt -84.9 157.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.827 . . . . 0.0 109.727 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -91.23 143.5 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.36 113.79 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.479 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.3 m -85.92 98.55 10.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 0.0 109.643 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.56 127.66 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 110.223 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.86 122.34 46.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 39.5 p -119.9 164.39 22.51 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 44.1 Cg_endo -71.31 60.85 2.59 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.61 1.321 . . . . 0.0 110.446 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -175.21 -42.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.58 176.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.387 -0.82 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -110.86 126.49 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 109.984 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -135.21 131.2 36.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.71 147.72 25.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.81 . . . . 0.0 109.833 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.15 144.93 48.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 110.281 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.25 133.2 45.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.048 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.2 m -143.6 143.12 22.51 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.234 -0.916 . . . . 0.0 108.853 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' ASN . 41.3 Cg_endo -68.22 127.98 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.622 1.328 . . . . 0.0 111.262 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -38.46 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.026 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 49' ' ' PRO . 31.7 t30 -113.36 61.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.772 -1.205 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -154.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.802 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 m -160.43 160.95 32.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.238 -0.914 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 59.7 t -61.08 -34.95 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.506 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -49.18 -46.79 45.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.682 -1.261 . . . . 0.0 109.849 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -78.01 -44.56 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 110.353 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.65 -51.42 65.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.867 . . . . 0.0 110.308 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.98 -31.74 67.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 110.037 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -23.43 35.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.2 82.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.342 -0.849 . . . . 0.0 110.186 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 4.7 mt -61.01 -36.96 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.6 p -53.85 -49.31 68.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.064 -1.022 . . . . 0.0 110.709 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -68.14 -54.21 19.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 111.521 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -54.09 10.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.092 -1.005 . . . . 0.0 111.406 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.16 -36.4 79.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.29 -0.881 . . . . 0.0 110.427 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER 71.79 80.62 0.15 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.535 -0.728 . . . . 0.0 110.094 -179.503 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.59 -164.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.493 -0.755 . . . . 0.0 109.951 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.39 173.87 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -139.46 -52.67 0.54 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.52 -61.36 2.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.171 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -61.15 -25.37 66.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 110.133 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.29 108.01 0.22 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.419 -0.801 . . . . 0.0 110.779 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.425 ' CG2' ' HD2' ' A' ' 82' ' ' LYS . 65.7 t -127.49 137.07 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.468 ' CB ' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.4 155.94 19.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.927 -1.108 . . . . 0.0 109.701 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.23 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.961 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 77' ' ' ALA . 48.3 t80 -69.78 70.64 0.33 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.261 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PHE . . . 28.68 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.895 -0.503 . . . . 0.0 112.283 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.58 -60.41 0.34 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.09 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.66 -160.81 0.77 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -1.174 . . . . 0.0 110.421 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -107.36 111.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.275 -0.89 . . . . 0.0 109.994 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' HB3' ' CB ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.73 74.65 0.42 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.29 -159.23 0.95 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.37 0.605 . . . . 0.0 109.782 -178.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.1 p-10 -73.32 -13.8 61.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -51.95 -32.53 33.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -174.77 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 110.008 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.411 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.38 136.88 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.719 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 19.1 tp -55.66 -47.84 76.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.185 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 2.6 pp -73.74 -15.17 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 111.151 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 86' ' ' THR . 23.3 tt0 -104.71 7.64 34.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.133 -0.98 . . . . 0.0 112.116 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.55 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.634 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 92' ' ' ILE . . . -59.37 -41.7 97.09 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.457 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 6.2 mm -135.85 131.76 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -1.059 . . . . 0.0 110.7 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 64.7 m170 -96.52 -38.92 9.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.893 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 25.3 t0 -178.44 34.37 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.749 -0.594 . . . . 0.0 109.673 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 112.53 68.12 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -1.134 . . . . 0.0 110.114 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.6 m -111.45 144.47 40.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.505 -0.747 . . . . 0.0 109.844 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' CG1' ' CD1' ' A' ' 81' ' ' LEU . 13.9 m -137.61 136.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.29 115.38 27.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.296 -0.877 . . . . 0.0 110.077 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 tt -83.2 133.58 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.303 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -162.39 117.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 110.071 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.56 137.01 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.309 -0.869 . . . . 0.0 110.185 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.5 mp -58.04 99.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.621 -0.674 . . . . 0.0 110.692 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.2 pt -78.74 146.29 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.123 -0.986 . . . . 0.0 109.353 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 25.5 mttp -91.44 132.76 36.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 46' ' ' PHE . 6.1 p -123.13 114.25 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 m -86.25 108.09 18.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 61.9 t -102.27 128.38 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.283 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -97.26 122.73 40.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.393 -0.817 . . . . 0.0 109.838 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 100' ' ' LEU . 2.3 p -120.67 168.03 11.59 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.269 -0.895 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.6 Cg_endo -70.54 62.44 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.679 1.357 . . . . 0.0 110.238 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.67 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.6 -179.2 1.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.418 -0.801 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -105.61 115.31 30.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 134.04 54.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.58 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.5 151.53 19.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 0.0 109.714 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.2 m-85 -126.45 150.1 48.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.458 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -102.16 133.43 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 33' ' ' ILE . 28.4 m -143.93 147.62 38.99 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.092 -1.005 . . . . 0.0 109.452 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.8 Cg_endo -67.24 126.29 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.76 1.4 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 88' ' ' ILE . 10.1 tt0 -42.45 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.93 -0.481 . . . . 0.0 111.769 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' PRO . 8.3 p-10 -115.01 63.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.601 -1.312 . . . . 0.0 110.378 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 154.99 47.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.129 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -98.8 156.46 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.364 -0.835 . . . . 0.0 109.853 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 82' ' ' LYS . 88.3 t -60.94 -34.34 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 110.699 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.54 -44.11 36.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.051 -1.031 . . . . 0.0 110.627 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -51.65 32.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.904 . . . . 0.0 109.915 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 71.5 t80 -59.88 -37.07 78.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.413 -0.804 . . . . 0.0 110.129 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 54' ' ' VAL . 2.1 mtpt -57.64 -46.05 84.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.516 -0.74 . . . . 0.0 109.8 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.25 -19.63 61.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.769 . . . . 0.0 110.167 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -65.72 -52.27 52.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.26 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.8 mt -63.74 -41.91 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.297 -0.877 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -53.71 -52.01 61.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.63 -53.94 19.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.286 -0.884 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.17 -54.27 10.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.121 -0.987 . . . . 0.0 111.454 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.01 -36.47 80.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.176 -0.953 . . . . 0.0 110.181 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 16.4 ttpt 68.72 81.3 0.18 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 110.224 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -152.98 -65.4 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.5 -0.75 . . . . 0.0 110.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -167.93 -176.95 3.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -145.95 -63.91 0.32 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.86 -63.58 1.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.923 . . . . 0.0 110.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -67.82 -25.46 65.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -61.33 125.2 22.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.822 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 82' ' ' LYS . 91.7 t -150.08 167.79 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 109.194 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.752 HD12 HG23 ' A' ' 98' ' ' VAL . 1.2 mm? -118.33 135.88 54.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.037 -1.04 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 101' ' ' VAL . 46.8 mm -97.19 96.91 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.42 -0.8 . . . . 0.0 109.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.847 ' CB ' HD13 ' A' ' 81' ' ' LEU . 9.3 t80 -95.31 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 110.232 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.49 35.86 18.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.403 -0.81 . . . . 0.0 110.697 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.01 -40.18 2.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -178.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.203 -1.175 . . . . 0.0 110.047 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.13 94.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.695 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.98 HD11 ' CA ' ' A' ' 91' ' ' GLY . 1.6 tp -65.07 81.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.741 ' O ' HG21 ' A' ' 54' ' ' VAL . 3.5 ttmt -137.98 -155.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.339 0.59 . . . . 0.0 110.364 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.84 -19.63 61.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 0.0 110.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.7 -32.81 53.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.852 . . . . 0.0 109.807 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -133.59 -175.45 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 109.972 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -105.84 130.36 53.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.96 . . . . 0.0 109.932 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 14.1 tp -55.42 -46.91 76.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.759 . . . . 0.0 110.26 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.5 pp -72.76 -14.98 17.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 110.472 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 53.5 tp60 -88.18 -10.83 48.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 112.062 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.35 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.45 -1.407 . . . . 0.0 111.574 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.98 ' CA ' HD11 ' A' ' 81' ' ' LEU . . . -58.97 -41.73 96.5 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.189 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 91' ' ' GLY . 4.0 mm -134.3 113.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -1.157 . . . . 0.0 111.023 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -87.11 -33.61 19.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 108.881 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.7 t70 -179.97 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.736 -0.603 . . . . 0.0 110.015 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 128.42 69.76 0.14 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 6.0 mt -108.83 162.64 14.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -1.211 . . . . 0.0 110.129 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.8 p -112.16 134.52 53.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.313 -0.867 . . . . 0.0 110.274 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.853 HG11 HD22 ' A' ' 81' ' ' LEU . 27.5 m -140.64 151.93 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.437 -0.789 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.688 ' O ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 110.382 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 39' ' ' THR . 8.2 tt -101.15 127.88 47.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.454 HG22 HG12 ' A' ' 75' ' ' ILE . 34.0 m -141.99 143.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.341 -0.849 . . . . 0.0 110.37 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mttt . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.51 124.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.734 -0.604 . . . . 0.0 110.724 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' A' ' 92' ' ' ILE . 18.0 pt -108.19 158.87 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.759 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 144.37 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 46' ' ' PHE . 9.0 p -134.81 113.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.7 m -79.21 105.22 10.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.41 127.88 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.825 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -112.88 122.28 47.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.516 HG22 ' HG ' ' A' ' 100' ' ' LEU . 18.1 p -122.46 166.07 18.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 109.851 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.1 Cg_endo -70.72 61.23 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.648 1.341 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.61 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.469 -0.77 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -169.65 166.98 9.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 118.6 29.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.33 135.55 40.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.898 . . . . 0.0 110.556 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.47 150.23 36.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.649 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.777 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.7 m-85 -120.38 108.89 14.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.532 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.63 105.22 13.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 0.0 109.503 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.53 157.05 79.23 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.363 -0.836 . . . . 0.0 110.711 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.61 108.42 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.793 1.417 . . . . 0.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 11.7 pt-20 -51.12 -25.49 5.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.492 -0.755 . . . . 0.0 110.741 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -53.6 -23.95 12.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 110.556 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.07 140.63 30.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.885 . . . . 0.0 110.462 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.1 m -70.82 171.83 9.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.6 t -66.8 -35.75 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -42.78 31.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.054 -1.029 . . . . 0.0 110.108 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.4 -46.07 64.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.615 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 84.2 t80 -69.92 -38.36 76.23 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.218 -0.927 . . . . 0.0 110.626 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.74 -45.18 86.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 69' ' ' THR . 17.8 tt0 -74.63 -16.7 60.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.893 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.11 -44.65 79.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.297 -0.877 . . . . 0.0 109.932 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.2 mt -60.87 -37.94 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.654 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 29.1 t -53.94 -46.3 71.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.915 . . . . 0.0 110.78 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -67.89 -54.76 16.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 111.44 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.79 -54.08 9.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.122 -0.987 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.38 -36.25 78.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.381 -0.824 . . . . 0.0 110.551 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 69.33 81.69 0.17 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.574 -0.704 . . . . 0.0 110.03 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -155.04 -75.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.554 -0.716 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.0 179.46 8.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 59' ' ' GLU . 62.2 m -139.99 -62.01 0.52 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.443 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.5 -66.69 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 0.0 110.32 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.63 -25.71 64.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.288 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 100' ' ' LEU . 11.5 tp -59.91 133.61 56.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.475 -0.766 . . . . 0.0 110.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.479 HG23 ' C ' ' A' ' 72' ' ' LEU . 78.1 t -152.53 158.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.418 -0.801 . . . . 0.0 109.28 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.1 mp -121.15 122.02 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.232 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 75' ' ' ILE . 25.4 mm -78.8 103.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.045 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.827 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.5 t80 -112.14 120.14 40.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.506 -0.746 . . . . 0.0 110.076 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.69 29.31 17.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.62 59.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -172.7 2.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -1.085 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.507 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -103.27 82.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 110.363 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.1 tt -66.43 83.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.242 -0.911 . . . . 0.0 108.645 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -148.96 -147.07 0.21 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.557 -0.715 . . . . 0.0 110.253 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.52 -14.36 61.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 111.315 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.449 ' HB3' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -52.15 -33.62 41.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.585 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -176.63 4.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 143.86 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 109.882 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.995 HD11 HD11 ' A' ' 92' ' ' ILE . 11.6 tp -56.23 -46.14 79.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.496 -0.752 . . . . 0.0 110.672 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.62 -8.27 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.411 -0.806 . . . . 0.0 111.095 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.536 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 14.3 mt-30 -110.08 -1.2 17.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.954 -1.092 . . . . 0.0 112.028 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.3 OUTLIER 176.54 -30.78 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.589 -1.32 . . . . 0.0 111.807 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.26 -47.68 88.06 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.543 -1.313 . . . . 0.0 109.919 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -144.42 161.95 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.273 -1.134 . . . . 0.0 110.183 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -122.64 -41.74 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.539 -0.726 . . . . 0.0 109.359 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.71 35.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.028 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.77 67.75 0.53 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' ' 96' ' ' LEU . 4.3 mm? -103.98 175.81 5.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 97' ' ' THR . 9.7 t -111.95 121.32 44.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.765 . . . . 0.0 110.082 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 81' ' ' LEU . 33.7 m -125.94 149.23 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 110.378 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.446 -0.784 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -92.98 120.12 32.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.373 -0.83 . . . . 0.0 110.019 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.533 ' N ' HD13 ' A' ' 100' ' ' LEU . 32.8 m -148.72 156.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.3 mm -58.47 124.15 11.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.705 -0.622 . . . . 0.0 110.85 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 88' ' ' ILE . 8.6 pt -106.77 149.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 0.0 109.522 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -91.8 144.23 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 110.647 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 92' ' ' ILE . 14.8 m -132.92 130.38 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 109.583 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.17 110.25 22.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' HD12 ' A' ' 100' ' ' LEU . 58.7 t -96.47 127.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 122.83 47.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -125.73 169.74 10.83 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.301 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.94 60.51 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.702 1.369 . . . . 0.0 110.372 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.7 -46.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.316 -0.865 . . . . 0.0 109.812 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -173.19 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.101 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -123.12 129.82 51.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -135.12 127.63 30.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -84.86 147.73 26.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.397 -0.815 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.8 m-85 -125.08 145.84 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.533 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.35 132.13 45.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.0 108.991 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.5 m -143.16 148.83 46.41 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.975 . . . . 0.0 110.266 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 32' ' ' ILE . 40.5 Cg_endo -71.08 119.43 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.705 1.371 . . . . 0.0 110.418 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -32.73 -41.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.223 0.535 . . . . 0.0 111.642 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -83.88 50.97 1.93 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.051 -1.03 . . . . 0.0 110.571 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 51.4 p -126.21 112.77 16.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.29 156.86 21.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -63.02 -35.4 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.197 -0.94 . . . . 0.0 110.913 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -49.31 -50.15 40.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.123 -0.985 . . . . 0.0 111.055 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.0 -55.27 27.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.99 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 35' ' ' VAL . 51.3 t80 -59.91 -36.57 77.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.457 -0.777 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -57.15 -36.74 71.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 0.0 110.386 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -79.05 -24.47 43.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.61 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 0.0 109.573 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.61 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.8 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.807 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -66.45 -44.55 82.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 110.625 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -58.85 -53.12 61.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.253 -0.904 . . . . 0.0 110.952 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -52.68 63.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.688 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 39' ' ' THR . 10.5 m-85 -67.5 -36.91 82.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 0.0 110.445 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.91 79.52 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.469 -0.769 . . . . 0.0 110.091 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 t -153.92 -71.08 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.38 -0.825 . . . . 0.0 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.647 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -151.87 -171.57 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.174 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.0 m -153.51 -57.79 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.36 -0.837 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.49 -70.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.322 -0.861 . . . . 0.0 110.413 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.879 ' O ' HG23 ' A' ' 73' ' ' VAL . 6.2 mt-30 -60.76 -25.53 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.698 ' HA ' HG22 ' A' ' 102' ' ' ILE . 1.2 tt -52.93 106.46 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 110.763 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.972 HG22 ' HD2' ' A' ' 82' ' ' LYS . 51.0 t -127.14 151.18 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.651 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.756 HD23 HG11 ' A' ' 98' ' ' VAL . 5.0 mp -102.04 146.2 28.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 75' ' ' ILE . 29.9 mm -107.76 83.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.45 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.844 ' HB2' HD12 ' A' ' 81' ' ' LEU . 3.2 t80 -98.84 124.04 43.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.386 -0.821 . . . . 0.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.07 26.35 6.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.37 -0.831 . . . . 0.0 110.556 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.32 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 1.2 tttm -129.48 136.54 50.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -1.09 . . . . 0.0 110.061 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.784 ' O ' HD12 ' A' ' 80' ' ' ILE . 1.4 pp -59.68 88.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.816 . . . . 0.0 111.351 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.3 tt -66.79 86.87 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.972 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.5 OUTLIER -140.34 -149.74 0.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.01 -177.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -74.1 -20.71 60.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.698 . . . . 0.0 110.834 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -52.7 -32.75 44.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.103 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.91 140.21 46.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 147.94 33.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.541 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 92' ' ' ILE . 13.8 tp -57.59 -48.52 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.705 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.756 HG22 HD13 ' A' ' 33' ' ' ILE . 1.8 pp -73.04 -13.7 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.051 -1.031 . . . . 0.0 110.367 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.73 -15.09 46.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 111.542 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 79' ' ' LYS . 4.9 t-80 -171.69 -38.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.624 -1.297 . . . . 0.0 111.431 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.839 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -59.44 -49.67 76.01 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.386 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -142.26 146.37 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -1.232 . . . . 0.0 110.808 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 13.1 m170 -109.76 -35.49 6.17 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.5 t0 -177.68 31.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.29 0.567 . . . . 0.0 109.861 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.4 69.33 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 92' ' ' ILE . 84.1 mt -109.17 174.22 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -1.223 . . . . 0.0 109.966 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.8 p -115.84 147.25 41.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.756 HG11 HD23 ' A' ' 74' ' ' LEU . 7.6 p -147.68 146.14 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.402 -0.811 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -90.63 116.15 28.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.489 -0.757 . . . . 0.0 110.118 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 72' ' ' LEU . 5.7 tt -74.17 121.28 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.306 -0.871 . . . . 0.0 110.13 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 100' ' ' LEU . 58.0 t -145.95 131.85 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.386 -0.821 . . . . 0.0 110.106 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.698 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.819 . . . . 0.0 110.218 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.2 mp -58.47 99.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.63 -0.669 . . . . 0.0 110.55 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 92' ' ' ILE . 4.3 pt -78.83 150.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -94.23 144.59 25.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 110.972 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 92' ' ' ILE . 7.9 p -137.97 113.96 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.495 -0.753 . . . . 0.0 109.866 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -85.89 112.72 21.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 110.605 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.16 127.96 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.55 122.51 43.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.605 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -124.12 170.73 8.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.812 . . . . 0.0 109.921 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.4 Cg_endo -68.94 -16.06 40.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.697 1.367 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -49.13 6.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -173.54 174.47 3.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -103.04 122.05 43.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.949 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.14 135.48 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -90.29 150.97 21.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.443 -0.785 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.9 m-85 -125.59 128.09 47.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.369 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -91.86 124.71 36.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.227 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.3 m -142.98 154.71 62.19 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 109.943 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.2 Cg_endo -66.48 121.65 8.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.814 1.429 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.6 pt-20 -36.31 -38.96 0.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.214 0.531 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 36.0 m120 -86.96 53.07 2.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.516 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.5 p -119.23 154.02 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.345 -0.847 . . . . 0.0 110.194 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 t -103.02 148.04 26.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.011 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 82' ' ' LYS . 71.3 t -59.38 -34.37 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -48.59 -46.12 38.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.047 -1.033 . . . . 0.0 110.547 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.72 -51.39 49.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -59.89 -36.91 77.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.54 -39.02 75.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.57 -22.13 47.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.22 78.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG23 ' CB ' ' A' ' 65' ' ' PHE . 20.0 mt -60.78 -38.76 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 109.669 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -53.75 -53.12 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.126 -0.984 . . . . 0.0 110.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -68.52 -54.76 14.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 111.694 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -72.55 -54.55 8.87 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.094 -1.004 . . . . 0.0 111.568 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.494 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.3 -36.48 79.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.189 -0.944 . . . . 0.0 110.443 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tttt 71.81 73.69 0.17 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -160.51 -153.91 0.35 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.529 -0.732 . . . . 0.0 109.959 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -173.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -148.18 -61.9 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.81 -63.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -59.32 -27.09 65.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 100' ' ' LEU . 11.6 tp -62.71 105.93 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.489 -0.757 . . . . 0.0 110.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 82' ' ' LYS . 77.3 t -128.82 161.54 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.027 HD22 HG23 ' A' ' 98' ' ' VAL . 9.8 mt -113.7 139.66 48.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 110.084 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 101' ' ' VAL . 43.1 mm -100.42 93.54 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.2 t80 -96.96 115.21 27.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.77 27.57 7.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -0.838 . . . . 0.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.79 -39.7 2.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -176.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -1.073 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.51 90.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.323 -0.861 . . . . 0.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 87' ' ' LEU . 10.1 tt -61.84 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.797 ' O ' HG21 ' A' ' 54' ' ' VAL . 20.5 tttt -154.03 -148.16 0.24 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.418 -0.801 . . . . 0.0 110.655 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t70 -72.13 -15.14 61.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.129 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -53.19 -32.52 48.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.68 161.38 39.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.631 -0.668 . . . . 0.0 109.9 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.425 ' OG1' ' CG ' ' A' ' 89' ' ' GLN . 64.4 p -79.21 165.0 23.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.697 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.718 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.24 -46.35 77.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.86 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.8 pt -64.62 -18.95 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.032 -1.043 . . . . 0.0 110.453 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' CG ' ' OG1' ' A' ' 86' ' ' THR . 27.5 mm-40 -92.11 -15.79 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.922 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.42 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.027 -1.046 . . . . 0.0 111.638 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.718 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.04 -50.23 67.93 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -148.86 171.65 2.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.529 -0.983 . . . . 0.0 108.706 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.488 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.65 -33.23 4.33 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.651 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.6 t70 179.83 34.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.569 -0.707 . . . . 0.0 109.97 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.05 69.98 0.34 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.529 HD22 ' CE1' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -114.04 -172.13 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m -131.42 146.35 52.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.027 HG23 HD22 ' A' ' 74' ' ' LEU . 27.4 m -143.7 149.51 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.356 -0.84 . . . . 0.0 110.504 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.57 118.71 30.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 110.352 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 ' CG2' ' A' ' 39' ' ' THR . 6.8 tt -77.37 149.52 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 75' ' ' ILE . 7.8 p -171.38 138.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.89 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 48' ' ' VAL . 2.8 mp -58.08 118.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.276 0.56 . . . . 0.0 110.905 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 92' ' ' ILE . 1.9 pt -87.85 152.33 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -91.49 144.61 25.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 46' ' ' PHE . 18.3 m -138.86 140.32 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.455 -0.778 . . . . 0.0 110.043 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -109.56 104.25 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.857 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 127.84 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 122.47 43.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.957 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 HD22 ' A' ' 100' ' ' LEU . 7.3 p -113.72 166.63 10.91 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.947 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.8 Cg_endo -71.27 61.31 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.604 1.318 . . . . 0.0 110.424 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.15 -42.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.7 -169.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.407 -0.808 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -123.42 129.07 50.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -0.816 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -135.16 134.89 40.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.16 150.87 20.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.688 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.5 m-85 -129.03 144.18 51.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.469 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -100.33 128.45 46.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.402 -0.811 . . . . 0.0 109.235 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' N ' HG23 ' A' ' 32' ' ' ILE . 33.1 m -141.2 146.04 41.2 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 52' ' ' SER . 40.4 Cg_endo -67.97 122.07 9.15 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.669 1.352 . . . . 0.0 110.377 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.524 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.7 pp20? -31.07 -39.1 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' PRO . 43.9 p-10 -92.03 49.5 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.725 -1.235 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 1.7 t -114.38 112.96 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.068 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -65.5 147.96 52.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.877 HG11 ' HA ' ' A' ' 82' ' ' LYS . 90.3 t -56.41 -34.8 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -48.79 -43.83 38.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.05 -1.031 . . . . 0.0 110.53 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -68.44 -53.54 22.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.189 -0.945 . . . . 0.0 109.96 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.87 -36.82 77.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.498 -0.751 . . . . 0.0 110.365 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.586 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 mtpt -57.42 -43.04 83.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.747 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 -23.25 54.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.525 -0.734 . . . . 0.0 109.941 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.94 86.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.2 mt -60.77 -40.05 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.404 -0.81 . . . . 0.0 109.729 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -53.71 -51.95 61.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -68.42 -54.64 15.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 111.666 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mmt-85 -72.36 -54.3 9.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.091 -1.006 . . . . 0.0 111.511 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.08 -36.35 79.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.373 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tptm 72.31 76.02 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.594 -0.691 . . . . 0.0 110.082 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.9 t -161.9 -153.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.818 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.612 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -71.47 165.11 24.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -136.13 -59.69 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.94 -72.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -57.96 -25.17 60.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.421 -0.799 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 68' ' ' GLN . 10.1 tp -59.81 128.47 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.477 -0.764 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 82' ' ' LYS . 88.6 t -151.1 167.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.242 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -117.92 133.38 55.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 0.0 110.159 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.09 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 32.0 t80 -70.07 62.73 0.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.637 -0.665 . . . . 0.0 110.554 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.28 26.49 2.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.143 -0.973 . . . . 0.0 110.738 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.03 -48.19 0.64 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.794 ' C ' HD13 ' A' ' 80' ' ' ILE . 3.7 mtpp -83.01 -166.99 1.49 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -1.062 . . . . 0.0 110.098 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.47 96.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.678 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -65.23 79.94 0.05 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.877 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ttmt -140.55 -156.5 0.68 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.32 -14.97 61.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -33.09 69.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.804 . . . . 0.0 110.015 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -143.8 164.55 30.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 110.767 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.27 153.47 17.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.872 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.678 HD11 ' CD2' ' A' ' 81' ' ' LEU . 1.1 mp -66.5 -46.65 75.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.342 -0.849 . . . . 0.0 110.897 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.1 pp -63.66 -19.62 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.023 . . . . 0.0 109.847 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -89.43 -18.79 26.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.805 . . . . 0.0 110.587 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.96 -26.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.948 -1.095 . . . . 0.0 112.063 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.32 -50.38 67.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.61 162.83 4.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -1.081 . . . . 0.0 108.682 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 5.9 m-70 -113.13 -30.8 6.85 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 109.75 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.3 t0 179.75 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 109.72 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.94 73.86 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.3 mm? -114.83 170.88 8.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -1.061 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.429 ' C ' HG23 ' A' ' 98' ' ' VAL . 6.5 t -115.25 144.64 43.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 74' ' ' LEU . 44.6 t -146.68 154.85 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -90.83 144.36 25.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -101.44 121.96 42.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.901 . . . . 0.0 110.052 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.04 150.7 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.303 -0.873 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.341 -0.849 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 28.1 mm -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.593 -0.692 . . . . 0.0 110.758 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.889 HD12 ' HB ' ' A' ' 92' ' ' ILE . 32.0 pt -110.78 144.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.636 -0.665 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 144.53 25.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.823 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 46' ' ' PHE . 7.4 p -135.94 113.57 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.0 109.759 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -85.17 102.35 13.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.619 ' CG1' HD13 ' A' ' 100' ' ' LEU . 60.4 t -94.92 127.63 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.97 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -111.44 122.71 48.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.164 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 HD22 ' A' ' 100' ' ' LEU . 29.1 p -120.37 168.24 10.96 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.454 -0.779 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.52 -10.28 28.36 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.577 1.303 . . . . 0.0 110.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -42.39 7.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.08 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.08 157.49 5.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -107.42 118.34 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 110.078 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -135.32 135.62 40.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.943 . . . . 0.0 110.811 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.51 154.38 22.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.47 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.71 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.0 m-85 -128.08 128.71 45.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -91.36 129.93 37.28 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.409 HG13 ' C ' ' A' ' 47' ' ' ALA . 26.5 m -143.31 153.71 59.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.041 -1.037 . . . . 0.0 110.492 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 32' ' ' ILE . 42.8 Cg_endo -71.59 119.82 6.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.875 1.461 . . . . 0.0 110.443 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -36.22 -37.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.812 -0.555 . . . . 0.0 111.091 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -82.9 50.12 1.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 t -126.66 141.25 51.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m -92.86 156.77 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 ' HG3' ' A' ' 58' ' ' LYS . 84.0 t -59.71 -34.59 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -48.96 -43.67 40.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.121 . . . . 0.0 110.532 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.74 -54.63 14.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -0.882 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.88 -36.97 78.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.385 -0.822 . . . . 0.0 110.191 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.882 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.32 -39.04 75.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.591 -0.693 . . . . 0.0 109.587 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.23 -18.78 44.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.501 -0.749 . . . . 0.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -49.68 71.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 65' ' ' PHE . 12.8 mt -60.91 -36.34 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.358 -0.838 . . . . 0.0 109.693 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -53.85 -51.73 62.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 110.535 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -68.43 -54.28 18.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.318 -0.864 . . . . 0.0 111.711 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -54.07 10.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.115 -0.991 . . . . 0.0 111.497 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.31 -36.24 79.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.278 -0.889 . . . . 0.0 110.351 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 8.5 mttm 68.72 81.86 0.18 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.601 -0.687 . . . . 0.0 109.942 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -157.12 -73.56 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 110.206 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.0 pt20 -166.45 -165.6 0.78 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.411 -0.806 . . . . 0.0 110.106 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -153.19 -51.19 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.594 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.36 -75.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.0 110.407 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.711 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.69 -25.56 62.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -55.55 104.24 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.387 -0.821 . . . . 0.0 110.876 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 71' ' ' GLN . 58.0 t -127.59 156.1 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.503 -0.748 . . . . 0.0 109.38 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.657 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -118.73 141.2 48.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.973 -1.079 . . . . 0.0 110.519 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.402 ' C ' HG23 ' A' ' 98' ' ' VAL . 46.5 mm -101.16 93.68 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.5 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.6 t80 -84.89 95.4 9.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.237 -0.914 . . . . 0.0 110.348 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.12 46.3 26.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 110.694 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.15 -45.72 2.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.0 179.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -115.84 93.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.267 -0.896 . . . . 0.0 110.855 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -65.28 82.44 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.745 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -144.09 -161.5 1.29 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.442 0.639 . . . . 0.0 110.491 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.5 p30 -73.33 -14.95 61.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.67 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 109.565 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -139.06 168.98 18.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 0.0 109.752 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.24 145.99 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.457 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 92' ' ' ILE . 16.5 tp -55.81 -47.01 77.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -72.39 -28.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.659 . . . . 0.0 110.058 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -76.82 -6.21 51.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.704 . . . . 0.0 111.761 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.39 -37.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.536 -1.353 . . . . 0.0 111.759 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.792 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.98 -48.31 86.48 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.161 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.4 156.55 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.434 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -115.98 -41.63 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -177.87 34.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 109.87 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 96' ' ' LEU . . . 123.95 71.08 0.22 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.573 HD22 ' C ' ' A' ' 95' ' ' GLY . 4.1 mm? -117.57 174.87 5.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -1.104 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.7 m -116.51 147.31 41.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 74' ' ' LEU . 7.4 p -149.96 150.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.404 -0.81 . . . . 0.0 110.296 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.632 ' O ' HD23 ' A' ' 74' ' ' LEU . 3.9 m-70 -90.68 132.83 35.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.948 HD22 HG22 ' A' ' 39' ' ' THR . 1.4 tp -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.4 p -166.21 144.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.837 . . . . 0.0 110.177 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.384 -0.823 . . . . 0.0 110.219 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.8 mttt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.28 116.48 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.668 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.068 HD12 HD11 ' A' ' 92' ' ' ILE . 2.1 pt -93.73 157.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.372 -0.83 . . . . 0.0 109.917 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -91.62 144.6 25.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.89 . . . . 0.0 110.865 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 87' ' ' LEU . 40.7 t -133.7 113.79 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.495 -0.753 . . . . 0.0 109.992 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -88.91 108.47 19.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.526 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.01 127.87 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.799 . . . . 0.0 110.09 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.75 122.57 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.589 HG22 HD22 ' A' ' 100' ' ' LEU . 7.2 p -121.64 165.12 20.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.949 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.41 60.78 2.66 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.637 1.335 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -175.1 -46.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.485 -0.759 . . . . 0.0 109.699 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -171.32 -176.74 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 110.018 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 126.88 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.03 120.03 22.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.17 147.17 28.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -123.78 121.1 34.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -87.64 126.32 34.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.5 m -143.34 150.35 51.36 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -67.63 123.33 10.64 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.768 1.404 . . . . 0.0 110.733 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -27.42 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.07 0.462 . . . . 0.0 112.058 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 p-10 -85.54 47.38 1.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.115 -0.991 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -111.48 103.49 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.075 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -60.62 150.78 30.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 82' ' ' LYS . 94.9 t -59.88 -34.28 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.731 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -48.38 -48.86 36.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.069 -1.02 . . . . 0.0 110.668 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -64.63 -50.56 66.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 109.726 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 56.5 t80 -60.44 -36.87 79.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.441 -0.787 . . . . 0.0 110.16 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -35.38 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.662 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.08 -17.99 31.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.89 74.65 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.501 HG23 ' CB ' ' A' ' 65' ' ' PHE . 11.2 mt -60.91 -37.48 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -53.9 -52.1 61.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.07 -1.019 . . . . 0.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -54.43 16.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.255 -0.903 . . . . 0.0 111.574 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -54.45 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 111.509 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HZ ' ' HG1' ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.17 -36.21 79.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.868 . . . . 0.0 110.36 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 74.03 77.75 0.12 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.2 p -163.4 -153.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 109.913 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.71 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 mm-40 -68.95 -178.57 1.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.182 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -146.71 -56.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 110.382 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.61 -64.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.854 . . . . 0.0 110.042 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt-30 -64.08 -25.47 68.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 68' ' ' GLN . 2.3 tt -55.43 106.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.93 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG22 ' HG3' ' A' ' 82' ' ' LYS . 99.3 t -136.57 163.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -115.16 139.25 50.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.012 -1.055 . . . . 0.0 109.918 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.1 mm -94.13 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 110.394 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.5 t80 -70.08 167.85 16.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.756 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.52 69.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 110.459 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.56 25.07 4.75 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.759 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -170.21 -174.33 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.232 -1.157 . . . . 0.0 109.994 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -116.72 109.41 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.992 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -69.72 72.03 0.36 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -131.62 -159.71 0.99 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.368 0.604 . . . . 0.0 109.949 -178.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.7 t0 -72.75 -14.94 61.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 110.16 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -58.08 -33.2 68.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 110.15 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -142.38 166.28 25.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 110.602 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.47 155.03 17.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.37 -46.65 75.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.451 HG21 ' CA ' ' A' ' 50' ' ' GLU . 1.3 pp -63.93 -17.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 7.4 tm0? -94.98 -14.64 24.2 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.426 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 175.94 -25.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.988 -1.07 . . . . 0.0 111.86 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.18 -49.89 71.47 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.068 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.15 168.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.345 -1.091 . . . . 0.0 109.158 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.633 ' H ' HD13 ' A' ' 96' ' ' LEU . 4.6 m-70 -114.72 -33.5 5.48 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.7 t0 -179.01 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.566 -0.709 . . . . 0.0 109.911 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.66 70.43 0.36 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.633 HD13 ' H ' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -111.2 174.48 5.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -1.066 . . . . 0.0 110.2 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.2 p -111.76 145.5 39.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.38 -0.825 . . . . 0.0 110.243 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 74' ' ' LEU . 59.0 t -143.28 151.13 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.272 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -90.26 115.78 27.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 110.213 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 74' ' ' LEU . 1.8 tt -74.22 148.38 41.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.59 152.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.805 . . . . 0.0 110.076 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 mttp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.572 HG23 ' C ' ' A' ' 48' ' ' VAL . 3.2 mp -58.44 115.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.684 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 92' ' ' ILE . 3.5 pt -87.99 166.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.49 144.28 25.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 HD23 ' A' ' 87' ' ' LEU . 27.5 t -134.62 113.45 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.186 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -101.92 106.41 17.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 110.026 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 61' ' ' ILE . 62.1 t -95.01 129.42 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 0.0 110.337 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -96.86 123.08 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.45 -0.781 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.783 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 1.8 p -121.34 169.32 9.28 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.049 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.7 Cg_endo -68.1 -12.32 34.77 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.642 1.338 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -94.37 -48.19 6.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.92 -165.57 0.37 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.402 -0.811 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -115.45 130.66 56.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.93 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.7 135.19 43.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -0.919 . . . . 0.0 110.669 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 36' ' ' THR . 6.1 mt-10 -92.08 153.67 19.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -136.76 129.45 30.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.12 126.43 37.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.22 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 ' C ' HG23 ' A' ' 32' ' ' ILE . 33.8 m -143.32 151.22 54.33 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.937 . . . . 0.0 109.768 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.6 Cg_endo -67.45 123.11 10.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.853 1.449 . . . . 0.0 110.469 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 51' ' ' ASN . 22.0 pt-20 -30.69 -39.78 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 120.965 0.412 . . . . 0.0 112.106 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 2.0 p-10 -91.27 49.56 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -111.52 111.4 22.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.034 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -59.94 144.69 48.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 110.306 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.889 HG11 ' HA ' ' A' ' 82' ' ' LYS . 70.5 t -60.58 -34.19 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -50.38 35.04 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.067 -1.021 . . . . 0.0 110.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -65.9 -50.63 63.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.457 ' CE2' HG11 ' A' ' 35' ' ' VAL . 31.4 t80 -59.72 -36.26 76.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.544 -0.722 . . . . 0.0 109.999 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.702 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -57.55 -38.39 74.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 109.727 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -81.96 -20.34 38.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.55 84.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.006 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -60.66 -30.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.525 -0.734 . . . . 0.0 110.134 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -60.57 -43.98 96.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.778 . . . . 0.0 110.509 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.67 -50.84 69.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.312 -0.868 . . . . 0.0 111.0 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -71.18 -52.66 17.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.204 -0.935 . . . . 0.0 111.045 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 39' ' ' THR . 16.6 m-85 -65.66 -36.55 83.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.89 . . . . 0.0 110.306 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 12.3 tttt 68.8 57.74 0.4 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.572 -0.705 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -138.02 -154.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.403 -0.811 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.25 160.71 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.928 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -113.01 -67.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 109.114 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 40.33 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.833 -0.542 . . . . 0.0 111.011 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' THR . 1.1 mp0 -79.08 -49.31 12.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 69' ' ' THR . 0.2 OUTLIER 36.18 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.708 -0.62 . . . . 0.0 111.457 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 74' ' ' LEU . 4.6 p -136.28 147.25 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.708 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 73' ' ' VAL . 8.2 mp -117.3 142.37 47.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.83 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.1 mm -92.79 100.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.821 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 82.0 t80 -74.59 78.28 1.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.501 -0.749 . . . . 0.0 109.522 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 55.79 23.53 6.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.41 -41.41 1.51 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -164.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.233 -1.157 . . . . 0.0 110.393 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -122.53 88.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 87' ' ' LEU . 10.3 tt -65.27 86.49 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.889 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.8 tttt -147.25 -150.25 0.33 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.571 -0.706 . . . . 0.0 110.53 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 19.5 p-10 -72.42 -21.6 61.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.522 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.42 -33.04 63.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.85 . . . . 0.0 110.006 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.34 157.11 44.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -84.91 161.7 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.748 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -65.93 -45.87 80.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.566 ' CG2' HD13 ' A' ' 33' ' ' ILE . 2.2 pt -62.13 -17.95 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 15.8 mm100 -98.08 -12.54 21.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -0.841 . . . . 0.0 111.191 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.99 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.883 -1.135 . . . . 0.0 111.934 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.53 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.51 -50.17 69.54 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.11 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -150.55 161.92 3.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.441 -1.035 . . . . 0.0 108.963 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -112.27 -24.51 9.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.992 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p30 179.84 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.373 -0.83 . . . . 0.0 110.077 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.97 68.08 0.78 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.03 -174.49 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -1.073 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -111.52 131.49 55.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 81' ' ' LEU . 27.4 m -127.91 153.6 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 0.0 110.475 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -90.58 144.46 25.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 39' ' ' THR . 8.7 tt -120.6 136.89 54.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.145 -0.972 . . . . 0.0 110.081 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 102' ' ' ILE . 11.1 p -166.12 170.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' N ' HG22 ' A' ' 101' ' ' VAL . 3.9 tt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 49' ' ' PRO . 41.4 mm -58.45 140.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.721 -0.612 . . . . 0.0 110.816 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.021 ' CD1' HD11 ' A' ' 92' ' ' ILE . 4.5 pt -119.64 152.33 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.412 -0.805 . . . . 0.0 109.353 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -91.03 144.16 25.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.616 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 87' ' ' LEU . 38.6 t -132.81 113.41 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.612 -0.68 . . . . 0.0 109.784 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.5 m -91.44 102.53 15.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HD21 ' A' ' 74' ' ' LEU . 53.1 t -94.85 127.55 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 110.184 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 122.51 46.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.0 109.846 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 100' ' ' LEU . 51.5 p -124.18 166.9 17.14 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.447 -0.783 . . . . 0.0 109.864 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.1 Cg_endo -68.22 -12.65 35.69 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.622 1.327 . . . . 0.0 110.528 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -92.32 -44.05 8.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -172.5 -167.23 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 110.294 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 3.1 ptmt -130.96 121.55 25.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 109.951 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -135.47 135.48 40.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.124 -0.985 . . . . 0.0 110.809 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.02 150.4 24.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.587 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.35 130.17 48.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.668 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.31 36.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.4 154.58 63.91 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.746 ' HA ' HD13 ' A' ' 32' ' ' ILE . 41.1 Cg_endo -69.51 120.48 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.671 1.353 . . . . 0.0 110.358 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.609 ' HA ' HD13 ' A' ' 33' ' ' ILE . 1.7 pp20? -37.61 -37.61 0.22 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.875 -0.515 . . . . 0.0 111.689 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.2 p-10 -86.74 52.04 2.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.029 -1.045 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.2 t -126.42 126.5 43.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 86' ' ' THR . 4.2 t -70.09 151.29 45.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 82' ' ' LYS . 91.6 t -61.77 -34.76 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.778 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -43.56 28.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.982 -1.074 . . . . 0.0 110.579 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -70.34 -46.53 63.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 37.7 t80 -65.71 -37.87 87.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.91 -39.28 77.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.406 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -20.94 60.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.607 -0.683 . . . . 0.0 109.942 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -66.86 -50.74 61.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 mt -63.13 -36.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -53.63 -44.92 69.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -54.72 15.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 111.336 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -72.89 -54.37 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.1 -1.0 . . . . 0.0 111.29 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.34 -36.5 79.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.2 tptt 71.7 79.19 0.16 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 t -131.78 -151.85 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 110.051 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -92.88 -17.28 24.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 110.565 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m 66.14 -66.09 0.17 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.783 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.7 t70 -55.12 -63.48 1.14 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.127 -0.983 . . . . 0.0 110.14 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' O ' HG23 ' A' ' 73' ' ' VAL . 31.7 mt-30 -68.93 -25.3 64.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.798 . . . . 0.0 110.02 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 100' ' ' LEU . 51.6 tp -56.21 95.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.397 -0.814 . . . . 0.0 110.826 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 71' ' ' GLN . 65.8 t -122.47 154.56 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.783 . . . . 0.0 109.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD2' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -115.06 141.13 48.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.014 -1.054 . . . . 0.0 110.315 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 99' ' ' HIS . 50.2 mm -94.75 98.63 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 75.6 t80 -68.74 72.63 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.407 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.83 38.41 19.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.895 . . . . 0.0 110.579 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 126.12 -50.13 0.89 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -74.21 -161.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -126.83 93.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.388 -0.82 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 91' ' ' GLY . 7.7 tt -64.05 89.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.802 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -152.81 -154.3 0.53 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.772 -0.58 . . . . 0.0 110.17 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.5 p30 -72.66 -19.52 61.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.431 -0.793 . . . . 0.0 110.219 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -33.05 62.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.71 149.01 33.64 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.476 -0.765 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 53' ' ' SER . 1.2 p -74.18 161.79 29.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 109.843 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.2 tp -65.56 -46.32 79.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 110.37 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 50' ' ' GLU . 2.1 pp -65.46 -18.37 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 110.211 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -96.79 -10.71 26.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 111.1 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 -30.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.935 -1.103 . . . . 0.0 111.962 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -59.08 -51.01 61.76 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.021 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -149.83 177.14 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.371 -1.076 . . . . 0.0 108.963 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.433 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.1 m-70 -126.94 -31.1 2.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.71 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -179.5 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -0.757 . . . . 0.0 109.703 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 113.38 58.07 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.3 mt -98.0 -169.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -1.109 . . . . 0.0 110.309 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -131.5 121.33 24.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.781 . . . . 0.0 110.299 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 74' ' ' LEU . 7.1 p -119.44 157.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 45.4 m80 -90.66 143.49 26.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 39' ' ' THR . 6.3 tt -112.46 121.4 44.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.289 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.474 HG13 ' C ' ' A' ' 100' ' ' LEU . 35.7 m -149.89 142.96 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.322 -0.861 . . . . 0.0 110.358 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.587 HG21 ' HB1' ' A' ' 47' ' ' ALA . 2.2 mp -58.47 108.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.693 -0.629 . . . . 0.0 110.654 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 92' ' ' ILE . 4.6 pt -81.86 159.64 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -91.43 144.48 25.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 110.759 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HD23 ' A' ' 87' ' ' LEU . 47.5 t -135.66 114.09 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.271 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.443 HG23 ' OE1' ' A' ' 45' ' ' GLU . 6.4 m -98.99 105.68 17.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.92 . . . . 0.0 110.175 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.92 128.63 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -92.27 122.66 34.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.992 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.591 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -118.63 173.91 3.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.432 -0.793 . . . . 0.0 109.966 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.3 Cg_endo -69.64 -10.61 29.09 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.728 1.383 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -98.84 -53.27 3.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.13 -176.62 1.68 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -0.814 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.93 139.95 31.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.9 121.71 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -89.02 146.17 25.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -0.806 . . . . 0.0 110.077 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -132.3 128.9 38.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -90.72 124.47 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.541 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.1 m -142.28 149.66 52.43 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.3 Cg_endo -67.24 121.23 8.35 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.775 1.408 . . . . 0.0 110.495 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.614 ' HA ' HD13 ' A' ' 33' ' ' ILE . 14.1 pt-20 -35.32 -39.02 0.11 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.257 0.551 . . . . 0.0 111.231 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.479 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -89.9 55.89 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.462 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -114.67 -179.66 3.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.217 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.4 140.99 52.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 82' ' ' LYS . 22.1 t -66.91 -35.04 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 110.578 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.6 -49.42 46.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.775 -1.203 . . . . 0.0 110.196 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -78.5 -45.91 20.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 110.354 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 61' ' ' ILE . 27.7 t80 -61.38 -51.21 69.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.543 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.5 -35.11 69.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.462 -0.774 . . . . 0.0 109.954 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HG3' HG21 ' A' ' 69' ' ' THR . 1.8 tt0 -78.33 -26.28 46.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.73 -52.55 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 109.817 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.69 -29.2 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.695 -0.628 . . . . 0.0 109.652 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 t -56.49 -44.16 80.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -0.827 . . . . 0.0 110.273 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.98 61.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -52.74 63.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.45 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -67.49 -35.88 80.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.0 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 3.2 ttpp 76.14 85.33 0.09 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.447 0.642 . . . . 0.0 110.213 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.47 -154.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.581 -0.699 . . . . 0.0 109.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.0 -177.85 6.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 59' ' ' GLU . 61.5 m -140.88 -53.86 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 0.0 110.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -51.14 70.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.821 . . . . 0.0 110.233 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 73' ' ' VAL . 21.1 mt-30 -77.98 -26.01 48.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 110.226 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.458 HD11 HD21 ' A' ' 100' ' ' LEU . 8.1 tt -65.18 120.22 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.0 110.28 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.86 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.2 m -135.6 157.39 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.711 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -113.8 118.69 34.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.884 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.71 97.26 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.394 -0.816 . . . . 0.0 110.492 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.656 ' CD1' HG22 ' A' ' 98' ' ' VAL . 6.7 t80 -98.89 109.61 22.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.455 -0.778 . . . . 0.0 109.913 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.58 26.48 12.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.409 -0.807 . . . . 0.0 110.358 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.13 -36.04 4.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -179.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -1.071 . . . . 0.0 110.145 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -110.17 82.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 110.316 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 98' ' ' VAL . 7.3 tt -59.97 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.86 ' CD ' HG12 ' A' ' 73' ' ' VAL . 7.4 ttpp -160.75 -146.76 0.14 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.535 -0.728 . . . . 0.0 110.579 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.01 -18.86 61.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.404 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -52.82 -32.76 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.051 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.45 167.67 28.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -0.855 . . . . 0.0 110.524 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 p -85.47 161.14 19.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.625 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.26 -46.44 77.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.882 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.7 pt -63.39 -19.09 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.008 . . . . 0.0 110.197 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 11.4 tp-100 -93.6 -12.85 28.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.96 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.03 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.916 -1.115 . . . . 0.0 111.752 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -59.05 -50.88 63.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -151.01 169.48 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.32 -1.106 . . . . 0.0 109.118 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -116.73 -31.34 5.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.4 t0 -178.65 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 117.48 70.21 0.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 96' ' ' LEU . 3.1 mm? -112.18 171.36 7.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.31 -1.112 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m -111.88 140.14 46.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 110.338 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 81' ' ' LEU . 61.6 t -137.75 155.71 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.432 -0.793 . . . . 0.0 110.282 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -90.69 121.97 33.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 HD11 ' A' ' 72' ' ' LEU . 9.4 tt -99.97 119.14 37.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.07 142.22 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.423 -0.798 . . . . 0.0 110.29 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.38 137.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.347 0.594 . . . . 0.0 111.085 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 92' ' ' ILE . 8.1 pt -107.78 160.05 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.437 -0.789 . . . . 0.0 109.542 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' O ' HG21 ' A' ' 92' ' ' ILE . 21.9 mttt -94.65 133.63 38.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.833 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 46' ' ' PHE . 2.6 p -128.51 118.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -96.01 114.62 26.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.35 -0.844 . . . . 0.0 110.187 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 74' ' ' LEU . 45.3 t -104.85 129.29 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.352 -0.843 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 122.46 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.445 -0.784 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.858 HG21 ' CE2' ' A' ' 65' ' ' PHE . 1.1 p -122.79 170.68 7.68 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.828 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.8 Cg_endo -67.93 -12.64 35.96 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.656 1.345 . . . . 0.0 110.726 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -51.24 5.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -173.74 178.4 2.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.351 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 125.86 44.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.902 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -135.1 134.89 40.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.689 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -90.26 151.08 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.495 -0.753 . . . . 0.0 109.682 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.718 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.2 m-85 -129.3 152.26 49.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -0.94 . . . . 0.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -105.55 133.37 50.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.074 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.3 m -143.35 143.7 25.27 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 51' ' ' ASN . 40.2 Cg_endo -66.82 128.82 19.58 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.706 1.371 . . . . 0.0 111.306 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.713 ' C ' HG21 ' A' ' 88' ' ' ILE . 2.2 tm-20 -39.43 -20.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' PRO . 17.2 p-10 -111.09 37.95 2.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.644 -1.285 . . . . 0.0 110.47 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.453 ' N ' HD12 ' A' ' 88' ' ' ILE . 27.8 p -96.55 -153.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -161.91 157.25 23.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.345 -0.847 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.673 HG11 ' C ' ' A' ' 82' ' ' LYS . 59.4 t -63.28 -34.91 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 110.793 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -49.17 -47.11 46.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.663 -1.273 . . . . 0.0 110.231 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -49.53 16.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.227 -0.921 . . . . 0.0 110.337 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 35' ' ' VAL . 28.3 t80 -60.34 -50.28 74.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.97 -30.56 66.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -26.84 26.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 110.051 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.62 82.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -29.85 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.571 -0.706 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t -62.32 -43.92 97.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.476 -0.765 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -57.81 -48.56 79.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.862 . . . . 0.0 111.024 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' NH1' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -71.15 -52.81 17.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.203 -0.936 . . . . 0.0 110.931 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CE2' HG21 ' A' ' 39' ' ' THR . 8.8 m-85 -67.18 -36.16 81.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.85 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 12.3 mttp 69.6 81.44 0.17 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.418 0.628 . . . . 0.0 110.092 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 p -168.15 -154.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -74.94 157.56 34.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -128.51 -41.67 1.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.16 -62.72 1.56 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.358 -0.839 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -69.4 -25.57 64.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.427 -0.796 . . . . 0.0 110.165 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.843 HD21 HD11 ' A' ' 100' ' ' LEU . 4.9 tt -64.36 118.01 8.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.339 -0.85 . . . . 0.0 110.524 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 82' ' ' LYS . 33.0 m -139.0 168.46 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.741 HD12 HG13 ' A' ' 98' ' ' VAL . 2.7 mm? -109.57 146.81 34.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 98' ' ' VAL . 33.8 mm -102.69 92.9 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 110.236 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 24.7 t80 -74.39 64.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.7 . . . . 0.0 110.357 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 49.2 79.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.86 -53.06 4.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.755 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.6 mttt -76.2 178.2 6.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -1.103 . . . . 0.0 109.873 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.755 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -115.97 106.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 0.0 109.916 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.932 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.8 OUTLIER -69.5 72.04 0.32 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.673 ' C ' HG11 ' A' ' 54' ' ' VAL . 7.9 ttmt -125.95 -160.1 0.95 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.511 0.672 . . . . 0.0 110.547 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.7 p-10 -73.74 -16.71 61.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.629 -0.669 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.83 -32.36 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.942 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -132.08 169.66 16.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.799 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.454 ' OG1' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -88.66 137.01 32.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.793 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 92' ' ' ILE . 22.3 tp -55.93 -47.49 77.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 110.428 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.713 HG21 ' C ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -73.62 -15.48 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.481 -0.762 . . . . 0.0 110.904 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.454 ' NE2' ' OG1' ' A' ' 86' ' ' THR . 0.7 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 111.847 -178.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -174.65 -36.61 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.586 -1.321 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.937 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.84 -42.8 96.77 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.937 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -138.64 138.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -1.19 . . . . 0.0 110.855 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.52 ' H ' HD13 ' A' ' 96' ' ' LEU . 12.2 m170 -103.68 -36.03 8.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 24.0 p-10 179.81 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 0.0 109.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.08 71.19 0.24 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 93' ' ' HIS . 6.5 mp -113.16 167.49 10.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 110.371 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.9 m -118.33 147.14 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.333 -0.854 . . . . 0.0 110.252 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.741 HG13 HD12 ' A' ' 74' ' ' LEU . 7.7 p -144.43 150.54 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 110.418 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -90.63 122.49 33.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.503 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.843 HD11 HD21 ' A' ' 72' ' ' LEU . 7.0 tt -82.94 149.98 26.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.204 -0.935 . . . . 0.0 110.673 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.561 HG12 HG12 ' A' ' 75' ' ' ILE . 14.0 p -168.05 131.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.09 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.4 pp . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' O ' HG23 ' A' ' 33' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.3 mm -58.33 102.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 110.654 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.99 HD13 HG22 ' A' ' 88' ' ' ILE . 7.1 pt -96.07 147.88 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.707 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.636 ' O ' HG21 ' A' ' 92' ' ' ILE . 10.7 mttp -91.81 141.39 28.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.103 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 87' ' ' LEU . 51.0 t -129.52 113.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.818 . . . . 0.0 110.129 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.7 m -90.15 109.4 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.832 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.78 127.79 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 110.285 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 122.51 47.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.437 -0.789 . . . . 0.0 109.67 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 1.11 HG22 HD13 ' A' ' 100' ' ' LEU . 62.1 p -124.13 162.22 42.84 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 59.54 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.71 1.373 . . . . 0.0 110.428 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.71 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -167.21 -170.02 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.513 -0.742 . . . . 0.0 109.922 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -142.7 125.37 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.831 . . . . 0.0 110.21 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -135.12 132.44 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.382 -0.824 . . . . 0.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -90.1 150.25 22.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -123.75 140.93 52.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 110.479 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.68 116.64 33.18 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 52' ' ' SER . 21.8 m -120.59 147.68 46.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.677 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.631 ' HA ' HD13 ' A' ' 32' ' ' ILE . 51.1 Cg_endo -76.65 52.83 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.856 1.451 . . . . 0.0 111.709 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' CG ' HG21 ' A' ' 88' ' ' ILE . 30.7 tp10 55.53 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.381 -0.824 . . . . 0.0 111.695 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.0 t30 -46.86 -20.06 0.12 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 0.0 112.063 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.422 ' CB ' ' HB ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -59.1 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 110.106 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.9 m -67.33 175.6 2.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.526 -0.734 . . . . 0.0 110.35 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 82' ' ' LYS . 37.6 t -68.12 -35.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 110.272 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -50.21 -49.01 54.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.772 -1.205 . . . . 0.0 109.733 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -76.37 -47.4 23.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -61.52 -50.98 70.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.367 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.55 -29.85 64.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.783 . . . . 0.0 109.897 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.766 ' OE2' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -80.37 -24.14 39.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.336 -0.852 . . . . 0.0 109.813 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.29 85.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 110.149 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.0 mt -60.9 -36.91 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.256 -0.903 . . . . 0.0 109.912 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 p -53.6 -49.64 67.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.0 110.506 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -68.21 -53.77 22.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.341 -0.849 . . . . 0.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -53.84 12.32 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.097 -1.002 . . . . 0.0 111.262 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.66 -36.45 80.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 109.991 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.06 81.68 0.19 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.612 -0.68 . . . . 0.0 110.224 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -156.04 -65.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.0 -176.15 2.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.437 -0.789 . . . . 0.0 110.061 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.766 HG21 ' OE2' ' A' ' 59' ' ' GLU . 3.2 m -140.85 -55.08 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.04 -67.4 0.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 73' ' ' VAL . 9.9 mt-30 -60.47 -25.61 66.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.309 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 72' ' ' LEU . 7.8 tt -53.29 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 110.826 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 71' ' ' GLN . 86.7 t -125.63 148.7 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 109.472 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -117.94 135.86 53.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.17 101.65 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.438 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 81' ' ' LEU . 71.8 t80 -77.35 82.71 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.238 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.79 36.19 13.88 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.33 -55.87 0.57 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -1.062 . . . . 0.0 110.056 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -118.05 94.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.281 -0.887 . . . . 0.0 110.694 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -67.09 79.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.003 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.772 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.5 ttmt -137.15 -158.86 0.9 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.414 0.625 . . . . 0.0 110.358 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 84' ' ' GLN . 35.5 p30 -73.32 -14.81 61.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.452 -0.78 . . . . 0.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -55.78 -33.04 64.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.353 -0.842 . . . . 0.0 109.72 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.39 154.4 49.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.474 -0.766 . . . . 0.0 110.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -70.27 147.03 50.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.853 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 35' ' ' VAL . 17.0 tp -55.59 -46.98 77.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.99 HG22 HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -72.48 -14.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 47.9 tp60 -85.63 -13.58 48.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 111.814 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -170.27 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.605 -1.309 . . . . 0.0 111.036 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.929 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.46 -46.92 93.14 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.929 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -137.47 143.66 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.012 -1.287 . . . . 0.0 111.333 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.438 ' H ' HD12 ' A' ' 96' ' ' LEU . 4.6 m80 -109.4 -33.72 6.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -179.73 35.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.246 0.546 . . . . 0.0 109.536 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 92' ' ' ILE . . . 118.67 71.97 0.39 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -114.61 -178.43 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.235 -1.156 . . . . 0.0 110.251 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -125.15 146.52 49.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 81' ' ' LEU . 8.1 p -142.68 151.09 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.874 . . . . 0.0 110.401 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.71 144.31 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.81 . . . . 0.0 110.258 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.11 HD13 HG22 ' A' ' 39' ' ' THR . 6.4 tt -97.44 119.97 36.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.67 128.57 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 0.0 110.045 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.6 mp -58.12 111.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.603 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.62 HD13 HG22 ' A' ' 88' ' ' ILE . 9.0 pt -89.68 154.46 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.38 -0.825 . . . . 0.0 110.039 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -94.11 144.89 25.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.56 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -138.52 119.14 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.4 -0.813 . . . . 0.0 110.108 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -87.05 102.22 14.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 0.0 110.095 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.729 ' CG1' HD12 ' A' ' 100' ' ' LEU . 61.6 t -96.3 128.38 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' CG ' ' HA ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -109.72 126.27 53.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 110.293 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.925 HG23 HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.46 175.73 2.6 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.613 -0.679 . . . . 0.0 109.69 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 39' ' ' THR . 44.4 Cg_endo -71.34 61.86 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.626 1.33 . . . . 0.0 110.395 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.447 -0.783 . . . . 0.0 109.928 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.71 179.48 3.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.39 -0.819 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -117.08 122.99 45.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.152 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.3 135.12 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.326 -0.859 . . . . 0.0 110.438 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -85.23 149.52 25.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.533 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -124.35 144.86 49.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.571 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -99.62 129.78 45.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 30.4 m -143.46 144.01 26.2 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.857 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 39.4 Cg_endo -67.08 121.44 8.61 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.756 1.398 . . . . 0.0 111.034 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -37.17 -34.73 0.09 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.117 0.484 . . . . 0.0 111.583 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.15 49.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 110.575 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 55.7 p -127.85 108.38 10.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.5 t -59.84 153.36 20.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.857 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.1 t -55.88 -35.0 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 110.86 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -48.48 -43.78 35.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.665 -1.272 . . . . 0.0 109.843 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.15 -41.48 41.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.636 ' O ' HG22 ' A' ' 61' ' ' ILE . 17.7 t80 -68.24 -51.46 45.11 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -30.8 65.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.921 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HA ' HG23 ' A' ' 69' ' ' THR . 32.0 tt0 -86.29 -26.85 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -49.32 60.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -0.785 . . . . 0.0 109.675 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.716 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.35 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.008 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 p -63.85 -44.43 93.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.174 -0.953 . . . . 0.0 110.351 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -56.39 -42.66 78.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.78 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -52.07 23.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.283 -0.885 . . . . 0.0 110.463 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 5.2 m-85 -67.0 -36.5 82.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.817 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 44.5 mtmt 64.23 79.49 0.26 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.582 -0.699 . . . . 0.0 110.179 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 t -154.87 -59.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.486 -0.759 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.416 ' O ' HD22 ' A' ' 72' ' ' LEU . 1.6 tt0 -169.45 174.83 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 0.0 110.005 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.54 HG23 ' HA ' ' A' ' 59' ' ' GLU . 31.1 m -143.31 -44.19 0.29 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.37 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -64.97 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.18 -26.19 60.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.226 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -53.16 139.75 28.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.326 -0.859 . . . . 0.0 110.523 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.0 p -172.84 169.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 109.928 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD11 HG22 ' A' ' 37' ' ' VAL . 2.6 mt -118.44 118.86 32.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -0.982 . . . . 0.0 109.31 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.61 103.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 110.146 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.772 ' HA ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -91.86 124.11 35.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.452 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.94 103.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.313 -0.867 . . . . 0.0 110.607 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.46 -31.13 3.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.609 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -166.65 -166.8 0.89 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -1.003 . . . . 0.0 109.712 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 79' ' ' LYS . 1.3 mm -108.77 118.26 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.874 HD12 HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.97 71.05 0.37 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.786 178.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.819 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ptmt -136.1 -152.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.368 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.9 p30 -72.94 -12.84 61.1 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.301 -0.874 . . . . 0.0 112.482 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.6 -33.5 33.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.056 . . . . 0.0 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.61 156.37 45.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.198 -0.939 . . . . 0.0 109.972 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 149.78 41.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 92' ' ' ILE . 16.0 tp -56.81 -48.16 78.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 110.868 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.62 HG22 HD13 ' A' ' 33' ' ' ILE . 2.1 pp -73.1 -18.45 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.172 -0.955 . . . . 0.0 110.829 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.29 -9.9 57.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 111.744 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.728 -1.233 . . . . 0.0 110.949 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.877 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.34 -47.0 92.98 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -145.56 156.23 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -1.176 . . . . 0.0 110.293 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -114.98 -42.42 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.4 t70 -178.49 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.28 65.91 0.18 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 96' ' ' LEU . 10.8 mt -112.58 160.08 18.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -1.12 . . . . 0.0 110.256 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 98' ' ' VAL . 7.0 t -115.06 145.72 42.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 81' ' ' LEU . 49.0 t -145.47 158.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.557 ' O ' HG22 ' A' ' 75' ' ' ILE . 11.4 m-70 -88.39 125.49 34.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 0.0 110.466 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.925 HD13 HG23 ' A' ' 39' ' ' THR . 5.5 tt -83.29 145.77 28.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.135 -0.978 . . . . 0.0 110.451 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 100' ' ' LEU . 7.8 p -167.36 159.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.327 -0.858 . . . . 0.0 110.204 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mptt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 2.9 mp -58.04 110.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.835 -0.541 . . . . 0.0 110.476 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.986 ' CD1' HD11 ' A' ' 92' ' ' ILE . 3.3 pt -83.55 152.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -91.97 144.4 25.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 110.282 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.744 HG23 HG21 ' A' ' 92' ' ' ILE . 7.3 p -139.69 113.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.093 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -82.33 109.08 16.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.396 -0.815 . . . . 0.0 110.018 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.55 127.59 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -0.859 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.38 122.64 46.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 80.7 p -121.58 165.93 18.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.726 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.1 Cg_endo -69.71 -10.28 28.2 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.636 1.335 . . . . 0.0 110.817 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -100.54 -35.91 9.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.184 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.36 -166.52 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.325 -0.859 . . . . 0.0 110.263 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 114.93 8.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 0.0 110.074 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -135.19 134.96 40.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 110.499 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.29 149.21 26.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.1 m-85 -121.4 147.68 45.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.36 125.86 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.6 m -142.49 150.48 54.65 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.206 -0.934 . . . . 0.0 109.758 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -68.36 122.61 9.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.699 1.368 . . . . 0.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.0 pt-20 -31.28 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.084 0.469 . . . . 0.0 111.716 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -88.58 50.83 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.213 -0.929 . . . . 0.0 110.121 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.1 t -115.12 130.77 57.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -82.14 146.47 29.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.997 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -61.16 -34.53 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.791 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -49.32 -48.07 46.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.988 -1.07 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.33 -49.76 52.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 38.5 t80 -59.82 -37.23 78.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 12.2 mtpt -57.77 -47.95 81.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.579 -0.701 . . . . 0.0 109.495 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.484 -0.76 . . . . 0.0 109.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -62.88 -51.89 65.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.842 . . . . 0.0 110.045 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 65' ' ' PHE . 19.6 mt -60.92 -39.65 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.603 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -53.7 -52.24 60.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.039 . . . . 0.0 110.326 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -54.17 19.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.324 -0.86 . . . . 0.0 111.508 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -72.02 -54.11 10.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 111.442 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.91 -36.6 80.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 110.275 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 4.9 tttp 69.17 80.66 0.19 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.437 -0.789 . . . . 0.0 110.203 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 t -153.38 -69.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -164.36 -175.18 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.5 m -144.11 -60.04 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.312 -0.868 . . . . 0.0 110.483 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 -61.03 2.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -66.32 -25.65 66.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 102' ' ' ILE . 36.2 tp -51.86 124.75 13.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.337 -0.852 . . . . 0.0 110.684 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.1 p -153.31 157.22 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 109.767 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.4 mp -123.6 123.76 41.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.134 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.19 104.33 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 110.626 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.3 t80 -70.52 67.06 0.34 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.755 . . . . 0.0 110.031 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.92 24.76 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.261 -0.899 . . . . 0.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.21 -39.24 1.51 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -162.14 0.53 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -1.121 . . . . 0.0 110.258 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.1 pp -123.49 84.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 110.61 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 87' ' ' LEU . 8.1 tt -67.74 84.29 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 108.765 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.997 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -153.99 -146.82 0.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 110.148 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.58 -15.56 61.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.035 -1.041 . . . . 0.0 111.363 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.448 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.4 mm-40 -53.73 -33.42 55.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.129 -0.982 . . . . 0.0 110.237 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -150.24 -169.88 3.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -102.91 158.14 16.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 81' ' ' LEU . 1.5 tp -66.09 -46.23 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.6 pt -63.84 -17.25 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.562 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -97.27 -12.82 22.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 111.091 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.911 -1.118 . . . . 0.0 111.859 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.658 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.39 -50.34 67.68 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -148.56 171.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.375 -1.074 . . . . 0.0 108.665 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -122.19 -29.62 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.967 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.8 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 109.982 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.91 59.5 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.38 -168.99 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.336 -1.097 . . . . 0.0 110.221 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -134.96 147.03 49.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 76' ' ' PHE . 11.9 p -140.47 157.56 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 0.0 110.199 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -90.7 115.81 28.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 HD11 ' A' ' 72' ' ' LEU . 7.9 tt -89.31 131.33 35.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 110.139 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 101' ' ' VAL . 35.2 m -145.08 130.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.783 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.711 HG22 HD12 ' A' ' 72' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 0.0 110.199 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tptp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -58.16 110.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.252 0.549 . . . . 0.0 110.723 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.668 ' CD1' HD11 ' A' ' 92' ' ' ILE . 1.6 pt -89.16 174.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.415 -0.803 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.45 144.39 37.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.768 . . . . 0.0 110.373 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 46' ' ' PHE . 8.7 p -136.14 113.84 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 110.033 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -84.24 103.8 13.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.501 HG13 HD21 ' A' ' 74' ' ' LEU . 66.9 t -94.75 128.75 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.002 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -101.24 122.5 43.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.415 -0.803 . . . . 0.0 110.071 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.742 HG22 HD13 ' A' ' 100' ' ' LEU . 4.3 p -119.93 167.71 11.85 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.9 Cg_endo -71.1 61.06 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.661 1.348 . . . . 0.0 110.401 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -46.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 109.64 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -172.05 176.75 3.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.53 -0.731 . . . . 0.0 110.081 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.67 127.97 54.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -134.5 131.2 37.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.3 149.79 25.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.9 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -127.12 123.08 35.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.898 . . . . 0.0 110.197 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.133 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 25.6 m -143.21 153.57 59.93 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.233 -0.917 . . . . 0.0 109.825 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.2 Cg_endo -67.9 122.37 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.803 1.423 . . . . 0.0 110.726 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.613 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -30.74 -42.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.66 48.7 1.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.925 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.9 t -113.41 108.07 16.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.087 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.7 m -59.84 148.84 33.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.847 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.5 t -63.42 -34.67 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.811 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.05 -43.93 41.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.953 -1.092 . . . . 0.0 110.705 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.45 -53.48 16.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.925 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 25.3 t80 -59.86 -37.21 78.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.339 -0.851 . . . . 0.0 110.118 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.74 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.52 -42.88 83.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.611 -0.68 . . . . 0.0 109.762 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -75.87 -20.72 57.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -63.93 -41.58 97.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.637 HG23 ' CB ' ' A' ' 65' ' ' PHE . 52.8 mt -60.39 -34.7 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.4 p -54.02 -52.98 59.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.985 -1.072 . . . . 0.0 110.464 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -54.73 14.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 111.78 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -72.7 -54.49 8.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.051 -1.031 . . . . 0.0 111.646 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.637 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.57 -36.11 78.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.887 . . . . 0.0 110.531 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 23.2 mtmt 70.67 79.97 0.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.662 -0.649 . . . . 0.0 110.015 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.9 t -168.24 -154.4 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.898 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.2 mt-30 -70.14 -170.03 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 110.05 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.7 m -157.33 -60.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -60.13 -70.31 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -61.86 -26.11 67.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 100' ' ' LEU . 1.9 tt -66.71 98.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 110.338 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.11 167.11 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.812 . . . . 0.0 109.951 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.006 HD23 HG11 ' A' ' 98' ' ' VAL . 5.5 mp -108.75 144.68 36.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 110.018 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 101' ' ' VAL . 47.1 mm -105.16 89.31 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.828 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 69.6 t80 -66.96 83.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.92 29.72 6.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.359 -0.838 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.04 -51.38 0.84 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 6.4 mttp -61.86 -175.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -1.046 . . . . 0.0 109.957 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -116.31 93.06 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.5 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.813 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -62.89 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.863 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.4 tttt -145.91 -153.13 0.46 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.734 -0.604 . . . . 0.0 110.169 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -72.58 -15.54 61.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.385 -0.822 . . . . 0.0 110.523 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HB3' HD13 ' A' ' 80' ' ' ILE . 44.8 tt0 -62.81 -33.14 74.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.973 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.63 168.15 19.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 p -99.06 148.92 23.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.252 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 ' HA3' ' A' ' 91' ' ' GLY . 22.0 tp -55.81 -43.58 77.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.526 HG22 HD13 ' A' ' 33' ' ' ILE . 1.2 pt -71.61 -14.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.254 -0.904 . . . . 0.0 111.604 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.37 -2.98 24.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 112.197 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -176.06 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 118.331 -1.347 . . . . 0.0 112.303 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.813 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -58.58 -50.32 68.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.8 pp -157.05 152.61 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -1.015 . . . . 0.0 109.322 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 14.5 m170 -100.8 -24.97 14.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 35.4 t70 179.96 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.622 -0.674 . . . . 0.0 109.596 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.07 73.93 0.86 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.539 ' CB ' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -117.46 176.85 4.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.248 -1.148 . . . . 0.0 110.186 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 13.4 m -115.9 147.32 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.006 HG11 HD23 ' A' ' 74' ' ' LEU . 8.5 p -138.93 146.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.75 . . . . 0.0 110.16 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.39 115.27 27.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 72' ' ' LEU . 6.7 tt -82.74 148.64 27.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.899 . . . . 0.0 110.632 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 75' ' ' ILE . 11.3 p -168.34 135.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.461 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -57.95 128.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.321 0.582 . . . . 0.0 111.006 -177.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.9 pt -98.4 159.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.696 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 92' ' ' ILE . 27.7 mmtm -91.45 144.08 25.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 110.533 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 HG21 ' A' ' 92' ' ' ILE . 57.6 t -137.0 113.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -90.31 102.99 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 57.8 t -98.05 127.84 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.463 -0.773 . . . . 0.0 110.12 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.44 122.45 46.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 HD22 ' A' ' 100' ' ' LEU . 66.6 p -117.1 163.81 21.54 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.9 Cg_endo -71.55 59.76 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.664 1.349 . . . . 0.0 110.581 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -175.67 -39.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 109.762 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -171.31 173.58 4.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 119.8 40.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.076 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.78 124.9 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -84.7 149.55 25.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.663 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.51 140.14 53.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.353 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -97.65 135.44 39.46 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 33' ' ' ILE . 28.1 m -143.43 143.1 22.77 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 109.018 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' CA ' HD12 ' A' ' 32' ' ' ILE . 39.4 Cg_endo -65.89 128.23 19.39 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.771 1.406 . . . . 0.0 110.825 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -38.05 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.008 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' PRO . 2.4 t30 -120.79 67.63 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.645 -1.284 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -149.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.0 110.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.809 ' HA ' HG23 ' A' ' 86' ' ' THR . 8.0 t -159.38 153.75 23.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.95 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.938 HG21 ' O ' ' A' ' 82' ' ' LYS . 48.5 t -55.92 -35.3 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 111.088 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -45.17 40.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -71.36 -49.73 39.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 43.7 t80 -62.69 -38.02 88.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.448 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.695 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -58.15 -45.22 87.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.829 . . . . 0.0 109.653 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -81.67 -18.16 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 110.194 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.1 -52.34 63.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 65' ' ' PHE . 26.5 mt -62.8 -33.65 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.345 -0.847 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -53.19 55.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.081 -1.012 . . . . 0.0 110.606 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.56 -54.56 15.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 111.797 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -54.48 8.97 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.083 -1.01 . . . . 0.0 111.633 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.22 -36.15 79.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 73.95 72.54 0.12 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.65 -0.657 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.6 p -159.06 -165.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.47 -0.768 . . . . 0.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' THR . 1.0 OUTLIER -74.74 -168.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.246 -0.909 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.77 -51.63 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.371 -0.831 . . . . 0.0 110.327 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.05 -51.94 66.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.701 ' O ' HG23 ' A' ' 73' ' ' VAL . 20.2 mt-30 -78.13 -25.57 47.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.834 HD11 HD21 ' A' ' 100' ' ' LEU . 22.0 tp -57.74 110.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 110.656 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 71' ' ' GLN . 61.9 t -129.72 151.47 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.82 . . . . 0.0 109.727 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.651 ' HB2' HD23 ' A' ' 81' ' ' LEU . 4.9 mp -111.39 122.07 46.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.109 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 75' ' ' ILE . 27.1 mm -79.84 100.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.775 ' CZ ' HD13 ' A' ' 96' ' ' LEU . 4.6 t80 -109.05 124.27 50.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 110.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.82 27.54 7.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.329 -0.857 . . . . 0.0 110.419 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.87 23.71 61.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -122.58 -167.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -1.084 . . . . 0.0 109.881 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.552 HG22 HG11 ' A' ' 73' ' ' VAL . 1.1 pp -112.13 79.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.221 -0.924 . . . . 0.0 110.499 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -61.37 89.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 108.54 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.938 ' O ' HG21 ' A' ' 54' ' ' VAL . 7.1 ttpt -155.82 -146.67 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.547 -0.72 . . . . 0.0 110.874 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.792 ' N ' HG11 ' A' ' 54' ' ' VAL . 20.0 t0 -62.48 -15.41 49.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.667 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.54 ' CG ' HD13 ' A' ' 80' ' ' ILE . 2.1 mm-40 -52.47 -30.81 31.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -159.88 162.5 34.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.387 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -76.83 134.2 39.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.583 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' HG ' HG12 ' A' ' 92' ' ' ILE . 1.9 mp -55.75 -39.2 70.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.632 HG22 HD13 ' A' ' 33' ' ' ILE . 2.4 pp -70.28 -17.88 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.141 -0.974 . . . . 0.0 109.566 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -88.78 -13.27 39.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.501 -0.749 . . . . 0.0 110.927 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.69 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.831 -1.168 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.822 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.12 -42.9 97.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 91' ' ' GLY . 3.7 mm -128.94 150.2 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -1.224 . . . . 0.0 111.004 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.69 -38.64 3.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 p30 179.88 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 116.88 69.95 0.42 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.775 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 4.9 mt -101.14 -177.18 3.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -1.151 . . . . 0.0 110.423 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.435 ' C ' HG13 ' A' ' 98' ' ' VAL . 8.0 t -128.46 142.76 50.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.435 HG13 ' C ' ' A' ' 97' ' ' THR . 34.6 m -147.52 146.22 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -90.43 119.37 30.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.908 HD22 HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -76.26 137.96 40.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 p -166.71 132.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.138 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.458 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.396 -0.815 . . . . 0.0 110.251 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 33' ' ' ILE . 4.4 mmtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.1 mp -58.23 120.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.681 -0.637 . . . . 0.0 110.557 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.942 HD12 HD11 ' A' ' 92' ' ' ILE . 1.6 pt -107.39 159.57 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -91.75 144.21 25.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.818 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG22 HD23 ' A' ' 87' ' ' LEU . 39.1 t -132.07 113.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.438 -0.789 . . . . 0.0 109.856 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.4 m -98.26 114.67 27.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.309 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.45 127.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.85 . . . . 0.0 110.138 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -92.86 122.55 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.581 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.845 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -121.86 172.43 5.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 110.176 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.8 Cg_endo -68.68 -8.27 22.84 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.69 1.363 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.7 tptm -101.46 -50.55 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 1.8 mt-10 -170.57 -161.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.556 -0.715 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.4 135.98 53.49 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -135.3 135.45 40.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.168 -0.958 . . . . 0.0 110.785 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 1.3 mp0 -92.14 145.75 24.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.45 -0.781 . . . . 0.0 109.75 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -128.29 124.88 37.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.948 . . . . 0.0 110.396 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -90.85 129.22 36.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 108.963 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.5 m -143.27 155.68 61.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.056 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -69.98 122.14 8.76 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.833 1.438 . . . . 0.0 110.409 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.872 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -25.83 -48.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.1 0.476 . . . . 0.0 111.597 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' PRO . 14.6 p-10 -86.25 52.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 t -109.13 111.48 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -64.07 144.19 57.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.949 HG11 ' HA ' ' A' ' 82' ' ' LYS . 85.4 t -59.12 -35.02 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.41 -44.51 35.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.015 -1.053 . . . . 0.0 110.479 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.32 -49.75 52.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.13 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 35' ' ' VAL . 7.0 t80 -63.21 -37.52 87.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.442 -0.786 . . . . 0.0 110.41 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.09 -39.54 78.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.4 -23.1 60.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.49 -0.757 . . . . 0.0 110.278 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.89 81.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.184 -0.948 . . . . 0.0 109.992 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -34.95 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 110.174 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 66' ' ' LYS . 27.1 p -59.41 -43.91 92.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -58.77 -49.55 77.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.267 -0.896 . . . . 0.0 111.014 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -53.11 15.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.156 -0.965 . . . . 0.0 110.828 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 39' ' ' THR . 23.8 m-85 -67.54 -37.08 82.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 0.0 110.23 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' SER . 5.4 tttt 63.76 79.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.446 -0.784 . . . . 0.0 110.138 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 t -155.43 -62.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.592 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.3 pt20 -168.52 -165.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 110.137 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -155.11 -44.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.863 . . . . 0.0 110.382 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -58.34 -62.49 1.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.839 ' O ' HG23 ' A' ' 73' ' ' VAL . 19.3 mt-30 -70.84 -25.75 62.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.805 . . . . 0.0 110.041 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.848 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -55.76 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 0.0 110.396 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.862 HG22 ' HD2' ' A' ' 82' ' ' LYS . 40.3 t -124.68 167.77 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.797 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -124.44 118.86 27.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 79' ' ' LYS . 5.5 tp -82.93 104.85 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.729 ' CD1' HG12 ' A' ' 98' ' ' VAL . 15.1 t80 -116.02 136.19 53.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 110.32 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.3 26.73 4.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.374 -0.829 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.67 24.4 70.17 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -125.83 -169.77 2.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.41 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -104.96 82.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.85 HD21 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -62.92 92.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.994 -1.067 . . . . 0.0 108.584 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.949 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.0 ttpt -153.95 -143.29 0.13 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.362 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 34.8 p-10 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -53.7 -32.84 53.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.864 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -147.88 163.67 36.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.582 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -87.19 158.7 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.85 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -66.42 -46.55 76.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.872 HG21 ' HG2' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -63.31 -17.49 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.045 . . . . 0.0 109.985 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.04 -15.41 24.82 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 110.884 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.83 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.897 -1.127 . . . . 0.0 111.947 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.75 -50.15 70.35 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.942 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -152.19 160.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -1.008 . . . . 0.0 108.873 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.7 OUTLIER -110.27 -28.31 8.67 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.4 t70 -179.09 36.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.562 -0.711 . . . . 0.0 110.026 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.16 69.89 0.51 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.24 173.37 6.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.402 -1.057 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.4 p -111.86 130.77 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 110.105 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 81' ' ' LEU . 34.2 m -127.41 150.35 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.766 ' O ' HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -90.78 133.75 34.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.106 -0.996 . . . . 0.0 110.03 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.848 HD11 HD21 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -86.92 134.67 33.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.242 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.7 p -149.41 125.78 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.336 -0.852 . . . . 0.0 110.185 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mttm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.71 118.2 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.701 -0.624 . . . . 0.0 110.56 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 pt -93.55 147.17 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -91.47 144.8 25.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 110.114 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 46' ' ' PHE . 14.0 m -140.81 136.49 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -107.7 117.37 33.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 0.0 110.214 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 44' ' ' GLU . 33.6 m -98.3 130.7 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.828 . . . . 0.0 110.249 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 122.67 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 110.0 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.916 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.1 p -127.09 166.16 24.4 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.11 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.49 61.12 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.728 1.383 . . . . 0.0 110.374 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.29 -47.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.13 -177.94 2.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.262 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -117.33 136.63 52.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.847 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -135.09 128.01 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.64 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 2.0 mp0 -84.05 149.5 26.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 109.796 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.1 m-85 -129.75 124.16 32.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.67 125.83 35.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.195 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.21 151.57 55.6 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.22 -0.925 . . . . 0.0 109.888 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -69.23 121.71 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.915 1.482 . . . . 0.0 110.743 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -27.89 -46.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.244 0.545 . . . . 0.0 111.566 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.76 52.38 2.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 17.8 t -112.81 124.5 52.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -0.817 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 m -71.19 144.55 50.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.921 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.9 t -62.43 -34.55 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.939 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -48.24 -44.07 32.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 110.873 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -53.77 21.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.009 . . . . 0.0 110.0 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.84 -37.27 78.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.487 -0.758 . . . . 0.0 110.255 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.637 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.76 -39.77 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.601 -0.687 . . . . 0.0 110.01 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -75.04 -21.89 58.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 110.318 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.94 82.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.965 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 ' CG1' ' CE2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -63.87 -33.2 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.718 . . . . 0.0 110.225 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 t -64.03 -43.95 94.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.452 -0.78 . . . . 0.0 110.509 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.91 -50.66 72.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.863 . . . . 0.0 110.936 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -69.61 -53.01 20.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.916 ' CE2' HG21 ' A' ' 39' ' ' THR . 15.1 m-30 -67.46 -37.06 82.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.17 78.16 0.3 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.332 -0.855 . . . . 0.0 109.971 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 p -156.1 -66.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.744 . . . . 0.0 110.105 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.42 -175.03 3.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.793 . . . . 0.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -154.78 -40.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.09 -64.57 0.8 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.596 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.787 ' O ' HG13 ' A' ' 73' ' ' VAL . 88.7 mm-40 -78.48 -25.78 45.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 100' ' ' LEU . 5.7 tt -56.86 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.395 -0.816 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.807 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.0 m -109.76 163.12 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.5 mp -112.21 118.98 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.037 -1.039 . . . . 0.0 109.198 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 77' ' ' ALA . 50.1 mm -78.27 103.19 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 110.628 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.6 t80 -69.83 65.78 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.557 -0.714 . . . . 0.0 110.003 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 53.74 24.26 4.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.244 -0.91 . . . . 0.0 110.409 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.87 -47.16 0.82 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -161.43 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.326 -1.102 . . . . 0.0 110.274 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.89 85.23 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.397 -0.814 . . . . 0.0 110.423 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 3.3 tt -61.84 93.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.921 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.3 ttpm? -159.16 -150.08 0.23 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.639 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 9.0 p-10 -73.0 -19.22 61.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.527 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -52.81 -32.44 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 109.896 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -151.39 150.4 30.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.33 151.41 44.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.768 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.677 HD23 HG11 ' A' ' 35' ' ' VAL . 1.1 mp -59.17 -46.08 89.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.2 pp -63.48 -18.42 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.788 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 50.8 tt0 -91.2 -16.52 27.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.2 OUTLIER 177.97 -27.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.95 -1.094 . . . . 0.0 111.799 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.655 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.66 -50.22 69.4 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 33' ' ' ILE . 2.8 pp -148.12 175.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.231 -1.158 . . . . 0.0 109.143 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 3.1 m170 -123.45 -36.09 2.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 110.13 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 37.4 t70 -179.76 36.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 122.08 65.6 0.23 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 168.9 9.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -1.099 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -112.19 134.71 53.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 14.6 p -123.97 157.61 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.34 139.48 30.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -105.49 122.3 45.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 100' ' ' LEU . 87.9 t -148.68 129.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.427 HG13 ' CB ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 109.911 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 33' ' ' ILE . 9.3 mmtt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.7 mp -58.28 100.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.222 0.534 . . . . 0.0 110.791 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 92' ' ' ILE . 5.2 pt -81.62 161.03 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.331 -0.855 . . . . 0.0 109.872 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.54 144.36 31.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.336 -0.853 . . . . 0.0 110.52 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 92' ' ' ILE . 8.4 p -137.59 114.11 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.0 109.992 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.748 HG23 ' OE1' ' A' ' 45' ' ' GLU . 3.2 m -80.92 110.28 16.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.98 127.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.455 -0.778 . . . . 0.0 110.051 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -108.85 122.54 47.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.794 HG22 HD13 ' A' ' 100' ' ' LEU . 23.1 p -126.84 166.81 20.01 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 109.836 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.04 -12.27 33.83 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.698 1.368 . . . . 0.0 110.57 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -40.76 10.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -172.35 -173.14 1.02 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.72 114.92 14.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.771 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -135.34 135.5 40.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.826 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -78.82 151.41 31.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.476 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.68 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.6 m-85 -126.09 116.16 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 110.684 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.48 123.38 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 0.0 108.935 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.7 m -143.21 155.06 61.75 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.144 -0.972 . . . . 0.0 110.006 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -68.72 122.52 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.967 1.509 . . . . 0.0 110.836 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.555 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -30.0 -44.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.871 0.367 . . . . 0.0 111.858 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 49' ' ' PRO . 51.5 p-10 -78.33 43.4 0.46 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.023 -1.048 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -111.56 100.69 9.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.136 -0.977 . . . . 0.0 110.016 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -62.22 164.45 6.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.146 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.948 HG21 ' O ' ' A' ' 82' ' ' LYS . 42.5 t -67.78 -35.32 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.824 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.48 -43.42 34.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.637 -1.29 . . . . 0.0 109.926 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -80.75 -37.47 30.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.326 -0.858 . . . . 0.0 110.361 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 35.4 t80 -70.08 -51.18 33.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.53 -42.32 82.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 109.738 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.494 ' HA ' HG23 ' A' ' 69' ' ' THR . 8.7 mt-10 -65.9 -25.85 67.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 109.917 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.22 -44.65 79.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 13.7 mt -60.85 -39.67 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.0 109.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.608 ' CB ' ' HG1' ' A' ' 69' ' ' THR . 3.1 m -53.57 -53.05 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.016 -1.053 . . . . 0.0 110.597 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -68.5 -53.92 20.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.331 -0.855 . . . . 0.0 111.655 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.86 -54.11 11.12 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.029 -1.044 . . . . 0.0 111.475 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -68.03 -36.61 80.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.223 -0.923 . . . . 0.0 110.21 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tptt 68.53 81.33 0.18 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -159.92 -71.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.778 . . . . 0.0 110.07 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.8 -170.14 3.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.608 ' HG1' ' CB ' ' A' ' 62' ' ' SER . 4.1 m -153.63 -48.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.377 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.21 -67.23 0.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 73' ' ' VAL . 51.6 mt-30 -61.19 -25.71 67.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.396 -0.815 . . . . 0.0 110.376 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 102' ' ' ILE . 10.3 tp -61.86 108.4 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.534 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 71' ' ' GLN . 90.7 t -127.86 156.85 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.617 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 100' ' ' LEU . 10.3 mt -113.51 142.79 45.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.224 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.552 ' C ' HG23 ' A' ' 98' ' ' VAL . 49.7 mm -104.94 89.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.426 -0.796 . . . . 0.0 110.385 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HZ ' HD22 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -78.09 83.54 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.06 63.13 2.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.631 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.22 -52.11 3.78 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -59.81 174.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -1.071 . . . . 0.0 110.23 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.14 99.23 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.836 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CA ' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -65.9 79.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.948 ' O ' HG21 ' A' ' 54' ' ' VAL . 8.6 tttt -146.21 -162.31 1.5 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.592 -0.693 . . . . 0.0 110.761 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 29.8 t70 -70.77 -14.26 62.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.649 -0.657 . . . . 0.0 110.298 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.432 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.2 mm-40 -52.06 -31.22 29.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.801 . . . . 0.0 109.756 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -147.87 -176.04 5.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.416 -0.802 . . . . 0.0 109.969 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 88' ' ' ILE . 73.4 p -102.69 157.04 17.22 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.069 -1.02 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 92' ' ' ILE . 6.2 mp -66.18 -29.73 70.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.641 HD12 ' HB ' ' A' ' 86' ' ' THR . 2.3 mt -66.0 -19.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.153 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 4.9 tp60 -105.7 -10.09 16.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 112.012 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 178.03 -26.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.554 -1.341 . . . . 0.0 111.525 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.74 -37.73 90.53 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.74 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 91' ' ' GLY . 1.4 mm -139.49 175.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -1.147 . . . . 0.0 110.085 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.69 ' HB2' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -147.03 -48.6 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.64 35.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.846 -0.533 . . . . 0.0 109.868 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.25 68.29 0.67 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 93' ' ' HIS . 4.8 mp -115.25 175.78 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -1.158 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 5.0 m -114.66 147.04 40.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 75' ' ' ILE . 5.4 p -139.23 148.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -90.96 115.92 28.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 39' ' ' THR . 2.8 tt -79.24 150.07 31.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.17 -0.956 . . . . 0.0 110.537 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 75' ' ' ILE . 9.6 p -169.01 125.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.05 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.798 HG22 HD12 ' A' ' 72' ' ' LEU . 2.5 pp . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 110.192 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.1 mttp . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.6 mp -57.47 117.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.814 -0.554 . . . . 0.0 110.813 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.706 HG12 HG23 ' A' ' 48' ' ' VAL . 13.1 pt -84.9 157.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.827 . . . . 0.0 109.727 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 92' ' ' ILE . 6.8 mtmt -91.23 143.5 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 92' ' ' ILE . 59.0 t -129.36 113.79 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.479 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.3 m -85.92 98.55 10.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 0.0 109.643 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 98' ' ' VAL . 57.4 t -94.56 127.66 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 110.223 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.86 122.34 46.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.751 HG22 HD13 ' A' ' 100' ' ' LEU . 39.5 p -119.9 164.39 22.51 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 44.1 Cg_endo -71.31 60.85 2.59 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.61 1.321 . . . . 0.0 110.446 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -175.21 -42.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.58 176.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.387 -0.82 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -110.86 126.49 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 109.984 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -135.21 131.2 36.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.71 147.72 25.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.81 . . . . 0.0 109.833 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.15 144.93 48.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 110.281 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -100.25 133.2 45.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.048 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 33' ' ' ILE . 33.2 m -143.6 143.12 22.51 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.234 -0.916 . . . . 0.0 108.853 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' ASN . 41.3 Cg_endo -68.22 127.98 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.622 1.328 . . . . 0.0 111.262 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.572 ' O ' HD13 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -38.46 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.026 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 49' ' ' PRO . 31.7 t30 -113.36 61.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.772 -1.205 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -154.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.802 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 m -160.43 160.95 32.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.238 -0.914 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.897 HG21 ' O ' ' A' ' 82' ' ' LYS . 59.7 t -61.08 -34.95 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.506 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -49.18 -46.79 45.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.682 -1.261 . . . . 0.0 109.849 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -78.01 -44.56 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 110.353 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' HD22 ' A' ' 87' ' ' LEU . 66.1 t80 -63.65 -51.42 65.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.867 . . . . 0.0 110.308 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.98 -31.74 67.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 110.037 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -23.43 35.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.2 82.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.342 -0.849 . . . . 0.0 110.186 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 4.7 mt -61.01 -36.96 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.6 p -53.85 -49.31 68.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.064 -1.022 . . . . 0.0 110.709 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -68.14 -54.21 19.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 111.521 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -54.09 10.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.092 -1.005 . . . . 0.0 111.406 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.16 -36.4 79.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.29 -0.881 . . . . 0.0 110.427 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER 71.79 80.62 0.15 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.535 -0.728 . . . . 0.0 110.094 -179.503 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.59 -164.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.493 -0.755 . . . . 0.0 109.951 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.39 173.87 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -139.46 -52.67 0.54 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.52 -61.36 2.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.171 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 73' ' ' VAL . 13.7 mt-30 -61.15 -25.37 66.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 110.133 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.29 108.01 0.22 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.419 -0.801 . . . . 0.0 110.779 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' HD2' ' A' ' 82' ' ' LYS . 65.7 t -127.49 137.07 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.4 155.94 19.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.927 -1.108 . . . . 0.0 109.701 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.23 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.961 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 77' ' ' ALA . 48.3 t80 -69.78 70.64 0.33 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.261 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PHE . . . 28.68 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.895 -0.503 . . . . 0.0 112.283 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.58 -60.41 0.34 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.09 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.631 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -105.66 -160.81 0.77 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -1.174 . . . . 0.0 110.421 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.631 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -107.36 111.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.275 -0.89 . . . . 0.0 109.994 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -69.73 74.65 0.42 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.033 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.913 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -130.29 -159.23 0.95 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.37 0.605 . . . . 0.0 109.782 -178.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.1 p-10 -73.32 -13.8 61.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -51.95 -32.53 33.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -174.77 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 110.008 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.38 136.88 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.719 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 57' ' ' PHE . 19.1 tp -55.66 -47.84 76.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.185 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.6 pp -73.74 -15.17 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 111.151 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' THR . 23.3 tt0 -104.71 7.64 34.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.133 -0.98 . . . . 0.0 112.116 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.55 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.634 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.985 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.37 -41.7 97.09 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 91' ' ' GLY . 6.2 mm -135.85 131.76 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -1.059 . . . . 0.0 110.7 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 64.7 m170 -96.52 -38.92 9.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.893 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 25.3 t0 -178.44 34.37 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.749 -0.594 . . . . 0.0 109.673 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 112.53 68.12 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -1.134 . . . . 0.0 110.114 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.6 m -111.45 144.47 40.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.505 -0.747 . . . . 0.0 109.844 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 36' ' ' THR . 13.9 m -137.61 136.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.29 115.38 27.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.296 -0.877 . . . . 0.0 110.077 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 HG22 ' A' ' 39' ' ' THR . 3.0 tt -83.2 133.58 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.303 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.7 p -162.39 117.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.309 -0.869 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.96 -44.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.373 -0.829 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 52.11 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.33 81.16 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.77 152.99 29.89 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -153.24 98.52 2.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -1.096 . . . . 0.0 110.258 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -100.17 34.87 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -102.49 131.31 49.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 110.219 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.25 -161.78 33.34 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 140.62 31.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.806 1.424 . . . . 0.0 110.404 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.79 168.9 23.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.646 1.34 . . . . 0.0 110.47 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -61.93 -56.08 35.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.824 . . . . 0.0 110.274 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.1 Cg_endo -73.6 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.483 1.254 . . . . 0.0 110.391 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -166.77 94.12 0.49 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.88 120.58 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.27 -152.36 8.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.61 135.16 23.51 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.8 1.421 . . . . 0.0 110.363 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.46 -161.4 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.422 -0.799 . . . . 0.0 110.212 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.22 61.49 4.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.838 . . . . 0.0 110.23 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.21 -25.54 67.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 52.29 -174.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.344 -0.847 . . . . 0.0 110.469 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.14 -30.67 2.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -119.8 66.91 0.81 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -1.071 . . . . 0.0 110.166 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.4 82.56 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.59 83.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 110.407 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.54 98.27 4.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.136 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.47 -173.62 1.2 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.698 1.367 . . . . 0.0 110.468 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.63 26.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.309 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 51.77 81.04 0.27 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.7 Cg_endo -81.97 38.75 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.741 1.39 . . . . 0.0 111.304 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -74.37 64.81 1.16 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.5 mp -58.04 99.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.621 -0.674 . . . . 0.0 110.692 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.2 pt -78.74 146.29 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.123 -0.986 . . . . 0.0 109.353 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 25.5 mttp -91.44 132.76 36.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 46' ' ' PHE . 6.1 p -123.13 114.25 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 m -86.25 108.09 18.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 61.9 t -102.27 128.38 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.283 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -97.26 122.73 40.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.393 -0.817 . . . . 0.0 109.838 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 100' ' ' LEU . 2.3 p -120.67 168.03 11.59 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.269 -0.895 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.6 Cg_endo -70.54 62.44 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.679 1.357 . . . . 0.0 110.238 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.67 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.6 -179.2 1.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.418 -0.801 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -105.61 115.31 30.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 134.04 54.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.58 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.5 151.53 19.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 0.0 109.714 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.2 m-85 -126.45 150.1 48.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.458 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -102.16 133.43 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 33' ' ' ILE . 28.4 m -143.93 147.62 38.99 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.092 -1.005 . . . . 0.0 109.452 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.8 Cg_endo -67.24 126.29 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.76 1.4 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 88' ' ' ILE . 10.1 tt0 -42.45 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.93 -0.481 . . . . 0.0 111.769 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' PRO . 8.3 p-10 -115.01 63.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.601 -1.312 . . . . 0.0 110.378 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 154.99 47.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.129 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -98.8 156.46 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.364 -0.835 . . . . 0.0 109.853 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 82' ' ' LYS . 88.3 t -60.94 -34.34 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 110.699 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.54 -44.11 36.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.051 -1.031 . . . . 0.0 110.627 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -51.65 32.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.904 . . . . 0.0 109.915 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 71.5 t80 -59.88 -37.07 78.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.413 -0.804 . . . . 0.0 110.129 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 54' ' ' VAL . 2.1 mtpt -57.64 -46.05 84.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.516 -0.74 . . . . 0.0 109.8 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.25 -19.63 61.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.769 . . . . 0.0 110.167 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -65.72 -52.27 52.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.26 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.8 mt -63.74 -41.91 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.297 -0.877 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -53.71 -52.01 61.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.63 -53.94 19.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.286 -0.884 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.17 -54.27 10.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.121 -0.987 . . . . 0.0 111.454 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.01 -36.47 80.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.176 -0.953 . . . . 0.0 110.181 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 16.4 ttpt 68.72 81.3 0.18 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 110.224 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -152.98 -65.4 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.5 -0.75 . . . . 0.0 110.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -167.93 -176.95 3.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -145.95 -63.91 0.32 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.86 -63.58 1.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.923 . . . . 0.0 110.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -67.82 -25.46 65.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -61.33 125.2 22.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.822 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 82' ' ' LYS . 91.7 t -150.08 167.79 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 109.194 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.752 HD12 HG23 ' A' ' 98' ' ' VAL . 1.2 mm? -118.33 135.88 54.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.037 -1.04 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 101' ' ' VAL . 46.8 mm -97.19 96.91 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.42 -0.8 . . . . 0.0 109.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.847 ' CB ' HD13 ' A' ' 81' ' ' LEU . 9.3 t80 -95.31 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 110.232 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.49 35.86 18.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.403 -0.81 . . . . 0.0 110.697 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.01 -40.18 2.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -178.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.203 -1.175 . . . . 0.0 110.047 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.13 94.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.695 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.98 HD11 ' CA ' ' A' ' 91' ' ' GLY . 1.6 tp -65.07 81.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.741 ' O ' HG21 ' A' ' 54' ' ' VAL . 3.5 ttmt -137.98 -155.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.339 0.59 . . . . 0.0 110.364 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.84 -19.63 61.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 0.0 110.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.7 -32.81 53.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.852 . . . . 0.0 109.807 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -133.59 -175.45 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 109.972 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -105.84 130.36 53.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.96 . . . . 0.0 109.932 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 14.1 tp -55.42 -46.91 76.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.759 . . . . 0.0 110.26 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.5 pp -72.76 -14.98 17.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 110.472 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 53.5 tp60 -88.18 -10.83 48.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 112.062 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.35 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.45 -1.407 . . . . 0.0 111.574 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.98 ' CA ' HD11 ' A' ' 81' ' ' LEU . . . -58.97 -41.73 96.5 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.189 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 91' ' ' GLY . 4.0 mm -134.3 113.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -1.157 . . . . 0.0 111.023 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -87.11 -33.61 19.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 108.881 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.7 t70 -179.97 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.736 -0.603 . . . . 0.0 110.015 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 128.42 69.76 0.14 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 6.0 mt -108.83 162.64 14.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -1.211 . . . . 0.0 110.129 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.8 p -112.16 134.52 53.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.313 -0.867 . . . . 0.0 110.274 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.853 HG11 HD22 ' A' ' 81' ' ' LEU . 27.5 m -140.64 151.93 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.437 -0.789 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.688 ' O ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 110.382 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 39' ' ' THR . 8.2 tt -101.15 127.88 47.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.454 HG22 HG12 ' A' ' 75' ' ' ILE . 34.0 m -141.99 143.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.77 104.98 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.341 -0.849 . . . . 0.0 110.37 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mtm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.71 134.75 14.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.04 141.5 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.377 -0.827 . . . . 0.0 110.108 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -161.8 89.77 0.75 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.246 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.62 -101.97 0.33 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -165.54 88.36 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -1.044 . . . . 0.0 110.231 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.43 58.74 1.61 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 0.0 110.237 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.3 m -118.0 -164.56 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.13 -163.2 30.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.16 153.64 51.65 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.798 1.42 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.72 -31.59 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.792 1.417 . . . . 0.0 110.558 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 51.87 63.16 9.67 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.22 -24.6 16.67 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.767 1.404 . . . . 0.0 110.476 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.71 133.63 56.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.37 -0.831 . . . . 0.0 110.287 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -108.31 112.69 25.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.442 -0.786 . . . . 0.0 110.257 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.73 58.16 12.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.83 66.89 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.763 1.402 . . . . 0.0 110.46 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.17 32.14 15.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.332 -0.855 . . . . 0.0 110.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.69 -42.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.16 50.51 1.87 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.87 47.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.1 -106.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.34 56.42 7.74 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.328 -1.101 . . . . 0.0 110.452 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.87 79.99 5.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -0.864 . . . . 0.0 110.28 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.61 25.74 10.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.282 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.16 62.56 0.48 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.348 -0.845 . . . . 0.0 110.226 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.05 66.25 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.685 1.361 . . . . 0.0 110.421 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.34 -172.82 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 9.1 pt-20 -151.95 79.37 6.37 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.369 -0.832 . . . . 0.0 110.267 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.872 ' O ' HD12 ' A' ' 32' ' ' ILE . 51.8 Cg_endo -78.77 43.0 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.708 1.373 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -73.2 65.63 0.83 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.3 mp -58.51 124.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.734 -0.604 . . . . 0.0 110.724 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' A' ' 92' ' ' ILE . 18.0 pt -108.19 158.87 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.759 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 144.37 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 46' ' ' PHE . 9.0 p -134.81 113.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.7 m -79.21 105.22 10.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.41 127.88 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.825 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -112.88 122.28 47.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.516 HG22 ' HG ' ' A' ' 100' ' ' LEU . 18.1 p -122.46 166.07 18.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 109.851 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.1 Cg_endo -70.72 61.23 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.648 1.341 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.61 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.469 -0.77 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -169.65 166.98 9.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 118.6 29.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.33 135.55 40.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.898 . . . . 0.0 110.556 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.47 150.23 36.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.649 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.777 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.7 m-85 -120.38 108.89 14.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.532 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.63 105.22 13.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 0.0 109.503 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.53 157.05 79.23 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.363 -0.836 . . . . 0.0 110.711 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.61 108.42 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.793 1.417 . . . . 0.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 11.7 pt-20 -51.12 -25.49 5.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.492 -0.755 . . . . 0.0 110.741 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -53.6 -23.95 12.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 110.556 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.07 140.63 30.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.885 . . . . 0.0 110.462 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.1 m -70.82 171.83 9.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.6 t -66.8 -35.75 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -42.78 31.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.054 -1.029 . . . . 0.0 110.108 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.4 -46.07 64.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.615 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 84.2 t80 -69.92 -38.36 76.23 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.218 -0.927 . . . . 0.0 110.626 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.74 -45.18 86.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 69' ' ' THR . 17.8 tt0 -74.63 -16.7 60.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.893 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.11 -44.65 79.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.297 -0.877 . . . . 0.0 109.932 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.2 mt -60.87 -37.94 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.654 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 29.1 t -53.94 -46.3 71.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.915 . . . . 0.0 110.78 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -67.89 -54.76 16.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 111.44 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.79 -54.08 9.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.122 -0.987 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.38 -36.25 78.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.381 -0.824 . . . . 0.0 110.551 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 69.33 81.69 0.17 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.574 -0.704 . . . . 0.0 110.03 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -155.04 -75.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.554 -0.716 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.0 179.46 8.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 59' ' ' GLU . 62.2 m -139.99 -62.01 0.52 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.443 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.5 -66.69 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 0.0 110.32 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.63 -25.71 64.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.288 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 100' ' ' LEU . 11.5 tp -59.91 133.61 56.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.475 -0.766 . . . . 0.0 110.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.479 HG23 ' C ' ' A' ' 72' ' ' LEU . 78.1 t -152.53 158.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.418 -0.801 . . . . 0.0 109.28 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.1 mp -121.15 122.02 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.232 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 75' ' ' ILE . 25.4 mm -78.8 103.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.045 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.827 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.5 t80 -112.14 120.14 40.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.506 -0.746 . . . . 0.0 110.076 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.69 29.31 17.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.62 59.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -172.7 2.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -1.085 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.507 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -103.27 82.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 110.363 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.1 tt -66.43 83.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.242 -0.911 . . . . 0.0 108.645 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -148.96 -147.07 0.21 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.557 -0.715 . . . . 0.0 110.253 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.52 -14.36 61.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 111.315 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.449 ' HB3' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -52.15 -33.62 41.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.585 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -176.63 4.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 143.86 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 109.882 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.995 HD11 HD11 ' A' ' 92' ' ' ILE . 11.6 tp -56.23 -46.14 79.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.496 -0.752 . . . . 0.0 110.672 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.62 -8.27 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.411 -0.806 . . . . 0.0 111.095 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.536 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 14.3 mt-30 -110.08 -1.2 17.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.954 -1.092 . . . . 0.0 112.028 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.3 OUTLIER 176.54 -30.78 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.589 -1.32 . . . . 0.0 111.807 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.26 -47.68 88.06 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.543 -1.313 . . . . 0.0 109.919 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -144.42 161.95 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.273 -1.134 . . . . 0.0 110.183 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -122.64 -41.74 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.539 -0.726 . . . . 0.0 109.359 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.71 35.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.028 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.77 67.75 0.53 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' ' 96' ' ' LEU . 4.3 mm? -103.98 175.81 5.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 97' ' ' THR . 9.7 t -111.95 121.32 44.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.765 . . . . 0.0 110.082 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 81' ' ' LEU . 33.7 m -125.94 149.23 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 110.378 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.446 -0.784 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -92.98 120.12 32.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.373 -0.83 . . . . 0.0 110.019 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' N ' HD13 ' A' ' 100' ' ' LEU . 32.8 m -148.72 156.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.82 137.16 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.215 0.531 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.3 44.78 0.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.258 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.03 130.93 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.348 -0.845 . . . . 0.0 110.177 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -140.43 81.75 1.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.96 138.14 24.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.31 81.42 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.338 -1.095 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 t -85.79 172.32 10.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m 52.51 -171.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.352 -0.842 . . . . 0.0 110.433 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.01 -88.23 2.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.4 162.2 40.76 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.741 1.39 . . . . 0.0 110.421 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.85 -179.66 4.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.75 1.395 . . . . 0.0 110.345 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 -62.34 138.62 96.32 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.26 -82.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.774 1.407 . . . . 0.0 110.7 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -141.01 -71.29 0.36 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.087 -1.008 . . . . 0.0 110.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.53 -60.02 2.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.32 57.39 15.37 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.97 116.4 4.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.709 1.373 . . . . 0.0 110.406 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.72 161.78 30.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.414 -0.804 . . . . 0.0 110.223 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.45 109.55 4.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.78 -35.12 10.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -58.82 -176.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.374 -0.829 . . . . 0.0 110.367 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.9 -29.14 12.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -70.81 -16.93 62.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.12 . . . . 0.0 110.452 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.52 136.8 38.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 110.392 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.71 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.24 78.81 12.06 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 110.163 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 150.26 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.766 1.403 . . . . 0.0 110.386 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.23 -54.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.29 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.67 71.11 1.54 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.862 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.5 Cg_endo -81.93 21.05 0.99 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.756 1.398 . . . . 0.0 111.454 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.46 67.25 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.3 mm -58.47 124.15 11.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.705 -0.622 . . . . 0.0 110.85 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 88' ' ' ILE . 8.6 pt -106.77 149.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 0.0 109.522 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -91.8 144.23 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 110.647 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 92' ' ' ILE . 14.8 m -132.92 130.38 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 109.583 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.17 110.25 22.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' HD12 ' A' ' 100' ' ' LEU . 58.7 t -96.47 127.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 122.83 47.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -125.73 169.74 10.83 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.301 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.94 60.51 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.702 1.369 . . . . 0.0 110.372 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.7 -46.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.316 -0.865 . . . . 0.0 109.812 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -173.19 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.101 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -123.12 129.82 51.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -135.12 127.63 30.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -84.86 147.73 26.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.397 -0.815 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.8 m-85 -125.08 145.84 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.533 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.35 132.13 45.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.0 108.991 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.5 m -143.16 148.83 46.41 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.975 . . . . 0.0 110.266 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 32' ' ' ILE . 40.5 Cg_endo -71.08 119.43 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.705 1.371 . . . . 0.0 110.418 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -32.73 -41.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.223 0.535 . . . . 0.0 111.642 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -83.88 50.97 1.93 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.051 -1.03 . . . . 0.0 110.571 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 51.4 p -126.21 112.77 16.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.29 156.86 21.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -63.02 -35.4 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.197 -0.94 . . . . 0.0 110.913 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -49.31 -50.15 40.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.123 -0.985 . . . . 0.0 111.055 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.0 -55.27 27.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.99 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 35' ' ' VAL . 51.3 t80 -59.91 -36.57 77.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.457 -0.777 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -57.15 -36.74 71.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 0.0 110.386 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -79.05 -24.47 43.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.61 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 0.0 109.573 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.61 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.8 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.807 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -66.45 -44.55 82.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 110.625 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -58.85 -53.12 61.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.253 -0.904 . . . . 0.0 110.952 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -52.68 63.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.688 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 39' ' ' THR . 10.5 m-85 -67.5 -36.91 82.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 0.0 110.445 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.91 79.52 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.469 -0.769 . . . . 0.0 110.091 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 t -153.92 -71.08 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.38 -0.825 . . . . 0.0 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.647 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -151.87 -171.57 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.174 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.0 m -153.51 -57.79 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.36 -0.837 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.49 -70.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.322 -0.861 . . . . 0.0 110.413 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.879 ' O ' HG23 ' A' ' 73' ' ' VAL . 6.2 mt-30 -60.76 -25.53 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.698 ' HA ' HG22 ' A' ' 102' ' ' ILE . 1.2 tt -52.93 106.46 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 110.763 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.972 HG22 ' HD2' ' A' ' 82' ' ' LYS . 51.0 t -127.14 151.18 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.651 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.756 HD23 HG11 ' A' ' 98' ' ' VAL . 5.0 mp -102.04 146.2 28.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 75' ' ' ILE . 29.9 mm -107.76 83.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.45 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.844 ' HB2' HD12 ' A' ' 81' ' ' LEU . 3.2 t80 -98.84 124.04 43.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.386 -0.821 . . . . 0.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.07 26.35 6.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.37 -0.831 . . . . 0.0 110.556 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.32 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 1.2 tttm -129.48 136.54 50.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -1.09 . . . . 0.0 110.061 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.784 ' O ' HD12 ' A' ' 80' ' ' ILE . 1.4 pp -59.68 88.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.816 . . . . 0.0 111.351 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.3 tt -66.79 86.87 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.972 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.5 OUTLIER -140.34 -149.74 0.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.01 -177.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -74.1 -20.71 60.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.698 . . . . 0.0 110.834 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -52.7 -32.75 44.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.103 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.91 140.21 46.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 147.94 33.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.541 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 92' ' ' ILE . 13.8 tp -57.59 -48.52 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.705 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.756 HG22 HD13 ' A' ' 33' ' ' ILE . 1.8 pp -73.04 -13.7 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.051 -1.031 . . . . 0.0 110.367 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.73 -15.09 46.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 111.542 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 79' ' ' LYS . 4.9 t-80 -171.69 -38.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.624 -1.297 . . . . 0.0 111.431 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.839 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -59.44 -49.67 76.01 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.386 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -142.26 146.37 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -1.232 . . . . 0.0 110.808 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 13.1 m170 -109.76 -35.49 6.17 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.5 t0 -177.68 31.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.29 0.567 . . . . 0.0 109.861 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.4 69.33 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 92' ' ' ILE . 84.1 mt -109.17 174.22 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -1.223 . . . . 0.0 109.966 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.8 p -115.84 147.25 41.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.756 HG11 HD23 ' A' ' 74' ' ' LEU . 7.6 p -147.68 146.14 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.402 -0.811 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -90.63 116.15 28.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.489 -0.757 . . . . 0.0 110.118 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 72' ' ' LEU . 5.7 tt -74.17 121.28 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.306 -0.871 . . . . 0.0 110.13 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 100' ' ' LEU . 58.0 t -145.95 131.85 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.386 -0.821 . . . . 0.0 110.106 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.698 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.3 pp -99.38 131.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.819 . . . . 0.0 110.218 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.218 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.35 116.98 19.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.7 -30.14 21.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.265 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -106.49 53.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.315 -0.866 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.04 83.8 0.21 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 167.25 16.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -1.098 . . . . 0.0 110.22 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -80.87 172.31 13.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -148.15 110.45 4.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.93 -79.08 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 113.11 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.731 1.385 . . . . 0.0 110.374 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.05 -27.99 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.661 1.348 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -105.54 127.6 28.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.88 -163.83 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.679 1.357 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.54 113.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.62 -49.59 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.9 -69.16 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.03 -28.2 13.21 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.826 1.435 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.31 -45.83 83.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.0 110.347 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 174.93 5.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.391 -0.818 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.37 -166.84 0.56 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.38 -0.825 . . . . 0.0 110.18 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.86 80.42 6.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.18 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 55.5 0.62 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 p -83.93 -73.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.347 -1.09 . . . . 0.0 110.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.82 62.88 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.77 93.2 5.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.239 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.873 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . -75.1 -55.12 2.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 110.64 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 47.4 Cg_endo -74.41 122.96 7.83 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.403 1.212 . . . . 0.0 110.445 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.8 131.43 24.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 51.9 73.09 1.02 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.377 -0.827 . . . . 0.0 110.512 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.812 ' O ' HD12 ' A' ' 32' ' ' ILE . 52.1 Cg_endo -81.7 37.87 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.774 1.407 . . . . 0.0 111.361 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 67.26 0.52 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.2 mp -58.47 99.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.63 -0.669 . . . . 0.0 110.55 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 92' ' ' ILE . 4.3 pt -78.83 150.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -94.23 144.59 25.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 110.972 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 92' ' ' ILE . 7.9 p -137.97 113.96 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.495 -0.753 . . . . 0.0 109.866 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -85.89 112.72 21.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 110.605 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.16 127.96 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.55 122.51 43.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.605 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -124.12 170.73 8.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.812 . . . . 0.0 109.921 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.4 Cg_endo -68.94 -16.06 40.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.697 1.367 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -49.13 6.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -173.54 174.47 3.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -103.04 122.05 43.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.949 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.14 135.48 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -90.29 150.97 21.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.443 -0.785 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.9 m-85 -125.59 128.09 47.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.369 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -91.86 124.71 36.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.227 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.3 m -142.98 154.71 62.19 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 109.943 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.2 Cg_endo -66.48 121.65 8.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.814 1.429 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.6 pt-20 -36.31 -38.96 0.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.214 0.531 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 36.0 m120 -86.96 53.07 2.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.516 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.5 p -119.23 154.02 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.345 -0.847 . . . . 0.0 110.194 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 t -103.02 148.04 26.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.011 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 82' ' ' LYS . 71.3 t -59.38 -34.37 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -48.59 -46.12 38.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.047 -1.033 . . . . 0.0 110.547 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.72 -51.39 49.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -59.89 -36.91 77.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.54 -39.02 75.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.57 -22.13 47.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.22 78.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG23 ' CB ' ' A' ' 65' ' ' PHE . 20.0 mt -60.78 -38.76 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 109.669 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -53.75 -53.12 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.126 -0.984 . . . . 0.0 110.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -68.52 -54.76 14.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 111.694 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -72.55 -54.55 8.87 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.094 -1.004 . . . . 0.0 111.568 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.494 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.3 -36.48 79.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.189 -0.944 . . . . 0.0 110.443 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tttt 71.81 73.69 0.17 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -160.51 -153.91 0.35 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.529 -0.732 . . . . 0.0 109.959 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -173.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -148.18 -61.9 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.81 -63.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -59.32 -27.09 65.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 100' ' ' LEU . 11.6 tp -62.71 105.93 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.489 -0.757 . . . . 0.0 110.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 82' ' ' LYS . 77.3 t -128.82 161.54 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.027 HD22 HG23 ' A' ' 98' ' ' VAL . 9.8 mt -113.7 139.66 48.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 110.084 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 101' ' ' VAL . 43.1 mm -100.42 93.54 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.2 t80 -96.96 115.21 27.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.77 27.57 7.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -0.838 . . . . 0.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.79 -39.7 2.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -176.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -1.073 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.51 90.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.323 -0.861 . . . . 0.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 87' ' ' LEU . 10.1 tt -61.84 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.797 ' O ' HG21 ' A' ' 54' ' ' VAL . 20.5 tttt -154.03 -148.16 0.24 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.418 -0.801 . . . . 0.0 110.655 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t70 -72.13 -15.14 61.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.129 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -53.19 -32.52 48.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.68 161.38 39.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.631 -0.668 . . . . 0.0 109.9 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.425 ' OG1' ' CG ' ' A' ' 89' ' ' GLN . 64.4 p -79.21 165.0 23.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.697 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.718 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.24 -46.35 77.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.86 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.8 pt -64.62 -18.95 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.032 -1.043 . . . . 0.0 110.453 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' CG ' ' OG1' ' A' ' 86' ' ' THR . 27.5 mm-40 -92.11 -15.79 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.922 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.42 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.027 -1.046 . . . . 0.0 111.638 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.718 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.04 -50.23 67.93 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -148.86 171.65 2.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.529 -0.983 . . . . 0.0 108.706 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.488 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.65 -33.23 4.33 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.651 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.6 t70 179.83 34.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.569 -0.707 . . . . 0.0 109.97 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.05 69.98 0.34 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD22 ' CE1' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -114.04 -172.13 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m -131.42 146.35 52.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.027 HG23 HD22 ' A' ' 74' ' ' LEU . 27.4 m -143.7 149.51 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.356 -0.84 . . . . 0.0 110.504 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.57 118.71 30.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 110.352 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 ' CG2' ' A' ' 39' ' ' THR . 6.8 tt -77.37 149.52 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 75' ' ' ILE . 7.8 p -171.38 138.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.89 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp -99.32 126.34 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.9 mttt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.19 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.204 0.526 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.13 102.54 15.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.19 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -96.21 38.92 1.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -97.56 27.77 4.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.307 -0.871 . . . . 0.0 110.251 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.72 -166.91 1.33 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.56 -46.08 41.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.352 -1.087 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -114.96 -26.77 7.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -0.832 . . . . 0.0 110.341 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m 54.99 177.5 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.304 -0.872 . . . . 0.0 110.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.6 93.52 0.1 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 158.67 51.33 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.66 1.347 . . . . 0.0 110.435 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.15 -164.82 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 0.0 110.321 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -62.84 -57.78 19.95 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.491 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 12' ' ' ARG . 46.3 Cg_endo -72.36 179.15 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.506 1.266 . . . . 0.0 110.487 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.92 -41.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 0.0 110.265 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.94 177.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.328 -0.858 . . . . 0.0 110.32 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.69 -145.83 5.64 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 19' ' ' ALA . 46.0 Cg_endo -72.64 65.86 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.687 1.361 . . . . 0.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . 55.77 -85.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 56.13 174.22 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -1.0 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.23 -44.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 110.248 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -141.2 -61.38 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.55 132.29 20.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -125.55 54.57 1.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 110.225 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.51 133.54 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 0.0 110.242 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.21 161.51 17.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.352 -0.842 . . . . 0.0 110.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.63 147.85 39.79 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.0 110.149 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.02 -53.53 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.777 1.409 . . . . 0.0 110.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.92 -48.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.326 -0.858 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 52.15 82.6 0.24 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.3 Cg_endo -71.68 -93.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.811 1.427 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 43.68 41.53 3.64 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 48' ' ' VAL . 2.8 mp -58.08 118.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.276 0.56 . . . . 0.0 110.905 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 92' ' ' ILE . 1.9 pt -87.85 152.33 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -91.49 144.61 25.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 46' ' ' PHE . 18.3 m -138.86 140.32 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.455 -0.778 . . . . 0.0 110.043 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -109.56 104.25 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.857 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 127.84 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 122.47 43.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.957 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 HD22 ' A' ' 100' ' ' LEU . 7.3 p -113.72 166.63 10.91 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.947 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.8 Cg_endo -71.27 61.31 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.604 1.318 . . . . 0.0 110.424 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.15 -42.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.7 -169.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.407 -0.808 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -123.42 129.07 50.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -0.816 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -135.16 134.89 40.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.16 150.87 20.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.688 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.5 m-85 -129.03 144.18 51.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.469 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -100.33 128.45 46.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.402 -0.811 . . . . 0.0 109.235 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' N ' HG23 ' A' ' 32' ' ' ILE . 33.1 m -141.2 146.04 41.2 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 52' ' ' SER . 40.4 Cg_endo -67.97 122.07 9.15 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.669 1.352 . . . . 0.0 110.377 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.524 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.7 pp20? -31.07 -39.1 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' PRO . 43.9 p-10 -92.03 49.5 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.725 -1.235 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 1.7 t -114.38 112.96 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.068 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -65.5 147.96 52.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.877 HG11 ' HA ' ' A' ' 82' ' ' LYS . 90.3 t -56.41 -34.8 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -48.79 -43.83 38.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.05 -1.031 . . . . 0.0 110.53 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -68.44 -53.54 22.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.189 -0.945 . . . . 0.0 109.96 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.87 -36.82 77.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.498 -0.751 . . . . 0.0 110.365 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.586 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 mtpt -57.42 -43.04 83.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.747 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 -23.25 54.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.525 -0.734 . . . . 0.0 109.941 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.94 86.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.2 mt -60.77 -40.05 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.404 -0.81 . . . . 0.0 109.729 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -53.71 -51.95 61.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -68.42 -54.64 15.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 111.666 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mmt-85 -72.36 -54.3 9.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.091 -1.006 . . . . 0.0 111.511 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.08 -36.35 79.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.373 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tptm 72.31 76.02 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.594 -0.691 . . . . 0.0 110.082 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.9 t -161.9 -153.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.818 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.612 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -71.47 165.11 24.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -136.13 -59.69 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.94 -72.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -57.96 -25.17 60.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.421 -0.799 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 68' ' ' GLN . 10.1 tp -59.81 128.47 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.477 -0.764 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 82' ' ' LYS . 88.6 t -151.1 167.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.242 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -117.92 133.38 55.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 0.0 110.159 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.09 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 32.0 t80 -70.07 62.73 0.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.637 -0.665 . . . . 0.0 110.554 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.28 26.49 2.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.143 -0.973 . . . . 0.0 110.738 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.03 -48.19 0.64 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.794 ' C ' HD13 ' A' ' 80' ' ' ILE . 3.7 mtpp -83.01 -166.99 1.49 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -1.062 . . . . 0.0 110.098 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.47 96.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.678 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -65.23 79.94 0.05 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.877 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ttmt -140.55 -156.5 0.68 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.32 -14.97 61.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -33.09 69.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.804 . . . . 0.0 110.015 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -143.8 164.55 30.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 110.767 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.27 153.47 17.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.872 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.678 HD11 ' CD2' ' A' ' 81' ' ' LEU . 1.1 mp -66.5 -46.65 75.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.342 -0.849 . . . . 0.0 110.897 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.1 pp -63.66 -19.62 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.023 . . . . 0.0 109.847 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -89.43 -18.79 26.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.805 . . . . 0.0 110.587 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.96 -26.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.948 -1.095 . . . . 0.0 112.063 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.32 -50.38 67.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.61 162.83 4.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -1.081 . . . . 0.0 108.682 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 5.9 m-70 -113.13 -30.8 6.85 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 109.75 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.3 t0 179.75 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 109.72 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.94 73.86 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.3 mm? -114.83 170.88 8.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -1.061 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.429 ' C ' HG23 ' A' ' 98' ' ' VAL . 6.5 t -115.25 144.64 43.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 74' ' ' LEU . 44.6 t -146.68 154.85 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -90.83 144.36 25.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -101.44 121.96 42.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.901 . . . . 0.0 110.052 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.04 150.7 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.303 -0.873 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.61 123.77 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.341 -0.849 . . . . 0.0 110.188 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.192 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.215 0.531 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.46 -56.24 0.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 52.27 78.8 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.86 106.85 3.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.872 . . . . 0.0 110.232 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.76 105.22 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.51 138.01 54.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -1.072 . . . . 0.0 110.171 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.6 p -129.25 123.24 31.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.846 . . . . 0.0 110.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -90.39 -169.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.216 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.05 -160.49 34.07 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.9 133.9 20.76 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.807 1.425 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.24 -29.55 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.636 1.335 . . . . 0.0 110.376 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.62 94.22 11.62 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.311 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 179.21 5.35 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.74 1.39 . . . . 0.0 110.337 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -142.43 35.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -165.33 49.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.25 71.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.83 148.08 45.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.786 1.414 . . . . 0.0 110.453 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.45 -34.8 6.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.5 -69.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.77 -70.24 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -116.53 -70.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -96.75 -175.67 35.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -115.89 136.09 53.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.233 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 52.41 87.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.392 -0.817 . . . . 0.0 110.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.74 -46.07 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 110.259 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.881 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . -68.74 -54.92 12.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 48.2 Cg_endo -74.58 177.42 8.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.559 1.294 . . . . 0.0 110.382 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.72 80.77 0.5 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.815 . . . . 0.0 110.28 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.93 67.07 2.07 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.6 Cg_endo -82.34 29.07 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.708 1.372 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -69.68 69.21 0.28 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 28.1 mm -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.593 -0.692 . . . . 0.0 110.758 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.889 HD12 ' HB ' ' A' ' 92' ' ' ILE . 32.0 pt -110.78 144.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.636 -0.665 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 144.53 25.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.823 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 46' ' ' PHE . 7.4 p -135.94 113.57 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.0 109.759 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -85.17 102.35 13.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.619 ' CG1' HD13 ' A' ' 100' ' ' LEU . 60.4 t -94.92 127.63 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.97 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -111.44 122.71 48.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.164 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 HD22 ' A' ' 100' ' ' LEU . 29.1 p -120.37 168.24 10.96 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.454 -0.779 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.52 -10.28 28.36 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.577 1.303 . . . . 0.0 110.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -42.39 7.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.08 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.08 157.49 5.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -107.42 118.34 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 110.078 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -135.32 135.62 40.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.943 . . . . 0.0 110.811 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.51 154.38 22.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.47 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.71 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.0 m-85 -128.08 128.71 45.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -91.36 129.93 37.28 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.409 HG13 ' C ' ' A' ' 47' ' ' ALA . 26.5 m -143.31 153.71 59.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.041 -1.037 . . . . 0.0 110.492 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 32' ' ' ILE . 42.8 Cg_endo -71.59 119.82 6.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.875 1.461 . . . . 0.0 110.443 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -36.22 -37.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.812 -0.555 . . . . 0.0 111.091 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -82.9 50.12 1.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 t -126.66 141.25 51.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m -92.86 156.77 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 ' HG3' ' A' ' 58' ' ' LYS . 84.0 t -59.71 -34.59 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -48.96 -43.67 40.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.121 . . . . 0.0 110.532 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.74 -54.63 14.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -0.882 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.88 -36.97 78.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.385 -0.822 . . . . 0.0 110.191 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.882 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.32 -39.04 75.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.591 -0.693 . . . . 0.0 109.587 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.23 -18.78 44.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.501 -0.749 . . . . 0.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -49.68 71.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 65' ' ' PHE . 12.8 mt -60.91 -36.34 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.358 -0.838 . . . . 0.0 109.693 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -53.85 -51.73 62.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 110.535 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -68.43 -54.28 18.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.318 -0.864 . . . . 0.0 111.711 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -54.07 10.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.115 -0.991 . . . . 0.0 111.497 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.31 -36.24 79.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.278 -0.889 . . . . 0.0 110.351 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 8.5 mttm 68.72 81.86 0.18 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.601 -0.687 . . . . 0.0 109.942 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -157.12 -73.56 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 110.206 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.0 pt20 -166.45 -165.6 0.78 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.411 -0.806 . . . . 0.0 110.106 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -153.19 -51.19 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.594 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.36 -75.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.0 110.407 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.711 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.69 -25.56 62.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -55.55 104.24 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.387 -0.821 . . . . 0.0 110.876 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 71' ' ' GLN . 58.0 t -127.59 156.1 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.503 -0.748 . . . . 0.0 109.38 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.657 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -118.73 141.2 48.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.973 -1.079 . . . . 0.0 110.519 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.402 ' C ' HG23 ' A' ' 98' ' ' VAL . 46.5 mm -101.16 93.68 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.5 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.6 t80 -84.89 95.4 9.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.237 -0.914 . . . . 0.0 110.348 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.12 46.3 26.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 110.694 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.15 -45.72 2.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.0 179.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -115.84 93.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.267 -0.896 . . . . 0.0 110.855 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -65.28 82.44 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.745 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -144.09 -161.5 1.29 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.442 0.639 . . . . 0.0 110.491 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.5 p30 -73.33 -14.95 61.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.67 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 109.565 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -139.06 168.98 18.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 0.0 109.752 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.24 145.99 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.457 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 92' ' ' ILE . 16.5 tp -55.81 -47.01 77.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -72.39 -28.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.659 . . . . 0.0 110.058 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -76.82 -6.21 51.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.704 . . . . 0.0 111.761 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.39 -37.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.536 -1.353 . . . . 0.0 111.759 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.792 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.98 -48.31 86.48 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.161 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.4 156.55 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.434 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -115.98 -41.63 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -177.87 34.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 109.87 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 96' ' ' LEU . . . 123.95 71.08 0.22 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.573 HD22 ' C ' ' A' ' 95' ' ' GLY . 4.1 mm? -117.57 174.87 5.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -1.104 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.7 m -116.51 147.31 41.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 74' ' ' LEU . 7.4 p -149.96 150.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.404 -0.81 . . . . 0.0 110.296 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.632 ' O ' HD23 ' A' ' 74' ' ' LEU . 3.9 m-70 -90.68 132.83 35.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.948 HD22 HG22 ' A' ' 39' ' ' THR . 1.4 tp -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.4 p -166.21 144.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.837 . . . . 0.0 110.177 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.4 136.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.384 -0.823 . . . . 0.0 110.219 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.17 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.29 0.566 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.67 96.98 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.25 -174.41 2.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -105.97 -171.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.08 99.81 2.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -131.95 -176.52 4.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -1.029 . . . . 0.0 110.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -78.99 111.3 15.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.37 -0.831 . . . . 0.0 110.206 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 t -62.97 87.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.83 -166.92 42.73 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 127.48 12.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.815 1.429 . . . . 0.0 110.28 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 -44.41 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.558 1.294 . . . . 0.0 110.453 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.08 136.62 16.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.139 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.79 102.92 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.594 1.313 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.27 35.4 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.11 -43.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 0.0 110.18 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.29 77.16 0.95 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.17 94.53 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.854 1.45 . . . . 0.0 110.484 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.6 -79.95 0.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.98 -75.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.88 48.61 1.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.25 92.78 1.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.361 -0.837 . . . . 0.0 110.216 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.28 8.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 p -117.26 -33.75 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.313 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 101.48 10.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.69 128.26 49.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.446 -0.783 . . . . 0.0 110.163 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 147.07 98.3 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.27 88.63 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.749 1.394 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.87 32.46 5.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.268 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.47 114.39 58.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 31' ' ' LYS . 46.5 Cg_endo -71.34 -93.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.671 1.353 . . . . 0.0 110.771 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 30' ' ' PRO . 28.8 mttt 45.02 37.59 2.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.98 -1.075 . . . . 0.0 108.104 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.28 116.48 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.668 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.068 HD12 HD11 ' A' ' 92' ' ' ILE . 2.1 pt -93.73 157.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.372 -0.83 . . . . 0.0 109.917 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -91.62 144.6 25.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.89 . . . . 0.0 110.865 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 87' ' ' LEU . 40.7 t -133.7 113.79 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.495 -0.753 . . . . 0.0 109.992 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -88.91 108.47 19.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.526 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.01 127.87 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.799 . . . . 0.0 110.09 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.75 122.57 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.589 HG22 HD22 ' A' ' 100' ' ' LEU . 7.2 p -121.64 165.12 20.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.949 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.41 60.78 2.66 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.637 1.335 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -175.1 -46.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.485 -0.759 . . . . 0.0 109.699 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -171.32 -176.74 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 110.018 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 126.88 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.03 120.03 22.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.17 147.17 28.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -123.78 121.1 34.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -87.64 126.32 34.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.5 m -143.34 150.35 51.36 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -67.63 123.33 10.64 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.768 1.404 . . . . 0.0 110.733 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -27.42 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.07 0.462 . . . . 0.0 112.058 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 p-10 -85.54 47.38 1.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.115 -0.991 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -111.48 103.49 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.075 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -60.62 150.78 30.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 82' ' ' LYS . 94.9 t -59.88 -34.28 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.731 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -48.38 -48.86 36.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.069 -1.02 . . . . 0.0 110.668 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -64.63 -50.56 66.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 109.726 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 56.5 t80 -60.44 -36.87 79.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.441 -0.787 . . . . 0.0 110.16 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -35.38 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.662 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.08 -17.99 31.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.89 74.65 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.501 HG23 ' CB ' ' A' ' 65' ' ' PHE . 11.2 mt -60.91 -37.48 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -53.9 -52.1 61.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.07 -1.019 . . . . 0.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -54.43 16.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.255 -0.903 . . . . 0.0 111.574 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -54.45 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 111.509 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HZ ' ' HG1' ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.17 -36.21 79.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.868 . . . . 0.0 110.36 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 74.03 77.75 0.12 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.2 p -163.4 -153.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 109.913 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.71 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 mm-40 -68.95 -178.57 1.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.182 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -146.71 -56.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 110.382 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.61 -64.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.854 . . . . 0.0 110.042 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt-30 -64.08 -25.47 68.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 68' ' ' GLN . 2.3 tt -55.43 106.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.93 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG22 ' HG3' ' A' ' 82' ' ' LYS . 99.3 t -136.57 163.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -115.16 139.25 50.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.012 -1.055 . . . . 0.0 109.918 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.1 mm -94.13 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 110.394 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.5 t80 -70.08 167.85 16.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.756 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.52 69.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 110.459 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.56 25.07 4.75 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.759 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -170.21 -174.33 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.232 -1.157 . . . . 0.0 109.994 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -116.72 109.41 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.992 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -69.72 72.03 0.36 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -131.62 -159.71 0.99 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.368 0.604 . . . . 0.0 109.949 -178.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.7 t0 -72.75 -14.94 61.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 110.16 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -58.08 -33.2 68.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 110.15 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -142.38 166.28 25.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 110.602 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.47 155.03 17.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.37 -46.65 75.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.451 HG21 ' CA ' ' A' ' 50' ' ' GLU . 1.3 pp -63.93 -17.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 7.4 tm0? -94.98 -14.64 24.2 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.426 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 175.94 -25.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.988 -1.07 . . . . 0.0 111.86 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.18 -49.89 71.47 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.068 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.15 168.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.345 -1.091 . . . . 0.0 109.158 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.633 ' H ' HD13 ' A' ' 96' ' ' LEU . 4.6 m-70 -114.72 -33.5 5.48 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.7 t0 -179.01 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.566 -0.709 . . . . 0.0 109.911 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.66 70.43 0.36 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.633 HD13 ' H ' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -111.2 174.48 5.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -1.066 . . . . 0.0 110.2 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.2 p -111.76 145.5 39.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.38 -0.825 . . . . 0.0 110.243 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 74' ' ' LEU . 59.0 t -143.28 151.13 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.272 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -90.26 115.78 27.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 110.213 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 74' ' ' LEU . 1.8 tt -74.22 148.38 41.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.59 152.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.805 . . . . 0.0 110.076 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -107.8 136.61 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.243 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.161 0.505 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.29 -158.77 0.7 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 110.189 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.69 -179.8 3.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 0.0 110.276 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -127.95 167.87 16.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.95 45.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -131.22 65.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.448 -1.031 . . . . 0.0 110.21 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 p -139.24 -64.97 0.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.794 . . . . 0.0 110.186 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.43 117.41 18.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.15 103.79 0.33 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.96 112.94 3.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.586 1.308 . . . . 0.0 110.287 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.33 165.57 32.27 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.607 1.319 . . . . 0.0 110.452 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.7 ptt-85 -136.87 158.25 73.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.376 -0.828 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.99 169.11 22.99 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.709 1.373 . . . . 0.0 110.442 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 t -165.11 147.16 7.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.07 78.02 1.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.224 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.15 -85.43 1.78 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.44 106.02 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.786 1.414 . . . . 0.0 110.384 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.02 -40.15 54.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 110.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.29 -161.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.405 -0.81 . . . . 0.0 110.124 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.82 83.22 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.867 . . . . 0.0 110.118 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -159.27 145.13 16.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.25 119.13 0.49 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -81.39 -39.51 24.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -1.099 . . . . 0.0 110.249 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.85 66.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.82 . . . . 0.0 110.202 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.47 -67.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.39 -0.819 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.1 93.65 46.61 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.33 -83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.798 1.42 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 176.23 6.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.036 -1.04 . . . . 0.0 110.216 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -111.75 142.11 26.01 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 110.119 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' LYS . 48.1 Cg_endo -73.27 -94.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.675 1.355 . . . . 0.0 110.741 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' PRO . 6.6 mttp 43.57 39.3 2.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 108.286 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.572 HG23 ' C ' ' A' ' 48' ' ' VAL . 3.2 mp -58.44 115.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.684 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 92' ' ' ILE . 3.5 pt -87.99 166.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.49 144.28 25.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 HD23 ' A' ' 87' ' ' LEU . 27.5 t -134.62 113.45 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.186 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -101.92 106.41 17.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 110.026 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 61' ' ' ILE . 62.1 t -95.01 129.42 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 0.0 110.337 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -96.86 123.08 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.45 -0.781 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.783 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 1.8 p -121.34 169.32 9.28 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.049 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.7 Cg_endo -68.1 -12.32 34.77 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.642 1.338 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -94.37 -48.19 6.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.92 -165.57 0.37 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.402 -0.811 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -115.45 130.66 56.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.93 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.7 135.19 43.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -0.919 . . . . 0.0 110.669 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 36' ' ' THR . 6.1 mt-10 -92.08 153.67 19.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -136.76 129.45 30.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.12 126.43 37.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.22 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 ' C ' HG23 ' A' ' 32' ' ' ILE . 33.8 m -143.32 151.22 54.33 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.937 . . . . 0.0 109.768 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.6 Cg_endo -67.45 123.11 10.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.853 1.449 . . . . 0.0 110.469 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 51' ' ' ASN . 22.0 pt-20 -30.69 -39.78 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 120.965 0.412 . . . . 0.0 112.106 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 11.2 p30 -91.27 49.56 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -111.52 111.4 22.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.034 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -59.94 144.69 48.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 110.306 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.889 HG11 ' HA ' ' A' ' 82' ' ' LYS . 70.5 t -60.58 -34.19 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -50.38 35.04 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.067 -1.021 . . . . 0.0 110.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -65.9 -50.63 63.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' CE2' HG11 ' A' ' 35' ' ' VAL . 31.4 t80 -59.72 -36.26 76.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.544 -0.722 . . . . 0.0 109.999 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.702 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -57.55 -38.39 74.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 109.727 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -81.96 -20.34 38.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.55 84.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.006 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -60.66 -30.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.525 -0.734 . . . . 0.0 110.134 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -60.57 -43.98 96.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.778 . . . . 0.0 110.509 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.67 -50.84 69.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.312 -0.868 . . . . 0.0 111.0 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -71.18 -52.66 17.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.204 -0.935 . . . . 0.0 111.045 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 39' ' ' THR . 16.6 m-85 -65.66 -36.55 83.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.89 . . . . 0.0 110.306 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 12.3 tttt 68.8 57.74 0.4 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.572 -0.705 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -138.02 -154.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.403 -0.811 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.25 160.71 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.928 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -113.01 -67.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 109.114 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 40.33 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.833 -0.542 . . . . 0.0 111.011 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' THR . 1.1 mp0 -79.08 -49.31 12.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 69' ' ' THR . 0.2 OUTLIER 36.18 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.708 -0.62 . . . . 0.0 111.457 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 74' ' ' LEU . 4.6 p -136.28 147.25 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.708 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 73' ' ' VAL . 8.2 mp -117.3 142.37 47.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.83 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.1 mm -92.79 100.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.821 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 82.0 t80 -74.59 78.28 1.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.501 -0.749 . . . . 0.0 109.522 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 55.79 23.53 6.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.41 -41.41 1.51 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -164.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.233 -1.157 . . . . 0.0 110.393 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -122.53 88.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 87' ' ' LEU . 10.3 tt -65.27 86.49 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.889 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.8 tttt -147.25 -150.25 0.33 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.571 -0.706 . . . . 0.0 110.53 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 19.5 p-10 -72.42 -21.6 61.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.522 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.42 -33.04 63.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.85 . . . . 0.0 110.006 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.34 157.11 44.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -84.91 161.7 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.748 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -65.93 -45.87 80.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.566 ' CG2' HD13 ' A' ' 33' ' ' ILE . 2.2 pt -62.13 -17.95 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 15.8 mm100 -98.08 -12.54 21.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -0.841 . . . . 0.0 111.191 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.99 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.883 -1.135 . . . . 0.0 111.934 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.53 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.51 -50.17 69.54 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.11 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -150.55 161.92 3.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.441 -1.035 . . . . 0.0 108.963 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -112.27 -24.51 9.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.992 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p30 179.84 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.373 -0.83 . . . . 0.0 110.077 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.97 68.08 0.78 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.03 -174.49 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -1.073 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -111.52 131.49 55.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 81' ' ' LEU . 27.4 m -127.91 153.6 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 0.0 110.475 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -90.58 144.46 25.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 39' ' ' THR . 8.7 tt -120.6 136.89 54.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.145 -0.972 . . . . 0.0 110.081 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 102' ' ' ILE . 11.1 p -166.12 170.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' N ' HG22 ' A' ' 101' ' ' VAL . 3.9 tt -105.9 136.26 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.298 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.184 0.516 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.25 -173.53 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.403 -0.81 . . . . 0.0 110.267 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.66 54.43 10.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -119.65 53.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.6 97.73 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.62 80.14 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.39 -1.065 . . . . 0.0 110.395 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.0 m -89.62 -167.73 1.94 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m -110.48 -29.38 8.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.6 75.78 1.17 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.97 148.57 45.52 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.745 1.392 . . . . 0.0 110.355 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 -32.56 8.18 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.753 1.397 . . . . 0.0 110.314 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.64 142.85 14.8 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.06 -51.79 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.634 1.334 . . . . 0.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -159.78 -45.72 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -167.24 170.83 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.814 . . . . 0.0 110.129 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.55 -85.49 0.18 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.06 152.98 51.85 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.788 1.415 . . . . 0.0 110.448 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.47 117.1 24.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -0.823 . . . . 0.0 110.107 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.23 -56.4 1.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.875 . . . . 0.0 110.307 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.95 -52.99 2.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.235 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 52.17 89.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.78 98.68 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.1 p -126.42 109.24 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.379 -1.071 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.83 112.17 13.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.137 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.48 38.38 3.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.42 151.41 40.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.46 104.1 1.74 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.788 1.415 . . . . 0.0 110.444 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.26 -36.13 9.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 96.86 5.07 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.749 . . . . 0.0 110.133 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ILE . 50.2 Cg_endo -81.16 30.09 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.699 1.368 . . . . 0.0 111.379 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.27 68.04 0.49 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 49' ' ' PRO . 41.4 mm -58.45 140.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.721 -0.612 . . . . 0.0 110.816 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.021 ' CD1' HD11 ' A' ' 92' ' ' ILE . 4.5 pt -119.64 152.33 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.412 -0.805 . . . . 0.0 109.353 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -91.03 144.16 25.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.616 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 87' ' ' LEU . 38.6 t -132.81 113.41 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.612 -0.68 . . . . 0.0 109.784 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.5 m -91.44 102.53 15.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HD21 ' A' ' 74' ' ' LEU . 53.1 t -94.85 127.55 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 110.184 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 122.51 46.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.0 109.846 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 100' ' ' LEU . 51.5 p -124.18 166.9 17.14 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.447 -0.783 . . . . 0.0 109.864 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.1 Cg_endo -68.22 -12.65 35.69 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.622 1.327 . . . . 0.0 110.528 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -92.32 -44.05 8.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -172.5 -167.23 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 110.294 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 3.1 ptmt -130.96 121.55 25.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 109.951 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -135.47 135.48 40.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.124 -0.985 . . . . 0.0 110.809 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.02 150.4 24.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.587 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.35 130.17 48.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.668 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.31 36.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.4 154.58 63.91 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.746 ' HA ' HD13 ' A' ' 32' ' ' ILE . 41.1 Cg_endo -69.51 120.48 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.671 1.353 . . . . 0.0 110.358 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.609 ' HA ' HD13 ' A' ' 33' ' ' ILE . 1.7 pp20? -37.61 -37.61 0.22 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.875 -0.515 . . . . 0.0 111.689 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.2 p-10 -86.74 52.04 2.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.029 -1.045 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.2 t -126.42 126.5 43.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 86' ' ' THR . 4.2 t -70.09 151.29 45.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 82' ' ' LYS . 91.6 t -61.77 -34.76 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.778 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -43.56 28.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.982 -1.074 . . . . 0.0 110.579 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -70.34 -46.53 63.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 37.7 t80 -65.71 -37.87 87.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.91 -39.28 77.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.406 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -20.94 60.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.607 -0.683 . . . . 0.0 109.942 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -66.86 -50.74 61.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 mt -63.13 -36.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -53.63 -44.92 69.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -54.72 15.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 111.336 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -72.89 -54.37 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.1 -1.0 . . . . 0.0 111.29 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.34 -36.5 79.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.2 tptt 71.7 79.19 0.16 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 t -131.78 -151.85 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 110.051 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -92.88 -17.28 24.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 110.565 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m 66.14 -66.09 0.17 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.783 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.7 t70 -55.12 -63.48 1.14 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.127 -0.983 . . . . 0.0 110.14 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' O ' HG23 ' A' ' 73' ' ' VAL . 31.7 mt-30 -68.93 -25.3 64.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.798 . . . . 0.0 110.02 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 100' ' ' LEU . 51.6 tp -56.21 95.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.397 -0.814 . . . . 0.0 110.826 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 71' ' ' GLN . 65.8 t -122.47 154.56 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.783 . . . . 0.0 109.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD2' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -115.06 141.13 48.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.014 -1.054 . . . . 0.0 110.315 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 99' ' ' HIS . 50.2 mm -94.75 98.63 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 75.6 t80 -68.74 72.63 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.407 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.83 38.41 19.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.895 . . . . 0.0 110.579 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 126.12 -50.13 0.89 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -74.21 -161.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -126.83 93.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.388 -0.82 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 91' ' ' GLY . 7.7 tt -64.05 89.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.802 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -152.81 -154.3 0.53 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.772 -0.58 . . . . 0.0 110.17 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.5 p30 -72.66 -19.52 61.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.431 -0.793 . . . . 0.0 110.219 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -33.05 62.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.71 149.01 33.64 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.476 -0.765 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 53' ' ' SER . 1.2 p -74.18 161.79 29.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 109.843 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.2 tp -65.56 -46.32 79.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 110.37 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 50' ' ' GLU . 2.1 pp -65.46 -18.37 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 110.211 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -96.79 -10.71 26.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 111.1 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 -30.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.935 -1.103 . . . . 0.0 111.962 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -59.08 -51.01 61.76 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.021 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -149.83 177.14 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.371 -1.076 . . . . 0.0 108.963 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.433 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.1 m-70 -126.94 -31.1 2.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.71 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -179.5 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -0.757 . . . . 0.0 109.703 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 113.38 58.07 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.3 mt -98.0 -169.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -1.109 . . . . 0.0 110.309 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -131.5 121.33 24.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.781 . . . . 0.0 110.299 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 74' ' ' LEU . 7.1 p -119.44 157.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 45.4 m80 -90.66 143.49 26.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 39' ' ' THR . 6.3 tt -112.46 121.4 44.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.289 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.474 HG13 ' C ' ' A' ' 100' ' ' LEU . 35.7 m -149.89 142.96 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.51 134.64 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.322 -0.861 . . . . 0.0 110.358 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.216 0.531 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.21 -166.2 1.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.226 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.39 87.59 0.7 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -161.05 -174.8 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.855 . . . . 0.0 110.188 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.44 -118.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -158.48 72.9 0.62 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -1.083 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -160.33 -72.65 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 0.0 110.292 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.2 m -65.36 110.43 2.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 110.184 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -80.29 128.15 8.33 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.606 ' HG2' ' HD3' ' A' ' 11' ' ' PRO . 39.5 Cg_endo -70.63 -31.58 16.4 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.666 1.351 . . . . 0.0 113.297 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 44.4 Cg_endo -73.43 -84.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 122.324 0.644 . . . . 0.0 110.638 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -156.14 76.87 4.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.983 -1.073 . . . . 0.0 110.174 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 97.58 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.867 1.456 . . . . 0.0 110.42 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 t -152.61 166.49 31.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 0.0 110.201 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.86 -158.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 110.242 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.74 152.34 16.84 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 119.7 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.732 1.385 . . . . 0.0 110.394 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.34 -165.46 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 110.231 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.63 154.02 26.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.227 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.62 90.44 0.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.413 -0.804 . . . . 0.0 110.149 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -71.3 126.99 31.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.191 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.74 32.1 6.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.5 t -101.75 49.98 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -1.079 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.81 80.61 1.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.444 -0.785 . . . . 0.0 110.219 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.98 -170.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.352 -0.842 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.61 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.54 144.39 35.89 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.831 1.437 . . . . 0.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.74 -53.12 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.38 -0.825 . . . . 0.0 110.116 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -136.37 90.14 18.14 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 110.057 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.796 ' O ' HD12 ' A' ' 32' ' ' ILE . 50.8 Cg_endo -81.24 20.18 1.06 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.814 1.429 . . . . 0.0 111.384 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.4 69.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.2 mp -58.47 108.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.693 -0.629 . . . . 0.0 110.654 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 92' ' ' ILE . 4.6 pt -81.86 159.64 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -91.43 144.48 25.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 110.759 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HD23 ' A' ' 87' ' ' LEU . 47.5 t -135.66 114.09 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.271 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.443 HG23 ' OE1' ' A' ' 45' ' ' GLU . 6.4 m -98.99 105.68 17.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.92 . . . . 0.0 110.175 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.92 128.63 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -92.27 122.66 34.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.992 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.591 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -118.63 173.91 3.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.432 -0.793 . . . . 0.0 109.966 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.3 Cg_endo -69.64 -10.61 29.09 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.728 1.383 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -98.84 -53.27 3.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.13 -176.62 1.68 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -0.814 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.93 139.95 31.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.9 121.71 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -89.02 146.17 25.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -0.806 . . . . 0.0 110.077 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -132.3 128.9 38.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -90.72 124.47 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.541 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.1 m -142.28 149.66 52.43 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.3 Cg_endo -67.24 121.23 8.35 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.775 1.408 . . . . 0.0 110.495 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.614 ' HA ' HD13 ' A' ' 33' ' ' ILE . 14.1 pt-20 -35.32 -39.02 0.11 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.257 0.551 . . . . 0.0 111.231 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.479 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -89.9 55.89 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.462 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -114.67 -179.66 3.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.217 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.4 140.99 52.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 82' ' ' LYS . 22.1 t -66.91 -35.04 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 110.578 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.6 -49.42 46.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.775 -1.203 . . . . 0.0 110.196 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -78.5 -45.91 20.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 110.354 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 61' ' ' ILE . 27.7 t80 -61.38 -51.21 69.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.543 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.5 -35.11 69.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.462 -0.774 . . . . 0.0 109.954 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HG3' HG21 ' A' ' 69' ' ' THR . 1.8 tt0 -78.33 -26.28 46.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.73 -52.55 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 109.817 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.69 -29.2 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.695 -0.628 . . . . 0.0 109.652 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 t -56.49 -44.16 80.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -0.827 . . . . 0.0 110.273 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.98 61.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -52.74 63.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.45 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -67.49 -35.88 80.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.0 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 3.2 ttpp 76.14 85.33 0.09 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.447 0.642 . . . . 0.0 110.213 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.47 -154.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.581 -0.699 . . . . 0.0 109.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.0 -177.85 6.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 59' ' ' GLU . 61.5 m -140.88 -53.86 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 0.0 110.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -51.14 70.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.821 . . . . 0.0 110.233 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 73' ' ' VAL . 21.1 mt-30 -77.98 -26.01 48.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 110.226 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.458 HD11 HD21 ' A' ' 100' ' ' LEU . 8.1 tt -65.18 120.22 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.0 110.28 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.86 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.2 m -135.6 157.39 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.711 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -113.8 118.69 34.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.884 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.71 97.26 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.394 -0.816 . . . . 0.0 110.492 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.656 ' CD1' HG22 ' A' ' 98' ' ' VAL . 6.7 t80 -98.89 109.61 22.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.455 -0.778 . . . . 0.0 109.913 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.58 26.48 12.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.409 -0.807 . . . . 0.0 110.358 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.13 -36.04 4.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -179.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -1.071 . . . . 0.0 110.145 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -110.17 82.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 110.316 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 98' ' ' VAL . 7.3 tt -59.97 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.86 ' CD ' HG12 ' A' ' 73' ' ' VAL . 7.4 ttpp -160.75 -146.76 0.14 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.535 -0.728 . . . . 0.0 110.579 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.01 -18.86 61.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.404 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -52.82 -32.76 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.051 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.45 167.67 28.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -0.855 . . . . 0.0 110.524 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 p -85.47 161.14 19.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.625 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.26 -46.44 77.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.882 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.7 pt -63.39 -19.09 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.008 . . . . 0.0 110.197 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 11.4 tp-100 -93.6 -12.85 28.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.96 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.03 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.916 -1.115 . . . . 0.0 111.752 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -59.05 -50.88 63.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -151.01 169.48 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.32 -1.106 . . . . 0.0 109.118 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -116.73 -31.34 5.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.4 t0 -178.65 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 117.48 70.21 0.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 96' ' ' LEU . 3.1 mm? -112.18 171.36 7.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.31 -1.112 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m -111.88 140.14 46.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 110.338 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 81' ' ' LEU . 61.6 t -137.75 155.71 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.432 -0.793 . . . . 0.0 110.282 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -90.69 121.97 33.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 HD11 ' A' ' 72' ' ' LEU . 9.4 tt -99.97 119.14 37.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.07 142.22 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp -107.13 137.13 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.423 -0.798 . . . . 0.0 110.29 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.1 mttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.165 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.2 0.524 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.13 -26.5 47.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.333 -0.854 . . . . 0.0 110.249 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.1 168.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 110.373 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -106.65 -30.39 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.77 92.16 0.08 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.01 85.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -1.085 . . . . 0.0 110.482 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 m -79.33 -4.74 52.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.323 -0.861 . . . . 0.0 110.581 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -32.07 8.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.7 176.36 46.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.06 126.23 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.777 1.409 . . . . 0.0 110.405 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.04 171.17 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.624 1.328 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.82 61.54 12.26 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.372 -0.83 . . . . 0.0 110.505 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.11 -8.23 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.758 1.399 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -57.37 108.4 0.54 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.187 -0.946 . . . . 0.0 110.342 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -148.63 -63.72 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.167 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.37 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.57 162.81 39.03 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.688 1.362 . . . . 0.0 110.398 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.53 -72.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.333 -0.854 . . . . 0.0 110.207 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 -29.79 15.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 52.85 -161.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 110.483 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 52.96 49.01 21.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 110.388 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.21 129.59 15.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 m -83.67 -67.24 0.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -1.092 . . . . 0.0 110.264 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -159.45 60.31 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.92 65.71 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.14 34.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.03 78.8 2.13 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.78 1.41 . . . . 0.0 110.404 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.48 -60.13 1.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.222 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -127.18 95.09 37.31 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.836 . . . . 0.0 110.179 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.3 Cg_endo -71.57 -93.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.71 1.373 . . . . 0.0 110.625 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER 44.01 41.95 4.41 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.38 137.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.347 0.594 . . . . 0.0 111.085 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 92' ' ' ILE . 8.1 pt -107.78 160.05 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.437 -0.789 . . . . 0.0 109.542 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' O ' HG21 ' A' ' 92' ' ' ILE . 21.9 mttt -94.65 133.63 38.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.833 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 46' ' ' PHE . 2.6 p -128.51 118.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -96.01 114.62 26.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.35 -0.844 . . . . 0.0 110.187 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 74' ' ' LEU . 45.3 t -104.85 129.29 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.352 -0.843 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 122.46 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.445 -0.784 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.858 HG21 ' CE2' ' A' ' 65' ' ' PHE . 1.1 p -122.79 170.68 7.68 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.828 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.8 Cg_endo -67.93 -12.64 35.96 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.656 1.345 . . . . 0.0 110.726 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -51.24 5.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -173.74 178.4 2.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.351 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 125.86 44.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.902 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -135.1 134.89 40.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.689 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -90.26 151.08 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.495 -0.753 . . . . 0.0 109.682 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.718 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.2 m-85 -129.3 152.26 49.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -0.94 . . . . 0.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -105.55 133.37 50.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.074 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.3 m -143.35 143.7 25.27 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 51' ' ' ASN . 40.2 Cg_endo -66.82 128.82 19.58 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.706 1.371 . . . . 0.0 111.306 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.713 ' C ' HG21 ' A' ' 88' ' ' ILE . 2.2 tm-20 -39.43 -20.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' PRO . 17.2 p-10 -111.09 37.95 2.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.644 -1.285 . . . . 0.0 110.47 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.453 ' N ' HD12 ' A' ' 88' ' ' ILE . 27.8 p -96.55 -153.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -161.91 157.25 23.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.345 -0.847 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.673 HG11 ' C ' ' A' ' 82' ' ' LYS . 59.4 t -63.28 -34.91 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 110.793 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -49.17 -47.11 46.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.663 -1.273 . . . . 0.0 110.231 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -49.53 16.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.227 -0.921 . . . . 0.0 110.337 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 35' ' ' VAL . 28.3 t80 -60.34 -50.28 74.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.97 -30.56 66.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -26.84 26.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 110.051 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.62 82.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -29.85 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.571 -0.706 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t -62.32 -43.92 97.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.476 -0.765 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -57.81 -48.56 79.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.862 . . . . 0.0 111.024 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' NH1' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -71.15 -52.81 17.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.203 -0.936 . . . . 0.0 110.931 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CE2' HG21 ' A' ' 39' ' ' THR . 8.8 m-85 -67.18 -36.16 81.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.85 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 12.3 mttp 69.6 81.44 0.17 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.418 0.628 . . . . 0.0 110.092 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 p -168.15 -154.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -74.94 157.56 34.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -128.51 -41.67 1.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.16 -62.72 1.56 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.358 -0.839 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -69.4 -25.57 64.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.427 -0.796 . . . . 0.0 110.165 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.843 HD21 HD11 ' A' ' 100' ' ' LEU . 4.9 tt -64.36 118.01 8.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.339 -0.85 . . . . 0.0 110.524 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 82' ' ' LYS . 33.0 m -139.0 168.46 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.741 HD12 HG13 ' A' ' 98' ' ' VAL . 2.7 mm? -109.57 146.81 34.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 98' ' ' VAL . 33.8 mm -102.69 92.9 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 110.236 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 24.7 t80 -74.39 64.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.7 . . . . 0.0 110.357 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 49.2 79.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.86 -53.06 4.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.755 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.6 mttt -76.2 178.2 6.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -1.103 . . . . 0.0 109.873 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.755 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -115.97 106.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 0.0 109.916 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.932 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.8 OUTLIER -69.5 72.04 0.32 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.673 ' C ' HG11 ' A' ' 54' ' ' VAL . 7.9 ttmt -125.95 -160.1 0.95 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.511 0.672 . . . . 0.0 110.547 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.7 p-10 -73.74 -16.71 61.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.629 -0.669 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.83 -32.36 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.942 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -132.08 169.66 16.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.799 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.454 ' OG1' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -88.66 137.01 32.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.793 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 92' ' ' ILE . 22.3 tp -55.93 -47.49 77.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 110.428 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.713 HG21 ' C ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -73.62 -15.48 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.481 -0.762 . . . . 0.0 110.904 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.454 ' NE2' ' OG1' ' A' ' 86' ' ' THR . 0.7 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 111.847 -178.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -174.65 -36.61 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.586 -1.321 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.937 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.84 -42.8 96.77 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.937 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -138.64 138.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -1.19 . . . . 0.0 110.855 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.52 ' H ' HD13 ' A' ' 96' ' ' LEU . 12.2 m170 -103.68 -36.03 8.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 24.0 p-10 179.81 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 0.0 109.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.08 71.19 0.24 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 93' ' ' HIS . 6.5 mp -113.16 167.49 10.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 110.371 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.9 m -118.33 147.14 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.333 -0.854 . . . . 0.0 110.252 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.741 HG13 HD12 ' A' ' 74' ' ' LEU . 7.7 p -144.43 150.54 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 110.418 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -90.63 122.49 33.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.503 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.843 HD11 HD21 ' A' ' 72' ' ' LEU . 7.0 tt -82.94 149.98 26.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.204 -0.935 . . . . 0.0 110.673 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.561 HG12 HG12 ' A' ' 75' ' ' ILE . 14.0 p -168.05 131.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.09 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.4 pp -94.89 131.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 tttt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.277 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.218 0.533 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.9 133.43 43.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.51 116.65 17.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.22 110.92 4.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.64 -118.98 0.67 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -65.18 169.07 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -1.101 . . . . 0.0 110.231 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -107.3 52.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 46.4 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.56 -164.24 34.61 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.21 166.99 28.48 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 132.78 18.47 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 110.437 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 9.7 mtp180 -67.42 -54.87 16.7 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 0.0 110.381 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.8 Cg_endo -73.78 66.01 4.87 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.588 1.309 . . . . 0.0 110.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -64.95 160.43 20.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.395 -0.815 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 118.42 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.0 -27.43 14.1 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.497 1.262 . . . . 0.0 110.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.36 50.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.872 . . . . 0.0 110.204 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.0 158.66 15.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.95 138.33 54.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.85 -41.09 6.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.91 -166.56 42.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -70.87 142.16 51.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -1.106 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.59 167.36 16.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 110.244 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.74 -61.55 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.877 . . . . 0.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.36 91.45 7.72 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.85 . . . . 0.0 110.208 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 142.67 37.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.761 1.4 . . . . 0.0 110.386 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.68 108.3 17.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mm-40 -177.81 -55.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 110.247 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 29' ' ' GLU . 53.1 Cg_endo -80.51 33.11 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.422 1.222 . . . . 0.0 111.463 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' O ' HG23 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -70.89 66.93 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.3 mm -58.33 102.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 110.654 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.99 HD13 HG22 ' A' ' 88' ' ' ILE . 7.1 pt -96.07 147.88 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.707 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.636 ' O ' HG21 ' A' ' 92' ' ' ILE . 10.7 mttp -91.81 141.39 28.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.103 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 87' ' ' LEU . 51.0 t -129.52 113.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.818 . . . . 0.0 110.129 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.7 m -90.15 109.4 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.832 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.78 127.79 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 110.285 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 122.51 47.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.437 -0.789 . . . . 0.0 109.67 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 1.11 HG22 HD13 ' A' ' 100' ' ' LEU . 62.1 p -124.13 162.22 42.84 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 59.54 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.71 1.373 . . . . 0.0 110.428 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.71 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -167.21 -170.02 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.513 -0.742 . . . . 0.0 109.922 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -142.7 125.37 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.831 . . . . 0.0 110.21 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -135.12 132.44 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.382 -0.824 . . . . 0.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -90.1 150.25 22.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -123.75 140.93 52.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 110.479 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.68 116.64 33.18 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 52' ' ' SER . 21.8 m -120.59 147.68 46.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.677 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.631 ' HA ' HD13 ' A' ' 32' ' ' ILE . 51.1 Cg_endo -76.65 52.83 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.856 1.451 . . . . 0.0 111.709 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' CG ' HG21 ' A' ' 88' ' ' ILE . 30.7 tp10 55.53 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.381 -0.824 . . . . 0.0 111.695 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.0 t30 -46.86 -20.06 0.12 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 0.0 112.063 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.422 ' CB ' ' HB ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -59.1 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 110.106 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.9 m -67.33 175.6 2.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.526 -0.734 . . . . 0.0 110.35 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 82' ' ' LYS . 37.6 t -68.12 -35.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 110.272 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -50.21 -49.01 54.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.772 -1.205 . . . . 0.0 109.733 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -76.37 -47.4 23.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -61.52 -50.98 70.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.367 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.55 -29.85 64.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.783 . . . . 0.0 109.897 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.766 ' OE2' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -80.37 -24.14 39.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.336 -0.852 . . . . 0.0 109.813 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.29 85.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 110.149 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.0 mt -60.9 -36.91 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.256 -0.903 . . . . 0.0 109.912 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 p -53.6 -49.64 67.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.0 110.506 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -68.21 -53.77 22.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.341 -0.849 . . . . 0.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -53.84 12.32 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.097 -1.002 . . . . 0.0 111.262 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.66 -36.45 80.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 109.991 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.06 81.68 0.19 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.612 -0.68 . . . . 0.0 110.224 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -156.04 -65.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.0 -176.15 2.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.437 -0.789 . . . . 0.0 110.061 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.766 HG21 ' OE2' ' A' ' 59' ' ' GLU . 3.2 m -140.85 -55.08 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.04 -67.4 0.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 73' ' ' VAL . 9.9 mt-30 -60.47 -25.61 66.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.309 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 72' ' ' LEU . 7.8 tt -53.29 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 110.826 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 71' ' ' GLN . 86.7 t -125.63 148.7 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 109.472 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -117.94 135.86 53.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.17 101.65 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.438 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 81' ' ' LEU . 71.8 t80 -77.35 82.71 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.238 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.79 36.19 13.88 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.33 -55.87 0.57 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -1.062 . . . . 0.0 110.056 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -118.05 94.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.281 -0.887 . . . . 0.0 110.694 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -67.09 79.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.003 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.772 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.5 ttmt -137.15 -158.86 0.9 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.414 0.625 . . . . 0.0 110.358 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 84' ' ' GLN . 35.5 p30 -73.32 -14.81 61.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.452 -0.78 . . . . 0.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -55.78 -33.04 64.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.353 -0.842 . . . . 0.0 109.72 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.39 154.4 49.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.474 -0.766 . . . . 0.0 110.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -70.27 147.03 50.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.853 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 35' ' ' VAL . 17.0 tp -55.59 -46.98 77.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.99 HG22 HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -72.48 -14.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 47.9 tp60 -85.63 -13.58 48.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 111.814 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -170.27 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.605 -1.309 . . . . 0.0 111.036 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.929 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.46 -46.92 93.14 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.929 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -137.47 143.66 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.012 -1.287 . . . . 0.0 111.333 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.438 ' H ' HD12 ' A' ' 96' ' ' LEU . 4.6 m80 -109.4 -33.72 6.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -179.73 35.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.246 0.546 . . . . 0.0 109.536 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 92' ' ' ILE . . . 118.67 71.97 0.39 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -114.61 -178.43 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.235 -1.156 . . . . 0.0 110.251 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -125.15 146.52 49.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 81' ' ' LEU . 8.1 p -142.68 151.09 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.874 . . . . 0.0 110.401 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.71 144.31 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.81 . . . . 0.0 110.258 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.11 HD13 HG22 ' A' ' 39' ' ' THR . 6.4 tt -97.44 119.97 36.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.67 128.57 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 0.0 110.045 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp -104.6 130.49 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.196 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.17 0.51 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.28 28.87 4.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.837 . . . . 0.0 110.111 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -116.79 -34.06 4.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -0.828 . . . . 0.0 110.141 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -113.7 100.65 8.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.183 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 164.3 44.59 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -138.13 -66.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -1.082 . . . . 0.0 110.123 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 p -112.27 -31.03 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 110.25 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 t -158.96 126.49 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.247 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.12 -84.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.56 163.92 36.26 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.84 1.442 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -23.11 20.33 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.797 1.42 . . . . 0.0 110.435 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -109.53 99.94 39.61 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.97 151.17 55.98 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.676 1.356 . . . . 0.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.21 172.96 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.224 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -126.81 -170.62 2.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.181 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.74 74.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 -167.92 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.815 1.429 . . . . 0.0 110.422 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 -40.03 15.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.83 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.01 79.69 1.49 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.758 . . . . 0.0 110.174 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.71 -170.95 3.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -117.27 126.7 53.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 110.121 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.17 98.78 0.29 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t -162.2 85.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.048 . . . . 0.0 110.169 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.6 145.09 56.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.217 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.77 59.4 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.139 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.47 72.24 3.84 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.871 . . . . 0.0 110.323 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -26.14 14.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.831 1.437 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 115.42 4.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -104.11 158.25 32.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.354 -0.841 . . . . 0.0 110.121 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.5 Cg_endo -71.87 -93.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.745 1.392 . . . . 0.0 110.641 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER 44.04 43.53 5.56 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.6 mp -58.12 111.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.603 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.62 HD13 HG22 ' A' ' 88' ' ' ILE . 9.0 pt -89.68 154.46 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.38 -0.825 . . . . 0.0 110.039 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -94.11 144.89 25.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.56 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -138.52 119.14 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.4 -0.813 . . . . 0.0 110.108 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -87.05 102.22 14.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 0.0 110.095 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.729 ' CG1' HD12 ' A' ' 100' ' ' LEU . 61.6 t -96.3 128.38 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' CG ' ' HA ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -109.72 126.27 53.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 110.293 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.925 HG23 HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.46 175.73 2.6 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.613 -0.679 . . . . 0.0 109.69 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 39' ' ' THR . 44.4 Cg_endo -71.34 61.86 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.626 1.33 . . . . 0.0 110.395 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.447 -0.783 . . . . 0.0 109.928 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.71 179.48 3.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.39 -0.819 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -117.08 122.99 45.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.152 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.3 135.12 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.326 -0.859 . . . . 0.0 110.438 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -85.23 149.52 25.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.533 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -124.35 144.86 49.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.571 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -99.62 129.78 45.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 30.4 m -143.46 144.01 26.2 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.857 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 39.4 Cg_endo -67.08 121.44 8.61 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.756 1.398 . . . . 0.0 111.034 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -37.17 -34.73 0.09 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.117 0.484 . . . . 0.0 111.583 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.15 49.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 110.575 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 55.7 p -127.85 108.38 10.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.5 t -59.84 153.36 20.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.857 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.1 t -55.88 -35.0 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 110.86 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -48.48 -43.78 35.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.665 -1.272 . . . . 0.0 109.843 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.15 -41.48 41.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.636 ' O ' HG22 ' A' ' 61' ' ' ILE . 17.7 t80 -68.24 -51.46 45.11 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -30.8 65.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.921 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HA ' HG23 ' A' ' 69' ' ' THR . 32.0 tt0 -86.29 -26.85 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -49.32 60.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -0.785 . . . . 0.0 109.675 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.716 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.35 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.008 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 p -63.85 -44.43 93.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.174 -0.953 . . . . 0.0 110.351 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -56.39 -42.66 78.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.78 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -52.07 23.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.283 -0.885 . . . . 0.0 110.463 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 5.2 m-85 -67.0 -36.5 82.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.817 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 44.5 mtmt 64.23 79.49 0.26 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.582 -0.699 . . . . 0.0 110.179 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 t -154.87 -59.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.486 -0.759 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.416 ' O ' HD22 ' A' ' 72' ' ' LEU . 1.6 tt0 -169.45 174.83 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 0.0 110.005 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.54 HG23 ' HA ' ' A' ' 59' ' ' GLU . 31.1 m -143.31 -44.19 0.29 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.37 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -64.97 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.18 -26.19 60.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.226 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -53.16 139.75 28.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.326 -0.859 . . . . 0.0 110.523 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.0 p -172.84 169.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 109.928 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD11 HG22 ' A' ' 37' ' ' VAL . 2.6 mt -118.44 118.86 32.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -0.982 . . . . 0.0 109.31 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.61 103.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 110.146 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.772 ' HA ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -91.86 124.11 35.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.452 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.94 103.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.313 -0.867 . . . . 0.0 110.607 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.46 -31.13 3.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.609 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -166.65 -166.8 0.89 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -1.003 . . . . 0.0 109.712 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 79' ' ' LYS . 1.3 mm -108.77 118.26 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.874 HD12 HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.97 71.05 0.37 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.786 178.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.819 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ptmt -136.1 -152.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.368 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.9 p30 -72.94 -12.84 61.1 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.301 -0.874 . . . . 0.0 112.482 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.6 -33.5 33.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.056 . . . . 0.0 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.61 156.37 45.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.198 -0.939 . . . . 0.0 109.972 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 149.78 41.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 92' ' ' ILE . 16.0 tp -56.81 -48.16 78.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 110.868 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.62 HG22 HD13 ' A' ' 33' ' ' ILE . 2.1 pp -73.1 -18.45 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.172 -0.955 . . . . 0.0 110.829 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.29 -9.9 57.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 111.744 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.728 -1.233 . . . . 0.0 110.949 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.877 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.34 -47.0 92.98 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -145.56 156.23 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -1.176 . . . . 0.0 110.293 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -114.98 -42.42 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.4 t70 -178.49 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.28 65.91 0.18 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 96' ' ' LEU . 10.8 mt -112.58 160.08 18.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -1.12 . . . . 0.0 110.256 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 98' ' ' VAL . 7.0 t -115.06 145.72 42.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 81' ' ' LEU . 49.0 t -145.47 158.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.557 ' O ' HG22 ' A' ' 75' ' ' ILE . 11.4 m-70 -88.39 125.49 34.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 0.0 110.466 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.925 HD13 HG23 ' A' ' 39' ' ' THR . 5.5 tt -83.29 145.77 28.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.135 -0.978 . . . . 0.0 110.451 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 100' ' ' LEU . 7.8 p -167.36 159.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -108.08 137.22 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.327 -0.858 . . . . 0.0 110.204 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.6 mttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.314 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.259 0.552 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.42 171.04 14.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.319 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.36 46.06 1.03 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.184 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -137.82 33.49 2.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.247 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.33 57.68 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -38.0 89.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -1.098 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.9 p -80.31 -165.04 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.02 150.38 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.831 . . . . 0.0 110.215 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.26 -132.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 156.97 55.34 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.525 1.276 . . . . 0.0 110.292 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.37 173.62 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.785 1.413 . . . . 0.0 110.409 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -128.9 98.91 23.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 110.276 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.21 112.33 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.692 1.364 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.75 -2.82 58.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.352 -0.842 . . . . 0.0 110.691 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.52 -42.18 87.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.179 -0.95 . . . . 0.0 110.22 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.68 134.0 2.44 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.83 87.3 1.15 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.576 1.303 . . . . 0.0 110.33 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.65 -164.53 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 110.426 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -170.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.857 . . . . 0.0 110.248 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.24 170.53 15.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.864 . . . . 0.0 110.284 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.69 117.6 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.39 -0.819 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.71 162.48 30.08 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.8 m -98.32 29.23 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.21 105.92 16.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.55 42.87 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.45 150.95 22.91 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.293 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 144.68 36.66 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.73 1.384 . . . . 0.0 110.367 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.81 101.19 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 12.6 tp10 -177.45 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.328 -0.858 . . . . 0.0 110.118 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 29' ' ' GLU . 43.4 Cg_endo -69.32 -92.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.291 1.153 . . . . 0.0 110.434 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 mptt 45.47 44.38 9.63 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 2.9 mp -58.04 110.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.835 -0.541 . . . . 0.0 110.476 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.986 ' CD1' HD11 ' A' ' 92' ' ' ILE . 3.3 pt -83.55 152.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -91.97 144.4 25.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 110.282 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.744 HG23 HG21 ' A' ' 92' ' ' ILE . 7.3 p -139.69 113.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.093 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -82.33 109.08 16.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.396 -0.815 . . . . 0.0 110.018 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.55 127.59 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -0.859 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.38 122.64 46.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 80.7 p -121.58 165.93 18.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.726 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.1 Cg_endo -69.71 -10.28 28.2 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.636 1.335 . . . . 0.0 110.817 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -100.54 -35.91 9.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.184 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.36 -166.52 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.325 -0.859 . . . . 0.0 110.263 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 114.93 8.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 0.0 110.074 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -135.19 134.96 40.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 110.499 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.29 149.21 26.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.1 m-85 -121.4 147.68 45.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.36 125.86 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.6 m -142.49 150.48 54.65 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.206 -0.934 . . . . 0.0 109.758 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -68.36 122.61 9.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.699 1.368 . . . . 0.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.0 pt-20 -31.28 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.084 0.469 . . . . 0.0 111.716 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -88.58 50.83 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.213 -0.929 . . . . 0.0 110.121 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.1 t -115.12 130.77 57.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -82.14 146.47 29.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.997 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -61.16 -34.53 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.791 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -49.32 -48.07 46.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.988 -1.07 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.33 -49.76 52.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 38.5 t80 -59.82 -37.23 78.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 12.2 mtpt -57.77 -47.95 81.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.579 -0.701 . . . . 0.0 109.495 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.484 -0.76 . . . . 0.0 109.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -62.88 -51.89 65.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.842 . . . . 0.0 110.045 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 65' ' ' PHE . 19.6 mt -60.92 -39.65 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.603 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -53.7 -52.24 60.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.039 . . . . 0.0 110.326 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -54.17 19.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.324 -0.86 . . . . 0.0 111.508 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -72.02 -54.11 10.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 111.442 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.91 -36.6 80.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 110.275 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 4.9 tttp 69.17 80.66 0.19 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.437 -0.789 . . . . 0.0 110.203 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 t -153.38 -69.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -164.36 -175.18 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.5 m -144.11 -60.04 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.312 -0.868 . . . . 0.0 110.483 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 -61.03 2.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -66.32 -25.65 66.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 102' ' ' ILE . 36.2 tp -51.86 124.75 13.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.337 -0.852 . . . . 0.0 110.684 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.1 p -153.31 157.22 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 109.767 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.4 mp -123.6 123.76 41.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.134 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.19 104.33 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 110.626 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.3 t80 -70.52 67.06 0.34 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.755 . . . . 0.0 110.031 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.92 24.76 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.261 -0.899 . . . . 0.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.21 -39.24 1.51 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -162.14 0.53 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -1.121 . . . . 0.0 110.258 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.1 pp -123.49 84.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 110.61 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 87' ' ' LEU . 8.1 tt -67.74 84.29 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 108.765 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.997 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -153.99 -146.82 0.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 110.148 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.58 -15.56 61.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.035 -1.041 . . . . 0.0 111.363 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.448 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.4 mm-40 -53.73 -33.42 55.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.129 -0.982 . . . . 0.0 110.237 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -150.24 -169.88 3.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -102.91 158.14 16.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 81' ' ' LEU . 1.5 tp -66.09 -46.23 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.6 pt -63.84 -17.25 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.562 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -97.27 -12.82 22.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 111.091 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.911 -1.118 . . . . 0.0 111.859 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.658 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.39 -50.34 67.68 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -148.56 171.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.375 -1.074 . . . . 0.0 108.665 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -122.19 -29.62 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.967 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.8 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 109.982 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.91 59.5 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.38 -168.99 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.336 -1.097 . . . . 0.0 110.221 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -134.96 147.03 49.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 76' ' ' PHE . 11.9 p -140.47 157.56 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 0.0 110.199 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -90.7 115.81 28.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 HD11 ' A' ' 72' ' ' LEU . 7.9 tt -89.31 131.33 35.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 110.139 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 101' ' ' VAL . 35.2 m -145.08 130.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.783 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.711 HG22 HD12 ' A' ' 72' ' ' LEU . 2.3 pp -106.79 130.09 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 0.0 110.199 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.106 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mtp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.22 0.533 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.3 147.33 34.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.12 138.3 33.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 52.82 49.81 19.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.338 -0.851 . . . . 0.0 110.463 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.96 -82.11 0.87 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.59 110.0 5.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -1.064 . . . . 0.0 110.19 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -68.08 0.15 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.451 -0.78 . . . . 0.0 110.186 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -93.14 -55.34 3.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.01 -153.32 9.4 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 160.49 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.801 1.422 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.49 119.73 6.11 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.89 1.469 . . . . 0.0 110.387 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 1.1 tpt180 -69.5 -54.8 10.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.5 Cg_endo -74.54 136.34 21.3 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.476 1.251 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.6 p -64.43 161.29 17.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.242 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.29 48.49 2.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.32 87.32 1.92 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.05 74.64 2.92 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.832 1.438 . . . . 0.0 110.355 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.54 164.33 18.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.98 80.53 5.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.23 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.25 40.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 155.34 18.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -0.911 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.76 63.32 0.23 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 m -88.13 123.99 33.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.239 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.23 -43.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.377 -0.827 . . . . 0.0 110.192 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.12 178.05 4.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -75.38 113.88 30.27 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.822 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.87 -17.33 29.02 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.545 1.287 . . . . 0.0 110.567 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -118.93 44.02 2.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.235 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 1.7 mt-10 -73.89 -55.81 3.06 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 31' ' ' LYS . 49.0 Cg_endo -73.46 -93.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.579 1.305 . . . . 0.0 110.502 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.5 tptp 42.71 41.74 2.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -58.16 110.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.252 0.549 . . . . 0.0 110.723 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.668 ' CD1' HD11 ' A' ' 92' ' ' ILE . 1.6 pt -89.16 174.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.415 -0.803 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.45 144.39 37.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.768 . . . . 0.0 110.373 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 46' ' ' PHE . 8.7 p -136.14 113.84 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 110.033 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -84.24 103.8 13.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.501 HG13 HD21 ' A' ' 74' ' ' LEU . 66.9 t -94.75 128.75 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.002 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -101.24 122.5 43.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.415 -0.803 . . . . 0.0 110.071 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.742 HG22 HD13 ' A' ' 100' ' ' LEU . 4.3 p -119.93 167.71 11.85 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.9 Cg_endo -71.1 61.06 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.661 1.348 . . . . 0.0 110.401 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -46.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 109.64 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -172.05 176.75 3.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.53 -0.731 . . . . 0.0 110.081 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.67 127.97 54.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -134.5 131.2 37.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.3 149.79 25.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.9 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -127.12 123.08 35.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.898 . . . . 0.0 110.197 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.133 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 25.6 m -143.21 153.57 59.93 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.233 -0.917 . . . . 0.0 109.825 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.2 Cg_endo -67.9 122.37 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.803 1.423 . . . . 0.0 110.726 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.613 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -30.74 -42.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.66 48.7 1.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.925 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.9 t -113.41 108.07 16.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.087 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.7 m -59.84 148.84 33.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.847 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.5 t -63.42 -34.67 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.811 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.05 -43.93 41.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.953 -1.092 . . . . 0.0 110.705 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.45 -53.48 16.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.925 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 25.3 t80 -59.86 -37.21 78.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.339 -0.851 . . . . 0.0 110.118 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.74 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.52 -42.88 83.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.611 -0.68 . . . . 0.0 109.762 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -75.87 -20.72 57.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -63.93 -41.58 97.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.637 HG23 ' CB ' ' A' ' 65' ' ' PHE . 52.8 mt -60.39 -34.7 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.4 p -54.02 -52.98 59.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.985 -1.072 . . . . 0.0 110.464 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -54.73 14.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 111.78 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -72.7 -54.49 8.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.051 -1.031 . . . . 0.0 111.646 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.637 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.57 -36.11 78.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.887 . . . . 0.0 110.531 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 23.2 mtmt 70.67 79.97 0.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.662 -0.649 . . . . 0.0 110.015 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.9 t -168.24 -154.4 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.898 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.2 mt-30 -70.14 -170.03 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 110.05 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.7 m -157.33 -60.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -60.13 -70.31 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -61.86 -26.11 67.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 100' ' ' LEU . 1.9 tt -66.71 98.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 110.338 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.11 167.11 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.812 . . . . 0.0 109.951 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.006 HD23 HG11 ' A' ' 98' ' ' VAL . 5.5 mp -108.75 144.68 36.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 110.018 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 101' ' ' VAL . 47.1 mm -105.16 89.31 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.828 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 69.6 t80 -66.96 83.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.92 29.72 6.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.359 -0.838 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.04 -51.38 0.84 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 6.4 mttp -61.86 -175.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -1.046 . . . . 0.0 109.957 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -116.31 93.06 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.5 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.813 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -62.89 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.863 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.4 tttt -145.91 -153.13 0.46 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.734 -0.604 . . . . 0.0 110.169 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -72.58 -15.54 61.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.385 -0.822 . . . . 0.0 110.523 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HB3' HD13 ' A' ' 80' ' ' ILE . 44.8 tt0 -62.81 -33.14 74.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.973 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.63 168.15 19.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 p -99.06 148.92 23.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.252 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 ' HA3' ' A' ' 91' ' ' GLY . 22.0 tp -55.81 -43.58 77.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.526 HG22 HD13 ' A' ' 33' ' ' ILE . 1.2 pt -71.61 -14.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.254 -0.904 . . . . 0.0 111.604 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.37 -2.98 24.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 112.197 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -176.06 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 118.331 -1.347 . . . . 0.0 112.303 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.813 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -58.58 -50.32 68.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.8 pp -157.05 152.61 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -1.015 . . . . 0.0 109.322 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 14.5 m170 -100.8 -24.97 14.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 35.4 t70 179.96 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.622 -0.674 . . . . 0.0 109.596 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.07 73.93 0.86 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.539 ' CB ' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -117.46 176.85 4.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.248 -1.148 . . . . 0.0 110.186 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 13.4 m -115.9 147.32 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.006 HG11 HD23 ' A' ' 74' ' ' LEU . 8.5 p -138.93 146.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.75 . . . . 0.0 110.16 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.39 115.27 27.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 72' ' ' LEU . 6.7 tt -82.74 148.64 27.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.899 . . . . 0.0 110.632 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 75' ' ' ILE . 11.3 p -168.34 135.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.461 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.82 136.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.81 162.71 37.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 110.181 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -82.97 -56.66 3.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 126.86 31.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.24 -32.32 83.74 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.53 42.44 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -1.101 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.5 t -144.69 60.29 1.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.83 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -108.44 59.04 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 110.265 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.75 -162.83 47.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 141.46 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.79 1.416 . . . . 0.0 110.319 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.56 -56.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.639 1.336 . . . . 0.0 110.516 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.443 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 179.6 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 12' ' ' ARG . 46.7 Cg_endo -73.05 73.54 3.12 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.464 1.244 . . . . 0.0 110.434 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -56.98 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.404 -0.81 . . . . 0.0 110.108 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 135.65 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.29 84.73 1.35 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 162.15 41.43 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.803 1.422 . . . . 0.0 110.362 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.62 -163.89 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.65 -69.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.265 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -95.45 -169.41 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 56.72 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.336 -0.853 . . . . 0.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.16 106.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -140.19 81.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 110.228 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.02 171.71 18.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.32 88.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.385 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.81 114.77 63.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 110.185 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 -168.68 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.661 1.348 . . . . 0.0 110.504 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -118.79 112.08 19.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.201 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 52.34 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 31' ' ' LYS . 46.3 Cg_endo -71.75 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.846 1.445 . . . . 0.0 110.557 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 42.32 45.01 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -57.95 128.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.321 0.582 . . . . 0.0 111.006 -177.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.9 pt -98.4 159.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.696 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 92' ' ' ILE . 27.7 mmtm -91.45 144.08 25.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 110.533 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 HG21 ' A' ' 92' ' ' ILE . 57.6 t -137.0 113.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -90.31 102.99 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 57.8 t -98.05 127.84 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.463 -0.773 . . . . 0.0 110.12 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.44 122.45 46.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 HD22 ' A' ' 100' ' ' LEU . 66.6 p -117.1 163.81 21.54 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.9 Cg_endo -71.55 59.76 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.664 1.349 . . . . 0.0 110.581 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -175.67 -39.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 109.762 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -171.31 173.58 4.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 119.8 40.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.076 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.78 124.9 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -84.7 149.55 25.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.663 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.51 140.14 53.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.353 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -97.65 135.44 39.46 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 33' ' ' ILE . 28.1 m -143.43 143.1 22.77 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 109.018 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' CA ' HD12 ' A' ' 32' ' ' ILE . 39.4 Cg_endo -65.89 128.23 19.39 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.771 1.406 . . . . 0.0 110.825 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -38.05 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.008 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' PRO . 2.4 t30 -120.79 67.63 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.645 -1.284 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -149.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.0 110.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.809 ' HA ' HG23 ' A' ' 86' ' ' THR . 8.0 t -159.38 153.75 23.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.95 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.938 HG21 ' O ' ' A' ' 82' ' ' LYS . 48.5 t -55.92 -35.3 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 111.088 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -45.17 40.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -71.36 -49.73 39.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 43.7 t80 -62.69 -38.02 88.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.448 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.695 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -58.15 -45.22 87.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.829 . . . . 0.0 109.653 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -81.67 -18.16 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 110.194 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.1 -52.34 63.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 65' ' ' PHE . 26.5 mt -62.8 -33.65 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.345 -0.847 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -53.19 55.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.081 -1.012 . . . . 0.0 110.606 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.56 -54.56 15.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 111.797 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -54.48 8.97 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.083 -1.01 . . . . 0.0 111.633 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.22 -36.15 79.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 73.95 72.54 0.12 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.65 -0.657 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.6 p -159.06 -165.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.47 -0.768 . . . . 0.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' THR . 1.0 OUTLIER -74.74 -168.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.246 -0.909 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.77 -51.63 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.371 -0.831 . . . . 0.0 110.327 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.05 -51.94 66.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.701 ' O ' HG23 ' A' ' 73' ' ' VAL . 7.9 mt-30 -78.13 -25.57 47.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.834 HD11 HD21 ' A' ' 100' ' ' LEU . 22.0 tp -57.74 110.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 110.656 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 71' ' ' GLN . 61.9 t -129.72 151.47 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.82 . . . . 0.0 109.727 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.651 ' HB2' HD23 ' A' ' 81' ' ' LEU . 4.9 mp -111.39 122.07 46.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.109 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 75' ' ' ILE . 27.1 mm -79.84 100.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.775 ' CZ ' HD13 ' A' ' 96' ' ' LEU . 4.6 t80 -109.05 124.27 50.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 110.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.82 27.54 7.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.329 -0.857 . . . . 0.0 110.419 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.87 23.71 61.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -122.58 -167.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -1.084 . . . . 0.0 109.881 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.552 HG22 HG11 ' A' ' 73' ' ' VAL . 1.1 pp -112.13 79.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.221 -0.924 . . . . 0.0 110.499 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -61.37 89.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 108.54 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.938 ' O ' HG21 ' A' ' 54' ' ' VAL . 7.1 ttpt -155.82 -146.67 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.547 -0.72 . . . . 0.0 110.874 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.792 ' N ' HG11 ' A' ' 54' ' ' VAL . 20.0 t0 -62.48 -15.41 49.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.667 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.54 ' CG ' HD13 ' A' ' 80' ' ' ILE . 2.1 mm-40 -52.47 -30.81 31.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -159.88 162.5 34.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.387 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -76.83 134.2 39.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.583 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' HG ' HG12 ' A' ' 92' ' ' ILE . 1.9 mp -55.75 -39.2 70.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.632 HG22 HD13 ' A' ' 33' ' ' ILE . 2.4 pp -70.28 -17.88 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.141 -0.974 . . . . 0.0 109.566 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -88.78 -13.27 39.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.501 -0.749 . . . . 0.0 110.927 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.69 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.831 -1.168 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.822 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.12 -42.9 97.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 91' ' ' GLY . 3.7 mm -128.94 150.2 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -1.224 . . . . 0.0 111.004 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.69 -38.64 3.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 p30 179.88 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 116.88 69.95 0.42 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.775 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 4.9 mt -101.14 -177.18 3.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -1.151 . . . . 0.0 110.423 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.435 ' C ' HG13 ' A' ' 98' ' ' VAL . 8.0 t -128.46 142.76 50.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.435 HG13 ' C ' ' A' ' 97' ' ' THR . 34.6 m -147.52 146.22 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -90.43 119.37 30.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.908 HD22 HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -76.26 137.96 40.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 p -166.71 132.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.138 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.458 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.66 137.08 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.396 -0.815 . . . . 0.0 110.251 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 tttt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.272 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mtt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.75 63.27 1.64 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 110.186 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 53.1 -178.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.283 -0.886 . . . . 0.0 110.441 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.67 55.18 9.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.6 49.06 1.0 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -96.77 -178.16 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -1.032 . . . . 0.0 110.136 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.91 -54.26 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 110.335 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -102.99 92.03 4.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.399 -0.813 . . . . 0.0 110.42 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.68 -149.35 7.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.17 145.36 43.86 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.691 1.364 . . . . 0.0 110.187 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.05 -175.88 2.14 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.734 1.386 . . . . 0.0 110.589 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -162.05 76.15 2.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 109.965 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.58 95.55 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.821 1.432 . . . . 0.0 110.568 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 t -94.84 -37.57 11.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 90.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -0.846 . . . . 0.0 110.428 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.64 -87.72 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.59 -42.96 0.72 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.704 1.371 . . . . 0.0 110.357 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.77 76.04 8.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 0.0 110.255 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.64 164.83 11.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.74 133.78 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -81.74 -29.64 32.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.867 . . . . 0.0 110.146 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.95 -147.93 5.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 19.8 m -144.38 107.78 4.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -1.09 . . . . 0.0 110.124 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . 58.42 165.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.462 -0.774 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -168.93 87.69 0.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . 55.31 175.97 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.325 -0.859 . . . . 0.0 110.381 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 46.1 Cg_endo -72.76 63.92 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.741 1.39 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.607 ' HB1' ' ND2' ' A' ' 51' ' ' ASN . . . -165.7 140.16 4.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 1.9 tt0 -112.91 153.56 45.17 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.859 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.825 ' O ' HD12 ' A' ' 32' ' ' ILE . 50.3 Cg_endo -79.2 41.21 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.776 1.408 . . . . 0.0 111.253 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 33' ' ' ILE . 4.4 mmtt -72.43 67.01 0.71 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.825 HD12 ' O ' ' A' ' 30' ' ' PRO . 1.1 mp -58.23 120.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.681 -0.637 . . . . 0.0 110.557 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.942 HD12 HD11 ' A' ' 92' ' ' ILE . 1.6 pt -107.39 159.57 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -91.75 144.21 25.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.818 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG22 HD23 ' A' ' 87' ' ' LEU . 39.1 t -132.07 113.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.438 -0.789 . . . . 0.0 109.856 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.4 m -98.26 114.67 27.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.309 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.45 127.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.85 . . . . 0.0 110.138 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -92.86 122.55 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.581 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.845 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -121.86 172.43 5.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 110.176 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.8 Cg_endo -68.68 -8.27 22.84 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.69 1.363 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.7 tptm -101.46 -50.55 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 1.8 mt-10 -170.57 -161.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.556 -0.715 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.4 135.98 53.49 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -135.3 135.45 40.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.168 -0.958 . . . . 0.0 110.785 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 1.3 mp0 -92.14 145.75 24.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.45 -0.781 . . . . 0.0 109.75 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -128.29 124.88 37.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.948 . . . . 0.0 110.396 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -90.85 129.22 36.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 108.963 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.5 m -143.27 155.68 61.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.056 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -69.98 122.14 8.76 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.833 1.438 . . . . 0.0 110.409 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.872 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -25.83 -48.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.1 0.476 . . . . 0.0 111.597 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.607 ' ND2' ' HB1' ' A' ' 28' ' ' ALA . 14.6 p-10 -86.25 52.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 t -109.13 111.48 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -64.07 144.19 57.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.949 HG11 ' HA ' ' A' ' 82' ' ' LYS . 85.4 t -59.12 -35.02 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.41 -44.51 35.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.015 -1.053 . . . . 0.0 110.479 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.32 -49.75 52.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.13 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 35' ' ' VAL . 7.0 t80 -63.21 -37.52 87.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.442 -0.786 . . . . 0.0 110.41 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.09 -39.54 78.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.4 -23.1 60.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.49 -0.757 . . . . 0.0 110.278 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.89 81.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.184 -0.948 . . . . 0.0 109.992 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -34.95 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 110.174 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 66' ' ' LYS . 27.1 p -59.41 -43.91 92.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -58.77 -49.55 77.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.267 -0.896 . . . . 0.0 111.014 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -53.11 15.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.156 -0.965 . . . . 0.0 110.828 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 39' ' ' THR . 23.8 m-85 -67.54 -37.08 82.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 0.0 110.23 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' SER . 5.4 tttt 63.76 79.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.446 -0.784 . . . . 0.0 110.138 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 t -155.43 -62.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.592 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.3 pt20 -168.52 -165.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 110.137 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -155.11 -44.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.863 . . . . 0.0 110.382 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -58.34 -62.49 1.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.839 ' O ' HG23 ' A' ' 73' ' ' VAL . 19.3 mt-30 -70.84 -25.75 62.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.805 . . . . 0.0 110.041 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.848 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -55.76 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 0.0 110.396 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.862 HG22 ' HD2' ' A' ' 82' ' ' LYS . 40.3 t -124.68 167.77 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.797 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -124.44 118.86 27.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 79' ' ' LYS . 5.5 tp -82.93 104.85 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.729 ' CD1' HG12 ' A' ' 98' ' ' VAL . 15.1 t80 -116.02 136.19 53.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 110.32 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.3 26.73 4.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.374 -0.829 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.67 24.4 70.17 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -125.83 -169.77 2.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.41 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -104.96 82.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.85 HD21 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -62.92 92.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.994 -1.067 . . . . 0.0 108.584 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.949 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.0 ttpt -153.95 -143.29 0.13 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.362 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 34.8 p-10 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -53.7 -32.84 53.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.864 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -147.88 163.67 36.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.582 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -87.19 158.7 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.85 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -66.42 -46.55 76.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.872 HG21 ' HG2' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -63.31 -17.49 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.045 . . . . 0.0 109.985 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.04 -15.41 24.82 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 110.884 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.83 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.897 -1.127 . . . . 0.0 111.947 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.75 -50.15 70.35 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.942 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -152.19 160.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -1.008 . . . . 0.0 108.873 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.7 OUTLIER -110.27 -28.31 8.67 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.4 t70 -179.09 36.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.562 -0.711 . . . . 0.0 110.026 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.16 69.89 0.51 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.24 173.37 6.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.402 -1.057 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.4 p -111.86 130.77 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 110.105 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 81' ' ' LEU . 34.2 m -127.41 150.35 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.766 ' O ' HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -90.78 133.75 34.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.106 -0.996 . . . . 0.0 110.03 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.848 HD11 HD21 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -86.92 134.67 33.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.242 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.7 p -149.41 125.78 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.4 pp -96.47 131.78 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.336 -0.852 . . . . 0.0 110.185 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.223 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ttp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.198 0.523 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.83 -43.28 10.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -162.99 164.47 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -133.77 32.55 3.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 110.274 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.18 77.42 0.34 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 51.88 -175.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.386 -1.067 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.37 -165.75 1.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.37 -0.831 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -118.55 27.1 9.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.308 -0.87 . . . . 0.0 110.322 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.3 159.19 32.06 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 148.05 43.04 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.906 1.477 . . . . 0.0 110.403 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.01 157.75 46.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.677 1.356 . . . . 0.0 110.385 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.08 137.39 6.21 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.77 100.12 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.655 1.345 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 86.0 p -84.16 116.47 22.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -94.48 -73.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.844 . . . . 0.0 110.279 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.85 91.22 0.08 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.15 81.76 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.632 1.333 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.2 96.7 5.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.435 -0.791 . . . . 0.0 110.247 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.66 81.69 5.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.142 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.43 45.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 110.22 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.62 -172.67 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.72 134.86 7.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -154.71 33.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -1.107 . . . . 0.0 110.235 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.07 162.02 35.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.08 56.02 0.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.8 113.64 41.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.65 126.22 11.26 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.561 1.295 . . . . 0.0 110.398 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.23 -166.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -136.13 64.44 54.37 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.81 ' O ' HD12 ' A' ' 32' ' ' ILE . 51.2 Cg_endo -82.77 30.0 0.54 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 0.0 111.293 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -70.6 66.3 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.0 mp -58.71 118.2 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.701 -0.624 . . . . 0.0 110.56 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 pt -93.55 147.17 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -91.47 144.8 25.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 110.114 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 46' ' ' PHE . 14.0 m -140.81 136.49 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -107.7 117.37 33.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 0.0 110.214 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 44' ' ' GLU . 33.6 m -98.3 130.7 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.828 . . . . 0.0 110.249 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 122.67 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 110.0 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.916 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.1 p -127.09 166.16 24.4 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.11 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.49 61.12 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.728 1.383 . . . . 0.0 110.374 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.29 -47.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.13 -177.94 2.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.262 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -117.33 136.63 52.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.847 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -135.09 128.01 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.64 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 2.0 mp0 -84.05 149.5 26.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 109.796 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.1 m-85 -129.75 124.16 32.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.67 125.83 35.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.195 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.21 151.57 55.6 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.22 -0.925 . . . . 0.0 109.888 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -69.23 121.71 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.915 1.482 . . . . 0.0 110.743 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -27.89 -46.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.244 0.545 . . . . 0.0 111.566 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.76 52.38 2.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 17.8 t -112.81 124.5 52.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -0.817 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 m -71.19 144.55 50.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.9 t -62.43 -34.55 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.939 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -48.24 -44.07 32.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 110.873 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -53.77 21.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.009 . . . . 0.0 110.0 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.84 -37.27 78.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.487 -0.758 . . . . 0.0 110.255 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.637 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.76 -39.77 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.601 -0.687 . . . . 0.0 110.01 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -75.04 -21.89 58.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 110.318 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.94 82.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.965 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 ' CG1' ' CE2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -63.87 -33.2 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.718 . . . . 0.0 110.225 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 t -64.03 -43.95 94.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.452 -0.78 . . . . 0.0 110.509 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.91 -50.66 72.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.863 . . . . 0.0 110.936 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -69.61 -53.01 20.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.916 ' CE2' HG21 ' A' ' 39' ' ' THR . 15.1 m-30 -67.46 -37.06 82.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.17 78.16 0.3 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.332 -0.855 . . . . 0.0 109.971 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 p -156.1 -66.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.744 . . . . 0.0 110.105 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.42 -175.03 3.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.793 . . . . 0.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -154.78 -40.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.09 -64.57 0.8 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.596 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.787 ' O ' HG13 ' A' ' 73' ' ' VAL . 88.7 mm-40 -78.48 -25.78 45.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 100' ' ' LEU . 5.7 tt -56.86 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.395 -0.816 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.807 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.0 m -109.76 163.12 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.5 mp -112.21 118.98 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.037 -1.039 . . . . 0.0 109.198 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 77' ' ' ALA . 50.1 mm -78.27 103.19 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 110.628 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.6 t80 -69.83 65.78 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.557 -0.714 . . . . 0.0 110.003 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 53.74 24.26 4.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.244 -0.91 . . . . 0.0 110.409 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.87 -47.16 0.82 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -161.43 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.326 -1.102 . . . . 0.0 110.274 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.89 85.23 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.397 -0.814 . . . . 0.0 110.423 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 3.3 tt -61.84 93.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.921 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.3 ttpm? -159.16 -150.08 0.23 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.639 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 9.0 p-10 -73.0 -19.22 61.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.527 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -52.81 -32.44 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 109.896 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -151.39 150.4 30.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.33 151.41 44.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.768 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.677 HD23 HG11 ' A' ' 35' ' ' VAL . 1.1 mp -59.17 -46.08 89.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.2 pp -63.48 -18.42 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.788 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 50.8 tt0 -91.2 -16.52 27.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.2 OUTLIER 177.97 -27.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.95 -1.094 . . . . 0.0 111.799 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.655 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.66 -50.22 69.4 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 33' ' ' ILE . 2.8 pp -148.12 175.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.231 -1.158 . . . . 0.0 109.143 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 3.1 m170 -123.45 -36.09 2.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 110.13 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 37.4 t70 -179.76 36.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 122.08 65.6 0.23 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 168.9 9.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -1.099 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -112.19 134.71 53.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 14.6 p -123.97 157.61 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.34 139.48 30.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -105.49 122.3 45.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 100' ' ' LEU . 87.9 t -148.68 129.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.427 HG13 ' CB ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -107.17 132.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 109.911 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.248 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tpp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.11 0.481 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.19 162.96 28.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.386 -0.821 . . . . 0.0 110.153 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.67 -42.78 1.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.243 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -67.87 95.38 0.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.233 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.03 156.57 28.57 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -92.09 -172.79 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -1.04 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 t -128.68 -41.09 1.52 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.0 p -59.42 142.76 51.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.314 -0.866 . . . . 0.0 110.282 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.05 88.47 1.9 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.55 135.12 23.57 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.691 1.364 . . . . 0.0 110.469 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 -161.78 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.683 1.359 . . . . 0.0 110.272 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -52.12 -55.43 31.18 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 46.4 Cg_endo -73.64 175.55 10.56 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.587 1.309 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -145.48 156.92 44.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 51.96 -170.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.426 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.9 132.49 11.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.98 62.76 4.97 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.531 1.279 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.97 117.86 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.24 21.53 11.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.29 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.49 83.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -118.0 -72.4 0.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.249 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.46 -134.02 11.98 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -145.63 105.37 3.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.396 -1.061 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.15 -160.23 0.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.49 -27.63 14.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 110.253 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -143.67 174.35 3.66 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.751 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 46.6 Cg_endo -72.72 179.58 5.1 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.821 1.432 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.97 76.13 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -130.5 148.43 69.93 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.315 -0.866 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.0 Cg_endo -72.68 -92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.736 1.388 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 30' ' ' PRO . 9.3 mmtt 44.97 42.28 6.14 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.7 mp -58.28 100.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.222 0.534 . . . . 0.0 110.791 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 92' ' ' ILE . 5.2 pt -81.62 161.03 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.331 -0.855 . . . . 0.0 109.872 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.54 144.36 31.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.336 -0.853 . . . . 0.0 110.52 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 92' ' ' ILE . 8.4 p -137.59 114.11 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.0 109.992 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.748 HG23 ' OE1' ' A' ' 45' ' ' GLU . 3.2 m -80.92 110.28 16.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.98 127.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.455 -0.778 . . . . 0.0 110.051 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -108.85 122.54 47.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.794 HG22 HD13 ' A' ' 100' ' ' LEU . 23.1 p -126.84 166.81 20.01 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 109.836 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.04 -12.27 33.83 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.698 1.368 . . . . 0.0 110.57 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -40.76 10.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -172.35 -173.14 1.02 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.72 114.92 14.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.771 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -135.34 135.5 40.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.826 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -78.82 151.41 31.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.476 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.68 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.6 m-85 -126.09 116.16 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 110.684 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.48 123.38 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 0.0 108.935 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.7 m -143.21 155.06 61.75 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.144 -0.972 . . . . 0.0 110.006 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -68.72 122.52 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.967 1.509 . . . . 0.0 110.836 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.555 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -30.0 -44.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.871 0.367 . . . . 0.0 111.858 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 49' ' ' PRO . 51.5 p-10 -78.33 43.4 0.46 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.023 -1.048 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -111.56 100.69 9.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.136 -0.977 . . . . 0.0 110.016 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -62.22 164.45 6.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.146 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.948 HG21 ' O ' ' A' ' 82' ' ' LYS . 42.5 t -67.78 -35.32 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.824 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.48 -43.42 34.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.637 -1.29 . . . . 0.0 109.926 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -80.75 -37.47 30.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.326 -0.858 . . . . 0.0 110.361 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 35.4 t80 -70.08 -51.18 33.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.53 -42.32 82.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 109.738 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.494 ' HA ' HG23 ' A' ' 69' ' ' THR . 8.7 mt-10 -65.9 -25.85 67.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 109.917 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.22 -44.65 79.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 13.7 mt -60.85 -39.67 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.0 109.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.608 ' CB ' ' HG1' ' A' ' 69' ' ' THR . 3.1 m -53.57 -53.05 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.016 -1.053 . . . . 0.0 110.597 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -68.5 -53.92 20.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.331 -0.855 . . . . 0.0 111.655 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.86 -54.11 11.12 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.029 -1.044 . . . . 0.0 111.475 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -68.03 -36.61 80.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.223 -0.923 . . . . 0.0 110.21 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tptt 68.53 81.33 0.18 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -159.92 -71.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.778 . . . . 0.0 110.07 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.8 -170.14 3.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.608 ' HG1' ' CB ' ' A' ' 62' ' ' SER . 4.1 m -153.63 -48.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.377 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.21 -67.23 0.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 73' ' ' VAL . 51.6 mt-30 -61.19 -25.71 67.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.396 -0.815 . . . . 0.0 110.376 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 102' ' ' ILE . 10.3 tp -61.86 108.4 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.534 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 71' ' ' GLN . 90.7 t -127.86 156.85 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.617 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 100' ' ' LEU . 10.3 mt -113.51 142.79 45.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.224 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.552 ' C ' HG23 ' A' ' 98' ' ' VAL . 49.7 mm -104.94 89.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.426 -0.796 . . . . 0.0 110.385 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HZ ' HD22 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -78.09 83.54 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.06 63.13 2.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.631 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.22 -52.11 3.78 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -59.81 174.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -1.071 . . . . 0.0 110.23 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.14 99.23 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.836 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CA ' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -65.9 79.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.948 ' O ' HG21 ' A' ' 54' ' ' VAL . 8.6 tttt -146.21 -162.31 1.5 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.592 -0.693 . . . . 0.0 110.761 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 29.8 t70 -70.77 -14.26 62.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.649 -0.657 . . . . 0.0 110.298 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.432 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.2 mm-40 -52.06 -31.22 29.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.801 . . . . 0.0 109.756 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -147.87 -176.04 5.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.416 -0.802 . . . . 0.0 109.969 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 88' ' ' ILE . 73.4 p -102.69 157.04 17.22 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.069 -1.02 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 92' ' ' ILE . 6.2 mp -66.18 -29.73 70.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.641 HD12 ' HB ' ' A' ' 86' ' ' THR . 2.3 mt -66.0 -19.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.153 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 4.9 tp60 -105.7 -10.09 16.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 112.012 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 178.03 -26.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.554 -1.341 . . . . 0.0 111.525 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.74 -37.73 90.53 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.74 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 91' ' ' GLY . 1.4 mm -139.49 175.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -1.147 . . . . 0.0 110.085 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.69 ' HB2' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -147.03 -48.6 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.64 35.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.846 -0.533 . . . . 0.0 109.868 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.25 68.29 0.67 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 93' ' ' HIS . 4.8 mp -115.25 175.78 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -1.158 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 5.0 m -114.66 147.04 40.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 75' ' ' ILE . 5.4 p -139.23 148.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -90.96 115.92 28.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 39' ' ' THR . 2.8 tt -79.24 150.07 31.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.17 -0.956 . . . . 0.0 110.537 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 75' ' ' ILE . 9.6 p -169.01 125.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.05 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.798 HG22 HD12 ' A' ' 72' ' ' LEU . 2.5 pp -79.07 132.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 110.192 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.107 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.156 0.503 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.7 -75.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.299 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 52.66 83.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.317 -0.864 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -85.59 124.96 32.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.7 -112.07 0.99 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -137.67 104.03 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.362 -1.081 . . . . 0.0 110.202 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 m -115.86 39.36 3.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.45 -0.781 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.85 91.16 1.84 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.61 -152.9 0.09 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.61 165.02 33.9 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.728 1.383 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.07 -52.63 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.87 113.34 44.73 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.15 157.72 50.11 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.503 1.265 . . . . 0.0 110.461 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.4 p -150.54 -58.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.129 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 -69.45 0.85 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.323 -0.86 . . . . 0.0 110.143 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.5 -153.95 16.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.91 -50.6 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.761 1.4 . . . . 0.0 110.405 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.2 -171.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.321 -0.862 . . . . 0.0 110.441 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.26 63.14 2.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.34 -0.85 . . . . 0.0 110.548 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.65 93.49 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.179 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -147.36 -70.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.828 . . . . 0.0 110.263 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.03 -88.05 1.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -82.01 75.98 8.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -1.083 . . . . 0.0 110.194 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.19 68.6 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 0.0 110.202 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.64 144.03 31.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.81 83.85 1.33 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 104.64 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.813 1.428 . . . . 0.0 110.375 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.65 53.41 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -0.831 . . . . 0.0 110.318 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -117.25 90.16 33.2 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' LYS . 48.1 Cg_endo -72.12 -93.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.763 1.402 . . . . 0.0 110.565 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 mttp 44.05 48.26 7.4 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.6 mp -57.47 117.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.814 -0.554 . . . . 0.0 110.813 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.706 HG12 HG23 ' A' ' 48' ' ' VAL . 13.1 pt -84.9 157.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.827 . . . . 0.0 109.727 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 92' ' ' ILE . 6.8 mtmt -91.23 143.5 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 92' ' ' ILE . 59.0 t -129.36 113.79 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.479 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.3 m -85.92 98.55 10.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 0.0 109.643 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 98' ' ' VAL . 57.4 t -94.56 127.66 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 110.223 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.86 122.34 46.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.751 HG22 HD13 ' A' ' 100' ' ' LEU . 39.5 p -119.9 164.39 22.51 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 44.1 Cg_endo -71.31 60.85 2.59 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.61 1.321 . . . . 0.0 110.446 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -175.21 -42.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.58 176.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.387 -0.82 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -110.86 126.49 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 109.984 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -135.21 131.2 36.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.71 147.72 25.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.81 . . . . 0.0 109.833 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.15 144.93 48.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 110.281 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -100.25 133.2 45.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.048 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 33' ' ' ILE . 33.2 m -143.6 143.12 22.51 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.234 -0.916 . . . . 0.0 108.853 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' ASN . 41.3 Cg_endo -68.22 127.98 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.622 1.328 . . . . 0.0 111.262 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.572 ' O ' HD13 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -38.46 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.026 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 49' ' ' PRO . 31.7 t30 -113.36 61.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.772 -1.205 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -154.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.802 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 m -160.43 160.95 32.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.238 -0.914 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.897 HG21 ' O ' ' A' ' 82' ' ' LYS . 59.7 t -61.08 -34.95 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.506 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -49.18 -46.79 45.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.682 -1.261 . . . . 0.0 109.849 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -78.01 -44.56 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 110.353 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' HD22 ' A' ' 87' ' ' LEU . 66.1 t80 -63.65 -51.42 65.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.867 . . . . 0.0 110.308 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.98 -31.74 67.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 110.037 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -23.43 35.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.2 82.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.342 -0.849 . . . . 0.0 110.186 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 4.7 mt -61.01 -36.96 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.6 p -53.85 -49.31 68.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.064 -1.022 . . . . 0.0 110.709 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -68.14 -54.21 19.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 111.521 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -54.09 10.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.092 -1.005 . . . . 0.0 111.406 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.16 -36.4 79.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.29 -0.881 . . . . 0.0 110.427 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER 71.79 80.62 0.15 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.535 -0.728 . . . . 0.0 110.094 -179.503 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.59 -164.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.493 -0.755 . . . . 0.0 109.951 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.39 173.87 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -139.46 -52.67 0.54 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.52 -61.36 2.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.171 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 73' ' ' VAL . 13.7 mt-30 -61.15 -25.37 66.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 110.133 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.29 108.01 0.22 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.419 -0.801 . . . . 0.0 110.779 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' HD2' ' A' ' 82' ' ' LYS . 65.7 t -127.49 137.07 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.4 155.94 19.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.927 -1.108 . . . . 0.0 109.701 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.23 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.961 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 77' ' ' ALA . 48.3 t80 -69.78 70.64 0.33 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.261 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PHE . . . 28.68 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.895 -0.503 . . . . 0.0 112.283 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.58 -60.41 0.34 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.09 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.631 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -105.66 -160.81 0.77 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -1.174 . . . . 0.0 110.421 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.631 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -107.36 111.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.275 -0.89 . . . . 0.0 109.994 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -69.73 74.65 0.42 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.913 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -130.29 -159.23 0.95 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.37 0.605 . . . . 0.0 109.782 -178.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.1 p-10 -73.32 -13.8 61.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -51.95 -32.53 33.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -174.77 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 110.008 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.38 136.88 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.719 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 57' ' ' PHE . 19.1 tp -55.66 -47.84 76.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.185 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.6 pp -73.74 -15.17 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 111.151 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' THR . 23.3 tt0 -104.71 7.64 34.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.133 -0.98 . . . . 0.0 112.116 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.55 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.634 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.985 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.37 -41.7 97.09 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 91' ' ' GLY . 6.2 mm -135.85 131.76 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -1.059 . . . . 0.0 110.7 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 64.7 m170 -96.52 -38.92 9.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.893 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 25.3 t0 -178.44 34.37 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.749 -0.594 . . . . 0.0 109.673 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 112.53 68.12 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -1.134 . . . . 0.0 110.114 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.6 m -111.45 144.47 40.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.505 -0.747 . . . . 0.0 109.844 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 36' ' ' THR . 13.9 m -137.61 136.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.29 115.38 27.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.296 -0.877 . . . . 0.0 110.077 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 HG22 ' A' ' 39' ' ' THR . 3.0 tt -83.2 133.58 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.303 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.7 p -162.39 117.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.56 137.01 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.309 -0.869 . . . . 0.0 110.185 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.5 mp -58.04 99.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.621 -0.674 . . . . 0.0 110.692 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.2 pt -78.74 146.29 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.123 -0.986 . . . . 0.0 109.353 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 25.5 mttp -91.44 132.76 36.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 46' ' ' PHE . 6.1 p -123.13 114.25 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 m -86.25 108.09 18.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 61.9 t -102.27 128.38 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.283 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -97.26 122.73 40.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.393 -0.817 . . . . 0.0 109.838 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 100' ' ' LEU . 2.3 p -120.67 168.03 11.59 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.269 -0.895 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.6 Cg_endo -70.54 62.44 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.679 1.357 . . . . 0.0 110.238 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.67 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.6 -179.2 1.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.418 -0.801 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -105.61 115.31 30.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 134.04 54.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.58 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.5 151.53 19.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 0.0 109.714 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.2 m-85 -126.45 150.1 48.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.458 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -102.16 133.43 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 33' ' ' ILE . 28.4 m -143.93 147.62 38.99 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.092 -1.005 . . . . 0.0 109.452 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.8 Cg_endo -67.24 126.29 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.76 1.4 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 88' ' ' ILE . 10.1 tt0 -42.45 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.93 -0.481 . . . . 0.0 111.769 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' PRO . 8.3 p-10 -115.01 63.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.601 -1.312 . . . . 0.0 110.378 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 154.99 47.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.129 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -98.8 156.46 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.364 -0.835 . . . . 0.0 109.853 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 82' ' ' LYS . 88.3 t -60.94 -34.34 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 110.699 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.54 -44.11 36.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.051 -1.031 . . . . 0.0 110.627 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -51.65 32.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.904 . . . . 0.0 109.915 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 71.5 t80 -59.88 -37.07 78.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.413 -0.804 . . . . 0.0 110.129 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 54' ' ' VAL . 2.1 mtpt -57.64 -46.05 84.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.516 -0.74 . . . . 0.0 109.8 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.25 -19.63 61.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.769 . . . . 0.0 110.167 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -65.72 -52.27 52.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.26 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.8 mt -63.74 -41.91 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.297 -0.877 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -53.71 -52.01 61.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.63 -53.94 19.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.286 -0.884 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.17 -54.27 10.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.121 -0.987 . . . . 0.0 111.454 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.01 -36.47 80.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.176 -0.953 . . . . 0.0 110.181 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 16.4 ttpt 68.72 81.3 0.18 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 110.224 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -152.98 -65.4 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.5 -0.75 . . . . 0.0 110.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -167.93 -176.95 3.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -145.95 -63.91 0.32 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.86 -63.58 1.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.923 . . . . 0.0 110.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.82 -25.46 65.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -61.33 125.2 22.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.822 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 82' ' ' LYS . 91.7 t -150.08 167.79 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 109.194 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.752 HD12 HG23 ' A' ' 98' ' ' VAL . 1.2 mm? -118.33 135.88 54.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.037 -1.04 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 101' ' ' VAL . 46.8 mm -97.19 96.91 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.42 -0.8 . . . . 0.0 109.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.847 ' CB ' HD13 ' A' ' 81' ' ' LEU . 9.3 t80 -95.31 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 110.232 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.49 35.86 18.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.403 -0.81 . . . . 0.0 110.697 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.01 -40.18 2.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -178.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.203 -1.175 . . . . 0.0 110.047 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.13 94.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.695 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.98 HD11 ' CA ' ' A' ' 91' ' ' GLY . 1.6 tp -65.07 81.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.741 ' O ' HG21 ' A' ' 54' ' ' VAL . 3.5 ttmt -137.98 -155.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.339 0.59 . . . . 0.0 110.364 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.84 -19.63 61.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 0.0 110.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.7 -32.81 53.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.852 . . . . 0.0 109.807 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -133.59 -175.45 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 109.972 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -105.84 130.36 53.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.96 . . . . 0.0 109.932 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 14.1 tp -55.42 -46.91 76.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.759 . . . . 0.0 110.26 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.5 pp -72.76 -14.98 17.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 110.472 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 53.5 tp60 -88.18 -10.83 48.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 112.062 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.35 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.45 -1.407 . . . . 0.0 111.574 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.98 ' CA ' HD11 ' A' ' 81' ' ' LEU . . . -58.97 -41.73 96.5 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.189 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 91' ' ' GLY . 4.0 mm -134.3 113.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -1.157 . . . . 0.0 111.023 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -87.11 -33.61 19.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 108.881 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.7 t70 -179.97 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.736 -0.603 . . . . 0.0 110.015 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 128.42 69.76 0.14 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 6.0 mt -108.83 162.64 14.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -1.211 . . . . 0.0 110.129 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.8 p -112.16 134.52 53.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.313 -0.867 . . . . 0.0 110.274 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.853 HG11 HD22 ' A' ' 81' ' ' LEU . 27.5 m -140.64 151.93 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.437 -0.789 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.688 ' O ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 110.382 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 39' ' ' THR . 8.2 tt -101.15 127.88 47.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.454 HG22 HG12 ' A' ' 75' ' ' ILE . 34.0 m -141.99 143.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.341 -0.849 . . . . 0.0 110.37 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mttt . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.51 124.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.734 -0.604 . . . . 0.0 110.724 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' A' ' 92' ' ' ILE . 18.0 pt -108.19 158.87 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.759 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 144.37 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 46' ' ' PHE . 9.0 p -134.81 113.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.7 m -79.21 105.22 10.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.41 127.88 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.825 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -112.88 122.28 47.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.516 HG22 ' HG ' ' A' ' 100' ' ' LEU . 18.1 p -122.46 166.07 18.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 109.851 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.1 Cg_endo -70.72 61.23 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.648 1.341 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.61 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.469 -0.77 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -169.65 166.98 9.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 118.6 29.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.33 135.55 40.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.898 . . . . 0.0 110.556 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.47 150.23 36.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.649 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.777 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.7 m-85 -120.38 108.89 14.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.532 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.63 105.22 13.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 0.0 109.503 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.53 157.05 79.23 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.363 -0.836 . . . . 0.0 110.711 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.61 108.42 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.793 1.417 . . . . 0.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 11.7 pt-20 -51.12 -25.49 5.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.492 -0.755 . . . . 0.0 110.741 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -53.6 -23.95 12.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 110.556 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.07 140.63 30.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.885 . . . . 0.0 110.462 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.1 m -70.82 171.83 9.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.6 t -66.8 -35.75 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -42.78 31.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.054 -1.029 . . . . 0.0 110.108 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.4 -46.07 64.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.615 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 84.2 t80 -69.92 -38.36 76.23 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.218 -0.927 . . . . 0.0 110.626 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.74 -45.18 86.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 69' ' ' THR . 17.8 tt0 -74.63 -16.7 60.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.893 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.11 -44.65 79.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.297 -0.877 . . . . 0.0 109.932 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.2 mt -60.87 -37.94 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.654 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 29.1 t -53.94 -46.3 71.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.915 . . . . 0.0 110.78 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -67.89 -54.76 16.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 111.44 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.79 -54.08 9.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.122 -0.987 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.38 -36.25 78.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.381 -0.824 . . . . 0.0 110.551 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 69.33 81.69 0.17 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.574 -0.704 . . . . 0.0 110.03 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -155.04 -75.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.554 -0.716 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -161.0 179.46 8.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 59' ' ' GLU . 62.2 m -139.99 -62.01 0.52 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.443 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.5 -66.69 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 0.0 110.32 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.63 -25.71 64.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.288 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 100' ' ' LEU . 11.5 tp -59.91 133.61 56.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.475 -0.766 . . . . 0.0 110.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.479 HG23 ' C ' ' A' ' 72' ' ' LEU . 78.1 t -152.53 158.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.418 -0.801 . . . . 0.0 109.28 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.1 mp -121.15 122.02 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.232 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 75' ' ' ILE . 25.4 mm -78.8 103.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.045 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.827 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.5 t80 -112.14 120.14 40.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.506 -0.746 . . . . 0.0 110.076 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.69 29.31 17.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.62 59.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -172.7 2.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -1.085 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.507 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -103.27 82.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 110.363 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.1 tt -66.43 83.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.242 -0.911 . . . . 0.0 108.645 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -148.96 -147.07 0.21 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.557 -0.715 . . . . 0.0 110.253 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.52 -14.36 61.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 111.315 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.449 ' HB3' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -52.15 -33.62 41.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.585 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -176.63 4.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 143.86 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 109.882 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.995 HD11 HD11 ' A' ' 92' ' ' ILE . 11.6 tp -56.23 -46.14 79.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.496 -0.752 . . . . 0.0 110.672 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.62 -8.27 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.411 -0.806 . . . . 0.0 111.095 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 14.3 mt-30 -110.08 -1.2 17.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.954 -1.092 . . . . 0.0 112.028 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 176.54 -30.78 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.589 -1.32 . . . . 0.0 111.807 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.26 -47.68 88.06 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.543 -1.313 . . . . 0.0 109.919 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -144.42 161.95 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.273 -1.134 . . . . 0.0 110.183 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -122.64 -41.74 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.539 -0.726 . . . . 0.0 109.359 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.71 35.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.028 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.77 67.75 0.53 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' ' 96' ' ' LEU . 4.3 mm? -103.98 175.81 5.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 97' ' ' THR . 9.7 t -111.95 121.32 44.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.765 . . . . 0.0 110.082 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 81' ' ' LEU . 33.7 m -125.94 149.23 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 110.378 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.446 -0.784 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -92.98 120.12 32.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.373 -0.83 . . . . 0.0 110.019 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.533 ' N ' HD13 ' A' ' 100' ' ' LEU . 32.8 m -148.72 156.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.3 mm -58.47 124.15 11.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.705 -0.622 . . . . 0.0 110.85 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 88' ' ' ILE . 8.6 pt -106.77 149.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 0.0 109.522 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -91.8 144.23 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 110.647 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 92' ' ' ILE . 14.8 m -132.92 130.38 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 109.583 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.17 110.25 22.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' HD12 ' A' ' 100' ' ' LEU . 58.7 t -96.47 127.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 122.83 47.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -125.73 169.74 10.83 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.301 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.94 60.51 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.702 1.369 . . . . 0.0 110.372 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.7 -46.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.316 -0.865 . . . . 0.0 109.812 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -173.19 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.101 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -123.12 129.82 51.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -135.12 127.63 30.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -84.86 147.73 26.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.397 -0.815 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.8 m-85 -125.08 145.84 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.533 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.35 132.13 45.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.0 108.991 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.5 m -143.16 148.83 46.41 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.975 . . . . 0.0 110.266 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 32' ' ' ILE . 40.5 Cg_endo -71.08 119.43 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.705 1.371 . . . . 0.0 110.418 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -32.73 -41.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.223 0.535 . . . . 0.0 111.642 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -83.88 50.97 1.93 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.051 -1.03 . . . . 0.0 110.571 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 51.4 p -126.21 112.77 16.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.29 156.86 21.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -63.02 -35.4 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.197 -0.94 . . . . 0.0 110.913 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -49.31 -50.15 40.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.123 -0.985 . . . . 0.0 111.055 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.0 -55.27 27.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.99 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 35' ' ' VAL . 51.3 t80 -59.91 -36.57 77.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.457 -0.777 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -57.15 -36.74 71.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 0.0 110.386 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -79.05 -24.47 43.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.61 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 0.0 109.573 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.61 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.8 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.807 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -66.45 -44.55 82.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 110.625 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -58.85 -53.12 61.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.253 -0.904 . . . . 0.0 110.952 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -52.68 63.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.688 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 39' ' ' THR . 10.5 m-85 -67.5 -36.91 82.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 0.0 110.445 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.91 79.52 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.469 -0.769 . . . . 0.0 110.091 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 t -153.92 -71.08 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.38 -0.825 . . . . 0.0 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.647 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -151.87 -171.57 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.174 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.0 m -153.51 -57.79 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.36 -0.837 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.49 -70.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.322 -0.861 . . . . 0.0 110.413 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.879 ' O ' HG23 ' A' ' 73' ' ' VAL . 6.2 mt-30 -60.76 -25.53 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.698 ' HA ' HG22 ' A' ' 102' ' ' ILE . 1.2 tt -52.93 106.46 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 110.763 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.972 HG22 ' HD2' ' A' ' 82' ' ' LYS . 51.0 t -127.14 151.18 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.651 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.756 HD23 HG11 ' A' ' 98' ' ' VAL . 5.0 mp -102.04 146.2 28.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 75' ' ' ILE . 29.9 mm -107.76 83.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.45 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.844 ' HB2' HD12 ' A' ' 81' ' ' LEU . 3.2 t80 -98.84 124.04 43.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.386 -0.821 . . . . 0.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.07 26.35 6.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.37 -0.831 . . . . 0.0 110.556 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.32 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 1.2 tttm -129.48 136.54 50.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -1.09 . . . . 0.0 110.061 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.784 ' O ' HD12 ' A' ' 80' ' ' ILE . 1.4 pp -59.68 88.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.816 . . . . 0.0 111.351 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.3 tt -66.79 86.87 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.972 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.5 OUTLIER -140.34 -149.74 0.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.01 -177.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -74.1 -20.71 60.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.698 . . . . 0.0 110.834 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -52.7 -32.75 44.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.103 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.91 140.21 46.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 147.94 33.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.541 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 92' ' ' ILE . 13.8 tp -57.59 -48.52 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.705 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.756 HG22 HD13 ' A' ' 33' ' ' ILE . 1.8 pp -73.04 -13.7 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.051 -1.031 . . . . 0.0 110.367 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.73 -15.09 46.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 111.542 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 79' ' ' LYS . 4.9 t-80 -171.69 -38.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.624 -1.297 . . . . 0.0 111.431 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.839 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -59.44 -49.67 76.01 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.386 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -142.26 146.37 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -1.232 . . . . 0.0 110.808 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 13.1 m170 -109.76 -35.49 6.17 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.5 t0 -177.68 31.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.29 0.567 . . . . 0.0 109.861 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.4 69.33 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 92' ' ' ILE . 84.1 mt -109.17 174.22 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -1.223 . . . . 0.0 109.966 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.8 p -115.84 147.25 41.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.756 HG11 HD23 ' A' ' 74' ' ' LEU . 7.6 p -147.68 146.14 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.402 -0.811 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -90.63 116.15 28.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.489 -0.757 . . . . 0.0 110.118 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 72' ' ' LEU . 5.7 tt -74.17 121.28 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.306 -0.871 . . . . 0.0 110.13 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 100' ' ' LEU . 58.0 t -145.95 131.85 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.386 -0.821 . . . . 0.0 110.106 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.698 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.819 . . . . 0.0 110.218 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.2 mp -58.47 99.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.63 -0.669 . . . . 0.0 110.55 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 92' ' ' ILE . 4.3 pt -78.83 150.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -94.23 144.59 25.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 110.972 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 92' ' ' ILE . 7.9 p -137.97 113.96 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.495 -0.753 . . . . 0.0 109.866 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -85.89 112.72 21.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 110.605 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.16 127.96 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.55 122.51 43.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.605 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -124.12 170.73 8.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.812 . . . . 0.0 109.921 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.4 Cg_endo -68.94 -16.06 40.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.697 1.367 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -49.13 6.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -173.54 174.47 3.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -103.04 122.05 43.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.949 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.14 135.48 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -90.29 150.97 21.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.443 -0.785 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.9 m-85 -125.59 128.09 47.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.369 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -91.86 124.71 36.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.227 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.3 m -142.98 154.71 62.19 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 109.943 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.2 Cg_endo -66.48 121.65 8.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.814 1.429 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.6 pt-20 -36.31 -38.96 0.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.214 0.531 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 71.9 m-80 -86.96 53.07 2.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.516 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.5 p -119.23 154.02 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.345 -0.847 . . . . 0.0 110.194 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 t -103.02 148.04 26.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.011 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 82' ' ' LYS . 71.3 t -59.38 -34.37 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -48.59 -46.12 38.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.047 -1.033 . . . . 0.0 110.547 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.72 -51.39 49.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -59.89 -36.91 77.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.54 -39.02 75.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.57 -22.13 47.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.22 78.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG23 ' CB ' ' A' ' 65' ' ' PHE . 20.0 mt -60.78 -38.76 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 109.669 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -53.75 -53.12 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.126 -0.984 . . . . 0.0 110.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -68.52 -54.76 14.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 111.694 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -72.55 -54.55 8.87 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.094 -1.004 . . . . 0.0 111.568 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.494 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.3 -36.48 79.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.189 -0.944 . . . . 0.0 110.443 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tttt 71.81 73.69 0.17 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -160.51 -153.91 0.35 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.529 -0.732 . . . . 0.0 109.959 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -173.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -148.18 -61.9 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.81 -63.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -59.32 -27.09 65.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 100' ' ' LEU . 11.6 tp -62.71 105.93 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.489 -0.757 . . . . 0.0 110.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 82' ' ' LYS . 77.3 t -128.82 161.54 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.027 HD22 HG23 ' A' ' 98' ' ' VAL . 9.8 mt -113.7 139.66 48.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 110.084 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 101' ' ' VAL . 43.1 mm -100.42 93.54 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.2 t80 -96.96 115.21 27.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.77 27.57 7.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -0.838 . . . . 0.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.79 -39.7 2.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -176.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -1.073 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.51 90.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.323 -0.861 . . . . 0.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 87' ' ' LEU . 10.1 tt -61.84 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.797 ' O ' HG21 ' A' ' 54' ' ' VAL . 20.5 tttt -154.03 -148.16 0.24 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.418 -0.801 . . . . 0.0 110.655 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t70 -72.13 -15.14 61.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.129 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -53.19 -32.52 48.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.68 161.38 39.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.631 -0.668 . . . . 0.0 109.9 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.425 ' OG1' ' CG ' ' A' ' 89' ' ' GLN . 64.4 p -79.21 165.0 23.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.697 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.718 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.24 -46.35 77.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.86 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.8 pt -64.62 -18.95 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.032 -1.043 . . . . 0.0 110.453 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' CG ' ' OG1' ' A' ' 86' ' ' THR . 27.5 mm-40 -92.11 -15.79 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.922 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 178.42 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.027 -1.046 . . . . 0.0 111.638 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.718 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.04 -50.23 67.93 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -148.86 171.65 2.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.529 -0.983 . . . . 0.0 108.706 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.488 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.65 -33.23 4.33 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.651 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.6 t70 179.83 34.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.569 -0.707 . . . . 0.0 109.97 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.05 69.98 0.34 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.529 HD22 ' CE1' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -114.04 -172.13 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m -131.42 146.35 52.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.027 HG23 HD22 ' A' ' 74' ' ' LEU . 27.4 m -143.7 149.51 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.356 -0.84 . . . . 0.0 110.504 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.57 118.71 30.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 110.352 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 ' CG2' ' A' ' 39' ' ' THR . 6.8 tt -77.37 149.52 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 75' ' ' ILE . 7.8 p -171.38 138.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.89 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 48' ' ' VAL . 2.8 mp -58.08 118.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.276 0.56 . . . . 0.0 110.905 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 92' ' ' ILE . 1.9 pt -87.85 152.33 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -91.49 144.61 25.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 46' ' ' PHE . 18.3 m -138.86 140.32 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.455 -0.778 . . . . 0.0 110.043 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -109.56 104.25 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.857 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 127.84 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 122.47 43.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.957 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 HD22 ' A' ' 100' ' ' LEU . 7.3 p -113.72 166.63 10.91 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.947 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.8 Cg_endo -71.27 61.31 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.604 1.318 . . . . 0.0 110.424 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.15 -42.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.7 -169.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.407 -0.808 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -123.42 129.07 50.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -0.816 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -135.16 134.89 40.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.16 150.87 20.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.688 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.5 m-85 -129.03 144.18 51.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.469 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -100.33 128.45 46.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.402 -0.811 . . . . 0.0 109.235 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' N ' HG23 ' A' ' 32' ' ' ILE . 33.1 m -141.2 146.04 41.2 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 52' ' ' SER . 40.4 Cg_endo -67.97 122.07 9.15 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.669 1.352 . . . . 0.0 110.377 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.524 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.7 pp20? -31.07 -39.1 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' PRO . 43.9 p-10 -92.03 49.5 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.725 -1.235 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 1.7 t -114.38 112.96 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.068 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -65.5 147.96 52.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.877 HG11 ' HA ' ' A' ' 82' ' ' LYS . 90.3 t -56.41 -34.8 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -48.79 -43.83 38.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.05 -1.031 . . . . 0.0 110.53 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -68.44 -53.54 22.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.189 -0.945 . . . . 0.0 109.96 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.87 -36.82 77.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.498 -0.751 . . . . 0.0 110.365 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.586 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 mtpt -57.42 -43.04 83.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.747 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 -23.25 54.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.525 -0.734 . . . . 0.0 109.941 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.94 86.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.2 mt -60.77 -40.05 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.404 -0.81 . . . . 0.0 109.729 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -53.71 -51.95 61.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -68.42 -54.64 15.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 111.666 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mmt-85 -72.36 -54.3 9.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.091 -1.006 . . . . 0.0 111.511 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.08 -36.35 79.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.373 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tptm 72.31 76.02 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.594 -0.691 . . . . 0.0 110.082 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.9 t -161.9 -153.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.818 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.612 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -71.47 165.11 24.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -136.13 -59.69 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.94 -72.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -57.96 -25.17 60.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.421 -0.799 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 68' ' ' GLN . 10.1 tp -59.81 128.47 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.477 -0.764 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 82' ' ' LYS . 88.6 t -151.1 167.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.242 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -117.92 133.38 55.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 0.0 110.159 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.09 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 32.0 t80 -70.07 62.73 0.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.637 -0.665 . . . . 0.0 110.554 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.28 26.49 2.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.143 -0.973 . . . . 0.0 110.738 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.03 -48.19 0.64 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.794 ' C ' HD13 ' A' ' 80' ' ' ILE . 3.7 mtpp -83.01 -166.99 1.49 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -1.062 . . . . 0.0 110.098 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.47 96.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.678 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -65.23 79.94 0.05 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.877 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ttmt -140.55 -156.5 0.68 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.32 -14.97 61.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -33.09 69.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.804 . . . . 0.0 110.015 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -143.8 164.55 30.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 110.767 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.27 153.47 17.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.872 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.678 HD11 ' CD2' ' A' ' 81' ' ' LEU . 1.1 mp -66.5 -46.65 75.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.342 -0.849 . . . . 0.0 110.897 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.1 pp -63.66 -19.62 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.023 . . . . 0.0 109.847 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -89.43 -18.79 26.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.805 . . . . 0.0 110.587 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.96 -26.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.948 -1.095 . . . . 0.0 112.063 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.32 -50.38 67.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.61 162.83 4.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -1.081 . . . . 0.0 108.682 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 5.9 m-70 -113.13 -30.8 6.85 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 109.75 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.3 t0 179.75 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 109.72 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.94 73.86 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.3 mm? -114.83 170.88 8.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -1.061 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.429 ' C ' HG23 ' A' ' 98' ' ' VAL . 6.5 t -115.25 144.64 43.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 74' ' ' LEU . 44.6 t -146.68 154.85 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -90.83 144.36 25.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -101.44 121.96 42.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.901 . . . . 0.0 110.052 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.04 150.7 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.303 -0.873 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.341 -0.849 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 28.1 mm -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.593 -0.692 . . . . 0.0 110.758 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.889 HD12 ' HB ' ' A' ' 92' ' ' ILE . 32.0 pt -110.78 144.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.636 -0.665 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 144.53 25.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.823 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 46' ' ' PHE . 7.4 p -135.94 113.57 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.0 109.759 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -85.17 102.35 13.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.619 ' CG1' HD13 ' A' ' 100' ' ' LEU . 60.4 t -94.92 127.63 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.97 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -111.44 122.71 48.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.164 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 HD22 ' A' ' 100' ' ' LEU . 29.1 p -120.37 168.24 10.96 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.454 -0.779 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.52 -10.28 28.36 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.577 1.303 . . . . 0.0 110.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -42.39 7.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.08 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.08 157.49 5.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -107.42 118.34 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 110.078 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -135.32 135.62 40.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.943 . . . . 0.0 110.811 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.51 154.38 22.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.47 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.71 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.0 m-85 -128.08 128.71 45.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -91.36 129.93 37.28 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.409 HG13 ' C ' ' A' ' 47' ' ' ALA . 26.5 m -143.31 153.71 59.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.041 -1.037 . . . . 0.0 110.492 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 32' ' ' ILE . 42.8 Cg_endo -71.59 119.82 6.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.875 1.461 . . . . 0.0 110.443 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -36.22 -37.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.812 -0.555 . . . . 0.0 111.091 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -82.9 50.12 1.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 t -126.66 141.25 51.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m -92.86 156.77 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 ' HG3' ' A' ' 58' ' ' LYS . 84.0 t -59.71 -34.59 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -48.96 -43.67 40.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.121 . . . . 0.0 110.532 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.74 -54.63 14.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -0.882 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.88 -36.97 78.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.385 -0.822 . . . . 0.0 110.191 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.882 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.32 -39.04 75.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.591 -0.693 . . . . 0.0 109.587 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.23 -18.78 44.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.501 -0.749 . . . . 0.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -49.68 71.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 65' ' ' PHE . 12.8 mt -60.91 -36.34 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.358 -0.838 . . . . 0.0 109.693 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -53.85 -51.73 62.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 110.535 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -68.43 -54.28 18.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.318 -0.864 . . . . 0.0 111.711 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -54.07 10.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.115 -0.991 . . . . 0.0 111.497 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.31 -36.24 79.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.278 -0.889 . . . . 0.0 110.351 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 8.5 mttm 68.72 81.86 0.18 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.601 -0.687 . . . . 0.0 109.942 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -157.12 -73.56 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 110.206 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.0 pt20 -166.45 -165.6 0.78 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.411 -0.806 . . . . 0.0 110.106 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -153.19 -51.19 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.594 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.36 -75.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.0 110.407 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.711 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.69 -25.56 62.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -55.55 104.24 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.387 -0.821 . . . . 0.0 110.876 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 71' ' ' GLN . 58.0 t -127.59 156.1 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.503 -0.748 . . . . 0.0 109.38 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.657 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -118.73 141.2 48.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.973 -1.079 . . . . 0.0 110.519 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.402 ' C ' HG23 ' A' ' 98' ' ' VAL . 46.5 mm -101.16 93.68 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.5 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.6 t80 -84.89 95.4 9.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.237 -0.914 . . . . 0.0 110.348 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.12 46.3 26.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 110.694 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.15 -45.72 2.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.0 179.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -115.84 93.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.267 -0.896 . . . . 0.0 110.855 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -65.28 82.44 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.745 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -144.09 -161.5 1.29 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.442 0.639 . . . . 0.0 110.491 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.5 p30 -73.33 -14.95 61.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.67 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 109.565 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -139.06 168.98 18.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 0.0 109.752 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.24 145.99 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.457 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 92' ' ' ILE . 16.5 tp -55.81 -47.01 77.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -72.39 -28.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.659 . . . . 0.0 110.058 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -76.82 -6.21 51.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.704 . . . . 0.0 111.761 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.39 -37.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.536 -1.353 . . . . 0.0 111.759 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.792 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.98 -48.31 86.48 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.161 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.4 156.55 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.434 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -115.98 -41.63 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -177.87 34.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 109.87 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 96' ' ' LEU . . . 123.95 71.08 0.22 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.573 HD22 ' C ' ' A' ' 95' ' ' GLY . 4.1 mm? -117.57 174.87 5.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -1.104 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.7 m -116.51 147.31 41.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 74' ' ' LEU . 7.4 p -149.96 150.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.404 -0.81 . . . . 0.0 110.296 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.632 ' O ' HD23 ' A' ' 74' ' ' LEU . 60.0 m170 -90.68 132.83 35.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.948 HD22 HG22 ' A' ' 39' ' ' THR . 1.4 tp -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.4 p -166.21 144.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.837 . . . . 0.0 110.177 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.384 -0.823 . . . . 0.0 110.219 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.8 mttt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.28 116.48 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.668 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.068 HD12 HD11 ' A' ' 92' ' ' ILE . 2.1 pt -93.73 157.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.372 -0.83 . . . . 0.0 109.917 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -91.62 144.6 25.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.89 . . . . 0.0 110.865 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 87' ' ' LEU . 40.7 t -133.7 113.79 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.495 -0.753 . . . . 0.0 109.992 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -88.91 108.47 19.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.526 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.01 127.87 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.799 . . . . 0.0 110.09 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.75 122.57 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.589 HG22 HD22 ' A' ' 100' ' ' LEU . 7.2 p -121.64 165.12 20.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.949 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.41 60.78 2.66 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.637 1.335 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -175.1 -46.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.485 -0.759 . . . . 0.0 109.699 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -171.32 -176.74 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 110.018 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 126.88 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.03 120.03 22.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.17 147.17 28.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -123.78 121.1 34.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -87.64 126.32 34.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.5 m -143.34 150.35 51.36 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -67.63 123.33 10.64 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.768 1.404 . . . . 0.0 110.733 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -27.42 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.07 0.462 . . . . 0.0 112.058 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.3 p30 -85.54 47.38 1.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.115 -0.991 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -111.48 103.49 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.075 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -60.62 150.78 30.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 82' ' ' LYS . 94.9 t -59.88 -34.28 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.731 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -48.38 -48.86 36.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.069 -1.02 . . . . 0.0 110.668 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -64.63 -50.56 66.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 109.726 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 56.5 t80 -60.44 -36.87 79.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.441 -0.787 . . . . 0.0 110.16 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -35.38 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.662 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.08 -17.99 31.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.89 74.65 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.501 HG23 ' CB ' ' A' ' 65' ' ' PHE . 11.2 mt -60.91 -37.48 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -53.9 -52.1 61.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.07 -1.019 . . . . 0.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -54.43 16.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.255 -0.903 . . . . 0.0 111.574 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -54.45 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 111.509 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HZ ' ' HG1' ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.17 -36.21 79.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.868 . . . . 0.0 110.36 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 74.03 77.75 0.12 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.2 p -163.4 -153.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 109.913 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.71 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 mm-40 -68.95 -178.57 1.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.182 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -146.71 -56.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 110.382 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.61 -64.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.854 . . . . 0.0 110.042 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt-30 -64.08 -25.47 68.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 68' ' ' GLN . 2.3 tt -55.43 106.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.93 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG22 ' HG3' ' A' ' 82' ' ' LYS . 99.3 t -136.57 163.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -115.16 139.25 50.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.012 -1.055 . . . . 0.0 109.918 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.1 mm -94.13 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 110.394 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.5 t80 -70.08 167.85 16.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.756 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.52 69.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 110.459 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.56 25.07 4.75 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.759 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -170.21 -174.33 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.232 -1.157 . . . . 0.0 109.994 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -116.72 109.41 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.992 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -69.72 72.03 0.36 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -131.62 -159.71 0.99 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.368 0.604 . . . . 0.0 109.949 -178.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.7 t0 -72.75 -14.94 61.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 110.16 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -58.08 -33.2 68.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 110.15 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -142.38 166.28 25.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 110.602 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.47 155.03 17.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.37 -46.65 75.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.451 HG21 ' CA ' ' A' ' 50' ' ' GLU . 1.3 pp -63.93 -17.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 7.4 tm0? -94.98 -14.64 24.2 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.426 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 175.94 -25.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.988 -1.07 . . . . 0.0 111.86 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.18 -49.89 71.47 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.068 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.15 168.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.345 -1.091 . . . . 0.0 109.158 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.633 ' H ' HD13 ' A' ' 96' ' ' LEU . 44.3 m170 -114.72 -33.5 5.48 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.7 t0 -179.01 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.566 -0.709 . . . . 0.0 109.911 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.66 70.43 0.36 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.633 HD13 ' H ' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -111.2 174.48 5.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -1.066 . . . . 0.0 110.2 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.2 p -111.76 145.5 39.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.38 -0.825 . . . . 0.0 110.243 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 74' ' ' LEU . 59.0 t -143.28 151.13 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.272 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -90.26 115.78 27.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 110.213 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 74' ' ' LEU . 1.8 tt -74.22 148.38 41.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.59 152.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.805 . . . . 0.0 110.076 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 mttp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.572 HG23 ' C ' ' A' ' 48' ' ' VAL . 3.2 mp -58.44 115.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.684 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 92' ' ' ILE . 3.5 pt -87.99 166.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.49 144.28 25.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 HD23 ' A' ' 87' ' ' LEU . 27.5 t -134.62 113.45 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.186 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -101.92 106.41 17.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 110.026 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 61' ' ' ILE . 62.1 t -95.01 129.42 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 0.0 110.337 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -96.86 123.08 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.45 -0.781 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.783 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 1.8 p -121.34 169.32 9.28 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.049 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.7 Cg_endo -68.1 -12.32 34.77 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.642 1.338 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -94.37 -48.19 6.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.92 -165.57 0.37 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.402 -0.811 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -115.45 130.66 56.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.93 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.7 135.19 43.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -0.919 . . . . 0.0 110.669 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 36' ' ' THR . 6.1 mt-10 -92.08 153.67 19.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -136.76 129.45 30.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.12 126.43 37.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.22 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 ' C ' HG23 ' A' ' 32' ' ' ILE . 33.8 m -143.32 151.22 54.33 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.937 . . . . 0.0 109.768 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.6 Cg_endo -67.45 123.11 10.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.853 1.449 . . . . 0.0 110.469 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 51' ' ' ASN . 22.0 pt-20 -30.69 -39.78 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 120.965 0.412 . . . . 0.0 112.106 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 11.2 p30 -91.27 49.56 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -111.52 111.4 22.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.034 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -59.94 144.69 48.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 110.306 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.889 HG11 ' HA ' ' A' ' 82' ' ' LYS . 70.5 t -60.58 -34.19 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -50.38 35.04 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.067 -1.021 . . . . 0.0 110.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -65.9 -50.63 63.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.457 ' CE2' HG11 ' A' ' 35' ' ' VAL . 31.4 t80 -59.72 -36.26 76.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.544 -0.722 . . . . 0.0 109.999 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.702 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -57.55 -38.39 74.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 109.727 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -81.96 -20.34 38.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.55 84.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.006 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -60.66 -30.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.525 -0.734 . . . . 0.0 110.134 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -60.57 -43.98 96.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.778 . . . . 0.0 110.509 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.67 -50.84 69.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.312 -0.868 . . . . 0.0 111.0 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -71.18 -52.66 17.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.204 -0.935 . . . . 0.0 111.045 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 39' ' ' THR . 16.6 m-85 -65.66 -36.55 83.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.89 . . . . 0.0 110.306 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 12.3 tttt 68.8 57.74 0.4 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.572 -0.705 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -138.02 -154.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.403 -0.811 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.25 160.71 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.928 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -113.01 -67.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 109.114 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 40.33 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.833 -0.542 . . . . 0.0 111.011 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' THR . 1.1 mp0 -79.08 -49.31 12.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 69' ' ' THR . 0.2 OUTLIER 36.18 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.708 -0.62 . . . . 0.0 111.457 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 74' ' ' LEU . 4.6 p -136.28 147.25 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.708 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 73' ' ' VAL . 8.2 mp -117.3 142.37 47.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.83 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.1 mm -92.79 100.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.821 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 82.0 t80 -74.59 78.28 1.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.501 -0.749 . . . . 0.0 109.522 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 55.79 23.53 6.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.41 -41.41 1.51 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -164.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.233 -1.157 . . . . 0.0 110.393 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -122.53 88.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 87' ' ' LEU . 10.3 tt -65.27 86.49 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.889 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.8 tttt -147.25 -150.25 0.33 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.571 -0.706 . . . . 0.0 110.53 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 19.5 p-10 -72.42 -21.6 61.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.522 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.42 -33.04 63.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.85 . . . . 0.0 110.006 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.34 157.11 44.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -84.91 161.7 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.748 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -65.93 -45.87 80.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.566 ' CG2' HD13 ' A' ' 33' ' ' ILE . 2.2 pt -62.13 -17.95 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 15.8 mm100 -98.08 -12.54 21.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -0.841 . . . . 0.0 111.191 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.99 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.883 -1.135 . . . . 0.0 111.934 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.53 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.51 -50.17 69.54 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.11 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -150.55 161.92 3.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.441 -1.035 . . . . 0.0 108.963 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -112.27 -24.51 9.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.992 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p30 179.84 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.373 -0.83 . . . . 0.0 110.077 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.97 68.08 0.78 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.03 -174.49 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -1.073 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -111.52 131.49 55.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 81' ' ' LEU . 27.4 m -127.91 153.6 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 0.0 110.475 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -90.58 144.46 25.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 39' ' ' THR . 8.7 tt -120.6 136.89 54.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.145 -0.972 . . . . 0.0 110.081 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 102' ' ' ILE . 11.1 p -166.12 170.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' N ' HG22 ' A' ' 101' ' ' VAL . 3.9 tt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 49' ' ' PRO . 41.4 mm -58.45 140.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.721 -0.612 . . . . 0.0 110.816 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.021 ' CD1' HD11 ' A' ' 92' ' ' ILE . 4.5 pt -119.64 152.33 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.412 -0.805 . . . . 0.0 109.353 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -91.03 144.16 25.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.616 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 87' ' ' LEU . 38.6 t -132.81 113.41 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.612 -0.68 . . . . 0.0 109.784 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.5 m -91.44 102.53 15.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HD21 ' A' ' 74' ' ' LEU . 53.1 t -94.85 127.55 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 110.184 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 122.51 46.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.0 109.846 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 100' ' ' LEU . 51.5 p -124.18 166.9 17.14 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.447 -0.783 . . . . 0.0 109.864 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.1 Cg_endo -68.22 -12.65 35.69 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.622 1.327 . . . . 0.0 110.528 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -92.32 -44.05 8.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -172.5 -167.23 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 110.294 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 3.1 ptmt -130.96 121.55 25.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 109.951 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -135.47 135.48 40.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.124 -0.985 . . . . 0.0 110.809 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.02 150.4 24.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.587 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.35 130.17 48.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.668 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.31 36.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.4 154.58 63.91 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.746 ' HA ' HD13 ' A' ' 32' ' ' ILE . 41.1 Cg_endo -69.51 120.48 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.671 1.353 . . . . 0.0 110.358 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.609 ' HA ' HD13 ' A' ' 33' ' ' ILE . 1.7 pp20? -37.61 -37.61 0.22 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.875 -0.515 . . . . 0.0 111.689 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -86.74 52.04 2.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.029 -1.045 . . . . 0.0 110.776 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.2 t -126.42 126.5 43.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 86' ' ' THR . 4.2 t -70.09 151.29 45.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 82' ' ' LYS . 91.6 t -61.77 -34.76 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.778 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -43.56 28.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.982 -1.074 . . . . 0.0 110.579 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -70.34 -46.53 63.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 37.7 t80 -65.71 -37.87 87.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.91 -39.28 77.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.406 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -20.94 60.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.607 -0.683 . . . . 0.0 109.942 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -66.86 -50.74 61.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 mt -63.13 -36.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -53.63 -44.92 69.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -54.72 15.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 111.336 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -72.89 -54.37 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.1 -1.0 . . . . 0.0 111.29 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.34 -36.5 79.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.2 tptt 71.7 79.19 0.16 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 t -131.78 -151.85 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 110.051 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -92.88 -17.28 24.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 110.565 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m 66.14 -66.09 0.17 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.783 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.7 t70 -55.12 -63.48 1.14 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.127 -0.983 . . . . 0.0 110.14 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' O ' HG23 ' A' ' 73' ' ' VAL . 31.7 mt-30 -68.93 -25.3 64.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.798 . . . . 0.0 110.02 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 100' ' ' LEU . 51.6 tp -56.21 95.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.397 -0.814 . . . . 0.0 110.826 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 71' ' ' GLN . 65.8 t -122.47 154.56 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.783 . . . . 0.0 109.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD2' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -115.06 141.13 48.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.014 -1.054 . . . . 0.0 110.315 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 99' ' ' HIS . 50.2 mm -94.75 98.63 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 75.6 t80 -68.74 72.63 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.407 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.83 38.41 19.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.895 . . . . 0.0 110.579 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 126.12 -50.13 0.89 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 2.4 mptt -74.21 -161.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -126.83 93.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.388 -0.82 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 91' ' ' GLY . 7.7 tt -64.05 89.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.802 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -152.81 -154.3 0.53 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.772 -0.58 . . . . 0.0 110.17 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.5 p30 -72.66 -19.52 61.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.431 -0.793 . . . . 0.0 110.219 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -33.05 62.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.71 149.01 33.64 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.476 -0.765 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 53' ' ' SER . 1.2 p -74.18 161.79 29.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 109.843 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.2 tp -65.56 -46.32 79.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 110.37 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 50' ' ' GLU . 2.1 pp -65.46 -18.37 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 110.211 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -96.79 -10.71 26.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 111.1 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.408 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 178.99 -30.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.935 -1.103 . . . . 0.0 111.962 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -59.08 -51.01 61.76 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.021 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -149.83 177.14 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.371 -1.076 . . . . 0.0 108.963 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.433 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.1 m-70 -126.94 -31.1 2.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.71 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -179.5 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -0.757 . . . . 0.0 109.703 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 113.38 58.07 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.3 mt -98.0 -169.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -1.109 . . . . 0.0 110.309 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -131.5 121.33 24.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.781 . . . . 0.0 110.299 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 74' ' ' LEU . 7.1 p -119.44 157.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 45.4 m80 -90.66 143.49 26.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 39' ' ' THR . 6.3 tt -112.46 121.4 44.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.289 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.474 HG13 ' C ' ' A' ' 100' ' ' LEU . 35.7 m -149.89 142.96 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.322 -0.861 . . . . 0.0 110.358 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.587 HG21 ' HB1' ' A' ' 47' ' ' ALA . 2.2 mp -58.47 108.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.693 -0.629 . . . . 0.0 110.654 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 92' ' ' ILE . 4.6 pt -81.86 159.64 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -91.43 144.48 25.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 110.759 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HD23 ' A' ' 87' ' ' LEU . 47.5 t -135.66 114.09 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.271 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.443 HG23 ' OE1' ' A' ' 45' ' ' GLU . 6.4 m -98.99 105.68 17.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.92 . . . . 0.0 110.175 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.92 128.63 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -92.27 122.66 34.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.992 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.591 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -118.63 173.91 3.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.432 -0.793 . . . . 0.0 109.966 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.3 Cg_endo -69.64 -10.61 29.09 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.728 1.383 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -98.84 -53.27 3.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.13 -176.62 1.68 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -0.814 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.93 139.95 31.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.9 121.71 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -89.02 146.17 25.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -0.806 . . . . 0.0 110.077 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -132.3 128.9 38.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -90.72 124.47 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.541 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.1 m -142.28 149.66 52.43 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.3 Cg_endo -67.24 121.23 8.35 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.775 1.408 . . . . 0.0 110.495 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.614 ' HA ' HD13 ' A' ' 33' ' ' ILE . 14.1 pt-20 -35.32 -39.02 0.11 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.257 0.551 . . . . 0.0 111.231 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.479 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -89.9 55.89 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.462 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -114.67 -179.66 3.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.217 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.4 140.99 52.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 82' ' ' LYS . 22.1 t -66.91 -35.04 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 110.578 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.6 -49.42 46.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.775 -1.203 . . . . 0.0 110.196 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -78.5 -45.91 20.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 110.354 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 61' ' ' ILE . 27.7 t80 -61.38 -51.21 69.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.543 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.5 -35.11 69.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.462 -0.774 . . . . 0.0 109.954 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HG3' HG21 ' A' ' 69' ' ' THR . 1.8 tt0 -78.33 -26.28 46.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.73 -52.55 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 109.817 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.69 -29.2 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.695 -0.628 . . . . 0.0 109.652 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 t -56.49 -44.16 80.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -0.827 . . . . 0.0 110.273 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.98 61.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -52.74 63.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.45 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -67.49 -35.88 80.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.0 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 3.2 ttpp 76.14 85.33 0.09 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.447 0.642 . . . . 0.0 110.213 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.47 -154.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.581 -0.699 . . . . 0.0 109.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.0 -177.85 6.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 59' ' ' GLU . 61.5 m -140.88 -53.86 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 0.0 110.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -51.14 70.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.821 . . . . 0.0 110.233 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 73' ' ' VAL . 21.1 mt-30 -77.98 -26.01 48.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 110.226 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.458 HD11 HD21 ' A' ' 100' ' ' LEU . 8.1 tt -65.18 120.22 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.0 110.28 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.86 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.2 m -135.6 157.39 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.711 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -113.8 118.69 34.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.884 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.71 97.26 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.394 -0.816 . . . . 0.0 110.492 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.656 ' CD1' HG22 ' A' ' 98' ' ' VAL . 6.7 t80 -98.89 109.61 22.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.455 -0.778 . . . . 0.0 109.913 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.58 26.48 12.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.409 -0.807 . . . . 0.0 110.358 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.13 -36.04 4.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -179.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -1.071 . . . . 0.0 110.145 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -110.17 82.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 110.316 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 98' ' ' VAL . 7.3 tt -59.97 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.86 ' CD ' HG12 ' A' ' 73' ' ' VAL . 7.4 ttpp -160.75 -146.76 0.14 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.535 -0.728 . . . . 0.0 110.579 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.01 -18.86 61.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.404 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -52.82 -32.76 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.051 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.45 167.67 28.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -0.855 . . . . 0.0 110.524 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 p -85.47 161.14 19.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.625 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.26 -46.44 77.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.882 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.7 pt -63.39 -19.09 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.008 . . . . 0.0 110.197 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 11.4 tp-100 -93.6 -12.85 28.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.96 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.03 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.916 -1.115 . . . . 0.0 111.752 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -59.05 -50.88 63.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -151.01 169.48 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.32 -1.106 . . . . 0.0 109.118 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 7.2 m170 -116.73 -31.34 5.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.4 t0 -178.65 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 117.48 70.21 0.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 96' ' ' LEU . 3.1 mm? -112.18 171.36 7.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.31 -1.112 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m -111.88 140.14 46.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 110.338 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 81' ' ' LEU . 61.6 t -137.75 155.71 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.432 -0.793 . . . . 0.0 110.282 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -90.69 121.97 33.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 HD11 ' A' ' 72' ' ' LEU . 9.4 tt -99.97 119.14 37.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.07 142.22 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.423 -0.798 . . . . 0.0 110.29 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.38 137.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.347 0.594 . . . . 0.0 111.085 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 92' ' ' ILE . 8.1 pt -107.78 160.05 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.437 -0.789 . . . . 0.0 109.542 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' O ' HG21 ' A' ' 92' ' ' ILE . 21.9 mttt -94.65 133.63 38.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.833 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 46' ' ' PHE . 2.6 p -128.51 118.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -96.01 114.62 26.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.35 -0.844 . . . . 0.0 110.187 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 74' ' ' LEU . 45.3 t -104.85 129.29 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.352 -0.843 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 122.46 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.445 -0.784 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.858 HG21 ' CE2' ' A' ' 65' ' ' PHE . 1.1 p -122.79 170.68 7.68 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.828 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.8 Cg_endo -67.93 -12.64 35.96 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.656 1.345 . . . . 0.0 110.726 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -51.24 5.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -173.74 178.4 2.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.351 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 125.86 44.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.902 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -135.1 134.89 40.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.689 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -90.26 151.08 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.495 -0.753 . . . . 0.0 109.682 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.718 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.2 m-85 -129.3 152.26 49.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -0.94 . . . . 0.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -105.55 133.37 50.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.074 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.3 m -143.35 143.7 25.27 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 51' ' ' ASN . 40.2 Cg_endo -66.82 128.82 19.58 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.706 1.371 . . . . 0.0 111.306 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.713 ' C ' HG21 ' A' ' 88' ' ' ILE . 2.2 tm-20 -39.43 -20.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' PRO . 17.2 p-10 -111.09 37.95 2.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.644 -1.285 . . . . 0.0 110.47 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.453 ' N ' HD12 ' A' ' 88' ' ' ILE . 27.8 p -96.55 -153.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -161.91 157.25 23.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.345 -0.847 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.673 HG11 ' C ' ' A' ' 82' ' ' LYS . 59.4 t -63.28 -34.91 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 110.793 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -49.17 -47.11 46.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.663 -1.273 . . . . 0.0 110.231 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -49.53 16.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.227 -0.921 . . . . 0.0 110.337 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 35' ' ' VAL . 28.3 t80 -60.34 -50.28 74.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.97 -30.56 66.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -26.84 26.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 110.051 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.62 82.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -29.85 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.571 -0.706 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t -62.32 -43.92 97.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.476 -0.765 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -57.81 -48.56 79.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.862 . . . . 0.0 111.024 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' NH1' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -71.15 -52.81 17.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.203 -0.936 . . . . 0.0 110.931 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CE2' HG21 ' A' ' 39' ' ' THR . 8.8 m-85 -67.18 -36.16 81.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.85 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 12.3 mttp 69.6 81.44 0.17 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.418 0.628 . . . . 0.0 110.092 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 p -168.15 -154.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -74.94 157.56 34.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -128.51 -41.67 1.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.16 -62.72 1.56 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.358 -0.839 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -69.4 -25.57 64.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.427 -0.796 . . . . 0.0 110.165 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.843 HD21 HD11 ' A' ' 100' ' ' LEU . 4.9 tt -64.36 118.01 8.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.339 -0.85 . . . . 0.0 110.524 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 82' ' ' LYS . 33.0 m -139.0 168.46 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.741 HD12 HG13 ' A' ' 98' ' ' VAL . 2.7 mm? -109.57 146.81 34.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 98' ' ' VAL . 33.8 mm -102.69 92.9 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 110.236 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 24.7 t80 -74.39 64.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.7 . . . . 0.0 110.357 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 49.2 79.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.86 -53.06 4.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.755 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.6 mttt -76.2 178.2 6.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -1.103 . . . . 0.0 109.873 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.755 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -115.97 106.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 0.0 109.916 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.932 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.8 OUTLIER -69.5 72.04 0.32 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.673 ' C ' HG11 ' A' ' 54' ' ' VAL . 7.9 ttmt -125.95 -160.1 0.95 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.511 0.672 . . . . 0.0 110.547 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.7 p-10 -73.74 -16.71 61.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.629 -0.669 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.83 -32.36 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.942 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -132.08 169.66 16.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.799 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.66 137.01 32.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 92' ' ' ILE . 22.3 tp -55.93 -47.49 77.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 110.428 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.713 HG21 ' C ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -73.62 -15.48 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.481 -0.762 . . . . 0.0 110.904 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 1.8 tt0 -90.35 -9.32 48.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 111.847 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -174.65 -36.61 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.586 -1.321 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.937 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.84 -42.8 96.77 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.937 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -138.64 138.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -1.19 . . . . 0.0 110.855 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.52 ' H ' HD13 ' A' ' 96' ' ' LEU . 12.2 m170 -103.68 -36.03 8.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 24.0 p-10 179.81 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 0.0 109.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.08 71.19 0.24 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 93' ' ' HIS . 6.5 mp -113.16 167.49 10.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 110.371 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.9 m -118.33 147.14 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.333 -0.854 . . . . 0.0 110.252 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.741 HG13 HD12 ' A' ' 74' ' ' LEU . 7.7 p -144.43 150.54 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 110.418 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -90.63 122.49 33.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.503 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.843 HD11 HD21 ' A' ' 72' ' ' LEU . 7.0 tt -82.94 149.98 26.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.204 -0.935 . . . . 0.0 110.673 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.561 HG12 HG12 ' A' ' 75' ' ' ILE . 14.0 p -168.05 131.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.09 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.4 pp . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' O ' HG23 ' A' ' 33' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.3 mm -58.33 102.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 110.654 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.99 HD13 HG22 ' A' ' 88' ' ' ILE . 7.1 pt -96.07 147.88 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.707 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.636 ' O ' HG21 ' A' ' 92' ' ' ILE . 10.7 mttp -91.81 141.39 28.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.103 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 87' ' ' LEU . 51.0 t -129.52 113.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.818 . . . . 0.0 110.129 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.7 m -90.15 109.4 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.832 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.78 127.79 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 110.285 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 122.51 47.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.437 -0.789 . . . . 0.0 109.67 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 1.11 HG22 HD13 ' A' ' 100' ' ' LEU . 62.1 p -124.13 162.22 42.84 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 59.54 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.71 1.373 . . . . 0.0 110.428 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.71 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -167.21 -170.02 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.513 -0.742 . . . . 0.0 109.922 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -142.7 125.37 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.831 . . . . 0.0 110.21 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -135.12 132.44 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.382 -0.824 . . . . 0.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -90.1 150.25 22.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -123.75 140.93 52.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 110.479 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.68 116.64 33.18 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 52' ' ' SER . 21.8 m -120.59 147.68 46.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.677 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.631 ' HA ' HD13 ' A' ' 32' ' ' ILE . 51.1 Cg_endo -76.65 52.83 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.856 1.451 . . . . 0.0 111.709 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' CG ' HG21 ' A' ' 88' ' ' ILE . 30.7 tp10 55.53 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.381 -0.824 . . . . 0.0 111.695 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.0 t30 -46.86 -20.06 0.12 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 0.0 112.063 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.422 ' CB ' ' HB ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -59.1 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 110.106 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.9 m -67.33 175.6 2.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.526 -0.734 . . . . 0.0 110.35 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 82' ' ' LYS . 37.6 t -68.12 -35.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 110.272 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -50.21 -49.01 54.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.772 -1.205 . . . . 0.0 109.733 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -76.37 -47.4 23.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -61.52 -50.98 70.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.367 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.55 -29.85 64.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.783 . . . . 0.0 109.897 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.766 ' OE2' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -80.37 -24.14 39.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.336 -0.852 . . . . 0.0 109.813 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.29 85.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 110.149 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.0 mt -60.9 -36.91 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.256 -0.903 . . . . 0.0 109.912 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 p -53.6 -49.64 67.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.0 110.506 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -68.21 -53.77 22.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.341 -0.849 . . . . 0.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -53.84 12.32 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.097 -1.002 . . . . 0.0 111.262 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.66 -36.45 80.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 109.991 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.06 81.68 0.19 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.612 -0.68 . . . . 0.0 110.224 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -156.04 -65.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.0 -176.15 2.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.437 -0.789 . . . . 0.0 110.061 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.766 HG21 ' OE2' ' A' ' 59' ' ' GLU . 3.2 m -140.85 -55.08 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.04 -67.4 0.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 73' ' ' VAL . 9.9 mt-30 -60.47 -25.61 66.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.309 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 72' ' ' LEU . 7.8 tt -53.29 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 110.826 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 71' ' ' GLN . 86.7 t -125.63 148.7 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 109.472 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -117.94 135.86 53.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.17 101.65 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.438 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 81' ' ' LEU . 71.8 t80 -77.35 82.71 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.238 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.79 36.19 13.88 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.33 -55.87 0.57 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -1.062 . . . . 0.0 110.056 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -118.05 94.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.281 -0.887 . . . . 0.0 110.694 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -67.09 79.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.003 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.772 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.5 ttmt -137.15 -158.86 0.9 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.414 0.625 . . . . 0.0 110.358 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 84' ' ' GLN . 35.5 p30 -73.32 -14.81 61.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.452 -0.78 . . . . 0.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -55.78 -33.04 64.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.353 -0.842 . . . . 0.0 109.72 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.39 154.4 49.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.474 -0.766 . . . . 0.0 110.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -70.27 147.03 50.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.853 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 35' ' ' VAL . 17.0 tp -55.59 -46.98 77.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.99 HG22 HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -72.48 -14.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 47.9 tp60 -85.63 -13.58 48.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 111.814 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -170.27 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.605 -1.309 . . . . 0.0 111.036 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.929 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.46 -46.92 93.14 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.929 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -137.47 143.66 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.012 -1.287 . . . . 0.0 111.333 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.438 ' H ' HD12 ' A' ' 96' ' ' LEU . 12.1 m-70 -109.4 -33.72 6.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -179.73 35.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.246 0.546 . . . . 0.0 109.536 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 92' ' ' ILE . . . 118.67 71.97 0.39 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -114.61 -178.43 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.235 -1.156 . . . . 0.0 110.251 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -125.15 146.52 49.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 81' ' ' LEU . 8.1 p -142.68 151.09 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.874 . . . . 0.0 110.401 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.71 144.31 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.81 . . . . 0.0 110.258 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.11 HD13 HG22 ' A' ' 39' ' ' THR . 6.4 tt -97.44 119.97 36.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.67 128.57 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 0.0 110.045 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.6 mp -58.12 111.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.603 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.62 HD13 HG22 ' A' ' 88' ' ' ILE . 9.0 pt -89.68 154.46 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.38 -0.825 . . . . 0.0 110.039 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -94.11 144.89 25.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.56 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -138.52 119.14 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.4 -0.813 . . . . 0.0 110.108 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -87.05 102.22 14.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 0.0 110.095 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.729 ' CG1' HD12 ' A' ' 100' ' ' LEU . 61.6 t -96.3 128.38 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' HE3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -109.72 126.27 53.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 110.293 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.925 HG23 HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.46 175.73 2.6 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.613 -0.679 . . . . 0.0 109.69 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 39' ' ' THR . 44.4 Cg_endo -71.34 61.86 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.626 1.33 . . . . 0.0 110.395 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.447 -0.783 . . . . 0.0 109.928 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.71 179.48 3.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.39 -0.819 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -117.08 122.99 45.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.152 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.3 135.12 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.326 -0.859 . . . . 0.0 110.438 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -85.23 149.52 25.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.533 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -124.35 144.86 49.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.571 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -99.62 129.78 45.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 30.4 m -143.46 144.01 26.2 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.857 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 39.4 Cg_endo -67.08 121.44 8.61 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.756 1.398 . . . . 0.0 111.034 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -37.17 -34.73 0.09 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.117 0.484 . . . . 0.0 111.583 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.15 49.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 110.575 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 55.7 p -127.85 108.38 10.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.5 t -59.84 153.36 20.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.857 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.1 t -55.88 -35.0 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 110.86 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -48.48 -43.78 35.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.665 -1.272 . . . . 0.0 109.843 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.15 -41.48 41.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.636 ' O ' HG22 ' A' ' 61' ' ' ILE . 17.7 t80 -68.24 -51.46 45.11 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -30.8 65.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.921 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HA ' HG23 ' A' ' 69' ' ' THR . 32.0 tt0 -86.29 -26.85 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -49.32 60.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -0.785 . . . . 0.0 109.675 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.716 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.35 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.008 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 p -63.85 -44.43 93.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.174 -0.953 . . . . 0.0 110.351 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -56.39 -42.66 78.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.78 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -52.07 23.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.283 -0.885 . . . . 0.0 110.463 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 5.2 m-85 -67.0 -36.5 82.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.817 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 44.5 mtmt 64.23 79.49 0.26 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.582 -0.699 . . . . 0.0 110.179 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 t -154.87 -59.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.486 -0.759 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.416 ' O ' HD22 ' A' ' 72' ' ' LEU . 1.6 tt0 -169.45 174.83 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 0.0 110.005 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.54 HG23 ' HA ' ' A' ' 59' ' ' GLU . 31.1 m -143.31 -44.19 0.29 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.37 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -64.97 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.18 -26.19 60.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.226 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -53.16 139.75 28.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.326 -0.859 . . . . 0.0 110.523 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.0 p -172.84 169.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 109.928 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD11 HG22 ' A' ' 37' ' ' VAL . 2.6 mt -118.44 118.86 32.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -0.982 . . . . 0.0 109.31 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.61 103.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 110.146 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.772 ' HA ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -91.86 124.11 35.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.452 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.94 103.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.313 -0.867 . . . . 0.0 110.607 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.46 -31.13 3.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.609 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -166.65 -166.8 0.89 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -1.003 . . . . 0.0 109.712 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 79' ' ' LYS . 1.3 mm -108.77 118.26 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.874 HD12 HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.97 71.05 0.37 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.786 178.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.819 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ptmt -136.1 -152.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.368 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.9 p30 -72.94 -12.84 61.1 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.301 -0.874 . . . . 0.0 112.482 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.6 -33.5 33.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.056 . . . . 0.0 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.61 156.37 45.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.198 -0.939 . . . . 0.0 109.972 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 149.78 41.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 92' ' ' ILE . 16.0 tp -56.81 -48.16 78.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 110.868 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.62 HG22 HD13 ' A' ' 33' ' ' ILE . 2.1 pp -73.1 -18.45 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.172 -0.955 . . . . 0.0 110.829 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.29 -9.9 57.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 111.744 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.728 -1.233 . . . . 0.0 110.949 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.877 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.34 -47.0 92.98 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -145.56 156.23 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -1.176 . . . . 0.0 110.293 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 19.2 m170 -114.98 -42.42 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.4 t70 -178.49 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.28 65.91 0.18 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 96' ' ' LEU . 10.8 mt -112.58 160.08 18.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -1.12 . . . . 0.0 110.256 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 98' ' ' VAL . 7.0 t -115.06 145.72 42.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 81' ' ' LEU . 49.0 t -145.47 158.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.557 ' O ' HG22 ' A' ' 75' ' ' ILE . 44.1 m170 -88.39 125.49 34.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 0.0 110.466 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.925 HD13 HG23 ' A' ' 39' ' ' THR . 5.5 tt -83.29 145.77 28.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.135 -0.978 . . . . 0.0 110.451 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 100' ' ' LEU . 7.8 p -167.36 159.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.327 -0.858 . . . . 0.0 110.204 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mptt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 2.9 mp -58.04 110.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.835 -0.541 . . . . 0.0 110.476 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.986 ' CD1' HD11 ' A' ' 92' ' ' ILE . 3.3 pt -83.55 152.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -91.97 144.4 25.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 110.282 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.744 HG23 HG21 ' A' ' 92' ' ' ILE . 7.3 p -139.69 113.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.093 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -82.33 109.08 16.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.396 -0.815 . . . . 0.0 110.018 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.55 127.59 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -0.859 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.38 122.64 46.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 80.7 p -121.58 165.93 18.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.726 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.1 Cg_endo -69.71 -10.28 28.2 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.636 1.335 . . . . 0.0 110.817 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -100.54 -35.91 9.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.184 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.36 -166.52 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.325 -0.859 . . . . 0.0 110.263 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 114.93 8.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 0.0 110.074 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -135.19 134.96 40.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 110.499 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.29 149.21 26.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.1 m-85 -121.4 147.68 45.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.36 125.86 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.6 m -142.49 150.48 54.65 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.206 -0.934 . . . . 0.0 109.758 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -68.36 122.61 9.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.699 1.368 . . . . 0.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.0 pt-20 -31.28 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.084 0.469 . . . . 0.0 111.716 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -88.58 50.83 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.213 -0.929 . . . . 0.0 110.121 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.1 t -115.12 130.77 57.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -82.14 146.47 29.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.997 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -61.16 -34.53 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.791 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -49.32 -48.07 46.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.988 -1.07 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.33 -49.76 52.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 38.5 t80 -59.82 -37.23 78.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 12.2 mtpt -57.77 -47.95 81.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.579 -0.701 . . . . 0.0 109.495 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.484 -0.76 . . . . 0.0 109.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -62.88 -51.89 65.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.842 . . . . 0.0 110.045 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 65' ' ' PHE . 19.6 mt -60.92 -39.65 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.603 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -53.7 -52.24 60.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.039 . . . . 0.0 110.326 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -54.17 19.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.324 -0.86 . . . . 0.0 111.508 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -72.02 -54.11 10.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 111.442 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.91 -36.6 80.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 110.275 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 4.9 tttp 69.17 80.66 0.19 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.437 -0.789 . . . . 0.0 110.203 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 t -153.38 -69.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -164.36 -175.18 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.5 m -144.11 -60.04 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.312 -0.868 . . . . 0.0 110.483 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 -61.03 2.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -66.32 -25.65 66.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 102' ' ' ILE . 36.2 tp -51.86 124.75 13.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.337 -0.852 . . . . 0.0 110.684 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.1 p -153.31 157.22 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 109.767 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.4 mp -123.6 123.76 41.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.134 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.19 104.33 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 110.626 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.3 t80 -70.52 67.06 0.34 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.755 . . . . 0.0 110.031 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.92 24.76 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.261 -0.899 . . . . 0.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.21 -39.24 1.51 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -162.14 0.53 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -1.121 . . . . 0.0 110.258 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.1 pp -123.49 84.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 110.61 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 87' ' ' LEU . 8.1 tt -67.74 84.29 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 108.765 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.997 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -153.99 -146.82 0.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 110.148 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.58 -15.56 61.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.035 -1.041 . . . . 0.0 111.363 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.448 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.4 mm-40 -53.73 -33.42 55.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.129 -0.982 . . . . 0.0 110.237 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -150.24 -169.88 3.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -102.91 158.14 16.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 81' ' ' LEU . 1.5 tp -66.09 -46.23 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.6 pt -63.84 -17.25 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.562 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -97.27 -12.82 22.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 111.091 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.911 -1.118 . . . . 0.0 111.859 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.658 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.39 -50.34 67.68 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -148.56 171.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.375 -1.074 . . . . 0.0 108.665 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -122.19 -29.62 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.967 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.8 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 109.982 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.91 59.5 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.38 -168.99 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.336 -1.097 . . . . 0.0 110.221 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -134.96 147.03 49.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 76' ' ' PHE . 11.9 p -140.47 157.56 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 0.0 110.199 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -90.7 115.81 28.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 HD11 ' A' ' 72' ' ' LEU . 7.9 tt -89.31 131.33 35.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 110.139 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 101' ' ' VAL . 35.2 m -145.08 130.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.783 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.711 HG22 HD12 ' A' ' 72' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 0.0 110.199 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tptp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -58.16 110.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.252 0.549 . . . . 0.0 110.723 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.668 ' CD1' HD11 ' A' ' 92' ' ' ILE . 1.6 pt -89.16 174.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.415 -0.803 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.45 144.39 37.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.768 . . . . 0.0 110.373 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 46' ' ' PHE . 8.7 p -136.14 113.84 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 110.033 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -84.24 103.8 13.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.501 HG13 HD21 ' A' ' 74' ' ' LEU . 66.9 t -94.75 128.75 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.002 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -101.24 122.5 43.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.415 -0.803 . . . . 0.0 110.071 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.742 HG22 HD13 ' A' ' 100' ' ' LEU . 4.3 p -119.93 167.71 11.85 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.9 Cg_endo -71.1 61.06 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.661 1.348 . . . . 0.0 110.401 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -46.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 109.64 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -172.05 176.75 3.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.53 -0.731 . . . . 0.0 110.081 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.67 127.97 54.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -134.5 131.2 37.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.3 149.79 25.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.9 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -127.12 123.08 35.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.898 . . . . 0.0 110.197 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.133 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 25.6 m -143.21 153.57 59.93 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.233 -0.917 . . . . 0.0 109.825 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.2 Cg_endo -67.9 122.37 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.803 1.423 . . . . 0.0 110.726 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.613 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -30.74 -42.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.66 48.7 1.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.925 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.9 t -113.41 108.07 16.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.087 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.7 m -59.84 148.84 33.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.847 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.5 t -63.42 -34.67 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.811 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.05 -43.93 41.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.953 -1.092 . . . . 0.0 110.705 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.45 -53.48 16.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.925 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 25.3 t80 -59.86 -37.21 78.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.339 -0.851 . . . . 0.0 110.118 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.74 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.52 -42.88 83.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.611 -0.68 . . . . 0.0 109.762 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -75.87 -20.72 57.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -63.93 -41.58 97.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.637 HG23 ' CB ' ' A' ' 65' ' ' PHE . 52.8 mt -60.39 -34.7 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.4 p -54.02 -52.98 59.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.985 -1.072 . . . . 0.0 110.464 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -54.73 14.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 111.78 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -72.7 -54.49 8.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.051 -1.031 . . . . 0.0 111.646 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.637 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.57 -36.11 78.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.887 . . . . 0.0 110.531 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 23.2 mtmt 70.67 79.97 0.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.662 -0.649 . . . . 0.0 110.015 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.9 t -168.24 -154.4 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.898 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.8 mt-30 -70.14 -170.03 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 110.05 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.7 m -157.33 -60.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -60.13 -70.31 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -61.86 -26.11 67.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 100' ' ' LEU . 1.9 tt -66.71 98.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 110.338 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.11 167.11 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.812 . . . . 0.0 109.951 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.006 HD23 HG11 ' A' ' 98' ' ' VAL . 5.5 mp -108.75 144.68 36.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 110.018 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 101' ' ' VAL . 47.1 mm -105.16 89.31 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.828 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 69.6 t80 -66.96 83.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.92 29.72 6.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.359 -0.838 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.04 -51.38 0.84 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 6.4 mttp -61.86 -175.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -1.046 . . . . 0.0 109.957 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -116.31 93.06 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.5 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.813 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -62.89 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.863 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.4 tttt -145.91 -153.13 0.46 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.734 -0.604 . . . . 0.0 110.169 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -72.58 -15.54 61.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.385 -0.822 . . . . 0.0 110.523 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HB3' HD13 ' A' ' 80' ' ' ILE . 44.8 tt0 -62.81 -33.14 74.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.973 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.63 168.15 19.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 p -99.06 148.92 23.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.252 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 ' HA3' ' A' ' 91' ' ' GLY . 22.0 tp -55.81 -43.58 77.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.526 HG22 HD13 ' A' ' 33' ' ' ILE . 1.2 pt -71.61 -14.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.254 -0.904 . . . . 0.0 111.604 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.37 -2.98 24.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 112.197 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -176.06 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 118.331 -1.347 . . . . 0.0 112.303 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.813 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -58.58 -50.32 68.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.8 pp -157.05 152.61 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -1.015 . . . . 0.0 109.322 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 14.5 m170 -100.8 -24.97 14.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 35.4 t70 179.96 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.622 -0.674 . . . . 0.0 109.596 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.07 73.93 0.86 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.539 ' CB ' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -117.46 176.85 4.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.248 -1.148 . . . . 0.0 110.186 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 13.4 m -115.9 147.32 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.006 HG11 HD23 ' A' ' 74' ' ' LEU . 8.5 p -138.93 146.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.75 . . . . 0.0 110.16 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.39 115.27 27.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 72' ' ' LEU . 6.7 tt -82.74 148.64 27.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.899 . . . . 0.0 110.632 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 75' ' ' ILE . 11.3 p -168.34 135.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.461 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -57.95 128.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.321 0.582 . . . . 0.0 111.006 -177.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.9 pt -98.4 159.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.696 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 92' ' ' ILE . 27.7 mmtm -91.45 144.08 25.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 110.533 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 HG21 ' A' ' 92' ' ' ILE . 57.6 t -137.0 113.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -90.31 102.99 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 57.8 t -98.05 127.84 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.463 -0.773 . . . . 0.0 110.12 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.44 122.45 46.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 HD22 ' A' ' 100' ' ' LEU . 66.6 p -117.1 163.81 21.54 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.9 Cg_endo -71.55 59.76 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.664 1.349 . . . . 0.0 110.581 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -175.67 -39.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 109.762 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -171.31 173.58 4.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 119.8 40.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.076 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.78 124.9 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -84.7 149.55 25.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.663 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.51 140.14 53.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.353 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -97.65 135.44 39.46 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 33' ' ' ILE . 28.1 m -143.43 143.1 22.77 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 109.018 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' CA ' HD12 ' A' ' 32' ' ' ILE . 39.4 Cg_endo -65.89 128.23 19.39 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.771 1.406 . . . . 0.0 110.825 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -38.05 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.008 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' PRO . 2.4 t30 -120.79 67.63 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.645 -1.284 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -149.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.0 110.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.809 ' HA ' HG23 ' A' ' 86' ' ' THR . 8.0 t -159.38 153.75 23.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.95 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.938 HG21 ' O ' ' A' ' 82' ' ' LYS . 48.5 t -55.92 -35.3 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 111.088 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -45.17 40.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -71.36 -49.73 39.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 43.7 t80 -62.69 -38.02 88.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.448 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.695 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -58.15 -45.22 87.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.829 . . . . 0.0 109.653 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -81.67 -18.16 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 110.194 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.1 -52.34 63.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 65' ' ' PHE . 26.5 mt -62.8 -33.65 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.345 -0.847 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -53.19 55.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.081 -1.012 . . . . 0.0 110.606 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.56 -54.56 15.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 111.797 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -54.48 8.97 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.083 -1.01 . . . . 0.0 111.633 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.22 -36.15 79.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 73.95 72.54 0.12 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.65 -0.657 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.6 p -159.06 -165.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.47 -0.768 . . . . 0.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' THR . 1.0 OUTLIER -74.74 -168.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.246 -0.909 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.77 -51.63 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.371 -0.831 . . . . 0.0 110.327 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.05 -51.94 66.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.701 ' O ' HG23 ' A' ' 73' ' ' VAL . 20.2 mt-30 -78.13 -25.57 47.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.834 HD11 HD21 ' A' ' 100' ' ' LEU . 22.0 tp -57.74 110.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 110.656 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 71' ' ' GLN . 61.9 t -129.72 151.47 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.82 . . . . 0.0 109.727 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.651 ' HB2' HD23 ' A' ' 81' ' ' LEU . 4.9 mp -111.39 122.07 46.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.109 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 75' ' ' ILE . 27.1 mm -79.84 100.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.775 ' CZ ' HD13 ' A' ' 96' ' ' LEU . 4.6 t80 -109.05 124.27 50.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 110.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.82 27.54 7.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.329 -0.857 . . . . 0.0 110.419 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.87 23.71 61.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -122.58 -167.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -1.084 . . . . 0.0 109.881 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.552 HG22 HG11 ' A' ' 73' ' ' VAL . 1.1 pp -112.13 79.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.221 -0.924 . . . . 0.0 110.499 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -61.37 89.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 108.54 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.938 ' O ' HG21 ' A' ' 54' ' ' VAL . 7.1 ttpt -155.82 -146.67 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.547 -0.72 . . . . 0.0 110.874 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.792 ' N ' HG11 ' A' ' 54' ' ' VAL . 20.0 t0 -62.48 -15.41 49.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.667 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.54 ' CG ' HD13 ' A' ' 80' ' ' ILE . 2.1 mm-40 -52.47 -30.81 31.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -159.88 162.5 34.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.387 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -76.83 134.2 39.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.583 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' HG ' HG12 ' A' ' 92' ' ' ILE . 1.9 mp -55.75 -39.2 70.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.632 HG22 HD13 ' A' ' 33' ' ' ILE . 2.4 pp -70.28 -17.88 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.141 -0.974 . . . . 0.0 109.566 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -88.78 -13.27 39.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.501 -0.749 . . . . 0.0 110.927 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.69 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.831 -1.168 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.822 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.12 -42.9 97.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 91' ' ' GLY . 3.7 mm -128.94 150.2 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -1.224 . . . . 0.0 111.004 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.69 -38.64 3.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 p30 179.88 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 116.88 69.95 0.42 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.775 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 4.9 mt -101.14 -177.18 3.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -1.151 . . . . 0.0 110.423 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.435 ' C ' HG13 ' A' ' 98' ' ' VAL . 8.0 t -128.46 142.76 50.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.435 HG13 ' C ' ' A' ' 97' ' ' THR . 34.6 m -147.52 146.22 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -90.43 119.37 30.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.908 HD22 HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -76.26 137.96 40.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 p -166.71 132.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.138 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.458 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.396 -0.815 . . . . 0.0 110.251 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 33' ' ' ILE . 4.4 mmtt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.1 mp -58.23 120.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.681 -0.637 . . . . 0.0 110.557 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.942 HD12 HD11 ' A' ' 92' ' ' ILE . 1.6 pt -107.39 159.57 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -91.75 144.21 25.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.818 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG22 HD23 ' A' ' 87' ' ' LEU . 39.1 t -132.07 113.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.438 -0.789 . . . . 0.0 109.856 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.4 m -98.26 114.67 27.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.309 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.45 127.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.85 . . . . 0.0 110.138 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -92.86 122.55 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.581 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.845 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -121.86 172.43 5.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 110.176 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.8 Cg_endo -68.68 -8.27 22.84 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.69 1.363 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.7 tptm -101.46 -50.55 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 1.8 mt-10 -170.57 -161.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.556 -0.715 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.4 135.98 53.49 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -135.3 135.45 40.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.168 -0.958 . . . . 0.0 110.785 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 1.3 mp0 -92.14 145.75 24.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.45 -0.781 . . . . 0.0 109.75 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -128.29 124.88 37.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.948 . . . . 0.0 110.396 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -90.85 129.22 36.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 108.963 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.5 m -143.27 155.68 61.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.056 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -69.98 122.14 8.76 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.833 1.438 . . . . 0.0 110.409 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.872 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -25.83 -48.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.1 0.476 . . . . 0.0 111.597 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' PRO . 14.6 p-10 -86.25 52.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 t -109.13 111.48 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -64.07 144.19 57.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.949 HG11 ' HA ' ' A' ' 82' ' ' LYS . 85.4 t -59.12 -35.02 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.41 -44.51 35.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.015 -1.053 . . . . 0.0 110.479 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.32 -49.75 52.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.13 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 35' ' ' VAL . 7.0 t80 -63.21 -37.52 87.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.442 -0.786 . . . . 0.0 110.41 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.09 -39.54 78.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.4 -23.1 60.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.49 -0.757 . . . . 0.0 110.278 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.89 81.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.184 -0.948 . . . . 0.0 109.992 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -34.95 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 110.174 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 66' ' ' LYS . 27.1 p -59.41 -43.91 92.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -58.77 -49.55 77.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.267 -0.896 . . . . 0.0 111.014 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -53.11 15.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.156 -0.965 . . . . 0.0 110.828 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 39' ' ' THR . 23.8 m-85 -67.54 -37.08 82.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 0.0 110.23 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' SER . 5.4 tttt 63.76 79.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.446 -0.784 . . . . 0.0 110.138 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 t -155.43 -62.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.592 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.3 pt20 -168.52 -165.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 110.137 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -155.11 -44.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.863 . . . . 0.0 110.382 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -58.34 -62.49 1.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.839 ' O ' HG23 ' A' ' 73' ' ' VAL . 19.3 mt-30 -70.84 -25.75 62.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.805 . . . . 0.0 110.041 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.848 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -55.76 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 0.0 110.396 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.862 HG22 ' HD2' ' A' ' 82' ' ' LYS . 40.3 t -124.68 167.77 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.797 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -124.44 118.86 27.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 79' ' ' LYS . 5.5 tp -82.93 104.85 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.729 ' CD1' HG12 ' A' ' 98' ' ' VAL . 15.1 t80 -116.02 136.19 53.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 110.32 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.3 26.73 4.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.374 -0.829 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.67 24.4 70.17 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -125.83 -169.77 2.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.41 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -104.96 82.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.85 HD21 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -62.92 92.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.994 -1.067 . . . . 0.0 108.584 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.949 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.0 ttpt -153.95 -143.29 0.13 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.362 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 34.8 p-10 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -53.7 -32.84 53.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.864 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -147.88 163.67 36.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.582 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -87.19 158.7 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.85 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -66.42 -46.55 76.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.872 HG21 ' HG2' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -63.31 -17.49 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.045 . . . . 0.0 109.985 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.04 -15.41 24.82 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 110.884 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.83 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.897 -1.127 . . . . 0.0 111.947 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.75 -50.15 70.35 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.942 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -152.19 160.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -1.008 . . . . 0.0 108.873 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.7 OUTLIER -110.27 -28.31 8.67 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.4 t70 -179.09 36.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.562 -0.711 . . . . 0.0 110.026 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.16 69.89 0.51 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.24 173.37 6.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.402 -1.057 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.4 p -111.86 130.77 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 110.105 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 81' ' ' LEU . 34.2 m -127.41 150.35 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.766 ' O ' HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -90.78 133.75 34.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.106 -0.996 . . . . 0.0 110.03 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.848 HD11 HD21 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -86.92 134.67 33.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.242 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.7 p -149.41 125.78 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.336 -0.852 . . . . 0.0 110.185 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mttm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.71 118.2 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.701 -0.624 . . . . 0.0 110.56 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 pt -93.55 147.17 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -91.47 144.8 25.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 110.114 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 46' ' ' PHE . 14.0 m -140.81 136.49 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -107.7 117.37 33.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 0.0 110.214 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 44' ' ' GLU . 33.6 m -98.3 130.7 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.828 . . . . 0.0 110.249 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 122.67 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 110.0 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.916 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.1 p -127.09 166.16 24.4 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.11 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.49 61.12 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.728 1.383 . . . . 0.0 110.374 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.29 -47.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.13 -177.94 2.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.262 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -117.33 136.63 52.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.847 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -135.09 128.01 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.64 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 2.0 mp0 -84.05 149.5 26.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 109.796 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.1 m-85 -129.75 124.16 32.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.67 125.83 35.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.195 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.21 151.57 55.6 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.22 -0.925 . . . . 0.0 109.888 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -69.23 121.71 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.915 1.482 . . . . 0.0 110.743 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -27.89 -46.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.244 0.545 . . . . 0.0 111.566 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.76 52.38 2.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 17.8 t -112.81 124.5 52.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -0.817 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 m -71.19 144.55 50.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.921 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.9 t -62.43 -34.55 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.939 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -48.24 -44.07 32.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 110.873 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -53.77 21.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.009 . . . . 0.0 110.0 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.84 -37.27 78.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.487 -0.758 . . . . 0.0 110.255 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.637 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.76 -39.77 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.601 -0.687 . . . . 0.0 110.01 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -75.04 -21.89 58.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 110.318 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.94 82.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.965 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 ' CG1' ' CE2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -63.87 -33.2 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.718 . . . . 0.0 110.225 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 t -64.03 -43.95 94.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.452 -0.78 . . . . 0.0 110.509 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.91 -50.66 72.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.863 . . . . 0.0 110.936 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -69.61 -53.01 20.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.916 ' CE2' HG21 ' A' ' 39' ' ' THR . 15.1 m-30 -67.46 -37.06 82.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.17 78.16 0.3 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.332 -0.855 . . . . 0.0 109.971 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 p -156.1 -66.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.744 . . . . 0.0 110.105 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.42 -175.03 3.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.793 . . . . 0.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -154.78 -40.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.09 -64.57 0.8 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.596 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.787 ' O ' HG13 ' A' ' 73' ' ' VAL . 88.7 mm-40 -78.48 -25.78 45.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 100' ' ' LEU . 5.7 tt -56.86 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.395 -0.816 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.807 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.0 m -109.76 163.12 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.5 mp -112.21 118.98 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.037 -1.039 . . . . 0.0 109.198 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 77' ' ' ALA . 50.1 mm -78.27 103.19 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 110.628 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.6 t80 -69.83 65.78 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.557 -0.714 . . . . 0.0 110.003 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 53.74 24.26 4.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.244 -0.91 . . . . 0.0 110.409 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.87 -47.16 0.82 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -161.43 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.326 -1.102 . . . . 0.0 110.274 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.89 85.23 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.397 -0.814 . . . . 0.0 110.423 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 3.3 tt -61.84 93.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.921 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.3 ttpm? -159.16 -150.08 0.23 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.639 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 9.0 p-10 -73.0 -19.22 61.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.527 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -52.81 -32.44 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 109.896 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -151.39 150.4 30.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.33 151.41 44.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.768 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.677 HD23 HG11 ' A' ' 35' ' ' VAL . 1.1 mp -59.17 -46.08 89.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.2 pp -63.48 -18.42 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.788 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 50.8 tt0 -91.2 -16.52 27.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.2 OUTLIER 177.97 -27.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.95 -1.094 . . . . 0.0 111.799 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.655 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.66 -50.22 69.4 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 33' ' ' ILE . 2.8 pp -148.12 175.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.231 -1.158 . . . . 0.0 109.143 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 3.1 m170 -123.45 -36.09 2.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 110.13 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 37.4 t70 -179.76 36.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 122.08 65.6 0.23 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 168.9 9.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -1.099 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -112.19 134.71 53.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 14.6 p -123.97 157.61 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.34 139.48 30.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -105.49 122.3 45.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 100' ' ' LEU . 87.9 t -148.68 129.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.427 HG13 ' CB ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 109.911 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 33' ' ' ILE . 9.3 mmtt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.7 mp -58.28 100.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.222 0.534 . . . . 0.0 110.791 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 92' ' ' ILE . 5.2 pt -81.62 161.03 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.331 -0.855 . . . . 0.0 109.872 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.54 144.36 31.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.336 -0.853 . . . . 0.0 110.52 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 92' ' ' ILE . 8.4 p -137.59 114.11 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.0 109.992 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.748 HG23 ' OE1' ' A' ' 45' ' ' GLU . 3.2 m -80.92 110.28 16.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.98 127.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.455 -0.778 . . . . 0.0 110.051 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -108.85 122.54 47.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.794 HG22 HD13 ' A' ' 100' ' ' LEU . 23.1 p -126.84 166.81 20.01 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 109.836 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.04 -12.27 33.83 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.698 1.368 . . . . 0.0 110.57 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -40.76 10.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -172.35 -173.14 1.02 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.72 114.92 14.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.771 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -135.34 135.5 40.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.826 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -78.82 151.41 31.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.476 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.68 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.6 m-85 -126.09 116.16 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 110.684 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.48 123.38 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 0.0 108.935 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.7 m -143.21 155.06 61.75 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.144 -0.972 . . . . 0.0 110.006 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -68.72 122.52 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.967 1.509 . . . . 0.0 110.836 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.555 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -30.0 -44.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.871 0.367 . . . . 0.0 111.858 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 49' ' ' PRO . 51.5 p-10 -78.33 43.4 0.46 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.023 -1.048 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -111.56 100.69 9.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.136 -0.977 . . . . 0.0 110.016 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -62.22 164.45 6.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.146 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.948 HG21 ' O ' ' A' ' 82' ' ' LYS . 42.5 t -67.78 -35.32 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.824 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.48 -43.42 34.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.637 -1.29 . . . . 0.0 109.926 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -80.75 -37.47 30.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.326 -0.858 . . . . 0.0 110.361 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 35.4 t80 -70.08 -51.18 33.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.53 -42.32 82.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 109.738 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.494 ' HA ' HG23 ' A' ' 69' ' ' THR . 8.7 mt-10 -65.9 -25.85 67.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 109.917 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.22 -44.65 79.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 13.7 mt -60.85 -39.67 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.0 109.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.608 ' CB ' ' HG1' ' A' ' 69' ' ' THR . 3.1 m -53.57 -53.05 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.016 -1.053 . . . . 0.0 110.597 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -68.5 -53.92 20.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.331 -0.855 . . . . 0.0 111.655 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.86 -54.11 11.12 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.029 -1.044 . . . . 0.0 111.475 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -68.03 -36.61 80.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.223 -0.923 . . . . 0.0 110.21 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tptt 68.53 81.33 0.18 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -159.92 -71.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.778 . . . . 0.0 110.07 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.8 -170.14 3.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.608 ' HG1' ' CB ' ' A' ' 62' ' ' SER . 4.1 m -153.63 -48.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.377 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.21 -67.23 0.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 73' ' ' VAL . 51.6 mt-30 -61.19 -25.71 67.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.396 -0.815 . . . . 0.0 110.376 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 102' ' ' ILE . 10.3 tp -61.86 108.4 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.534 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 71' ' ' GLN . 90.7 t -127.86 156.85 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.617 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 100' ' ' LEU . 10.3 mt -113.51 142.79 45.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.224 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.552 ' C ' HG23 ' A' ' 98' ' ' VAL . 49.7 mm -104.94 89.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.426 -0.796 . . . . 0.0 110.385 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HZ ' HD22 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -78.09 83.54 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.06 63.13 2.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.631 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.22 -52.11 3.78 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -59.81 174.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -1.071 . . . . 0.0 110.23 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.14 99.23 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.836 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CA ' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -65.9 79.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.948 ' O ' HG21 ' A' ' 54' ' ' VAL . 8.6 tttt -146.21 -162.31 1.5 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.592 -0.693 . . . . 0.0 110.761 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 29.8 t70 -70.77 -14.26 62.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.649 -0.657 . . . . 0.0 110.298 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.432 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.2 mm-40 -52.06 -31.22 29.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.801 . . . . 0.0 109.756 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -147.87 -176.04 5.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.416 -0.802 . . . . 0.0 109.969 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 88' ' ' ILE . 73.4 p -102.69 157.04 17.22 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.069 -1.02 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 92' ' ' ILE . 6.2 mp -66.18 -29.73 70.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.641 HD12 ' HB ' ' A' ' 86' ' ' THR . 2.3 mt -66.0 -19.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.153 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.9 tp60 -105.7 -10.09 16.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 112.012 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 178.03 -26.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.554 -1.341 . . . . 0.0 111.525 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.74 -37.73 90.53 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.74 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 91' ' ' GLY . 1.4 mm -139.49 175.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -1.147 . . . . 0.0 110.085 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.69 ' HB2' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -147.03 -48.6 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.64 35.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.846 -0.533 . . . . 0.0 109.868 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.25 68.29 0.67 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 93' ' ' HIS . 4.8 mp -115.25 175.78 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -1.158 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 5.0 m -114.66 147.04 40.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 75' ' ' ILE . 5.4 p -139.23 148.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -90.96 115.92 28.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 39' ' ' THR . 2.8 tt -79.24 150.07 31.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.17 -0.956 . . . . 0.0 110.537 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 75' ' ' ILE . 9.6 p -169.01 125.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.05 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.798 HG22 HD12 ' A' ' 72' ' ' LEU . 2.5 pp . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 110.192 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.1 mttp . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.6 mp -57.47 117.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.814 -0.554 . . . . 0.0 110.813 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.706 HG12 HG23 ' A' ' 48' ' ' VAL . 13.1 pt -84.9 157.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.827 . . . . 0.0 109.727 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 92' ' ' ILE . 6.8 mtmt -91.23 143.5 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 92' ' ' ILE . 59.0 t -129.36 113.79 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.479 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.3 m -85.92 98.55 10.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 0.0 109.643 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 98' ' ' VAL . 57.4 t -94.56 127.66 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 110.223 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.86 122.34 46.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.751 HG22 HD13 ' A' ' 100' ' ' LEU . 39.5 p -119.9 164.39 22.51 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 44.1 Cg_endo -71.31 60.85 2.59 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.61 1.321 . . . . 0.0 110.446 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -175.21 -42.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.58 176.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.387 -0.82 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -110.86 126.49 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 109.984 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -135.21 131.2 36.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.71 147.72 25.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.81 . . . . 0.0 109.833 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.15 144.93 48.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 110.281 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -100.25 133.2 45.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.048 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 33' ' ' ILE . 33.2 m -143.6 143.12 22.51 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.234 -0.916 . . . . 0.0 108.853 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' ASN . 41.3 Cg_endo -68.22 127.98 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.622 1.328 . . . . 0.0 111.262 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.572 ' O ' HD13 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -38.46 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.026 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 49' ' ' PRO . 31.7 t30 -113.36 61.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.772 -1.205 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -154.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.802 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 m -160.43 160.95 32.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.238 -0.914 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.897 HG21 ' O ' ' A' ' 82' ' ' LYS . 59.7 t -61.08 -34.95 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.506 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -49.18 -46.79 45.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.682 -1.261 . . . . 0.0 109.849 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -78.01 -44.56 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 110.353 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' HD22 ' A' ' 87' ' ' LEU . 66.1 t80 -63.65 -51.42 65.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.867 . . . . 0.0 110.308 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.98 -31.74 67.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 110.037 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -23.43 35.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.2 82.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.342 -0.849 . . . . 0.0 110.186 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 4.7 mt -61.01 -36.96 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.6 p -53.85 -49.31 68.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.064 -1.022 . . . . 0.0 110.709 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -68.14 -54.21 19.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 111.521 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -54.09 10.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.092 -1.005 . . . . 0.0 111.406 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.16 -36.4 79.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.29 -0.881 . . . . 0.0 110.427 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER 71.79 80.62 0.15 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.535 -0.728 . . . . 0.0 110.094 -179.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.59 -164.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.493 -0.755 . . . . 0.0 109.951 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.39 173.87 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -139.46 -52.67 0.54 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.52 -61.36 2.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.171 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.9 mt-30 -61.15 -25.37 66.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 110.133 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.29 108.01 0.22 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.419 -0.801 . . . . 0.0 110.779 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' HD2' ' A' ' 82' ' ' LYS . 65.7 t -127.49 137.07 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.4 155.94 19.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.927 -1.108 . . . . 0.0 109.701 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.23 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.961 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 77' ' ' ALA . 48.3 t80 -69.78 70.64 0.33 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.261 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PHE . . . 28.68 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.895 -0.503 . . . . 0.0 112.283 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.58 -60.41 0.34 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.09 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.631 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -105.66 -160.81 0.77 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -1.174 . . . . 0.0 110.421 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.631 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -107.36 111.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.275 -0.89 . . . . 0.0 109.994 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -69.73 74.65 0.42 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.913 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -130.29 -159.23 0.95 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.37 0.605 . . . . 0.0 109.782 -178.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.1 p-10 -73.32 -13.8 61.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -51.95 -32.53 33.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -174.77 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 110.008 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.38 136.88 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.719 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 57' ' ' PHE . 19.1 tp -55.66 -47.84 76.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.185 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.6 pp -73.74 -15.17 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 111.151 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' THR . 23.3 tt0 -104.71 7.64 34.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.133 -0.98 . . . . 0.0 112.116 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.55 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.634 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.985 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.37 -41.7 97.09 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 91' ' ' GLY . 6.2 mm -135.85 131.76 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -1.059 . . . . 0.0 110.7 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 64.7 m170 -96.52 -38.92 9.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.893 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 25.3 t0 -178.44 34.37 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.749 -0.594 . . . . 0.0 109.673 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 112.53 68.12 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -1.134 . . . . 0.0 110.114 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.6 m -111.45 144.47 40.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.505 -0.747 . . . . 0.0 109.844 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 36' ' ' THR . 13.9 m -137.61 136.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.29 115.38 27.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.296 -0.877 . . . . 0.0 110.077 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 HG22 ' A' ' 39' ' ' THR . 3.0 tt -83.2 133.58 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.303 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.7 p -162.39 117.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.309 -0.869 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.96 -44.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.373 -0.829 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 52.11 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.33 81.16 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.254 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.77 152.99 29.89 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -153.24 98.52 2.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -1.096 . . . . 0.0 110.258 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -100.17 34.87 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -102.49 131.31 49.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 110.219 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.25 -161.78 33.34 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 140.62 31.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.806 1.424 . . . . 0.0 110.404 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.79 168.9 23.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.646 1.34 . . . . 0.0 110.47 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -61.93 -56.08 35.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.824 . . . . 0.0 110.274 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.1 Cg_endo -73.6 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.483 1.254 . . . . 0.0 110.391 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -166.77 94.12 0.49 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.88 120.58 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.27 -152.36 8.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.61 135.16 23.51 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.8 1.421 . . . . 0.0 110.363 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.46 -161.4 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.422 -0.799 . . . . 0.0 110.212 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.22 61.49 4.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.838 . . . . 0.0 110.23 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.21 -25.54 67.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 52.29 -174.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.344 -0.847 . . . . 0.0 110.469 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.14 -30.67 2.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -119.8 66.91 0.81 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -1.071 . . . . 0.0 110.166 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.4 82.56 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.59 83.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 110.407 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.54 98.27 4.24 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.136 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.47 -173.62 1.2 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.698 1.367 . . . . 0.0 110.468 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.63 26.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.309 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 51.77 81.04 0.27 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.7 Cg_endo -81.97 38.75 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.741 1.39 . . . . 0.0 111.304 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -74.37 64.81 1.16 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.5 mp -58.04 99.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.621 -0.674 . . . . 0.0 110.692 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.2 pt -78.74 146.29 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.123 -0.986 . . . . 0.0 109.353 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 25.5 mttp -91.44 132.76 36.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 46' ' ' PHE . 6.1 p -123.13 114.25 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 m -86.25 108.09 18.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 61.9 t -102.27 128.38 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.283 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -97.26 122.73 40.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.393 -0.817 . . . . 0.0 109.838 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 100' ' ' LEU . 2.3 p -120.67 168.03 11.59 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.269 -0.895 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.6 Cg_endo -70.54 62.44 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.679 1.357 . . . . 0.0 110.238 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.67 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.6 -179.2 1.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.418 -0.801 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -105.61 115.31 30.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 134.04 54.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.58 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.5 151.53 19.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 0.0 109.714 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.648 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.2 m-85 -126.45 150.1 48.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.458 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -102.16 133.43 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 33' ' ' ILE . 28.4 m -143.93 147.62 38.99 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.092 -1.005 . . . . 0.0 109.452 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 51' ' ' ASN . 39.8 Cg_endo -67.24 126.29 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.76 1.4 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 88' ' ' ILE . 10.1 tt0 -42.45 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.93 -0.481 . . . . 0.0 111.769 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' PRO . 8.3 p-10 -115.01 63.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.601 -1.312 . . . . 0.0 110.378 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 154.99 47.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.129 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -98.8 156.46 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.364 -0.835 . . . . 0.0 109.853 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 82' ' ' LYS . 88.3 t -60.94 -34.34 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 110.699 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.54 -44.11 36.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.051 -1.031 . . . . 0.0 110.627 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -51.65 32.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.904 . . . . 0.0 109.915 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 71.5 t80 -59.88 -37.07 78.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.413 -0.804 . . . . 0.0 110.129 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 54' ' ' VAL . 2.1 mtpt -57.64 -46.05 84.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.516 -0.74 . . . . 0.0 109.8 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.25 -19.63 61.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.769 . . . . 0.0 110.167 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -65.72 -52.27 52.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.26 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.8 mt -63.74 -41.91 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.297 -0.877 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -53.71 -52.01 61.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.63 -53.94 19.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.286 -0.884 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.17 -54.27 10.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.121 -0.987 . . . . 0.0 111.454 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.01 -36.47 80.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.176 -0.953 . . . . 0.0 110.181 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 16.4 ttpt 68.72 81.3 0.18 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 110.224 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -152.98 -65.4 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.5 -0.75 . . . . 0.0 110.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -167.93 -176.95 3.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -145.95 -63.91 0.32 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.86 -63.58 1.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.923 . . . . 0.0 110.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.82 -25.46 65.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -61.33 125.2 22.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.822 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 82' ' ' LYS . 91.7 t -150.08 167.79 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 109.194 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.752 HD12 HG23 ' A' ' 98' ' ' VAL . 1.2 mm? -118.33 135.88 54.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.037 -1.04 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 101' ' ' VAL . 46.8 mm -97.19 96.91 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.42 -0.8 . . . . 0.0 109.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.847 ' CB ' HD13 ' A' ' 81' ' ' LEU . 9.3 t80 -95.31 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 110.232 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.49 35.86 18.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.403 -0.81 . . . . 0.0 110.697 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.01 -40.18 2.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -178.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.203 -1.175 . . . . 0.0 110.047 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.13 94.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.695 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.98 HD11 ' CA ' ' A' ' 91' ' ' GLY . 1.6 tp -65.07 81.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.741 ' O ' HG21 ' A' ' 54' ' ' VAL . 3.5 ttmt -137.98 -155.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.339 0.59 . . . . 0.0 110.364 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.84 -19.63 61.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 0.0 110.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.7 -32.81 53.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.852 . . . . 0.0 109.807 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -133.59 -175.45 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 109.972 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -105.84 130.36 53.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.96 . . . . 0.0 109.932 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 92' ' ' ILE . 14.1 tp -55.42 -46.91 76.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.759 . . . . 0.0 110.26 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.5 pp -72.76 -14.98 17.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 110.472 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 53.5 tp60 -88.18 -10.83 48.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 112.062 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.35 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.45 -1.407 . . . . 0.0 111.574 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.98 ' CA ' HD11 ' A' ' 81' ' ' LEU . . . -58.97 -41.73 96.5 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.189 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 91' ' ' GLY . 4.0 mm -134.3 113.65 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -1.157 . . . . 0.0 111.023 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -87.11 -33.61 19.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 108.881 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.7 t70 -179.97 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.736 -0.603 . . . . 0.0 110.015 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 128.42 69.76 0.14 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 6.0 mt -108.83 162.64 14.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -1.211 . . . . 0.0 110.129 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.8 p -112.16 134.52 53.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.313 -0.867 . . . . 0.0 110.274 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.853 HG11 HD22 ' A' ' 81' ' ' LEU . 27.5 m -140.64 151.93 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.437 -0.789 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.688 ' O ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.0 110.382 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 39' ' ' THR . 8.2 tt -101.15 127.88 47.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.454 HG22 HG12 ' A' ' 75' ' ' ILE . 34.0 m -141.99 143.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.77 104.98 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.341 -0.849 . . . . 0.0 110.37 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mtm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.71 134.75 14.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.04 141.5 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.377 -0.827 . . . . 0.0 110.108 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -161.8 89.77 0.75 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.246 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.62 -101.97 0.33 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -165.54 88.36 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -1.044 . . . . 0.0 110.231 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.43 58.74 1.61 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 0.0 110.237 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.3 m -118.0 -164.56 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.13 -163.2 30.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.16 153.64 51.65 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.798 1.42 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.72 -31.59 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.792 1.417 . . . . 0.0 110.558 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 51.87 63.16 9.67 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.22 -24.6 16.67 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.767 1.404 . . . . 0.0 110.476 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.71 133.63 56.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.37 -0.831 . . . . 0.0 110.287 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -108.31 112.69 25.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.442 -0.786 . . . . 0.0 110.257 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.73 58.16 12.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.83 66.89 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.763 1.402 . . . . 0.0 110.46 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.17 32.14 15.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.332 -0.855 . . . . 0.0 110.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.69 -42.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.16 50.51 1.87 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.87 47.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.1 -106.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.34 56.42 7.74 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.328 -1.101 . . . . 0.0 110.452 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.87 79.99 5.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -0.864 . . . . 0.0 110.28 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.61 25.74 10.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.282 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.16 62.56 0.48 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.348 -0.845 . . . . 0.0 110.226 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.05 66.25 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.685 1.361 . . . . 0.0 110.421 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.34 -172.82 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 9.1 pt-20 -151.95 79.37 6.37 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.369 -0.832 . . . . 0.0 110.267 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.872 ' O ' HD12 ' A' ' 32' ' ' ILE . 51.8 Cg_endo -78.77 43.0 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.708 1.373 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -73.2 65.63 0.83 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.3 mp -58.51 124.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.734 -0.604 . . . . 0.0 110.724 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' A' ' 92' ' ' ILE . 18.0 pt -108.19 158.87 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.759 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 144.37 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 46' ' ' PHE . 9.0 p -134.81 113.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.842 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.7 m -79.21 105.22 10.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.41 127.88 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.825 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -112.88 122.28 47.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.11 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.516 HG22 ' HG ' ' A' ' 100' ' ' LEU . 18.1 p -122.46 166.07 18.78 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 109.851 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.1 Cg_endo -70.72 61.23 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.648 1.341 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.61 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.469 -0.77 . . . . 0.0 109.798 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -169.65 166.98 9.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 118.6 29.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.33 135.55 40.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.898 . . . . 0.0 110.556 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.47 150.23 36.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.649 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.777 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.7 m-85 -120.38 108.89 14.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.532 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.63 105.22 13.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 0.0 109.503 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.53 157.05 79.23 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.363 -0.836 . . . . 0.0 110.711 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.61 108.42 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.793 1.417 . . . . 0.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 11.7 pt-20 -51.12 -25.49 5.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.492 -0.755 . . . . 0.0 110.741 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -53.6 -23.95 12.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.362 -0.836 . . . . 0.0 110.556 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.07 140.63 30.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.885 . . . . 0.0 110.462 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.1 m -70.82 171.83 9.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.6 t -66.8 -35.75 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -42.78 31.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.054 -1.029 . . . . 0.0 110.108 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.4 -46.07 64.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.615 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 84.2 t80 -69.92 -38.36 76.23 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.218 -0.927 . . . . 0.0 110.626 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.74 -45.18 86.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 69' ' ' THR . 17.8 tt0 -74.63 -16.7 60.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.893 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.11 -44.65 79.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.297 -0.877 . . . . 0.0 109.932 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.2 mt -60.87 -37.94 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.654 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 29.1 t -53.94 -46.3 71.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.915 . . . . 0.0 110.78 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -67.89 -54.76 16.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 111.44 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.79 -54.08 9.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.122 -0.987 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.38 -36.25 78.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.381 -0.824 . . . . 0.0 110.551 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 69.33 81.69 0.17 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.574 -0.704 . . . . 0.0 110.03 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -155.04 -75.0 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.554 -0.716 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -161.0 179.46 8.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 59' ' ' GLU . 62.2 m -139.99 -62.01 0.52 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.83 . . . . 0.0 110.443 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.5 -66.69 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 0.0 110.32 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -59.63 -25.71 64.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.288 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 100' ' ' LEU . 11.5 tp -59.91 133.61 56.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.475 -0.766 . . . . 0.0 110.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.479 HG23 ' C ' ' A' ' 72' ' ' LEU . 78.1 t -152.53 158.43 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.418 -0.801 . . . . 0.0 109.28 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.1 mp -121.15 122.02 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.232 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 75' ' ' ILE . 25.4 mm -78.8 103.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.045 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.827 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.5 t80 -112.14 120.14 40.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.506 -0.746 . . . . 0.0 110.076 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.69 29.31 17.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.62 59.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -172.7 2.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -1.085 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.507 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -103.27 82.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 110.363 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.1 tt -66.43 83.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.242 -0.911 . . . . 0.0 108.645 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -148.96 -147.07 0.21 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.557 -0.715 . . . . 0.0 110.253 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.52 -14.36 61.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 111.315 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.449 ' HB3' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -52.15 -33.62 41.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.585 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -176.63 4.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 143.86 27.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 109.882 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.995 HD11 HD11 ' A' ' 92' ' ' ILE . 11.6 tp -56.23 -46.14 79.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.496 -0.752 . . . . 0.0 110.672 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.62 -8.27 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.411 -0.806 . . . . 0.0 111.095 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 14.3 mt-30 -110.08 -1.2 17.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.954 -1.092 . . . . 0.0 112.028 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 176.54 -30.78 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.589 -1.32 . . . . 0.0 111.807 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.26 -47.68 88.06 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.543 -1.313 . . . . 0.0 109.919 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -144.42 161.95 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.273 -1.134 . . . . 0.0 110.183 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -122.64 -41.74 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.539 -0.726 . . . . 0.0 109.359 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.71 35.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.028 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.77 67.75 0.53 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' ' 96' ' ' LEU . 4.3 mm? -103.98 175.81 5.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 97' ' ' THR . 9.7 t -111.95 121.32 44.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.765 . . . . 0.0 110.082 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 81' ' ' LEU . 33.7 m -125.94 149.23 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 110.378 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.446 -0.784 . . . . 0.0 110.172 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -92.98 120.12 32.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.373 -0.83 . . . . 0.0 110.019 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' N ' HD13 ' A' ' 100' ' ' LEU . 32.8 m -148.72 156.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.82 137.16 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.215 0.531 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.3 44.78 0.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.258 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.03 130.93 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.348 -0.845 . . . . 0.0 110.177 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -140.43 81.75 1.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.96 138.14 24.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.31 81.42 2.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.338 -1.095 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 t -85.79 172.32 10.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m 52.51 -171.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.352 -0.842 . . . . 0.0 110.433 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.01 -88.23 2.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.4 162.2 40.76 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.741 1.39 . . . . 0.0 110.421 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.85 -179.66 4.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.75 1.395 . . . . 0.0 110.345 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 -62.34 138.62 96.32 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.26 -82.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.774 1.407 . . . . 0.0 110.7 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 m -141.01 -71.29 0.36 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.087 -1.008 . . . . 0.0 110.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.53 -60.02 2.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.32 57.39 15.37 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.97 116.4 4.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.709 1.373 . . . . 0.0 110.406 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.72 161.78 30.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.414 -0.804 . . . . 0.0 110.223 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.45 109.55 4.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.78 -35.12 10.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -58.82 -176.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.374 -0.829 . . . . 0.0 110.367 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.9 -29.14 12.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -70.81 -16.93 62.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -1.12 . . . . 0.0 110.452 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.52 136.8 38.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 110.392 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.71 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.392 -0.818 . . . . 0.0 110.609 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.24 78.81 12.06 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 110.163 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 150.26 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.766 1.403 . . . . 0.0 110.386 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.23 -54.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.29 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.67 71.11 1.54 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.862 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.5 Cg_endo -81.93 21.05 0.99 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.756 1.398 . . . . 0.0 111.454 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.46 67.25 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.3 mm -58.47 124.15 11.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.705 -0.622 . . . . 0.0 110.85 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.756 HD13 HG22 ' A' ' 88' ' ' ILE . 8.6 pt -106.77 149.61 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 0.0 109.522 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -91.8 144.23 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 110.647 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 92' ' ' ILE . 14.8 m -132.92 130.38 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 109.583 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.17 110.25 22.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' HD12 ' A' ' 100' ' ' LEU . 58.7 t -96.47 127.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.799 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 122.83 47.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -125.73 169.74 10.83 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.301 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.94 60.51 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.702 1.369 . . . . 0.0 110.372 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.7 -46.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.316 -0.865 . . . . 0.0 109.812 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -173.19 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.101 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -123.12 129.82 51.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -135.12 127.63 30.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -84.86 147.73 26.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.397 -0.815 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.8 m-85 -125.08 145.84 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.533 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.35 132.13 45.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 0.0 108.991 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.5 m -143.16 148.83 46.41 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.975 . . . . 0.0 110.266 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 32' ' ' ILE . 40.5 Cg_endo -71.08 119.43 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.705 1.371 . . . . 0.0 110.418 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -32.73 -41.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.223 0.535 . . . . 0.0 111.642 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -83.88 50.97 1.93 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.051 -1.03 . . . . 0.0 110.571 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 51.4 p -126.21 112.77 16.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.29 156.86 21.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -63.02 -35.4 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.197 -0.94 . . . . 0.0 110.913 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -49.31 -50.15 40.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.123 -0.985 . . . . 0.0 111.055 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -63.0 -55.27 27.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.99 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 35' ' ' VAL . 51.3 t80 -59.91 -36.57 77.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.457 -0.777 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -57.15 -36.74 71.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 0.0 110.386 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -79.05 -24.47 43.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.61 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 0.0 109.573 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.61 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.8 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.807 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -66.45 -44.55 82.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 110.625 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -58.85 -53.12 61.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.253 -0.904 . . . . 0.0 110.952 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -52.68 63.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.688 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 39' ' ' THR . 10.5 m-85 -67.5 -36.91 82.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 0.0 110.445 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.91 79.52 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.469 -0.769 . . . . 0.0 110.091 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 t -153.92 -71.08 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.38 -0.825 . . . . 0.0 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.647 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -151.87 -171.57 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.174 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.0 m -153.51 -57.79 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.36 -0.837 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.49 -70.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.322 -0.861 . . . . 0.0 110.413 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.879 ' O ' HG23 ' A' ' 73' ' ' VAL . 6.2 mt-30 -60.76 -25.53 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.698 ' HA ' HG22 ' A' ' 102' ' ' ILE . 1.2 tt -52.93 106.46 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 110.763 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.972 HG22 ' HD2' ' A' ' 82' ' ' LYS . 51.0 t -127.14 151.18 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.651 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.756 HD23 HG11 ' A' ' 98' ' ' VAL . 5.0 mp -102.04 146.2 28.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 75' ' ' ILE . 29.9 mm -107.76 83.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.45 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.844 ' HB2' HD12 ' A' ' 81' ' ' LEU . 3.2 t80 -98.84 124.04 43.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.386 -0.821 . . . . 0.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.07 26.35 6.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.37 -0.831 . . . . 0.0 110.556 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.04 26.32 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 1.2 tttm -129.48 136.54 50.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -1.09 . . . . 0.0 110.061 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.784 ' O ' HD12 ' A' ' 80' ' ' ILE . 1.4 pp -59.68 88.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.816 . . . . 0.0 111.351 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 76' ' ' PHE . 1.3 tt -66.79 86.87 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.972 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.5 OUTLIER -140.34 -149.74 0.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.01 -177.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -74.1 -20.71 60.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.698 . . . . 0.0 110.834 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -52.7 -32.75 44.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.103 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.91 140.21 46.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 147.94 33.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.541 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 92' ' ' ILE . 13.8 tp -57.59 -48.52 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.705 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.756 HG22 HD13 ' A' ' 33' ' ' ILE . 1.8 pp -73.04 -13.7 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.051 -1.031 . . . . 0.0 110.367 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.73 -15.09 46.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 111.542 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 79' ' ' LYS . 4.9 t-80 -171.69 -38.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.624 -1.297 . . . . 0.0 111.431 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.839 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -59.44 -49.67 76.01 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.386 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -142.26 146.37 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -1.232 . . . . 0.0 110.808 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 13.1 m170 -109.76 -35.49 6.17 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.5 t0 -177.68 31.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.29 0.567 . . . . 0.0 109.861 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.4 69.33 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.677 HD12 ' HA ' ' A' ' 92' ' ' ILE . 84.1 mt -109.17 174.22 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -1.223 . . . . 0.0 109.966 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.8 p -115.84 147.25 41.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.756 HG11 HD23 ' A' ' 74' ' ' LEU . 7.6 p -147.68 146.14 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.402 -0.811 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -90.63 116.15 28.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.489 -0.757 . . . . 0.0 110.118 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 72' ' ' LEU . 5.7 tt -74.17 121.28 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.306 -0.871 . . . . 0.0 110.13 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 100' ' ' LEU . 58.0 t -145.95 131.85 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.386 -0.821 . . . . 0.0 110.106 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.698 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.3 pp -99.38 131.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.819 . . . . 0.0 110.218 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.218 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.262 0.553 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.35 116.98 19.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.7 -30.14 21.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -0.847 . . . . 0.0 110.265 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -106.49 53.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.315 -0.866 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.04 83.8 0.21 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 167.25 16.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -1.098 . . . . 0.0 110.22 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -80.87 172.31 13.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -148.15 110.45 4.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.93 -79.08 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 113.11 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.731 1.385 . . . . 0.0 110.374 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.05 -27.99 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.661 1.348 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -105.54 127.6 28.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.88 -163.83 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.679 1.357 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.54 113.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 110.424 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.62 -49.59 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.39 -0.819 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.9 -69.16 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.03 -28.2 13.21 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.826 1.435 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.31 -45.83 83.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.0 110.347 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 174.93 5.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.391 -0.818 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.37 -166.84 0.56 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.38 -0.825 . . . . 0.0 110.18 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.86 80.42 6.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.18 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.66 55.5 0.62 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 p -83.93 -73.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.347 -1.09 . . . . 0.0 110.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.82 62.88 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.77 93.2 5.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.239 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.873 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . -75.1 -55.12 2.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 110.64 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 47.4 Cg_endo -74.41 122.96 7.83 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.403 1.212 . . . . 0.0 110.445 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.8 131.43 24.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.28 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 51.9 73.09 1.02 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.377 -0.827 . . . . 0.0 110.512 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.812 ' O ' HD12 ' A' ' 32' ' ' ILE . 52.1 Cg_endo -81.7 37.87 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.774 1.407 . . . . 0.0 111.361 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 67.26 0.52 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.2 mp -58.47 99.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.63 -0.669 . . . . 0.0 110.55 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 92' ' ' ILE . 4.3 pt -78.83 150.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -94.23 144.59 25.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.0 110.972 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 92' ' ' ILE . 7.9 p -137.97 113.96 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.495 -0.753 . . . . 0.0 109.866 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -85.89 112.72 21.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 110.605 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.16 127.96 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.55 122.51 43.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.605 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -124.12 170.73 8.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.812 . . . . 0.0 109.921 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.4 Cg_endo -68.94 -16.06 40.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.697 1.367 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -49.13 6.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.016 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -173.54 174.47 3.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -103.04 122.05 43.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.949 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.14 135.48 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -90.29 150.97 21.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.443 -0.785 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' HG12 ' A' ' 35' ' ' VAL . 3.9 m-85 -125.59 128.09 47.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.369 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -91.86 124.71 36.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.227 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.3 m -142.98 154.71 62.19 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 109.943 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.2 Cg_endo -66.48 121.65 8.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.814 1.429 . . . . 0.0 110.63 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.6 pt-20 -36.31 -38.96 0.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.214 0.531 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 71.9 m-80 -86.96 53.07 2.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.516 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.5 p -119.23 154.02 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.345 -0.847 . . . . 0.0 110.194 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 t -103.02 148.04 26.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.011 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 82' ' ' LYS . 71.3 t -59.38 -34.37 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -48.59 -46.12 38.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.047 -1.033 . . . . 0.0 110.547 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.72 -51.39 49.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -59.89 -36.91 77.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.54 -39.02 75.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.491 -0.756 . . . . 0.0 109.563 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.57 -22.13 47.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.36 -48.22 78.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG23 ' CB ' ' A' ' 65' ' ' PHE . 20.0 mt -60.78 -38.76 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 109.669 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -53.75 -53.12 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.126 -0.984 . . . . 0.0 110.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -68.52 -54.76 14.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 111.694 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -72.55 -54.55 8.87 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.094 -1.004 . . . . 0.0 111.568 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.494 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.3 -36.48 79.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.189 -0.944 . . . . 0.0 110.443 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tttt 71.81 73.69 0.17 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -160.51 -153.91 0.35 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.529 -0.732 . . . . 0.0 109.959 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -173.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -148.18 -61.9 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.81 -63.64 1.23 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -59.32 -27.09 65.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 100' ' ' LEU . 11.6 tp -62.71 105.93 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.489 -0.757 . . . . 0.0 110.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 82' ' ' LYS . 77.3 t -128.82 161.54 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.027 HD22 HG23 ' A' ' 98' ' ' VAL . 9.8 mt -113.7 139.66 48.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 110.084 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 101' ' ' VAL . 43.1 mm -100.42 93.54 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.2 t80 -96.96 115.21 27.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.77 27.57 7.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -0.838 . . . . 0.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.79 -39.7 2.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -176.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -1.073 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.51 90.92 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.323 -0.861 . . . . 0.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 87' ' ' LEU . 10.1 tt -61.84 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.797 ' O ' HG21 ' A' ' 54' ' ' VAL . 20.5 tttt -154.03 -148.16 0.24 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.418 -0.801 . . . . 0.0 110.655 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.0 t70 -72.13 -15.14 61.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.129 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -53.19 -32.52 48.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.68 161.38 39.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.631 -0.668 . . . . 0.0 109.9 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.425 ' OG1' ' CG ' ' A' ' 89' ' ' GLN . 64.4 p -79.21 165.0 23.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.697 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.718 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.24 -46.35 77.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.86 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.8 pt -64.62 -18.95 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.032 -1.043 . . . . 0.0 110.453 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' CG ' ' OG1' ' A' ' 86' ' ' THR . 27.5 mm-40 -92.11 -15.79 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.922 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 178.42 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.027 -1.046 . . . . 0.0 111.638 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.718 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.04 -50.23 67.93 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -148.86 171.65 2.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.529 -0.983 . . . . 0.0 108.706 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.488 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.65 -33.23 4.33 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.651 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.6 t70 179.83 34.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.569 -0.707 . . . . 0.0 109.97 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.05 69.98 0.34 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD22 ' CE1' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -114.04 -172.13 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m -131.42 146.35 52.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.027 HG23 HD22 ' A' ' 74' ' ' LEU . 27.4 m -143.7 149.51 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.356 -0.84 . . . . 0.0 110.504 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.57 118.71 30.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 110.352 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 ' CG2' ' A' ' 39' ' ' THR . 6.8 tt -77.37 149.52 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 75' ' ' ILE . 7.8 p -171.38 138.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.89 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp -99.32 126.34 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.9 mttt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.19 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.204 0.526 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.13 102.54 15.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.19 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -96.21 38.92 1.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -97.56 27.77 4.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.307 -0.871 . . . . 0.0 110.251 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.72 -166.91 1.33 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.56 -46.08 41.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.352 -1.087 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -114.96 -26.77 7.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -0.832 . . . . 0.0 110.341 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 m 54.99 177.5 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.304 -0.872 . . . . 0.0 110.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.6 93.52 0.1 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 158.67 51.33 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.66 1.347 . . . . 0.0 110.435 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.15 -164.82 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 0.0 110.321 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -62.84 -57.78 19.95 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.491 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 12' ' ' ARG . 46.3 Cg_endo -72.36 179.15 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.506 1.266 . . . . 0.0 110.487 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.92 -41.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 0.0 110.265 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.94 177.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.328 -0.858 . . . . 0.0 110.32 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.69 -145.83 5.64 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 19' ' ' ALA . 46.0 Cg_endo -72.64 65.86 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.687 1.361 . . . . 0.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . 55.77 -85.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 56.13 174.22 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -1.0 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.23 -44.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 110.248 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -141.2 -61.38 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.55 132.29 20.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -125.55 54.57 1.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 110.225 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.51 133.54 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 0.0 110.242 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.21 161.51 17.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.352 -0.842 . . . . 0.0 110.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.63 147.85 39.79 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.0 110.149 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.02 -53.53 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.777 1.409 . . . . 0.0 110.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.92 -48.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.326 -0.858 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 52.15 82.6 0.24 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.3 Cg_endo -71.68 -93.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.811 1.427 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 43.68 41.53 3.64 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 48' ' ' VAL . 2.8 mp -58.08 118.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.276 0.56 . . . . 0.0 110.905 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 92' ' ' ILE . 1.9 pt -87.85 152.33 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.598 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -91.49 144.61 25.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 46' ' ' PHE . 18.3 m -138.86 140.32 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.455 -0.778 . . . . 0.0 110.043 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -109.56 104.25 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.857 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 127.84 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 122.47 43.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.957 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 HD22 ' A' ' 100' ' ' LEU . 7.3 p -113.72 166.63 10.91 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.947 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.8 Cg_endo -71.27 61.31 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.604 1.318 . . . . 0.0 110.424 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.15 -42.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.7 -169.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.407 -0.808 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -123.42 129.07 50.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -0.816 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -135.16 134.89 40.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.16 150.87 20.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.688 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.5 m-85 -129.03 144.18 51.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.469 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -100.33 128.45 46.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.402 -0.811 . . . . 0.0 109.235 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' N ' HG23 ' A' ' 32' ' ' ILE . 33.1 m -141.2 146.04 41.2 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 52' ' ' SER . 40.4 Cg_endo -67.97 122.07 9.15 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.669 1.352 . . . . 0.0 110.377 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.524 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.7 pp20? -31.07 -39.1 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' PRO . 43.9 p-10 -92.03 49.5 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.725 -1.235 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 1.7 t -114.38 112.96 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.484 -0.76 . . . . 0.0 110.068 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -65.5 147.96 52.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.877 HG11 ' HA ' ' A' ' 82' ' ' LYS . 90.3 t -56.41 -34.8 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -48.79 -43.83 38.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.05 -1.031 . . . . 0.0 110.53 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -68.44 -53.54 22.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.189 -0.945 . . . . 0.0 109.96 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.87 -36.82 77.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.498 -0.751 . . . . 0.0 110.365 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.586 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 mtpt -57.42 -43.04 83.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.504 -0.747 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 -23.25 54.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.525 -0.734 . . . . 0.0 109.941 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.94 86.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.2 mt -60.77 -40.05 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.404 -0.81 . . . . 0.0 109.729 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -53.71 -51.95 61.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -68.42 -54.64 15.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 111.666 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mmt-85 -72.36 -54.3 9.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.091 -1.006 . . . . 0.0 111.511 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.08 -36.35 79.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.373 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tptm 72.31 76.02 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.594 -0.691 . . . . 0.0 110.082 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.9 t -161.9 -153.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.547 -0.721 . . . . 0.0 109.818 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.612 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -71.47 165.11 24.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -136.13 -59.69 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.94 -72.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -57.96 -25.17 60.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.421 -0.799 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 68' ' ' GLN . 10.1 tp -59.81 128.47 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.477 -0.764 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 82' ' ' LYS . 88.6 t -151.1 167.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.565 -0.709 . . . . 0.0 109.242 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -117.92 133.38 55.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 0.0 110.159 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.09 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 32.0 t80 -70.07 62.73 0.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.637 -0.665 . . . . 0.0 110.554 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.28 26.49 2.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.143 -0.973 . . . . 0.0 110.738 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.03 -48.19 0.64 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.794 ' C ' HD13 ' A' ' 80' ' ' ILE . 3.7 mtpp -83.01 -166.99 1.49 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -1.062 . . . . 0.0 110.098 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.47 96.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.678 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -65.23 79.94 0.05 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.877 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ttmt -140.55 -156.5 0.68 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.7 p30 -72.32 -14.97 61.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -33.09 69.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.804 . . . . 0.0 110.015 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -143.8 164.55 30.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 110.767 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.27 153.47 17.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.872 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.678 HD11 ' CD2' ' A' ' 81' ' ' LEU . 1.1 mp -66.5 -46.65 75.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.342 -0.849 . . . . 0.0 110.897 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.1 pp -63.66 -19.62 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.023 . . . . 0.0 109.847 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -89.43 -18.79 26.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.805 . . . . 0.0 110.587 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.96 -26.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.948 -1.095 . . . . 0.0 112.063 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.32 -50.38 67.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.61 162.83 4.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -1.081 . . . . 0.0 108.682 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 5.9 m-70 -113.13 -30.8 6.85 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 109.75 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.3 t0 179.75 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 109.72 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.94 73.86 0.26 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.3 mm? -114.83 170.88 8.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.396 -1.061 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.429 ' C ' HG23 ' A' ' 98' ' ' VAL . 6.5 t -115.25 144.64 43.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 74' ' ' LEU . 44.6 t -146.68 154.85 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -90.83 144.36 25.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -101.44 121.96 42.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.901 . . . . 0.0 110.052 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.04 150.7 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.303 -0.873 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.61 123.77 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.341 -0.849 . . . . 0.0 110.188 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.192 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.215 0.531 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.46 -56.24 0.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 52.27 78.8 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.86 106.85 3.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.872 . . . . 0.0 110.232 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.76 105.22 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.51 138.01 54.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -1.072 . . . . 0.0 110.171 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.6 p -129.25 123.24 31.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.846 . . . . 0.0 110.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -90.39 -169.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.216 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.05 -160.49 34.07 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.9 133.9 20.76 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.807 1.425 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.24 -29.55 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.636 1.335 . . . . 0.0 110.376 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.62 94.22 11.62 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.311 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 179.21 5.35 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.74 1.39 . . . . 0.0 110.337 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -142.43 35.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -165.33 49.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.25 71.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.83 148.08 45.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.786 1.414 . . . . 0.0 110.453 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.45 -34.8 6.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.5 -69.07 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 110.253 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.77 -70.24 0.33 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -116.53 -70.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -96.75 -175.67 35.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -115.89 136.09 53.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.233 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 52.41 87.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.392 -0.817 . . . . 0.0 110.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.74 -46.07 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 110.259 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.881 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . -68.74 -54.92 12.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 48.2 Cg_endo -74.58 177.42 8.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.559 1.294 . . . . 0.0 110.382 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.72 80.77 0.5 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.815 . . . . 0.0 110.28 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.93 67.07 2.07 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 32' ' ' ILE . 51.6 Cg_endo -82.34 29.07 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.708 1.372 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -69.68 69.21 0.28 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 28.1 mm -57.78 128.26 18.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.593 -0.692 . . . . 0.0 110.758 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.889 HD12 ' HB ' ' A' ' 92' ' ' ILE . 32.0 pt -110.78 144.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.636 -0.665 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 144.53 25.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.823 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 46' ' ' PHE . 7.4 p -135.94 113.57 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.0 109.759 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -85.17 102.35 13.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.619 ' CG1' HD13 ' A' ' 100' ' ' LEU . 60.4 t -94.92 127.63 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.97 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -111.44 122.71 48.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.164 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 HD22 ' A' ' 100' ' ' LEU . 29.1 p -120.37 168.24 10.96 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.454 -0.779 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.52 -10.28 28.36 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.577 1.303 . . . . 0.0 110.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -42.39 7.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.08 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.08 157.49 5.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -107.42 118.34 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 110.078 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -135.32 135.62 40.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.943 . . . . 0.0 110.811 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.51 154.38 22.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 0.0 109.47 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.71 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.0 m-85 -128.08 128.71 45.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -91.36 129.93 37.28 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.409 HG13 ' C ' ' A' ' 47' ' ' ALA . 26.5 m -143.31 153.71 59.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.041 -1.037 . . . . 0.0 110.492 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 32' ' ' ILE . 42.8 Cg_endo -71.59 119.82 6.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.875 1.461 . . . . 0.0 110.443 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -36.22 -37.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.812 -0.555 . . . . 0.0 111.091 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -82.9 50.12 1.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 t -126.66 141.25 51.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.3 m -92.86 156.77 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 ' HG3' ' A' ' 58' ' ' LYS . 84.0 t -59.71 -34.59 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -48.96 -43.67 40.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.121 . . . . 0.0 110.532 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.74 -54.63 14.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -0.882 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.88 -36.97 78.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.385 -0.822 . . . . 0.0 110.191 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.882 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.32 -39.04 75.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.591 -0.693 . . . . 0.0 109.587 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.23 -18.78 44.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.501 -0.749 . . . . 0.0 109.917 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -49.68 71.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 65' ' ' PHE . 12.8 mt -60.91 -36.34 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.358 -0.838 . . . . 0.0 109.693 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -53.85 -51.73 62.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 0.0 110.535 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -68.43 -54.28 18.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.318 -0.864 . . . . 0.0 111.711 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -54.07 10.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.115 -0.991 . . . . 0.0 111.497 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.31 -36.24 79.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.278 -0.889 . . . . 0.0 110.351 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 8.5 mttm 68.72 81.86 0.18 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.601 -0.687 . . . . 0.0 109.942 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -157.12 -73.56 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 110.206 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.0 pt20 -166.45 -165.6 0.78 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.411 -0.806 . . . . 0.0 110.106 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -153.19 -51.19 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.594 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.36 -75.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.0 110.407 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.711 ' O ' HG23 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.69 -25.56 62.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -55.55 104.24 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.387 -0.821 . . . . 0.0 110.876 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 71' ' ' GLN . 58.0 t -127.59 156.1 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.503 -0.748 . . . . 0.0 109.38 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.657 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -118.73 141.2 48.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.973 -1.079 . . . . 0.0 110.519 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.402 ' C ' HG23 ' A' ' 98' ' ' VAL . 46.5 mm -101.16 93.68 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.5 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 81' ' ' LEU . 1.6 t80 -84.89 95.4 9.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.237 -0.914 . . . . 0.0 110.348 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.12 46.3 26.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 110.694 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.15 -45.72 2.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.0 179.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -115.84 93.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.267 -0.896 . . . . 0.0 110.855 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -65.28 82.44 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.745 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -144.09 -161.5 1.29 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.442 0.639 . . . . 0.0 110.491 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 2.5 p30 -73.33 -14.95 61.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.307 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.67 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 109.565 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -139.06 168.98 18.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 0.0 109.752 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.24 145.99 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.457 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 92' ' ' ILE . 16.5 tp -55.81 -47.01 77.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -72.39 -28.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.645 -0.659 . . . . 0.0 110.058 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -76.82 -6.21 51.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.704 . . . . 0.0 111.761 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.39 -37.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.536 -1.353 . . . . 0.0 111.759 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.792 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.98 -48.31 86.48 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.161 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.4 156.55 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.434 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -115.98 -41.63 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -177.87 34.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 109.87 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.573 ' C ' HD22 ' A' ' 96' ' ' LEU . . . 123.95 71.08 0.22 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.573 HD22 ' C ' ' A' ' 95' ' ' GLY . 4.1 mm? -117.57 174.87 5.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -1.104 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.7 m -116.51 147.31 41.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 74' ' ' LEU . 7.4 p -149.96 150.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.404 -0.81 . . . . 0.0 110.296 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.632 ' O ' HD23 ' A' ' 74' ' ' LEU . 60.0 m170 -90.68 132.83 35.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.948 HD22 HG22 ' A' ' 39' ' ' THR . 1.4 tp -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.4 p -166.21 144.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.837 . . . . 0.0 110.177 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.4 136.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.384 -0.823 . . . . 0.0 110.219 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.17 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.29 0.566 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.67 96.98 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.25 -174.41 2.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -105.97 -171.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.08 99.81 2.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -131.95 -176.52 4.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -1.029 . . . . 0.0 110.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -78.99 111.3 15.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.37 -0.831 . . . . 0.0 110.206 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 t -62.97 87.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.83 -166.92 42.73 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 127.48 12.07 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.815 1.429 . . . . 0.0 110.28 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 -44.41 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.558 1.294 . . . . 0.0 110.453 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.08 136.62 16.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.139 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.79 102.92 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.594 1.313 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.27 35.4 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.11 -43.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 0.0 110.18 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.29 77.16 0.95 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.17 94.53 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.854 1.45 . . . . 0.0 110.484 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.6 -79.95 0.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.98 -75.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.88 48.61 1.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.25 92.78 1.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.361 -0.837 . . . . 0.0 110.216 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.28 8.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 p -117.26 -33.75 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.313 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 101.48 10.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.69 128.26 49.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.446 -0.783 . . . . 0.0 110.163 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 147.07 98.3 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.27 88.63 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.749 1.394 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.87 32.46 5.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.268 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.47 114.39 58.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 31' ' ' LYS . 46.5 Cg_endo -71.34 -93.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.671 1.353 . . . . 0.0 110.771 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 30' ' ' PRO . 28.8 mttt 45.02 37.59 2.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.98 -1.075 . . . . 0.0 108.104 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.8 mp -58.28 116.48 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.668 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.068 HD12 HD11 ' A' ' 92' ' ' ILE . 2.1 pt -93.73 157.59 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.372 -0.83 . . . . 0.0 109.917 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -91.62 144.6 25.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.89 . . . . 0.0 110.865 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 87' ' ' LEU . 40.7 t -133.7 113.79 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.495 -0.753 . . . . 0.0 109.992 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -88.91 108.47 19.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.526 HG13 HD21 ' A' ' 74' ' ' LEU . 62.0 t -101.01 127.87 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.421 -0.799 . . . . 0.0 110.09 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.75 122.57 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.589 HG22 HD22 ' A' ' 100' ' ' LEU . 7.2 p -121.64 165.12 20.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.949 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.41 60.78 2.66 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.637 1.335 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -175.1 -46.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.485 -0.759 . . . . 0.0 109.699 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -171.32 -176.74 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.486 -0.759 . . . . 0.0 110.018 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 126.88 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.03 120.03 22.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.17 147.17 28.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -123.78 121.1 34.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -87.64 126.32 34.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.5 m -143.34 150.35 51.36 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -67.63 123.33 10.64 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.768 1.404 . . . . 0.0 110.733 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -27.42 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.07 0.462 . . . . 0.0 112.058 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.3 p30 -85.54 47.38 1.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.115 -0.991 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -111.48 103.49 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.075 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -60.62 150.78 30.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 82' ' ' LYS . 94.9 t -59.88 -34.28 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.731 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -48.38 -48.86 36.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.069 -1.02 . . . . 0.0 110.668 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -64.63 -50.56 66.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 109.726 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 56.5 t80 -60.44 -36.87 79.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.441 -0.787 . . . . 0.0 110.16 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -35.38 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.662 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.08 -17.99 31.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.89 74.65 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.501 HG23 ' CB ' ' A' ' 65' ' ' PHE . 11.2 mt -60.91 -37.48 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -53.9 -52.1 61.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.07 -1.019 . . . . 0.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -54.43 16.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.255 -0.903 . . . . 0.0 111.574 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -54.45 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 111.509 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HZ ' ' HG1' ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.17 -36.21 79.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.868 . . . . 0.0 110.36 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 74.03 77.75 0.12 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.2 p -163.4 -153.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 109.913 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.71 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 mm-40 -68.95 -178.57 1.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.182 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -146.71 -56.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 110.382 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.61 -64.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.854 . . . . 0.0 110.042 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt-30 -64.08 -25.47 68.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 68' ' ' GLN . 2.3 tt -55.43 106.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.93 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG22 ' HG3' ' A' ' 82' ' ' LYS . 99.3 t -136.57 163.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -115.16 139.25 50.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.012 -1.055 . . . . 0.0 109.918 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.1 mm -94.13 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 110.394 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' HB2' HD12 ' A' ' 81' ' ' LEU . 30.5 t80 -70.08 167.85 16.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.756 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.52 69.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 110.459 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.56 25.07 4.75 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.759 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -170.21 -174.33 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.232 -1.157 . . . . 0.0 109.994 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -116.72 109.41 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.992 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -69.72 72.03 0.36 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.842 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -131.62 -159.71 0.99 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.368 0.604 . . . . 0.0 109.949 -178.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.7 t0 -72.75 -14.94 61.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 110.16 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -58.08 -33.2 68.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 110.15 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -142.38 166.28 25.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 110.602 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.47 155.03 17.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.37 -46.65 75.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.451 HG21 ' CA ' ' A' ' 50' ' ' GLU . 1.3 pp -63.93 -17.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 7.4 tm0? -94.98 -14.64 24.2 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.426 ' CD2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER 175.94 -25.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.988 -1.07 . . . . 0.0 111.86 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.18 -49.89 71.47 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.068 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -149.15 168.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.345 -1.091 . . . . 0.0 109.158 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.633 ' H ' HD13 ' A' ' 96' ' ' LEU . 44.3 m170 -114.72 -33.5 5.48 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 23.7 t0 -179.01 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.566 -0.709 . . . . 0.0 109.911 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.66 70.43 0.36 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.633 HD13 ' H ' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -111.2 174.48 5.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -1.066 . . . . 0.0 110.2 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.2 p -111.76 145.5 39.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.38 -0.825 . . . . 0.0 110.243 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 74' ' ' LEU . 59.0 t -143.28 151.13 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.272 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -90.26 115.78 27.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 110.213 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 74' ' ' LEU . 1.8 tt -74.22 148.38 41.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.59 152.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.805 . . . . 0.0 110.076 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -107.8 136.61 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.243 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.161 0.505 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.29 -158.77 0.7 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 110.189 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.69 -179.8 3.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 0.0 110.276 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -127.95 167.87 16.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.95 45.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -131.22 65.76 1.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.448 -1.031 . . . . 0.0 110.21 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 p -139.24 -64.97 0.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.794 . . . . 0.0 110.186 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.43 117.41 18.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.126 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.15 103.79 0.33 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.96 112.94 3.53 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.586 1.308 . . . . 0.0 110.287 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.33 165.57 32.27 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.607 1.319 . . . . 0.0 110.452 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.7 ptt-85 -136.87 158.25 73.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.376 -0.828 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.99 169.11 22.99 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.709 1.373 . . . . 0.0 110.442 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 t -165.11 147.16 7.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.07 78.02 1.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.224 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.15 -85.43 1.78 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.44 106.02 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.786 1.414 . . . . 0.0 110.384 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.02 -40.15 54.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 110.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.29 -161.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.405 -0.81 . . . . 0.0 110.124 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.82 83.22 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.867 . . . . 0.0 110.118 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -159.27 145.13 16.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.25 119.13 0.49 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -81.39 -39.51 24.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -1.099 . . . . 0.0 110.249 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.85 66.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.82 . . . . 0.0 110.202 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.47 -67.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.39 -0.819 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.1 93.65 46.61 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.33 -83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.798 1.42 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 176.23 6.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.036 -1.04 . . . . 0.0 110.216 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -111.75 142.11 26.01 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 110.119 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' LYS . 48.1 Cg_endo -73.27 -94.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.675 1.355 . . . . 0.0 110.741 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' PRO . 6.6 mttp 43.57 39.3 2.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 108.286 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.572 HG23 ' C ' ' A' ' 48' ' ' VAL . 3.2 mp -58.44 115.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.684 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 92' ' ' ILE . 3.5 pt -87.99 166.49 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.49 144.28 25.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 HD23 ' A' ' 87' ' ' LEU . 27.5 t -134.62 113.45 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.186 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -101.92 106.41 17.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 110.026 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 61' ' ' ILE . 62.1 t -95.01 129.42 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 0.0 110.337 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -96.86 123.08 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.45 -0.781 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.783 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 1.8 p -121.34 169.32 9.28 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.407 -0.808 . . . . 0.0 110.049 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.7 Cg_endo -68.1 -12.32 34.77 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.642 1.338 . . . . 0.0 110.875 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -94.37 -48.19 6.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.92 -165.57 0.37 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.402 -0.811 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -115.45 130.66 56.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.93 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.7 135.19 43.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -0.919 . . . . 0.0 110.669 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 36' ' ' THR . 6.1 mt-10 -92.08 153.67 19.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -136.76 129.45 30.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.12 126.43 37.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.22 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 ' C ' HG23 ' A' ' 32' ' ' ILE . 33.8 m -143.32 151.22 54.33 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.937 . . . . 0.0 109.768 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 39.6 Cg_endo -67.45 123.11 10.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.853 1.449 . . . . 0.0 110.469 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 51' ' ' ASN . 22.0 pt-20 -30.69 -39.78 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 120.965 0.412 . . . . 0.0 112.106 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 11.2 p30 -91.27 49.56 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -111.52 111.4 22.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.034 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -59.94 144.69 48.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 110.306 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.889 HG11 ' HA ' ' A' ' 82' ' ' LYS . 70.5 t -60.58 -34.19 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -50.38 35.04 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.067 -1.021 . . . . 0.0 110.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -65.9 -50.63 63.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' CE2' HG11 ' A' ' 35' ' ' VAL . 31.4 t80 -59.72 -36.26 76.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.544 -0.722 . . . . 0.0 109.999 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.702 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -57.55 -38.39 74.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 109.727 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -81.96 -20.34 38.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.55 84.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.006 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -60.66 -30.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.525 -0.734 . . . . 0.0 110.134 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -60.57 -43.98 96.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -0.778 . . . . 0.0 110.509 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.67 -50.84 69.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.312 -0.868 . . . . 0.0 111.0 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -71.18 -52.66 17.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.204 -0.935 . . . . 0.0 111.045 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 39' ' ' THR . 16.6 m-85 -65.66 -36.55 83.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.89 . . . . 0.0 110.306 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 12.3 tttt 68.8 57.74 0.4 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.572 -0.705 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -138.02 -154.11 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.403 -0.811 . . . . 0.0 109.852 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.25 160.71 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -0.911 . . . . 0.0 110.233 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.928 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -113.01 -67.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 109.114 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 40.33 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.833 -0.542 . . . . 0.0 111.011 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 69' ' ' THR . 1.1 mp0 -79.08 -49.31 12.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 69' ' ' THR . 0.2 OUTLIER 36.18 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.708 -0.62 . . . . 0.0 111.457 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 74' ' ' LEU . 4.6 p -136.28 147.25 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.708 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 73' ' ' VAL . 8.2 mp -117.3 142.37 47.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.83 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.1 mm -92.79 100.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.821 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 82.0 t80 -74.59 78.28 1.99 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.501 -0.749 . . . . 0.0 109.522 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 55.79 23.53 6.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.41 -41.41 1.51 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -164.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.233 -1.157 . . . . 0.0 110.393 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -122.53 88.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 87' ' ' LEU . 10.3 tt -65.27 86.49 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.889 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.8 tttt -147.25 -150.25 0.33 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.571 -0.706 . . . . 0.0 110.53 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 19.5 p-10 -72.42 -21.6 61.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.522 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -55.42 -33.04 63.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.85 . . . . 0.0 110.006 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.34 157.11 44.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -84.91 161.7 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.748 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -65.93 -45.87 80.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.566 ' CG2' HD13 ' A' ' 33' ' ' ILE . 2.2 pt -62.13 -17.95 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 15.8 mm100 -98.08 -12.54 21.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -0.841 . . . . 0.0 111.191 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.99 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.883 -1.135 . . . . 0.0 111.934 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.53 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.51 -50.17 69.54 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.11 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -150.55 161.92 3.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.441 -1.035 . . . . 0.0 108.963 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -112.27 -24.51 9.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.992 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p30 179.84 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.373 -0.83 . . . . 0.0 110.077 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.97 68.08 0.78 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.03 -174.49 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -1.073 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -111.52 131.49 55.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 81' ' ' LEU . 27.4 m -127.91 153.6 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 0.0 110.475 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -90.58 144.46 25.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 39' ' ' THR . 8.7 tt -120.6 136.89 54.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.145 -0.972 . . . . 0.0 110.081 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 102' ' ' ILE . 11.1 p -166.12 170.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' N ' HG22 ' A' ' 101' ' ' VAL . 3.9 tt -105.9 136.26 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.298 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.184 0.516 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.25 -173.53 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.403 -0.81 . . . . 0.0 110.267 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.66 54.43 10.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -119.65 53.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.6 97.73 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.62 80.14 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.39 -1.065 . . . . 0.0 110.395 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.0 m -89.62 -167.73 1.94 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m -110.48 -29.38 8.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.6 75.78 1.17 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.97 148.57 45.52 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.745 1.392 . . . . 0.0 110.355 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 -32.56 8.18 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.753 1.397 . . . . 0.0 110.314 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.64 142.85 14.8 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.06 -51.79 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.634 1.334 . . . . 0.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -159.78 -45.72 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -167.24 170.83 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.814 . . . . 0.0 110.129 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.55 -85.49 0.18 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.06 152.98 51.85 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.788 1.415 . . . . 0.0 110.448 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.47 117.1 24.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -0.823 . . . . 0.0 110.107 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.23 -56.4 1.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.875 . . . . 0.0 110.307 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.95 -52.99 2.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.235 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 52.17 89.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.78 98.68 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.1 p -126.42 109.24 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.379 -1.071 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.83 112.17 13.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.137 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.48 38.38 3.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.42 151.41 40.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.46 104.1 1.74 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.788 1.415 . . . . 0.0 110.444 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.26 -36.13 9.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 96.86 5.07 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.749 . . . . 0.0 110.133 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ILE . 50.2 Cg_endo -81.16 30.09 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.699 1.368 . . . . 0.0 111.379 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -71.27 68.04 0.49 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 49' ' ' PRO . 41.4 mm -58.45 140.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.721 -0.612 . . . . 0.0 110.816 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.021 ' CD1' HD11 ' A' ' 92' ' ' ILE . 4.5 pt -119.64 152.33 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.412 -0.805 . . . . 0.0 109.353 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -91.03 144.16 25.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.616 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 87' ' ' LEU . 38.6 t -132.81 113.41 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.612 -0.68 . . . . 0.0 109.784 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.5 m -91.44 102.53 15.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HD21 ' A' ' 74' ' ' LEU . 53.1 t -94.85 127.55 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 110.184 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 122.51 46.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.0 109.846 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 100' ' ' LEU . 51.5 p -124.18 166.9 17.14 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.447 -0.783 . . . . 0.0 109.864 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.1 Cg_endo -68.22 -12.65 35.69 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.622 1.327 . . . . 0.0 110.528 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -92.32 -44.05 8.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -172.5 -167.23 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 110.294 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 3.1 ptmt -130.96 121.55 25.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.422 -0.799 . . . . 0.0 109.951 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -135.47 135.48 40.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.124 -0.985 . . . . 0.0 110.809 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.02 150.4 24.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.587 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.35 130.17 48.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.668 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.31 36.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.4 154.58 63.91 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.746 ' HA ' HD13 ' A' ' 32' ' ' ILE . 41.1 Cg_endo -69.51 120.48 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.671 1.353 . . . . 0.0 110.358 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.609 ' HA ' HD13 ' A' ' 33' ' ' ILE . 1.7 pp20? -37.61 -37.61 0.22 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.875 -0.515 . . . . 0.0 111.689 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -86.74 52.04 2.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.029 -1.045 . . . . 0.0 110.776 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.2 t -126.42 126.5 43.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 86' ' ' THR . 4.2 t -70.09 151.29 45.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.802 HG11 ' HA ' ' A' ' 82' ' ' LYS . 91.6 t -61.77 -34.76 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.778 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -43.56 28.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.982 -1.074 . . . . 0.0 110.579 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -70.34 -46.53 63.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 37.7 t80 -65.71 -37.87 87.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.91 -39.28 77.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.406 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -20.94 60.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.607 -0.683 . . . . 0.0 109.942 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -66.86 -50.74 61.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 2.5 mt -63.13 -36.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 109.468 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -53.63 -44.92 69.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -54.72 15.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 111.336 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -72.89 -54.37 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.1 -1.0 . . . . 0.0 111.29 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.34 -36.5 79.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.2 tptt 71.7 79.19 0.16 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 t -131.78 -151.85 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.69 . . . . 0.0 110.051 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -92.88 -17.28 24.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 110.565 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m 66.14 -66.09 0.17 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.783 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.7 t70 -55.12 -63.48 1.14 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.127 -0.983 . . . . 0.0 110.14 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' O ' HG23 ' A' ' 73' ' ' VAL . 31.7 mt-30 -68.93 -25.3 64.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.798 . . . . 0.0 110.02 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 100' ' ' LEU . 51.6 tp -56.21 95.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.397 -0.814 . . . . 0.0 110.826 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 71' ' ' GLN . 65.8 t -122.47 154.56 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.783 . . . . 0.0 109.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD2' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -115.06 141.13 48.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.014 -1.054 . . . . 0.0 110.315 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 99' ' ' HIS . 50.2 mm -94.75 98.63 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.506 ' HA ' HG23 ' A' ' 98' ' ' VAL . 75.6 t80 -68.74 72.63 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.407 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.83 38.41 19.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.895 . . . . 0.0 110.579 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 126.12 -50.13 0.89 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 2.4 mptt -74.21 -161.44 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -126.83 93.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.388 -0.82 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 91' ' ' GLY . 7.7 tt -64.05 89.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.802 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -152.81 -154.3 0.53 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.772 -0.58 . . . . 0.0 110.17 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.5 p30 -72.66 -19.52 61.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.431 -0.793 . . . . 0.0 110.219 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -33.05 62.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.71 149.01 33.64 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.476 -0.765 . . . . 0.0 110.17 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 53' ' ' SER . 1.2 p -74.18 161.79 29.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 109.843 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.2 tp -65.56 -46.32 79.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 110.37 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 50' ' ' GLU . 2.1 pp -65.46 -18.37 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 110.211 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -96.79 -10.71 26.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 111.1 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.408 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 178.99 -30.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.935 -1.103 . . . . 0.0 111.962 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -59.08 -51.01 61.76 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.021 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -149.83 177.14 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.371 -1.076 . . . . 0.0 108.963 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.433 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.1 m-70 -126.94 -31.1 2.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.71 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -179.5 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -0.757 . . . . 0.0 109.703 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 113.38 58.07 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.3 mt -98.0 -169.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -1.109 . . . . 0.0 110.309 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -131.5 121.33 24.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.781 . . . . 0.0 110.299 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 74' ' ' LEU . 7.1 p -119.44 157.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 45.4 m80 -90.66 143.49 26.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 39' ' ' THR . 6.3 tt -112.46 121.4 44.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.289 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.474 HG13 ' C ' ' A' ' 100' ' ' LEU . 35.7 m -149.89 142.96 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.51 134.64 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.322 -0.861 . . . . 0.0 110.358 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.216 0.531 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.21 -166.2 1.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.226 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.39 87.59 0.7 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -161.05 -174.8 4.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.855 . . . . 0.0 110.188 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.44 -118.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -158.48 72.9 0.62 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -1.083 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -160.33 -72.65 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 0.0 110.292 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.2 m -65.36 110.43 2.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 110.184 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -80.29 128.15 8.33 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.606 ' HG2' ' HD3' ' A' ' 11' ' ' PRO . 39.5 Cg_endo -70.63 -31.58 16.4 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.666 1.351 . . . . 0.0 113.297 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD3' ' HG2' ' A' ' 10' ' ' PRO . 44.4 Cg_endo -73.43 -84.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 122.324 0.644 . . . . 0.0 110.638 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -156.14 76.87 4.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.983 -1.073 . . . . 0.0 110.174 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 97.58 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.867 1.456 . . . . 0.0 110.42 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 t -152.61 166.49 31.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 0.0 110.201 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.86 -158.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 110.242 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.74 152.34 16.84 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 119.7 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.732 1.385 . . . . 0.0 110.394 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.34 -165.46 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 110.231 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.63 154.02 26.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.227 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.62 90.44 0.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.413 -0.804 . . . . 0.0 110.149 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -71.3 126.99 31.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.191 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.74 32.1 6.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.5 t -101.75 49.98 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -1.079 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.81 80.61 1.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.444 -0.785 . . . . 0.0 110.219 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.98 -170.88 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.352 -0.842 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.61 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.54 144.39 35.89 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.831 1.437 . . . . 0.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.74 -53.12 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.38 -0.825 . . . . 0.0 110.116 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -136.37 90.14 18.14 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 110.057 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.796 ' O ' HD12 ' A' ' 32' ' ' ILE . 50.8 Cg_endo -81.24 20.18 1.06 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.814 1.429 . . . . 0.0 111.384 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.4 69.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.2 mp -58.47 108.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.693 -0.629 . . . . 0.0 110.654 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 92' ' ' ILE . 4.6 pt -81.86 159.64 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -91.43 144.48 25.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 110.759 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HD23 ' A' ' 87' ' ' LEU . 47.5 t -135.66 114.09 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.271 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.443 HG23 ' OE1' ' A' ' 45' ' ' GLU . 6.4 m -98.99 105.68 17.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.92 . . . . 0.0 110.175 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.92 128.63 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -92.27 122.66 34.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.992 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.591 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -118.63 173.91 3.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.432 -0.793 . . . . 0.0 109.966 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.3 Cg_endo -69.64 -10.61 29.09 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.728 1.383 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -98.84 -53.27 3.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.13 -176.62 1.68 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -0.814 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.93 139.95 31.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.9 121.71 20.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -89.02 146.17 25.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -0.806 . . . . 0.0 110.077 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -132.3 128.9 38.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -90.72 124.47 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.541 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 35.1 m -142.28 149.66 52.43 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.3 Cg_endo -67.24 121.23 8.35 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.775 1.408 . . . . 0.0 110.495 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.614 ' HA ' HD13 ' A' ' 33' ' ' ILE . 14.1 pt-20 -35.32 -39.02 0.11 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.257 0.551 . . . . 0.0 111.231 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.479 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -89.9 55.89 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.462 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -114.67 -179.66 3.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.217 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.4 140.99 52.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 82' ' ' LYS . 22.1 t -66.91 -35.04 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 110.578 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.6 -49.42 46.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.775 -1.203 . . . . 0.0 110.196 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -78.5 -45.91 20.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 110.354 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 61' ' ' ILE . 27.7 t80 -61.38 -51.21 69.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.543 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -57.5 -35.11 69.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.462 -0.774 . . . . 0.0 109.954 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HG3' HG21 ' A' ' 69' ' ' THR . 1.8 tt0 -78.33 -26.28 46.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.73 -52.55 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 109.817 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.69 -29.2 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.695 -0.628 . . . . 0.0 109.652 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 t -56.49 -44.16 80.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -0.827 . . . . 0.0 110.273 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.98 61.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.709 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -52.74 63.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.45 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -67.49 -35.88 80.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.0 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 3.2 ttpp 76.14 85.33 0.09 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.447 0.642 . . . . 0.0 110.213 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.47 -154.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.581 -0.699 . . . . 0.0 109.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.0 -177.85 6.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 59' ' ' GLU . 61.5 m -140.88 -53.86 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 0.0 110.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -51.14 70.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.821 . . . . 0.0 110.233 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 73' ' ' VAL . 21.1 mt-30 -77.98 -26.01 48.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 110.226 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.458 HD11 HD21 ' A' ' 100' ' ' LEU . 8.1 tt -65.18 120.22 12.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.0 110.28 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.86 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.2 m -135.6 157.39 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.711 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -113.8 118.69 34.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.884 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.71 97.26 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.394 -0.816 . . . . 0.0 110.492 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.656 ' CD1' HG22 ' A' ' 98' ' ' VAL . 6.7 t80 -98.89 109.61 22.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.455 -0.778 . . . . 0.0 109.913 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 76' ' ' PHE . . . 57.58 26.48 12.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.409 -0.807 . . . . 0.0 110.358 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.13 -36.04 4.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -179.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -1.071 . . . . 0.0 110.145 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -110.17 82.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 110.316 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 98' ' ' VAL . 7.3 tt -59.97 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.86 ' CD ' HG12 ' A' ' 73' ' ' VAL . 7.4 ttpp -160.75 -146.76 0.14 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.535 -0.728 . . . . 0.0 110.579 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.01 -18.86 61.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.404 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -52.82 -32.76 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.051 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.45 167.67 28.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -0.855 . . . . 0.0 110.524 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 p -85.47 161.14 19.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.625 HD12 ' HA3' ' A' ' 91' ' ' GLY . 1.1 mp -66.26 -46.44 77.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.882 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 50' ' ' GLU . 1.7 pt -63.39 -19.09 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.008 . . . . 0.0 110.197 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 11.4 tp-100 -93.6 -12.85 28.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.96 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER 178.03 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.916 -1.115 . . . . 0.0 111.752 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -59.05 -50.88 63.05 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -151.01 169.48 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.32 -1.106 . . . . 0.0 109.118 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 7.2 m170 -116.73 -31.34 5.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 24.4 t0 -178.65 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 117.48 70.21 0.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 96' ' ' LEU . 3.1 mm? -112.18 171.36 7.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.31 -1.112 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m -111.88 140.14 46.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 110.338 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 81' ' ' LEU . 61.6 t -137.75 155.71 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.432 -0.793 . . . . 0.0 110.282 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -90.69 121.97 33.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.415 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 HD11 ' A' ' 72' ' ' LEU . 9.4 tt -99.97 119.14 37.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.07 142.22 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp -107.13 137.13 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.423 -0.798 . . . . 0.0 110.29 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.1 mttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.165 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.2 0.524 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.13 -26.5 47.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.333 -0.854 . . . . 0.0 110.249 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.1 168.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 110.373 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -106.65 -30.39 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.77 92.16 0.08 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.01 85.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -1.085 . . . . 0.0 110.482 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 m -79.33 -4.74 52.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.323 -0.861 . . . . 0.0 110.581 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -32.07 8.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.7 176.36 46.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.06 126.23 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.777 1.409 . . . . 0.0 110.405 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.04 171.17 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.624 1.328 . . . . 0.0 110.442 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.82 61.54 12.26 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.372 -0.83 . . . . 0.0 110.505 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.11 -8.23 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.758 1.399 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -57.37 108.4 0.54 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.187 -0.946 . . . . 0.0 110.342 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -148.63 -63.72 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.167 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.37 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.57 162.81 39.03 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.688 1.362 . . . . 0.0 110.398 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.53 -72.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.333 -0.854 . . . . 0.0 110.207 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 -29.79 15.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 52.85 -161.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 110.483 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 52.96 49.01 21.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 110.388 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.21 129.59 15.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 m -83.67 -67.24 0.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -1.092 . . . . 0.0 110.264 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -159.45 60.31 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.92 65.71 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.14 34.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.03 78.8 2.13 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.78 1.41 . . . . 0.0 110.404 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.48 -60.13 1.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.371 -0.83 . . . . 0.0 110.222 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -127.18 95.09 37.31 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.836 . . . . 0.0 110.179 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.3 Cg_endo -71.57 -93.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.71 1.373 . . . . 0.0 110.625 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER 44.01 41.95 4.41 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.0 mp -58.38 137.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.347 0.594 . . . . 0.0 111.085 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 92' ' ' ILE . 8.1 pt -107.78 160.05 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.437 -0.789 . . . . 0.0 109.542 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' O ' HG21 ' A' ' 92' ' ' ILE . 21.9 mttt -94.65 133.63 38.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.833 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 46' ' ' PHE . 2.6 p -128.51 118.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -96.01 114.62 26.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.35 -0.844 . . . . 0.0 110.187 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 74' ' ' LEU . 45.3 t -104.85 129.29 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.352 -0.843 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 122.46 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.445 -0.784 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.858 HG21 ' CE2' ' A' ' 65' ' ' PHE . 1.1 p -122.79 170.68 7.68 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.828 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 41.8 Cg_endo -67.93 -12.64 35.96 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.656 1.345 . . . . 0.0 110.726 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -51.24 5.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -173.74 178.4 2.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.351 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 125.86 44.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.902 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -135.1 134.89 40.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.689 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -90.26 151.08 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.495 -0.753 . . . . 0.0 109.682 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.718 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.2 m-85 -129.3 152.26 49.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -0.94 . . . . 0.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -105.55 133.37 50.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.074 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 27.3 m -143.35 143.7 25.27 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 51' ' ' ASN . 40.2 Cg_endo -66.82 128.82 19.58 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.706 1.371 . . . . 0.0 111.306 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.713 ' C ' HG21 ' A' ' 88' ' ' ILE . 2.2 tm-20 -39.43 -20.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' PRO . 17.2 p-10 -111.09 37.95 2.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.644 -1.285 . . . . 0.0 110.47 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.453 ' N ' HD12 ' A' ' 88' ' ' ILE . 27.8 p -96.55 -153.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 0.0 110.162 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -161.91 157.25 23.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.345 -0.847 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.673 HG11 ' C ' ' A' ' 82' ' ' LYS . 59.4 t -63.28 -34.91 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 110.793 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -49.17 -47.11 46.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.663 -1.273 . . . . 0.0 110.231 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -49.53 16.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.227 -0.921 . . . . 0.0 110.337 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 35' ' ' VAL . 28.3 t80 -60.34 -50.28 74.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.97 -30.56 66.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.99 -26.84 26.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 110.051 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.62 82.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -29.85 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.571 -0.706 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t -62.32 -43.92 97.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.476 -0.765 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -57.81 -48.56 79.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.862 . . . . 0.0 111.024 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' NH1' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -71.15 -52.81 17.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.203 -0.936 . . . . 0.0 110.931 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CE2' HG21 ' A' ' 39' ' ' THR . 8.8 m-85 -67.18 -36.16 81.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.85 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 12.3 mttp 69.6 81.44 0.17 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.418 0.628 . . . . 0.0 110.092 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 p -168.15 -154.77 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -74.94 157.56 34.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 m -128.51 -41.67 1.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.16 -62.72 1.56 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.358 -0.839 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -69.4 -25.57 64.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.427 -0.796 . . . . 0.0 110.165 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.843 HD21 HD11 ' A' ' 100' ' ' LEU . 4.9 tt -64.36 118.01 8.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.339 -0.85 . . . . 0.0 110.524 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 82' ' ' LYS . 33.0 m -139.0 168.46 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.741 HD12 HG13 ' A' ' 98' ' ' VAL . 2.7 mm? -109.57 146.81 34.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 98' ' ' VAL . 33.8 mm -102.69 92.9 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 110.236 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 24.7 t80 -74.39 64.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.579 -0.7 . . . . 0.0 110.357 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 49.2 79.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.86 -53.06 4.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.755 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.6 mttt -76.2 178.2 6.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -1.103 . . . . 0.0 109.873 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.755 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -115.97 106.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 0.0 109.916 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.932 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.8 OUTLIER -69.5 72.04 0.32 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.673 ' C ' HG11 ' A' ' 54' ' ' VAL . 7.9 ttmt -125.95 -160.1 0.95 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.511 0.672 . . . . 0.0 110.547 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.7 p-10 -73.74 -16.71 61.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.629 -0.669 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.83 -32.36 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.942 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -132.08 169.66 16.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.799 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.66 137.01 32.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 92' ' ' ILE . 22.3 tp -55.93 -47.49 77.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 110.428 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.713 HG21 ' C ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -73.62 -15.48 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.481 -0.762 . . . . 0.0 110.904 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 1.8 tt0 -90.35 -9.32 48.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 111.847 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -174.65 -36.61 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.586 -1.321 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.937 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.84 -42.8 96.77 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.937 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -138.64 138.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -1.19 . . . . 0.0 110.855 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.52 ' H ' HD13 ' A' ' 96' ' ' LEU . 12.2 m170 -103.68 -36.03 8.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 24.0 p-10 179.81 34.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 0.0 109.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.08 71.19 0.24 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 93' ' ' HIS . 6.5 mp -113.16 167.49 10.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 110.371 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.9 m -118.33 147.14 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.333 -0.854 . . . . 0.0 110.252 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.741 HG13 HD12 ' A' ' 74' ' ' LEU . 7.7 p -144.43 150.54 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 110.418 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -90.63 122.49 33.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.503 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.843 HD11 HD21 ' A' ' 72' ' ' LEU . 7.0 tt -82.94 149.98 26.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.204 -0.935 . . . . 0.0 110.673 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.561 HG12 HG12 ' A' ' 75' ' ' ILE . 14.0 p -168.05 131.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.09 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 72' ' ' LEU . 2.4 pp -94.89 131.42 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 tttt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.277 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.218 0.533 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.9 133.43 43.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.51 116.65 17.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.22 110.92 4.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.64 -118.98 0.67 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -65.18 169.07 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -1.101 . . . . 0.0 110.231 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -107.3 52.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 46.4 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.56 -164.24 34.61 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.21 166.99 28.48 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 132.78 18.47 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 110.437 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 9.7 mtp180 -67.42 -54.87 16.7 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 0.0 110.381 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.8 Cg_endo -73.78 66.01 4.87 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.588 1.309 . . . . 0.0 110.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -64.95 160.43 20.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.395 -0.815 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 118.42 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.0 -27.43 14.1 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.497 1.262 . . . . 0.0 110.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.36 50.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.872 . . . . 0.0 110.204 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.0 158.66 15.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.95 138.33 54.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.85 -41.09 6.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.91 -166.56 42.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -70.87 142.16 51.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -1.106 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.59 167.36 16.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 110.244 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.74 -61.55 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.877 . . . . 0.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.36 91.45 7.72 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.85 . . . . 0.0 110.208 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 142.67 37.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.761 1.4 . . . . 0.0 110.386 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.68 108.3 17.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mm-40 -177.81 -55.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 110.247 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 29' ' ' GLU . 53.1 Cg_endo -80.51 33.11 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.422 1.222 . . . . 0.0 111.463 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' O ' HG23 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -70.89 66.93 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.3 mm -58.33 102.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 110.654 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.99 HD13 HG22 ' A' ' 88' ' ' ILE . 7.1 pt -96.07 147.88 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.707 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.636 ' O ' HG21 ' A' ' 92' ' ' ILE . 10.7 mttp -91.81 141.39 28.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.103 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 87' ' ' LEU . 51.0 t -129.52 113.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.818 . . . . 0.0 110.129 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.7 m -90.15 109.4 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.832 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.78 127.79 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.427 -0.796 . . . . 0.0 110.285 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 122.51 47.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.437 -0.789 . . . . 0.0 109.67 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 1.11 HG22 HD13 ' A' ' 100' ' ' LEU . 62.1 p -124.13 162.22 42.84 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 59.54 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.71 1.373 . . . . 0.0 110.428 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.71 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -167.21 -170.02 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.513 -0.742 . . . . 0.0 109.922 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -142.7 125.37 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.831 . . . . 0.0 110.21 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -135.12 132.44 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.382 -0.824 . . . . 0.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -90.1 150.25 22.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -123.75 140.93 52.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 110.479 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.68 116.64 33.18 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 52' ' ' SER . 21.8 m -120.59 147.68 46.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 110.677 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.631 ' HA ' HD13 ' A' ' 32' ' ' ILE . 51.1 Cg_endo -76.65 52.83 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.856 1.451 . . . . 0.0 111.709 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' CG ' HG21 ' A' ' 88' ' ' ILE . 30.7 tp10 55.53 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.381 -0.824 . . . . 0.0 111.695 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' PRO . 11.0 t30 -46.86 -20.06 0.12 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 0.0 112.063 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.422 ' CB ' ' HB ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -59.1 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 110.106 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.9 m -67.33 175.6 2.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.526 -0.734 . . . . 0.0 110.35 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 82' ' ' LYS . 37.6 t -68.12 -35.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 110.272 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -50.21 -49.01 54.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.772 -1.205 . . . . 0.0 109.733 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -76.37 -47.4 23.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -61.52 -50.98 70.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.367 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.55 -29.85 64.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.783 . . . . 0.0 109.897 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.766 ' OE2' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -80.37 -24.14 39.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.336 -0.852 . . . . 0.0 109.813 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.29 85.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 110.149 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.0 mt -60.9 -36.91 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.256 -0.903 . . . . 0.0 109.912 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 p -53.6 -49.64 67.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.0 110.506 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -68.21 -53.77 22.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.341 -0.849 . . . . 0.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -53.84 12.32 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.097 -1.002 . . . . 0.0 111.262 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.66 -36.45 80.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 109.991 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.06 81.68 0.19 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.612 -0.68 . . . . 0.0 110.224 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -156.04 -65.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.0 -176.15 2.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.437 -0.789 . . . . 0.0 110.061 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.766 HG21 ' OE2' ' A' ' 59' ' ' GLU . 3.2 m -140.85 -55.08 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.04 -67.4 0.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 73' ' ' VAL . 9.9 mt-30 -60.47 -25.61 66.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.309 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 72' ' ' LEU . 7.8 tt -53.29 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 110.826 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 71' ' ' GLN . 86.7 t -125.63 148.7 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 109.472 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.6 mp -117.94 135.86 53.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.17 101.65 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.438 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 81' ' ' LEU . 71.8 t80 -77.35 82.71 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.238 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 50.79 36.19 13.88 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.33 -55.87 0.57 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.395 -1.062 . . . . 0.0 110.056 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -118.05 94.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.281 -0.887 . . . . 0.0 110.694 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -67.09 79.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.003 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.772 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.5 ttmt -137.15 -158.86 0.9 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.414 0.625 . . . . 0.0 110.358 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 84' ' ' GLN . 35.5 p30 -73.32 -14.81 61.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.452 -0.78 . . . . 0.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -55.78 -33.04 64.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.353 -0.842 . . . . 0.0 109.72 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.39 154.4 49.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.474 -0.766 . . . . 0.0 110.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 89' ' ' GLN . 0.2 OUTLIER -70.27 147.03 50.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.853 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 35' ' ' VAL . 17.0 tp -55.59 -46.98 77.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.99 HG22 HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -72.48 -14.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 47.9 tp60 -85.63 -13.58 48.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 111.814 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -170.27 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.605 -1.309 . . . . 0.0 111.036 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.929 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.46 -46.92 93.14 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.929 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER -137.47 143.66 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.012 -1.287 . . . . 0.0 111.333 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.438 ' H ' HD12 ' A' ' 96' ' ' LEU . 12.1 m-70 -109.4 -33.72 6.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -179.73 35.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.246 0.546 . . . . 0.0 109.536 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 92' ' ' ILE . . . 118.67 71.97 0.39 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 93' ' ' HIS . 0.2 OUTLIER -114.61 -178.43 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.235 -1.156 . . . . 0.0 110.251 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -125.15 146.52 49.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 81' ' ' LEU . 8.1 p -142.68 151.09 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.874 . . . . 0.0 110.401 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.71 144.31 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.81 . . . . 0.0 110.258 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.11 HD13 HG22 ' A' ' 39' ' ' THR . 6.4 tt -97.44 119.97 36.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.67 128.57 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 0.0 110.045 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.3 pp -104.6 130.49 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.196 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.17 0.51 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.28 28.87 4.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.837 . . . . 0.0 110.111 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -116.79 -34.06 4.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -0.828 . . . . 0.0 110.141 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -113.7 100.65 8.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.183 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 164.3 44.59 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -138.13 -66.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -1.082 . . . . 0.0 110.123 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 p -112.27 -31.03 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 110.25 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.5 t -158.96 126.49 4.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.247 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.12 -84.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.56 163.92 36.26 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.84 1.442 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.55 -23.11 20.33 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.797 1.42 . . . . 0.0 110.435 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -109.53 99.94 39.61 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.97 151.17 55.98 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.676 1.356 . . . . 0.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.21 172.96 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 110.224 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -126.81 -170.62 2.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.181 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.74 74.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 -167.92 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.815 1.429 . . . . 0.0 110.422 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 -40.03 15.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.83 . . . . 0.0 110.14 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.01 79.69 1.49 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.488 -0.758 . . . . 0.0 110.174 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.71 -170.95 3.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -117.27 126.7 53.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 110.121 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.17 98.78 0.29 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t -162.2 85.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.048 . . . . 0.0 110.169 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.6 145.09 56.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.217 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.77 59.4 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.139 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.47 72.24 3.84 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.871 . . . . 0.0 110.323 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.28 -26.14 14.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.831 1.437 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 115.42 4.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -104.11 158.25 32.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.354 -0.841 . . . . 0.0 110.121 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.5 Cg_endo -71.87 -93.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.745 1.392 . . . . 0.0 110.641 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER 44.04 43.53 5.56 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.6 mp -58.12 111.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.603 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.62 HD13 HG22 ' A' ' 88' ' ' ILE . 9.0 pt -89.68 154.46 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.38 -0.825 . . . . 0.0 110.039 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -94.11 144.89 25.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.56 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -138.52 119.14 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.4 -0.813 . . . . 0.0 110.108 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -87.05 102.22 14.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 0.0 110.095 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.729 ' CG1' HD12 ' A' ' 100' ' ' LEU . 61.6 t -96.3 128.38 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' HE3' ' CD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -109.72 126.27 53.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 110.293 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.925 HG23 HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.46 175.73 2.6 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.613 -0.679 . . . . 0.0 109.69 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 39' ' ' THR . 44.4 Cg_endo -71.34 61.86 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.626 1.33 . . . . 0.0 110.395 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.447 -0.783 . . . . 0.0 109.928 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.71 179.48 3.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.39 -0.819 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -117.08 122.99 45.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.152 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.3 135.12 40.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.326 -0.859 . . . . 0.0 110.438 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -85.23 149.52 25.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.533 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -124.35 144.86 49.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.571 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 32' ' ' ILE . . . -99.62 129.78 45.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 30.4 m -143.46 144.01 26.2 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.857 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 52' ' ' SER . 39.4 Cg_endo -67.08 121.44 8.61 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.756 1.398 . . . . 0.0 111.034 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -37.17 -34.73 0.09 Allowed 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.117 0.484 . . . . 0.0 111.583 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.15 49.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 110.575 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 55.7 p -127.85 108.38 10.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.5 t -59.84 153.36 20.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.849 . . . . 0.0 109.857 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.1 t -55.88 -35.0 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 110.86 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -48.48 -43.78 35.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.665 -1.272 . . . . 0.0 109.843 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.15 -41.48 41.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.636 ' O ' HG22 ' A' ' 61' ' ' ILE . 17.7 t80 -68.24 -51.46 45.11 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -0.884 . . . . 0.0 110.369 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -30.8 65.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.921 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HA ' HG23 ' A' ' 69' ' ' THR . 32.0 tt0 -86.29 -26.85 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -49.32 60.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -0.785 . . . . 0.0 109.675 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.716 ' C ' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -60.41 -29.35 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.008 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 p -63.85 -44.43 93.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.174 -0.953 . . . . 0.0 110.351 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -56.39 -42.66 78.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.78 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -52.07 23.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.283 -0.885 . . . . 0.0 110.463 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 5.2 m-85 -67.0 -36.5 82.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.817 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 44.5 mtmt 64.23 79.49 0.26 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.582 -0.699 . . . . 0.0 110.179 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 t -154.87 -59.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.486 -0.759 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.416 ' O ' HD22 ' A' ' 72' ' ' LEU . 1.6 tt0 -169.45 174.83 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 0.0 110.005 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.54 HG23 ' HA ' ' A' ' 59' ' ' GLU . 31.1 m -143.31 -44.19 0.29 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.37 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -64.97 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.18 -26.19 60.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.226 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -53.16 139.75 28.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.326 -0.859 . . . . 0.0 110.523 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.0 p -172.84 169.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 109.928 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD11 HG22 ' A' ' 37' ' ' VAL . 2.6 mt -118.44 118.86 32.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -0.982 . . . . 0.0 109.31 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.61 103.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 110.146 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.772 ' HA ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -91.86 124.11 35.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.452 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.94 103.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.313 -0.867 . . . . 0.0 110.607 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.46 -31.13 3.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.609 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -166.65 -166.8 0.89 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -1.003 . . . . 0.0 109.712 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 79' ' ' LYS . 1.3 mm -108.77 118.26 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.874 HD12 HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -69.97 71.05 0.37 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.786 178.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.819 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.6 ptmt -136.1 -152.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.368 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.9 p30 -72.94 -12.84 61.1 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.301 -0.874 . . . . 0.0 112.482 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.6 -33.5 33.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.056 . . . . 0.0 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.61 156.37 45.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.198 -0.939 . . . . 0.0 109.972 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.49 149.78 41.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 92' ' ' ILE . 16.0 tp -56.81 -48.16 78.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 110.868 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.62 HG22 HD13 ' A' ' 33' ' ' ILE . 2.1 pp -73.1 -18.45 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.172 -0.955 . . . . 0.0 110.829 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.29 -9.9 57.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 111.744 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.728 -1.233 . . . . 0.0 110.949 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.877 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.34 -47.0 92.98 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -145.56 156.23 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -1.176 . . . . 0.0 110.293 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 19.2 m170 -114.98 -42.42 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 34.4 t70 -178.49 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.28 65.91 0.18 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 96' ' ' LEU . 10.8 mt -112.58 160.08 18.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -1.12 . . . . 0.0 110.256 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.419 ' C ' HG23 ' A' ' 98' ' ' VAL . 7.0 t -115.06 145.72 42.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 81' ' ' LEU . 49.0 t -145.47 158.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.557 ' O ' HG22 ' A' ' 75' ' ' ILE . 44.1 m170 -88.39 125.49 34.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 0.0 110.466 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.925 HD13 HG23 ' A' ' 39' ' ' THR . 5.5 tt -83.29 145.77 28.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.135 -0.978 . . . . 0.0 110.451 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 100' ' ' LEU . 7.8 p -167.36 159.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -108.08 137.22 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.327 -0.858 . . . . 0.0 110.204 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.6 mttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.314 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.259 0.552 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.42 171.04 14.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.319 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.36 46.06 1.03 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.184 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -137.82 33.49 2.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.247 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.33 57.68 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -38.0 89.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -1.098 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.9 p -80.31 -165.04 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.02 150.38 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.831 . . . . 0.0 110.215 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.26 -132.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 156.97 55.34 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.525 1.276 . . . . 0.0 110.292 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.37 173.62 12.84 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.785 1.413 . . . . 0.0 110.409 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -128.9 98.91 23.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 110.276 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.21 112.33 3.41 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.692 1.364 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.75 -2.82 58.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.352 -0.842 . . . . 0.0 110.691 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.52 -42.18 87.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.179 -0.95 . . . . 0.0 110.22 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.68 134.0 2.44 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.83 87.3 1.15 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.576 1.303 . . . . 0.0 110.33 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.65 -164.53 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 110.426 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -170.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.857 . . . . 0.0 110.248 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.24 170.53 15.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.864 . . . . 0.0 110.284 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.69 117.6 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.39 -0.819 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.71 162.48 30.08 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.8 m -98.32 29.23 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -1.068 . . . . 0.0 110.274 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.21 105.92 16.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.55 42.87 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.45 150.95 22.91 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.293 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 144.68 36.66 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.73 1.384 . . . . 0.0 110.367 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.81 101.19 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 12.6 tp10 -177.45 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.328 -0.858 . . . . 0.0 110.118 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 29' ' ' GLU . 43.4 Cg_endo -69.32 -92.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.291 1.153 . . . . 0.0 110.434 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 mptt 45.47 44.38 9.63 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 2.9 mp -58.04 110.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.835 -0.541 . . . . 0.0 110.476 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.986 ' CD1' HD11 ' A' ' 92' ' ' ILE . 3.3 pt -83.55 152.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -91.97 144.4 25.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 110.282 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.744 HG23 HG21 ' A' ' 92' ' ' ILE . 7.3 p -139.69 113.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.093 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -82.33 109.08 16.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.396 -0.815 . . . . 0.0 110.018 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.55 127.59 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -0.859 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.38 122.64 46.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.098 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 80.7 p -121.58 165.93 18.14 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.726 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.1 Cg_endo -69.71 -10.28 28.2 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.636 1.335 . . . . 0.0 110.817 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -100.54 -35.91 9.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.184 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.36 -166.52 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.325 -0.859 . . . . 0.0 110.263 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 114.93 8.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.361 -0.837 . . . . 0.0 110.074 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -135.19 134.96 40.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 110.499 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.29 149.21 26.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 35' ' ' VAL . 4.1 m-85 -121.4 147.68 45.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.36 125.86 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.6 m -142.49 150.48 54.65 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.206 -0.934 . . . . 0.0 109.758 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -68.36 122.61 9.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.699 1.368 . . . . 0.0 110.395 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 33' ' ' ILE . 17.0 pt-20 -31.28 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.084 0.469 . . . . 0.0 111.716 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -88.58 50.83 2.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.213 -0.929 . . . . 0.0 110.121 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 2.1 t -115.12 130.77 57.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.409 -0.807 . . . . 0.0 110.265 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -82.14 146.47 29.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.997 HG11 ' HA ' ' A' ' 82' ' ' LYS . 61.0 t -61.16 -34.53 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.791 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -49.32 -48.07 46.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.988 -1.07 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.33 -49.76 52.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 38.5 t80 -59.82 -37.23 78.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 12.2 mtpt -57.77 -47.95 81.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.579 -0.701 . . . . 0.0 109.495 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.484 -0.76 . . . . 0.0 109.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -62.88 -51.89 65.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.842 . . . . 0.0 110.045 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 65' ' ' PHE . 19.6 mt -60.92 -39.65 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.603 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -53.7 -52.24 60.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.039 . . . . 0.0 110.326 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -54.17 19.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.324 -0.86 . . . . 0.0 111.508 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -72.02 -54.11 10.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 111.442 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -67.91 -36.6 80.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 110.275 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 4.9 tttp 69.17 80.66 0.19 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.437 -0.789 . . . . 0.0 110.203 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 t -153.38 -69.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -164.36 -175.18 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.5 m -144.11 -60.04 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.312 -0.868 . . . . 0.0 110.483 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 -61.03 2.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -66.32 -25.65 66.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 102' ' ' ILE . 36.2 tp -51.86 124.75 13.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.337 -0.852 . . . . 0.0 110.684 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 101' ' ' VAL . 8.1 p -153.31 157.22 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 109.767 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.4 mp -123.6 123.76 41.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.134 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.19 104.33 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 110.626 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.3 t80 -70.52 67.06 0.34 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.755 . . . . 0.0 110.031 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.92 24.76 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.261 -0.899 . . . . 0.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.21 -39.24 1.51 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -162.14 0.53 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -1.121 . . . . 0.0 110.258 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' HG2' ' A' ' 82' ' ' LYS . 1.1 pp -123.49 84.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 110.61 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 87' ' ' LEU . 8.1 tt -67.74 84.29 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 108.765 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.997 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -153.99 -146.82 0.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 110.148 -179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.58 -15.56 61.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.035 -1.041 . . . . 0.0 111.363 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.448 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.4 mm-40 -53.73 -33.42 55.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.129 -0.982 . . . . 0.0 110.237 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -150.24 -169.88 3.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -102.91 158.14 16.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 110.186 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 81' ' ' LEU . 1.5 tp -66.09 -46.23 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.6 pt -63.84 -17.25 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.562 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -97.27 -12.82 22.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 111.091 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.911 -1.118 . . . . 0.0 111.859 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.658 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.39 -50.34 67.68 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.7 pp -148.56 171.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.375 -1.074 . . . . 0.0 108.665 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 94' ' ' ASP . 0.4 OUTLIER -122.19 -29.62 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.967 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.8 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 109.982 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.91 59.5 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.38 -168.99 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.336 -1.097 . . . . 0.0 110.221 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -134.96 147.03 49.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 76' ' ' PHE . 11.9 p -140.47 157.56 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 0.0 110.199 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -90.7 115.81 28.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 HD11 ' A' ' 72' ' ' LEU . 7.9 tt -89.31 131.33 35.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 110.139 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 101' ' ' VAL . 35.2 m -145.08 130.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.783 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.711 HG22 HD12 ' A' ' 72' ' ' LEU . 2.3 pp -106.79 130.09 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 0.0 110.199 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.106 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mtp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.22 0.533 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.3 147.33 34.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -84.12 138.3 33.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 52.82 49.81 19.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.338 -0.851 . . . . 0.0 110.463 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.96 -82.11 0.87 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.59 110.0 5.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -1.064 . . . . 0.0 110.19 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -68.08 0.15 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.451 -0.78 . . . . 0.0 110.186 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -93.14 -55.34 3.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.01 -153.32 9.4 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 160.49 46.11 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.801 1.422 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.49 119.73 6.11 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.89 1.469 . . . . 0.0 110.387 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 1.1 tpt180 -69.5 -54.8 10.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 47.5 Cg_endo -74.54 136.34 21.3 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.476 1.251 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.6 p -64.43 161.29 17.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.242 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.29 48.49 2.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.32 87.32 1.92 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.05 74.64 2.92 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.832 1.438 . . . . 0.0 110.355 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.54 164.33 18.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.98 80.53 5.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.23 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.25 40.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 155.34 18.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -0.911 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.76 63.32 0.23 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 m -88.13 123.99 33.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.239 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.23 -43.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.377 -0.827 . . . . 0.0 110.192 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.12 178.05 4.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.226 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -75.38 113.88 30.27 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.822 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.87 -17.33 29.02 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.545 1.287 . . . . 0.0 110.567 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -118.93 44.02 2.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.235 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 1.7 mt-10 -73.89 -55.81 3.06 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 31' ' ' LYS . 49.0 Cg_endo -73.46 -93.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.579 1.305 . . . . 0.0 110.502 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.5 tptp 42.71 41.74 2.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -58.16 110.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.252 0.549 . . . . 0.0 110.723 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.668 ' CD1' HD11 ' A' ' 92' ' ' ILE . 1.6 pt -89.16 174.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.415 -0.803 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.45 144.39 37.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.768 . . . . 0.0 110.373 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 46' ' ' PHE . 8.7 p -136.14 113.84 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 110.033 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 97' ' ' THR . 3.2 m -84.24 103.8 13.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.501 HG13 HD21 ' A' ' 74' ' ' LEU . 66.9 t -94.75 128.75 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.002 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -101.24 122.5 43.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.415 -0.803 . . . . 0.0 110.071 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.742 HG22 HD13 ' A' ' 100' ' ' LEU . 4.3 p -119.93 167.71 11.85 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 43.9 Cg_endo -71.1 61.06 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.661 1.348 . . . . 0.0 110.401 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -46.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 109.64 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -172.05 176.75 3.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.53 -0.731 . . . . 0.0 110.081 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.67 127.97 54.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -134.5 131.2 37.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.3 149.79 25.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.9 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.9 m-85 -127.12 123.08 35.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.898 . . . . 0.0 110.197 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.133 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 25.6 m -143.21 153.57 59.93 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.233 -0.917 . . . . 0.0 109.825 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 50' ' ' GLU . 40.2 Cg_endo -67.9 122.37 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.803 1.423 . . . . 0.0 110.726 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.613 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -30.74 -42.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.66 48.7 1.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.925 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.9 t -113.41 108.07 16.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.087 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.7 m -59.84 148.84 33.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.847 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.5 t -63.42 -34.67 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.811 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.05 -43.93 41.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.953 -1.092 . . . . 0.0 110.705 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.45 -53.48 16.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.925 . . . . 0.0 110.252 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 25.3 t80 -59.86 -37.21 78.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.339 -0.851 . . . . 0.0 110.118 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.74 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.52 -42.88 83.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.611 -0.68 . . . . 0.0 109.762 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -75.87 -20.72 57.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -63.93 -41.58 97.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.637 HG23 ' CB ' ' A' ' 65' ' ' PHE . 52.8 mt -60.39 -34.7 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.4 p -54.02 -52.98 59.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.985 -1.072 . . . . 0.0 110.464 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -54.73 14.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -0.916 . . . . 0.0 111.78 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -72.7 -54.49 8.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.051 -1.031 . . . . 0.0 111.646 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.637 ' CB ' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.57 -36.11 78.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.887 . . . . 0.0 110.531 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 23.2 mtmt 70.67 79.97 0.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.662 -0.649 . . . . 0.0 110.015 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.9 t -168.24 -154.4 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.898 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.8 mt-30 -70.14 -170.03 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 110.05 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.7 m -157.33 -60.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -60.13 -70.31 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -61.86 -26.11 67.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 100' ' ' LEU . 1.9 tt -66.71 98.97 0.56 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.785 . . . . 0.0 110.338 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.11 167.11 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.812 . . . . 0.0 109.951 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.006 HD23 HG11 ' A' ' 98' ' ' VAL . 5.5 mp -108.75 144.68 36.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 110.018 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 101' ' ' VAL . 47.1 mm -105.16 89.31 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.828 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 91' ' ' GLY . 69.6 t80 -66.96 83.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.92 29.72 6.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.359 -0.838 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.04 -51.38 0.84 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 6.4 mttp -61.86 -175.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -1.046 . . . . 0.0 109.957 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -116.31 93.06 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.28 -0.887 . . . . 0.0 110.5 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.813 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -62.89 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.863 ' HA ' HG11 ' A' ' 54' ' ' VAL . 2.4 tttt -145.91 -153.13 0.46 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.734 -0.604 . . . . 0.0 110.169 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -72.58 -15.54 61.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.385 -0.822 . . . . 0.0 110.523 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HB3' HD13 ' A' ' 80' ' ' ILE . 44.8 tt0 -62.81 -33.14 74.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.973 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.63 168.15 19.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 p -99.06 148.92 23.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.252 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 ' HA3' ' A' ' 91' ' ' GLY . 22.0 tp -55.81 -43.58 77.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.526 HG22 HD13 ' A' ' 33' ' ' ILE . 1.2 pt -71.61 -14.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.254 -0.904 . . . . 0.0 111.604 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.37 -2.98 24.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 112.197 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -176.06 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 118.331 -1.347 . . . . 0.0 112.303 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.813 ' HA3' HD21 ' A' ' 81' ' ' LEU . . . -58.58 -50.32 68.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.668 HD11 ' CD1' ' A' ' 33' ' ' ILE . 2.8 pp -157.05 152.61 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -1.015 . . . . 0.0 109.322 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 14.5 m170 -100.8 -24.97 14.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 35.4 t70 179.96 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.622 -0.674 . . . . 0.0 109.596 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.07 73.93 0.86 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.539 ' CB ' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -117.46 176.85 4.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.248 -1.148 . . . . 0.0 110.186 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 13.4 m -115.9 147.32 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.006 HG11 HD23 ' A' ' 74' ' ' LEU . 8.5 p -138.93 146.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.499 -0.75 . . . . 0.0 110.16 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.39 115.27 27.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 72' ' ' LEU . 6.7 tt -82.74 148.64 27.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.899 . . . . 0.0 110.632 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 75' ' ' ILE . 11.3 p -168.34 135.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.461 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.82 136.23 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.81 162.71 37.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.0 110.181 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -82.97 -56.66 3.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.386 -0.821 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 126.86 31.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.24 -32.32 83.74 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.53 42.44 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -1.101 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.5 t -144.69 60.29 1.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.83 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -108.44 59.04 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 110.265 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.75 -162.83 47.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 141.46 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.79 1.416 . . . . 0.0 110.319 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.56 -56.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.639 1.336 . . . . 0.0 110.516 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.443 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 179.6 -57.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 12' ' ' ARG . 46.7 Cg_endo -73.05 73.54 3.12 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.464 1.244 . . . . 0.0 110.434 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -56.98 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.404 -0.81 . . . . 0.0 110.108 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 135.65 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.29 84.73 1.35 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 162.15 41.43 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.803 1.422 . . . . 0.0 110.362 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.62 -163.89 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.65 -69.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.265 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -95.45 -169.41 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 56.72 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.336 -0.853 . . . . 0.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.16 106.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -140.19 81.09 1.8 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 110.228 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.02 171.71 18.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.354 -0.841 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.32 88.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.385 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.81 114.77 63.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 110.185 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 -168.68 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.661 1.348 . . . . 0.0 110.504 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -118.79 112.08 19.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.201 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 52.34 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' O ' ' C ' ' A' ' 31' ' ' LYS . 46.3 Cg_endo -71.75 -93.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.846 1.445 . . . . 0.0 110.557 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 42.32 45.01 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -57.95 128.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.321 0.582 . . . . 0.0 111.006 -177.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 92' ' ' ILE . 12.9 pt -98.4 159.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.696 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 92' ' ' ILE . 27.7 mmtm -91.45 144.08 25.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 110.533 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 HG21 ' A' ' 92' ' ' ILE . 57.6 t -137.0 113.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -90.31 102.99 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 57' ' ' PHE . 57.8 t -98.05 127.84 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.463 -0.773 . . . . 0.0 110.12 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.44 122.45 46.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -0.82 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 HD22 ' A' ' 100' ' ' LEU . 66.6 p -117.1 163.81 21.54 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 45.9 Cg_endo -71.55 59.76 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.664 1.349 . . . . 0.0 110.581 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -175.67 -39.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 109.762 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -171.31 173.58 4.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 119.8 40.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.076 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.78 124.9 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -84.7 149.55 25.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.663 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.51 140.14 53.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.353 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -97.65 135.44 39.46 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 33' ' ' ILE . 28.1 m -143.43 143.1 22.77 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 109.018 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' CA ' HD12 ' A' ' 32' ' ' ILE . 39.4 Cg_endo -65.89 128.23 19.39 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.771 1.406 . . . . 0.0 110.825 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -38.05 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.008 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' PRO . 2.4 t30 -120.79 67.63 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.645 -1.284 . . . . 0.0 110.19 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -149.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.0 110.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.809 ' HA ' HG23 ' A' ' 86' ' ' THR . 8.0 t -159.38 153.75 23.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.95 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.938 HG21 ' O ' ' A' ' 82' ' ' LYS . 48.5 t -55.92 -35.3 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 111.088 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -45.17 40.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -71.36 -49.73 39.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 43.7 t80 -62.69 -38.02 88.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.448 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.695 ' CD ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -58.15 -45.22 87.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.829 . . . . 0.0 109.653 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -81.67 -18.16 45.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 110.194 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.1 -52.34 63.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 65' ' ' PHE . 26.5 mt -62.8 -33.65 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.345 -0.847 . . . . 0.0 109.682 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -53.19 55.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.081 -1.012 . . . . 0.0 110.606 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.56 -54.56 15.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 111.797 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -54.48 8.97 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.083 -1.01 . . . . 0.0 111.633 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -68.22 -36.15 79.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 73.95 72.54 0.12 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.65 -0.657 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.6 p -159.06 -165.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.47 -0.768 . . . . 0.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' THR . 1.0 OUTLIER -74.74 -168.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.246 -0.909 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.77 -51.63 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.371 -0.831 . . . . 0.0 110.327 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.05 -51.94 66.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.701 ' O ' HG23 ' A' ' 73' ' ' VAL . 20.2 mt-30 -78.13 -25.57 47.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.834 HD11 HD21 ' A' ' 100' ' ' LEU . 22.0 tp -57.74 110.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 110.656 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 71' ' ' GLN . 61.9 t -129.72 151.47 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.389 -0.82 . . . . 0.0 109.727 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.651 ' HB2' HD23 ' A' ' 81' ' ' LEU . 4.9 mp -111.39 122.07 46.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.109 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 75' ' ' ILE . 27.1 mm -79.84 100.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.775 ' CZ ' HD13 ' A' ' 96' ' ' LEU . 4.6 t80 -109.05 124.27 50.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 110.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.82 27.54 7.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.329 -0.857 . . . . 0.0 110.419 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.87 23.71 61.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -122.58 -167.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.357 -1.084 . . . . 0.0 109.881 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.552 HG22 HG11 ' A' ' 73' ' ' VAL . 1.1 pp -112.13 79.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.221 -0.924 . . . . 0.0 110.499 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -61.37 89.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 108.54 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.938 ' O ' HG21 ' A' ' 54' ' ' VAL . 7.1 ttpt -155.82 -146.67 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.547 -0.72 . . . . 0.0 110.874 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.792 ' N ' HG11 ' A' ' 54' ' ' VAL . 20.0 t0 -62.48 -15.41 49.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.38 -0.825 . . . . 0.0 110.667 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.54 ' CG ' HD13 ' A' ' 80' ' ' ILE . 2.1 mm-40 -52.47 -30.81 31.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -159.88 162.5 34.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.387 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -76.83 134.2 39.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.583 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' HG ' HG12 ' A' ' 92' ' ' ILE . 1.9 mp -55.75 -39.2 70.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.632 HG22 HD13 ' A' ' 33' ' ' ILE . 2.4 pp -70.28 -17.88 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.141 -0.974 . . . . 0.0 109.566 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -88.78 -13.27 39.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.501 -0.749 . . . . 0.0 110.927 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.69 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.831 -1.168 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.822 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.12 -42.9 97.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 91' ' ' GLY . 3.7 mm -128.94 150.2 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -1.224 . . . . 0.0 111.004 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.69 -38.64 3.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 p30 179.88 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 116.88 69.95 0.42 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.775 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 4.9 mt -101.14 -177.18 3.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -1.151 . . . . 0.0 110.423 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.435 ' C ' HG13 ' A' ' 98' ' ' VAL . 8.0 t -128.46 142.76 50.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.435 HG13 ' C ' ' A' ' 97' ' ' THR . 34.6 m -147.52 146.22 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -90.43 119.37 30.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.908 HD22 HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -76.26 137.96 40.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 p -166.71 132.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.138 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.458 ' CD1' ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.66 137.08 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.396 -0.815 . . . . 0.0 110.251 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 tttt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.272 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mtt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.279 0.561 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.75 63.27 1.64 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 110.186 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 53.1 -178.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.283 -0.886 . . . . 0.0 110.441 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.67 55.18 9.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.6 49.06 1.0 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -96.77 -178.16 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -1.032 . . . . 0.0 110.136 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.91 -54.26 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 110.335 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -102.99 92.03 4.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.399 -0.813 . . . . 0.0 110.42 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.68 -149.35 7.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.17 145.36 43.86 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.691 1.364 . . . . 0.0 110.187 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.05 -175.88 2.14 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.734 1.386 . . . . 0.0 110.589 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -162.05 76.15 2.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.465 -0.772 . . . . 0.0 109.965 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.58 95.55 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.821 1.432 . . . . 0.0 110.568 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 t -94.84 -37.57 11.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 90.31 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -0.846 . . . . 0.0 110.428 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.64 -87.72 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.59 -42.96 0.72 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.704 1.371 . . . . 0.0 110.357 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.77 76.04 8.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 0.0 110.255 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.64 164.83 11.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.74 133.78 34.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -81.74 -29.64 32.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.867 . . . . 0.0 110.146 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.95 -147.93 5.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 19.8 m -144.38 107.78 4.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -1.09 . . . . 0.0 110.124 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . 58.42 165.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.462 -0.774 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -168.93 87.69 0.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . 55.31 175.97 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.325 -0.859 . . . . 0.0 110.381 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 46.1 Cg_endo -72.76 63.92 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.741 1.39 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.607 ' HB1' ' ND2' ' A' ' 51' ' ' ASN . . . -165.7 140.16 4.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.367 -0.833 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 1.9 tt0 -112.91 153.56 45.17 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.859 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.825 ' O ' HD12 ' A' ' 32' ' ' ILE . 50.3 Cg_endo -79.2 41.21 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.776 1.408 . . . . 0.0 111.253 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 33' ' ' ILE . 4.4 mmtt -72.43 67.01 0.71 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.825 HD12 ' O ' ' A' ' 30' ' ' PRO . 1.1 mp -58.23 120.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.681 -0.637 . . . . 0.0 110.557 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.942 HD12 HD11 ' A' ' 92' ' ' ILE . 1.6 pt -107.39 159.57 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.829 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -91.75 144.21 25.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.818 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG22 HD23 ' A' ' 87' ' ' LEU . 39.1 t -132.07 113.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.438 -0.789 . . . . 0.0 109.856 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.4 m -98.26 114.67 27.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.309 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.45 127.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.85 . . . . 0.0 110.138 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -92.86 122.55 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.581 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.845 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -121.86 172.43 5.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 110.176 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.8 Cg_endo -68.68 -8.27 22.84 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.69 1.363 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.7 tptm -101.46 -50.55 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 1.8 mt-10 -170.57 -161.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.556 -0.715 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.4 135.98 53.49 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -135.3 135.45 40.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.168 -0.958 . . . . 0.0 110.785 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 1.3 mp0 -92.14 145.75 24.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.45 -0.781 . . . . 0.0 109.75 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -128.29 124.88 37.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.948 . . . . 0.0 110.396 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -90.85 129.22 36.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 108.963 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.5 m -143.27 155.68 61.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.056 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -69.98 122.14 8.76 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.833 1.438 . . . . 0.0 110.409 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.872 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -25.83 -48.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.1 0.476 . . . . 0.0 111.597 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.607 ' ND2' ' HB1' ' A' ' 28' ' ' ALA . 14.6 p-10 -86.25 52.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 t -109.13 111.48 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -64.07 144.19 57.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.949 HG11 ' HA ' ' A' ' 82' ' ' LYS . 85.4 t -59.12 -35.02 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.41 -44.51 35.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.015 -1.053 . . . . 0.0 110.479 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -69.32 -49.75 52.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.13 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 35' ' ' VAL . 7.0 t80 -63.21 -37.52 87.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.442 -0.786 . . . . 0.0 110.41 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.09 -39.54 78.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.4 -23.1 60.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.49 -0.757 . . . . 0.0 110.278 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.89 81.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.184 -0.948 . . . . 0.0 109.992 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -34.95 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 110.174 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 66' ' ' LYS . 27.1 p -59.41 -43.91 92.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -58.77 -49.55 77.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.267 -0.896 . . . . 0.0 111.014 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -53.11 15.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.156 -0.965 . . . . 0.0 110.828 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 39' ' ' THR . 23.8 m-85 -67.54 -37.08 82.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 0.0 110.23 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' SER . 5.4 tttt 63.76 79.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.446 -0.784 . . . . 0.0 110.138 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.3 t -155.43 -62.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.592 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.3 pt20 -168.52 -165.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 110.137 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -155.11 -44.0 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.863 . . . . 0.0 110.382 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -58.34 -62.49 1.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.839 ' O ' HG23 ' A' ' 73' ' ' VAL . 19.3 mt-30 -70.84 -25.75 62.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.805 . . . . 0.0 110.041 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.848 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -55.76 100.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 0.0 110.396 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.862 HG22 ' HD2' ' A' ' 82' ' ' LYS . 40.3 t -124.68 167.77 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.797 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 4.9 mp -124.44 118.86 27.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.433 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 79' ' ' LYS . 5.5 tp -82.93 104.85 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.729 ' CD1' HG12 ' A' ' 98' ' ' VAL . 15.1 t80 -116.02 136.19 53.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 110.32 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.3 26.73 4.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.374 -0.829 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.67 24.4 70.17 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.809 ' O ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -125.83 -169.77 2.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.41 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 1.1 pp -104.96 82.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.85 HD21 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -62.92 92.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.994 -1.067 . . . . 0.0 108.584 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.949 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.0 ttpt -153.95 -143.29 0.13 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.362 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 34.8 p-10 -72.08 -18.71 61.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -53.7 -32.84 53.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.864 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -147.88 163.67 36.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.582 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -87.19 158.7 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.85 HD11 HD21 ' A' ' 81' ' ' LEU . 1.1 mp -66.42 -46.55 76.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.872 HG21 ' HG2' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -63.31 -17.49 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.045 . . . . 0.0 109.985 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.04 -15.41 24.82 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 110.884 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.83 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.897 -1.127 . . . . 0.0 111.947 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.75 -50.15 70.35 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.942 HD11 HD12 ' A' ' 33' ' ' ILE . 2.7 pp -152.19 160.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -1.008 . . . . 0.0 108.873 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 0.7 OUTLIER -110.27 -28.31 8.67 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.165 -0.959 . . . . 0.0 109.607 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 33.4 t70 -179.09 36.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.562 -0.711 . . . . 0.0 110.026 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.16 69.89 0.51 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.24 173.37 6.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.402 -1.057 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.4 p -111.86 130.77 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 110.105 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 81' ' ' LEU . 34.2 m -127.41 150.35 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.766 ' O ' HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -90.78 133.75 34.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.106 -0.996 . . . . 0.0 110.03 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.848 HD11 HD21 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -86.92 134.67 33.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.242 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.7 p -149.41 125.78 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.4 pp -96.47 131.78 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.336 -0.852 . . . . 0.0 110.185 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.223 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ttp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.198 0.523 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.83 -43.28 10.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -162.99 164.47 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -133.77 32.55 3.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.85 . . . . 0.0 110.274 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.18 77.42 0.34 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 51.88 -175.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.386 -1.067 . . . . 0.0 110.593 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.37 -165.75 1.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.37 -0.831 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -118.55 27.1 9.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.308 -0.87 . . . . 0.0 110.322 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.3 159.19 32.06 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 148.05 43.04 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.906 1.477 . . . . 0.0 110.403 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.01 157.75 46.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.677 1.356 . . . . 0.0 110.385 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.08 137.39 6.21 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.77 100.12 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.655 1.345 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 86.0 p -84.16 116.47 22.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -94.48 -73.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.844 . . . . 0.0 110.279 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.85 91.22 0.08 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.15 81.76 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.632 1.333 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.2 96.7 5.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.435 -0.791 . . . . 0.0 110.247 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.66 81.69 5.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.142 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.43 45.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 110.22 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.62 -172.67 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.72 134.86 7.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -154.71 33.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -1.107 . . . . 0.0 110.235 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.07 162.02 35.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.08 56.02 0.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.8 113.64 41.84 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.65 126.22 11.26 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.561 1.295 . . . . 0.0 110.398 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.23 -166.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.114 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -136.13 64.44 54.37 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.81 ' O ' HD12 ' A' ' 32' ' ' ILE . 51.2 Cg_endo -82.77 30.0 0.54 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 0.0 111.293 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -70.6 66.3 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 30' ' ' PRO . 2.0 mp -58.71 118.2 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.701 -0.624 . . . . 0.0 110.56 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 pt -93.55 147.17 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -91.47 144.8 25.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 110.114 -179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 46' ' ' PHE . 14.0 m -140.81 136.49 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -107.7 117.37 33.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 0.0 110.214 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 44' ' ' GLU . 33.6 m -98.3 130.7 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.828 . . . . 0.0 110.249 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.99 122.67 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 110.0 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.916 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.1 p -127.09 166.16 24.4 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.11 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.49 61.12 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.728 1.383 . . . . 0.0 110.374 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.29 -47.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.13 -177.94 2.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 110.262 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -117.33 136.63 52.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.847 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -135.09 128.01 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.64 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 2.0 mp0 -84.05 149.5 26.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.34 -0.85 . . . . 0.0 109.796 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 2.1 m-85 -129.75 124.16 32.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.67 125.83 35.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.195 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 33.8 m -143.21 151.57 55.6 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.22 -0.925 . . . . 0.0 109.888 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.2 Cg_endo -69.23 121.71 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.915 1.482 . . . . 0.0 110.743 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -27.89 -46.66 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.244 0.545 . . . . 0.0 111.566 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.76 52.38 2.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 17.8 t -112.81 124.5 52.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -0.817 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 m -71.19 144.55 50.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG11 ' HA ' ' A' ' 82' ' ' LYS . 64.9 t -62.43 -34.55 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.925 . . . . 0.0 110.939 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -48.24 -44.07 32.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 110.873 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -53.77 21.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.009 . . . . 0.0 110.0 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.84 -37.27 78.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.487 -0.758 . . . . 0.0 110.255 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.637 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.76 -39.77 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.601 -0.687 . . . . 0.0 110.01 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -75.04 -21.89 58.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 110.318 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -41.94 82.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.965 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 ' CG1' ' CE2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -63.87 -33.2 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.718 . . . . 0.0 110.225 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.5 t -64.03 -43.95 94.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.452 -0.78 . . . . 0.0 110.509 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.91 -50.66 72.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.863 . . . . 0.0 110.936 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -69.61 -53.01 20.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.916 ' CE2' HG21 ' A' ' 39' ' ' THR . 15.1 m-30 -67.46 -37.06 82.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.263 -0.898 . . . . 0.0 110.315 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.17 78.16 0.3 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.332 -0.855 . . . . 0.0 109.971 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 p -156.1 -66.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.509 -0.744 . . . . 0.0 110.105 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.42 -175.03 3.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.793 . . . . 0.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -154.78 -40.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.09 -64.57 0.8 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.596 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.787 ' O ' HG13 ' A' ' 73' ' ' VAL . 88.7 mm-40 -78.48 -25.78 45.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 100' ' ' LEU . 5.7 tt -56.86 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.395 -0.816 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.807 HG12 ' CD ' ' A' ' 82' ' ' LYS . 26.0 m -109.76 163.12 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 3.5 mp -112.21 118.98 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.037 -1.039 . . . . 0.0 109.198 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 77' ' ' ALA . 50.1 mm -78.27 103.19 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 110.628 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 53.6 t80 -69.83 65.78 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.557 -0.714 . . . . 0.0 110.003 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 53.74 24.26 4.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.244 -0.91 . . . . 0.0 110.409 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.87 -47.16 0.82 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -161.43 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.326 -1.102 . . . . 0.0 110.274 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.89 85.23 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.397 -0.814 . . . . 0.0 110.423 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 74' ' ' LEU . 3.3 tt -61.84 93.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.921 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.3 ttpm? -159.16 -150.08 0.23 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.639 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 9.0 p-10 -73.0 -19.22 61.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.402 -0.811 . . . . 0.0 110.527 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -52.81 -32.44 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 109.896 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -151.39 150.4 30.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.33 151.41 44.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.768 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.677 HD23 HG11 ' A' ' 35' ' ' VAL . 1.1 mp -59.17 -46.08 89.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CG2' HD13 ' A' ' 33' ' ' ILE . 1.2 pp -63.48 -18.42 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 109.788 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 90' ' ' HIS . 50.8 tt0 -91.2 -16.52 27.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 0.2 OUTLIER 177.97 -27.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.95 -1.094 . . . . 0.0 111.799 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.655 ' HA3' HD12 ' A' ' 87' ' ' LEU . . . -58.66 -50.22 69.4 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 33' ' ' ILE . 2.8 pp -148.12 175.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.231 -1.158 . . . . 0.0 109.143 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 3.1 m170 -123.45 -36.09 2.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 110.13 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 37.4 t70 -179.76 36.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 109.861 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 122.08 65.6 0.23 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 168.9 9.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -1.099 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -112.19 134.71 53.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 74' ' ' LEU . 14.6 p -123.97 157.61 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.34 139.48 30.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -105.49 122.3 45.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 100' ' ' LEU . 87.9 t -148.68 129.85 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.427 HG13 ' CB ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -107.17 132.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 109.911 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.248 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tpp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.11 0.481 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.19 162.96 28.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.386 -0.821 . . . . 0.0 110.153 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.67 -42.78 1.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.243 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -67.87 95.38 0.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.233 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.03 156.57 28.57 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -92.09 -172.79 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -1.04 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 t -128.68 -41.09 1.52 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.0 p -59.42 142.76 51.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.314 -0.866 . . . . 0.0 110.282 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.05 88.47 1.9 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.55 135.12 23.57 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.691 1.364 . . . . 0.0 110.469 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 -161.78 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.683 1.359 . . . . 0.0 110.272 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -52.12 -55.43 31.18 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 110.662 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 46.4 Cg_endo -73.64 175.55 10.56 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.587 1.309 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -145.48 156.92 44.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 51.96 -170.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.426 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.9 132.49 11.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.98 62.76 4.97 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.531 1.279 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.97 117.86 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.24 21.53 11.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.29 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.49 83.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -118.0 -72.4 0.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.249 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.46 -134.02 11.98 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -145.63 105.37 3.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.396 -1.061 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.15 -160.23 0.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.49 -27.63 14.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 110.253 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -143.67 174.35 3.66 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.751 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 46.6 Cg_endo -72.72 179.58 5.1 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.821 1.432 . . . . 0.0 110.485 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.97 76.13 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -130.5 148.43 69.93 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.315 -0.866 . . . . 0.0 110.231 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 31' ' ' LYS . 47.0 Cg_endo -72.68 -92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.736 1.388 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 30' ' ' PRO . 9.3 mmtt 44.97 42.28 6.14 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 2.7 mp -58.28 100.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.222 0.534 . . . . 0.0 110.791 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.824 HD12 ' HB ' ' A' ' 92' ' ' ILE . 5.2 pt -81.62 161.03 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.331 -0.855 . . . . 0.0 109.872 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.54 144.36 31.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.336 -0.853 . . . . 0.0 110.52 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 92' ' ' ILE . 8.4 p -137.59 114.11 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.0 109.992 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.748 HG23 ' OE1' ' A' ' 45' ' ' GLU . 3.2 m -80.92 110.28 16.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.98 127.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.455 -0.778 . . . . 0.0 110.051 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -108.85 122.54 47.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.794 HG22 HD13 ' A' ' 100' ' ' LEU . 23.1 p -126.84 166.81 20.01 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.436 -0.79 . . . . 0.0 109.836 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 42.3 Cg_endo -69.04 -12.27 33.83 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.698 1.368 . . . . 0.0 110.57 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -40.76 10.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -172.35 -173.14 1.02 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.72 114.92 14.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.771 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -135.34 135.5 40.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 110.826 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -78.82 151.41 31.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.476 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.68 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.6 m-85 -126.09 116.16 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 110.684 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.48 123.38 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.817 . . . . 0.0 108.935 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 34.7 m -143.21 155.06 61.75 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.144 -0.972 . . . . 0.0 110.006 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 50' ' ' GLU . 41.8 Cg_endo -68.72 122.52 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.967 1.509 . . . . 0.0 110.836 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.555 ' HG2' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -30.0 -44.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.871 0.367 . . . . 0.0 111.858 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 49' ' ' PRO . 51.5 p-10 -78.33 43.4 0.46 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.023 -1.048 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -111.56 100.69 9.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.136 -0.977 . . . . 0.0 110.016 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -62.22 164.45 6.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.146 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.948 HG21 ' O ' ' A' ' 82' ' ' LYS . 42.5 t -67.78 -35.32 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.824 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.48 -43.42 34.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.637 -1.29 . . . . 0.0 109.926 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -80.75 -37.47 30.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.326 -0.858 . . . . 0.0 110.361 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 35.4 t80 -70.08 -51.18 33.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.53 -42.32 82.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 109.738 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.494 ' HA ' HG23 ' A' ' 69' ' ' THR . 8.7 mt-10 -65.9 -25.85 67.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 109.917 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' PHE . . . -67.22 -44.65 79.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 13.7 mt -60.85 -39.67 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.0 109.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.608 ' CB ' ' HG1' ' A' ' 69' ' ' THR . 3.1 m -53.57 -53.05 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.016 -1.053 . . . . 0.0 110.597 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -68.5 -53.92 20.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.331 -0.855 . . . . 0.0 111.655 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.86 -54.11 11.12 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.029 -1.044 . . . . 0.0 111.475 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -68.03 -36.61 80.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.223 -0.923 . . . . 0.0 110.21 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tptt 68.53 81.33 0.18 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -159.92 -71.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.778 . . . . 0.0 110.07 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.8 -170.14 3.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.608 ' HG1' ' CB ' ' A' ' 62' ' ' SER . 4.1 m -153.63 -48.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.377 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.21 -67.23 0.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 73' ' ' VAL . 51.6 mt-30 -61.19 -25.71 67.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.396 -0.815 . . . . 0.0 110.376 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 HG22 ' A' ' 102' ' ' ILE . 10.3 tp -61.86 108.4 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.534 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 71' ' ' GLN . 90.7 t -127.86 156.85 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.617 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 100' ' ' LEU . 10.3 mt -113.51 142.79 45.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.224 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.552 ' C ' HG23 ' A' ' 98' ' ' VAL . 49.7 mm -104.94 89.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.426 -0.796 . . . . 0.0 110.385 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HZ ' HD22 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -78.09 83.54 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 51.06 63.13 2.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.404 -0.81 . . . . 0.0 110.631 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.22 -52.11 3.78 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -59.81 174.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -1.071 . . . . 0.0 110.23 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -117.14 99.23 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.836 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CA ' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -65.9 79.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.948 ' O ' HG21 ' A' ' 54' ' ' VAL . 8.6 tttt -146.21 -162.31 1.5 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.592 -0.693 . . . . 0.0 110.761 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 29.8 t70 -70.77 -14.26 62.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.649 -0.657 . . . . 0.0 110.298 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.432 ' CB ' HD13 ' A' ' 80' ' ' ILE . 1.2 mm-40 -52.06 -31.22 29.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.801 . . . . 0.0 109.756 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -147.87 -176.04 5.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.416 -0.802 . . . . 0.0 109.969 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 88' ' ' ILE . 73.4 p -102.69 157.04 17.22 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.069 -1.02 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 92' ' ' ILE . 6.2 mp -66.18 -29.73 70.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.641 HD12 ' HB ' ' A' ' 86' ' ' THR . 2.3 mt -66.0 -19.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.153 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.9 tp60 -105.7 -10.09 16.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.405 -0.809 . . . . 0.0 112.012 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 178.03 -26.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.554 -1.341 . . . . 0.0 111.525 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -58.74 -37.73 90.53 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.74 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 91' ' ' GLY . 1.4 mm -139.49 175.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -1.147 . . . . 0.0 110.085 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.69 ' HB2' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -147.03 -48.6 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 93' ' ' HIS . 2.2 p30 179.64 35.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.846 -0.533 . . . . 0.0 109.868 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.25 68.29 0.67 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 93' ' ' HIS . 4.8 mp -115.25 175.78 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -1.158 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 36' ' ' THR . 5.0 m -114.66 147.04 40.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 75' ' ' ILE . 5.4 p -139.23 148.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -90.96 115.92 28.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 39' ' ' THR . 2.8 tt -79.24 150.07 31.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.17 -0.956 . . . . 0.0 110.537 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.515 HG12 HG12 ' A' ' 75' ' ' ILE . 9.6 p -169.01 125.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.05 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.798 HG22 HD12 ' A' ' 72' ' ' LEU . 2.5 pp -79.07 132.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 110.192 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.107 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.156 0.503 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.7 -75.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.299 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 52.66 83.26 0.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.317 -0.864 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -85.59 124.96 32.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.7 -112.07 0.99 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -137.67 104.03 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.362 -1.081 . . . . 0.0 110.202 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 m -115.86 39.36 3.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.45 -0.781 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.85 91.16 1.84 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.61 -152.9 0.09 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.61 165.02 33.9 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.728 1.383 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.07 -52.63 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.87 113.34 44.73 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.15 157.72 50.11 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.503 1.265 . . . . 0.0 110.461 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.4 p -150.54 -58.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.129 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 -69.45 0.85 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.323 -0.86 . . . . 0.0 110.143 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.5 -153.95 16.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.91 -50.6 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.761 1.4 . . . . 0.0 110.405 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.2 -171.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.321 -0.862 . . . . 0.0 110.441 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.26 63.14 2.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.34 -0.85 . . . . 0.0 110.548 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.65 93.49 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.179 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -147.36 -70.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.828 . . . . 0.0 110.263 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.03 -88.05 1.32 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -82.01 75.98 8.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -1.083 . . . . 0.0 110.194 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.19 68.6 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 0.0 110.202 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.64 144.03 31.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.81 83.85 1.33 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 104.64 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.813 1.428 . . . . 0.0 110.375 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -116.65 53.41 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -0.831 . . . . 0.0 110.318 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -117.25 90.16 33.2 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' LYS . 48.1 Cg_endo -72.12 -93.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.763 1.402 . . . . 0.0 110.565 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 mttp 44.05 48.26 7.4 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 1.6 mp -57.47 117.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.814 -0.554 . . . . 0.0 110.813 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.706 HG12 HG23 ' A' ' 48' ' ' VAL . 13.1 pt -84.9 157.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.827 . . . . 0.0 109.727 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 92' ' ' ILE . 6.8 mtmt -91.23 143.5 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 92' ' ' ILE . 59.0 t -129.36 113.79 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.479 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.3 m -85.92 98.55 10.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 0.0 109.643 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 98' ' ' VAL . 57.4 t -94.56 127.66 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 110.223 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.86 122.34 46.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.751 HG22 HD13 ' A' ' 100' ' ' LEU . 39.5 p -119.9 164.39 22.51 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 44.1 Cg_endo -71.31 60.85 2.59 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.61 1.321 . . . . 0.0 110.446 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -175.21 -42.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.58 176.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.387 -0.82 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -110.86 126.49 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 109.984 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -135.21 131.2 36.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.71 147.72 25.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.81 . . . . 0.0 109.833 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.15 144.93 48.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 110.281 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -100.25 133.2 45.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.048 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 33' ' ' ILE . 33.2 m -143.6 143.12 22.51 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.234 -0.916 . . . . 0.0 108.853 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' ASN . 41.3 Cg_endo -68.22 127.98 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.622 1.328 . . . . 0.0 111.262 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.572 ' O ' HD13 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -38.46 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.026 179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 49' ' ' PRO . 31.7 t30 -113.36 61.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.772 -1.205 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -154.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.802 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 m -160.43 160.95 32.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.238 -0.914 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.897 HG21 ' O ' ' A' ' 82' ' ' LYS . 59.7 t -61.08 -34.95 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.506 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -49.18 -46.79 45.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.682 -1.261 . . . . 0.0 109.849 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -78.01 -44.56 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 110.353 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.67 ' CG ' HD22 ' A' ' 87' ' ' LEU . 66.1 t80 -63.65 -51.42 65.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.867 . . . . 0.0 110.308 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HB3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -57.98 -31.74 67.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 110.037 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -23.43 35.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.114 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.2 82.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.342 -0.849 . . . . 0.0 110.186 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 4.7 mt -61.01 -36.96 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.6 p -53.85 -49.31 68.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.064 -1.022 . . . . 0.0 110.709 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -68.14 -54.21 19.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 111.521 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -54.09 10.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.092 -1.005 . . . . 0.0 111.406 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 39' ' ' THR . 0.1 OUTLIER -68.16 -36.4 79.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.29 -0.881 . . . . 0.0 110.427 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER 71.79 80.62 0.15 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.535 -0.728 . . . . 0.0 110.094 -179.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.59 -164.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.493 -0.755 . . . . 0.0 109.951 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.39 173.87 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 110.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.6 m -139.46 -52.67 0.54 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.52 -61.36 2.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.866 . . . . 0.0 110.171 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.9 mt-30 -61.15 -25.37 66.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 110.133 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.29 108.01 0.22 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.419 -0.801 . . . . 0.0 110.779 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' HD2' ' A' ' 82' ' ' LYS . 65.7 t -127.49 137.07 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.575 -0.703 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 5.5 mp -108.4 155.94 19.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.927 -1.108 . . . . 0.0 109.701 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.23 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.961 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 77' ' ' ALA . 48.3 t80 -69.78 70.64 0.33 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.261 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PHE . . . 28.68 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.895 -0.503 . . . . 0.0 112.283 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.58 -60.41 0.34 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.09 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.631 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -105.66 -160.81 0.77 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -1.174 . . . . 0.0 110.421 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.631 HD13 ' C ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -107.36 111.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.275 -0.89 . . . . 0.0 109.994 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -69.73 74.65 0.42 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.913 ' HD2' HG22 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -130.29 -159.23 0.95 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.37 0.605 . . . . 0.0 109.782 -178.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 13.1 p-10 -73.32 -13.8 61.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -51.95 -32.53 33.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.16 -174.77 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 110.008 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.38 136.88 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.719 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 57' ' ' PHE . 19.1 tp -55.66 -47.84 76.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.185 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 50' ' ' GLU . 2.6 pp -73.74 -15.17 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 111.151 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' THR . 23.3 tt0 -104.71 7.64 34.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.133 -0.98 . . . . 0.0 112.116 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.55 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.634 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.985 ' O ' HD13 ' A' ' 92' ' ' ILE . . . -59.37 -41.7 97.09 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 91' ' ' GLY . 6.2 mm -135.85 131.76 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -1.059 . . . . 0.0 110.7 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 64.7 m170 -96.52 -38.92 9.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.893 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 25.3 t0 -178.44 34.37 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.749 -0.594 . . . . 0.0 109.673 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 112.53 68.12 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -1.134 . . . . 0.0 110.114 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.6 m -111.45 144.47 40.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.505 -0.747 . . . . 0.0 109.844 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 36' ' ' THR . 13.9 m -137.61 136.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.29 115.38 27.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.296 -0.877 . . . . 0.0 110.077 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 HG22 ' A' ' 39' ' ' THR . 3.0 tt -83.2 133.58 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.303 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.7 p -162.39 117.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -78.56 137.01 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.309 -0.869 . . . . 0.0 110.185 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 stop_ save_